<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">8914275</journal-id><journal-id journal-id-type="pubmed-jr-id">1426</journal-id><journal-id journal-id-type="nlm-ta">Crit Rev Toxicol</journal-id><journal-id journal-id-type="iso-abbrev">Crit Rev Toxicol</journal-id><journal-title-group><journal-title>Critical reviews in toxicology</journal-title></journal-title-group><issn pub-type="ppub">1040-8444</issn><issn pub-type="epub">1547-6898</issn></journal-meta><article-meta><article-id pub-id-type="pmid">37431804</article-id><article-id pub-id-type="pmc">10395451</article-id><article-id pub-id-type="doi">10.1080/10408444.2023.2229925</article-id><article-id pub-id-type="manuscript">NIHMS1917928</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Low Level Exposure to Hydrogen Sulfide: A Review of Emissions, Community Exposure, Health Effects, and Exposure Guidelines</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Batterman</surname><given-names>Stuart</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Grant-Alfieri</surname><given-names>Amelia</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Seo</surname><given-names>Sung-Hee</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>a</label>Department of Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, MI, 48109, United States</aff><author-notes><corresp id="CR1"><label>*</label>Corresponding author: Department of Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, MI, 48109, United States, <email>shseo@umich.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>28</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>11</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="pmc-release"><day>11</day><month>7</month><year>2024</year></pub-date><volume>53</volume><issue>4</issue><fpage>244</fpage><lpage>295</lpage><abstract id="ABS1"><p id="P1">Hydrogen sulfide (H<sub>2</sub>S) is a toxic gas that is well-known for its acute health risks in occupational settings, but less is known about effects of chronic and low-level exposures. This critical review investigates toxicological and experimental studies, exposure sources, standards, and epidemiological studies pertaining to chronic exposure to H<sub>2</sub>S from both natural and anthropogenic sources. H<sub>2</sub>S releases, while poorly documented, appear to have increased in recent years from oil and gas and possibly other facilities. Chronic exposures below 10 ppm have long been associated with odor aversion, ocular, nasal, respiratory and neurological effects. However, exposure to much lower levels, below 0.03 ppm (30 ppb), has been associated with increased prevalence of neurological effects, and increments below 0.001 ppm (1 ppb) in H<sub>2</sub>S concentrations have been associated with ocular, nasal and respiratory effects. Many of the studies in the epidemiological literature are limited by exposure measurement error, co-pollutant exposures and potential confounding, small sample size, and concerns of representativeness, and studies have yet to consider vulnerable populations. Long-term community-based studies are needed to confirm the low concentration findings and to refine exposure guidelines. Revised guidelines that incorporate both short- and long-term limits are needed to protect communities, especially sensitive populations living near H<sub>2</sub>S sources.</p></abstract><kwd-group><kwd>hydrogen sulfide</kwd><kwd>chronic</kwd><kwd>environmental</kwd><kwd>epidemiology</kwd><kwd>occupational</kwd></kwd-group></article-meta></front><body><sec id="S1"><label>1</label><title>Introduction</title><sec id="S2"><label>1.1</label><title>Background</title><p id="P2">Hydrogen sulfide (H<sub>2</sub>S) is a toxic gas also known as dihydrogen monosulfide, dihydrogen sulfide, hydrosulfuric acid, sewer gas, stink damp, sulfur hydride, and sulfureted hydrogen. Exposure to high concentrations of H<sub>2</sub>S has been considered a serious risk in occupational settings for hundreds of years (e.g., <xref rid="R84" ref-type="bibr">Fuller and Suruda 2000</xref>; <xref rid="R92" ref-type="bibr">Guidotti 2010</xref>, <xref rid="R93" ref-type="bibr">1996</xref>; <xref rid="R129" ref-type="bibr">Lambert et al. 2006</xref>; <xref rid="R156" ref-type="bibr">NIOSH 1978</xref>), and is the second most common cause of fatal gas inhalation exposure in the workplace, second only to carbon monoxide (<xref rid="R92" ref-type="bibr">Guidotti 2010</xref>). A recent and disturbing trend is deliberate H<sub>2</sub>S poisoning, which in Japan caused 208 fatalities in 220 suicide attempts over a 100 day period in 2008 using &#x0201c;homemade&#x0201d; H<sub>2</sub>S gas and information disseminated by social media (<xref rid="R153" ref-type="bibr">Morii et al. 2010</xref>).</p><p id="P3">The dose-response relationship for mortality from acute, high-level exposure of H<sub>2</sub>S is reasonably well understood. Less is known about the health impacts of chronic, low-level exposures and exposure-response relationships for morbidity, the focus of this review. Community exposure to H<sub>2</sub>S and other reduced sulfur compounds, which is common around industrial, agricultural and natural sources that emit these gases, mostly occurs concentrations below 0.1 ppm, much lower than in occupational settings. Community exposure has long been considered a nuisance issue. Because people living near H<sub>2</sub>S-emitting facilities can experience long-term exposures and frequently have health, racial, socioeconomic, and other disparities that can increase their vulnerability and susceptibility to pollutants, H<sub>2</sub>S exposures and health impacts are an environmental justice issue.</p></sec><sec id="S3"><label>1.2</label><title>H<sub>2</sub>S sources</title><p id="P4">H<sub>2</sub>S is emitted at numerous locations from a variety of sources. These include naturally occurring geothermal and volcanic sources where emissions cannot be altered, and anthropogenic sources such as confined animal feeding operations (CAFOs), oil and gas facilities, paper mills, and wastewater plants where emissions can be controlled using standards, operation practices, and administrative and engineering controls. Geothermal and volcanic sources produce H<sub>2</sub>S by hydrolysis of sulfide minerals (<xref rid="R142" ref-type="bibr">Ma et al., 2019</xref>). Industrial source such as petroleum refineries release H<sub>2</sub>S present in the feedstock (e.g., sour gas) and from the hydrodesulfurization process which generates H<sub>2</sub>S prior to removing sulfur from the petroleum product by partial combustion via the Claus process (<xref rid="R93" ref-type="bibr">Guidotti, 1996</xref>). In sewers, tanneries, Kraft pulping and paper mills, landfills and waste lagoons (as found at CAFOs) where anaerobic conditions occur, reduced sulfur gases including H<sub>2</sub>S but also methyl mercaptan (CH<sub>3</sub>SH), dimethyl sulfide (CH<sub>3</sub>)<sub>2</sub>S and dimethyl disulfide (CH<sub>3</sub>)<sub>2</sub>S<sub>2</sub> are produced by sulfate reducing bacteria that decompose sulfur-containing organic constituents (<xref rid="R93" ref-type="bibr">Guidotti, 1996</xref>); Rava et al. 2008).</p><p id="P5">Trends of airborne and non-air H<sub>2</sub>S emissions in the USA are shown in <xref rid="F1" ref-type="fig">Figure 1</xref>, based on industry-provided data reported to the U.S. Environmental Protection Agency (EPA) Toxic Release Inventory (TRI) System since 2012 when reporting was first required (<xref rid="R67" ref-type="bibr">EPA 2020</xref>). (<xref rid="S4" ref-type="sec">Section 1.3</xref> following describes the inclusion of H<sub>2</sub>S in the TRI.) Most H<sub>2</sub>S releases reported to TRI are emissions to air (9114 tons/year), equal to 65% of reported releases in the U.S. averaged over the last three years. Industrial sectors responsible for most air emissions include the paper industry (5367 tons/year, 54% of total air emissions), chemical industry (1889 tons/year, 21%), and the oil/gas industry including extraction (914 tons/year, 10%). Other economic sectors include the food sector, which has only a small share of H<sub>2</sub>S releases (384 tons/year, 4% of airborne emissions), and agriculture. Notably, agricultural sources like CAFOs, are not required to report to the TRI. Our &#x0201c;high-end&#x0201d; H<sub>2</sub>S emission estimates for CAFOs, discussed below, could double emissions to air. Overall, airborne emissions from the industries covered in TRI appear to have slightly decreased in recent years. In contrast, H<sub>2</sub>S releases to other media, such as wastewater, increased from 2012 to 2018 due to growth in the oil/gas sector, which is responsible for most non-air releases (<xref rid="R67" ref-type="bibr">EPA 2020</xref>). While <xref rid="F1" ref-type="fig">Figure 1</xref> does not directly represent exposures or health effects, and TRI information itself has uncertainties and omissions (e.g., agricultural and geothermal sources are not included), the emission trends show continuing emissions and increases in some sectors, supporting the need to understand H<sub>2</sub>S exposures and health implications.</p><p id="P6">The existing health literature focuses on a subset of H<sub>2</sub>S sources: geothermal or volcanic sources, concentrated animal feeding operations (CAFOs), pulp or paper mills, and wastewater facilities. As detailed later in this review, exposure and health studies examining the top industrial sources (oil and gas extraction, chemical, and petroleum industries) are limited, while the number of studies examining agricultural sources, specifically CAFOs, is growing.</p><p id="P7">National-level H<sub>2</sub>S emission information from agribusiness was not identified. We attempt a rough and preliminary estimate of CAFO H<sub>2</sub>S emissions by estimating the surface area of waste lagoons where most releases occur, then multiply this area by the H<sub>2</sub>S flux rate (emission per time per surface area of waste lagoon). Because a national total for lagoon surface area was not identified, we considered the number of swine in the U.S. (72.2 million, <xref rid="R210" ref-type="bibr">USDA 2022</xref>), the optimal lagoon area (approximately 285 ft<sup>2</sup>/AU across a range of animal ages, where AU = animal unit (AU) or 1000 lbs (453.6 kg) live weight; <xref rid="R45" ref-type="bibr">Chastain and Henry 2002</xref>), and assume a weight of 55 lb (25.0 kg) per animal; together this gives 1.05 &#x000d7; 10<sup>8</sup> m<sup>2</sup> of swine waste lagoons. Available measurements of H<sub>2</sub>S fluxes from lagoons are limited and highly variable, e.g., <xref rid="R180" ref-type="bibr">Rumsey and Aneja (2014)</xref> used a flux chamber to estimate an average winter and summer flux (0.0324 &#x003bc;g/m<sup>2</sup>-s) at one CAFO in North Carolina (NC), and <xref rid="R89" ref-type="bibr">Grant et al. (2013)</xref> used air monitoring coupled with inverse dispersion modeling to estimate long-term fluxes (0.218, 2.148 and 3.849 &#x003bc;g/m<sup>2</sup>-s) at three CAFOs in NC, Indiana and Oklahoma. These flux rates with the estimated lagoon area give a very large range for U.S. emissions: 107 to 12,760 tons/year. The low estimate, based on flux chamber measurements, may incompletely represent mixing processes that might increase emissions; the high estimate, based on inverse modeling, has considerable uncertainty; both may incompletely represent seasonal variation, among other limitations. Overall, the flux rate estimates lack representativeness, a result of the small number of CAFOs tested and strong dependences on the temperature, sulfide content, mixing and pumping activity in the lagoon, wind speed, season, time of day, precipitation, and other factors. In consequence, we cannot provide a reasonably accurate total for CAFO emissions. Because H<sub>2</sub>S exposure tends to occur near sources, local conditions are critical. At large waste lagoons (e.g., exceeding 20,000 m<sup>2</sup> in area), annual H<sub>2</sub>S emissions may approach 3 tons/year, and short-term emission rates may be considerably higher (<xref rid="R89" ref-type="bibr">Grant et al. 2013</xref>).</p></sec><sec id="S4"><label>1.3</label><title>Overview of regulations</title><p id="P8">There is a long and somewhat contorted history of H<sub>2</sub>S regulation in the U.S. (e.g., <xref rid="R232" ref-type="bibr">Woodall et al. 2005</xref>). In brief, the U.S. Congress removed H<sub>2</sub>S as a hazardous air pollutant (HAP) under Title III of the 1990 Clean Air Amendments under pressure from industry (e.g., the American Petroleum Institute; <xref rid="R154" ref-type="bibr">Morris 1997</xref>) and the perception that its major impact was nuisance (<xref rid="R120" ref-type="bibr">Kilburn et al. 2010</xref>). In its 1993 Report to Congress, the U.S. Environmental Protection Agency (EPA) concluded that there was no evidence that routine releases from the oil and gas industry posed a significant public health or environmental threat and that no legislative action for accidental releases was warranted (<xref rid="R76" ref-type="bibr">EPA, 1993a</xref>). EPA&#x02019;s health assessment at that time noted some neurological, respiratory and irritation associated with H<sub>2</sub>S exposures below 0.02 ppm, and the lack of long-term and low level epidemiological studies (<xref rid="R77" ref-type="bibr">EPA 1993b</xref>). As part of its final rule, EPA added H<sub>2</sub>S to the Emergency Planning and Community Right-to-Know Act (EPCRA) Section 313 toxic chemical release reporting (TRI) requirements on December 1, 1993, on the basis of chronic neurotoxicity in humans and acute aquatic toxicity. On August 22, 1994, EPA issued an Administrative Stay of the EPCRA reporting requirements for H<sub>2</sub>S to evaluate issues brought to the Agency&#x02019;s attention after promulgation of the final rule, which concerned the human health effects basis for the listing and the Agency&#x02019;s use of exposure analyses in TRI listing decisions (<xref rid="R71" ref-type="bibr">EPA 2011</xref>). This occurred despite recommendations by the Agency for Toxic Substance Diseases and Registry (ATSDR), the federal public health agency established to address chemical exposures, in their draft Toxicological Profile for H<sub>2</sub>S to set a reference concentration (RfC) of 0.010 ppm. In 1996, H<sub>2</sub>S became subject to the Risk Management Program rule under section 112(r) of the Clean Air Act, a state-administered program that applies to many facilities if a short-term emergency release of H<sub>2</sub>S can exceed 10,000 lbs (4536 kg), however, this limit would not apply to most sources since H<sub>2</sub>S is not stored or accumulated. In 2003, the EPA derived an inhalation RfC for chronic exposure of 0.0015 ppm (2 &#x003bc;g/m<sup>3</sup>), based on a no observed adverse effects level (NOAEL) of 10 ppm and a lowest observed adverse effects level (LOAEL) of 30 ppm for nasal lesions. On February 26, 2010, EPA published a notice in the Federal Register (FR) that provided an opportunity for public comment on its review of the available data on the human health and environmental effects of H<sub>2</sub>S and EPA&#x02019;s belief that, based on those data, the administrative stay should be lifted (EPA 2010). The FR notice addressed the concerns raised regarding the exposure analyses in the TRI listing decisions, essentially indicating that exposure analyses need not be considered given the moderate-to-high chronic toxicity of H<sub>2</sub>S. EPA (2010) determined that H<sub>2</sub>S can reasonably be anticipated to cause serious or irreversible chronic human health effects at relatively low doses and thus is considered to have moderately high to high chronic toxicity, and that it is not appropriate to consider exposure for such chemicals assessment when determining a listing for chronic health effects pursuant to EPCRA Section 313(d)(2)(B) (see 59 FR 61432, 61433, 61440&#x02013;61442). Although beyond the scope of this review, EPA also determined that H<sub>2</sub>S causes ecotoxicity at relatively low concentrations and thus it is not required to consider its exposure when determining listings pursuant to EPCRA Section 313(d)(2)(C) (see 59 FR 61432, 61433, 61440&#x02013;61442). On October 17, 2011, EPA published a FR notice that it was lifting the Administrative Stay of the TRI reporting requirements, and it summarized and responded to comments received regarding the previous FR notice (<xref rid="R71" ref-type="bibr">EPA 2011</xref>). In brief, EPA concluded that H<sub>2</sub>S can reasonably be anticipated to cause chronic health effects in humans and significant adverse effects in aquatic organisms, and reiterated that an exposure assessment was not required to meet TRI listing criteria. Listed chronic human health effects included both upper respiratory tract toxicity (e.g., nasal lesions) and neurotoxicity. The notice references a controlled study of perception and neurological impacts and two dosimetry studies. The effect of lifting the stay was to once again include H<sub>2</sub>S on the TRI list of reportable chemicals under EPCRA Section 313 (40 CFR Part 372, Subpart D) beginning with the 2012 reporting year, as illustrated earlier in <xref rid="F1" ref-type="fig">Figure 1</xref> which trended reported H<sub>2</sub>S emissions. Other regulatory levels are described in <xref rid="S74" ref-type="sec">Section 4</xref>. While H<sub>2</sub>S remains off the EPA HAP list, which would require source controls and limit ambient exposure, several states have pursued regulatory programs for H<sub>2</sub>S or total reduced sulfur (TRS) compounds (<xref rid="R232" ref-type="bibr">Woodall et al. 2005</xref>).</p><sec id="S5"><label>1.3.1</label><title>Rationale and context</title><p id="P9">This report builds upon prior reviews, which noted the inconsistent evidence regarding health effects and the need for more robust exposure assessments (<xref rid="R134" ref-type="bibr">Lewis and Copley 2015</xref>; <xref rid="R136" ref-type="bibr">Lim et al. 2016</xref>; <xref rid="R178" ref-type="bibr">Roth and Goodwin 2003</xref>; <xref rid="R199" ref-type="bibr">Skrtic 2006</xref>). The most recent review, conducted by Exxon Mobil, found that chronic low-level H<sub>2</sub>S was associated with temporary respiratory impairment and possible ocular and neurological effects (<xref rid="R134" ref-type="bibr">Lewis and Copley 2015</xref>). A review of neurological and respiratory health in occupational and community settings found inconsistent associations (<xref rid="R136" ref-type="bibr">Lim et al. 2016</xref>). An earlier review examining communities near oil and gas facilities found that chronic exposure to low concentrations of H<sub>2</sub>S was associated a range of with neurological symptoms, including fatigue, impaired memory, altered moods, headaches and dizziness (<xref rid="R199" ref-type="bibr">Skrtic 2006</xref>). However, low-level H<sub>2</sub>S exposures in community settings from sources such as oil and gas facilities, CAFOs and landfills are typically experienced as mixtures of contaminants, and unless the mixture components are sufficiently characterized to minimize the likelihood of confounding in health studies, epidemiological findings may be compromised. The potential for this problem is suggested by conflicting results obtained by the few studies using controlled exposures. These and other issues affecting the understanding of low-level exposures are not unique to H<sub>2</sub>S, but their importance and implications should be recognized. Having identified the need for more comprehensive analyses of health effects and emission sources, we take an interdisciplinary approach, contextualizing epidemiological studies with toxicology, exposure science, and regulatory perspectives, to better understand the significance of chronic, low-level and community-wide exposures.</p></sec></sec><sec id="S6"><label>1.4</label><title>Objective and approach</title><p id="P10">This report examines the recent literature pertaining to health effects caused by the inhalation of hydrogen sulfide (H<sub>2</sub>S) gas, focusing on effects at low exposure levels that are relevant to community exposure. We seek to gather and critically assess evidence of community exposure to H<sub>2</sub>S, identify culpable emission sources, and analyze human health effects associated with chronic exposure to H<sub>2</sub>S at low concentrations. We specifically focus on literature relevant to low-level community exposure to assess the minimum exposure levels associated with adverse health effects, although we also consider low-level occupational exposures given its relevance to understanding chronic health effects. We define low level exposures as H<sub>2</sub>S concentrations below 0.1 ppm, medium level as between 0.1 and 1 ppm, and high level exposures as above 1 ppm. These limits are flexible given the importance of exposure duration and the variation of concentrations that may be measured or estimated in any particular study. An important distinction, however, is that the low and medium-level categories are distinctly lower than current standards or guidelines for workplace settings, which mostly range from 1 to 50 ppm.</p><p id="P11">The review is designed to reflect our current understanding of the effects of low level H<sub>2</sub>S exposure, as based on published papers, reports and other materials prioritized as follows.</p><list list-type="bullet" id="L2"><list-item><p id="P12"><underline>Articles.</underline> Recent, published, peer-reviewed studies in the literature were the primary data source.</p></list-item><list-item><p id="P13"><underline>Reviews</underline>. The health effects of H<sub>2</sub>S have been the subject of many previous reviews. Many of these are authored by well-known authorities, such as U.S. Environmental Protection Agency (EPA), U.S. Agency for Toxic Disease and Registry (ATSDR), and the World Health Organization (WHO), while others have been commissioned by governmental authorities and industry. Reviews were primarily used to summarize older literature and to identify key studies (typically older studies), which were then examined. Key assumptions and statements in the reviews were verified by reference to the original articles.</p></list-item><list-item><p id="P14"><underline>Abstracts, conference papers, dissertations, industry studies, and presentations.</underline> These sources were reviewed, but published peer-reviewed articles were given priority.</p></list-item><list-item><p id="P15"><underline>Dates of publications</underline>. This review focuses on the recent H<sub>2</sub>S literature, beginning in 2004. Previous reviews were examined for literature prior to this year and, as mentioned, original articles were obtained when applicable.</p></list-item><list-item><p id="P16"><underline>Exposure routes</underline>. While several exposure routes may be relevant, H<sub>2</sub>S exposure is dominated by the inhalation pathway in community settings, as well as in the vast majority of workplaces. Exposures via ingestion (e.g., drinking water) and dermal permeation were excluded from the present review.</p></list-item><list-item><p id="P17"><underline>Nature of exposure</underline>. We focus on low-level and often chronic exposure that is relevant to community (and many workplace) settings. Generally, concentrations in community and most workplace settings fall well below 100 ppm (1,500 &#x003bc;g/m<sup>3</sup>).</p></list-item><list-item><p id="P18"><underline>Units</underline>. H<sub>2</sub>S concentrations are converted to units of parts per million (ppm) at 25 C and 1 bar, which for H<sub>2</sub>S means that 0.001 ppm = 1 ppb = 1.5 &#x003bc;g/m<sup>3</sup> and 1 &#x003bc;g/m<sup>3</sup> = 0.00067 ppm = 0.67 ppb. If concentrations in the original report were provided other units, these are shown in parentheses.</p></list-item></list></sec></sec><sec id="S7"><label>2</label><title>Health effects of exposures to H<sub>2</sub>S</title><p id="P19">Inhalation is the main exposure pathway for the vast majority of exposed communities, although H<sub>2</sub>S can be absorbed through the gastrointestinal tract. H<sub>2</sub>S and its metabolites (e.g., sulfate, thiosulfate) are distributed throughout the body after exposure (<xref rid="R28" ref-type="bibr">Beauchamp et al., 1984</xref>). Considered a broad-spectrum toxicant, H<sub>2</sub>S primarily affects tissues with exposed mucous membranes (eyes, nose) and with high oxygen demand (lungs, brain) (<xref rid="R10" ref-type="bibr">Ammann 1986</xref>; <xref rid="R131" ref-type="bibr">Legator et al. 2001</xref>). H<sub>2</sub>S exposure can cause a wide variety of effects, depending on the concentration, exposure duration, and target tissue, and the literature describes effects on the central nervous, cardiovascular, and gastrointestinal systems. &#x0201c;Primary&#x0201d; toxic effects of H<sub>2</sub>S have been characterized as &#x0201c;knockdown&#x0201d; (acute central neurotoxicity), pulmonary edema, conjunctivitis, and odor perception, followed by olfactory paralysis. &#x0201c;Secondary&#x0201d; effects which accompany or are complications of toxicity that include non-specific symptoms such as headaches, memory loss, and acute and chronic respiratory effects (<xref rid="R92" ref-type="bibr">Guidotti 2010</xref>). Effects of H<sub>2</sub>S exposure can include:</p><list list-type="bullet" id="L4"><list-item><p id="P20"><underline>Asphyxia</underline>. At high concentrations, above roughly 200 to 1000 ppm, H<sub>2</sub>S acts as an asphyxiant, causing instantaneous loss of consciousness, pulmonary edema, hyperpnoea (rapid breathing), rapid apnea (slowed or temporarily stopped breathing), and death.</p></list-item><list-item><p id="P21"><underline>Irritation</underline>. At intermediate concentrations (between 100 and 150 ppm), H<sub>2</sub>S acts as a tissue irritant, causing keratoconjunctivitis (combined inflammation of the cornea and conjunctiva), respiratory irritation with lacrimation (tears), and coughing (<xref rid="R123" ref-type="bibr">Knight and Presnell 2005</xref>). Skin irritation is also common.</p></list-item><list-item><p id="P22"><underline>Neurological effects</underline>. Neurological effects include dizziness, vertigo, agitation, confusion, headache, somnolence, tremulousness, nausea, vomiting, convulsions, dilated pupils, unconsciousness, anosmia (loss of sense of smell), depression and suicide.</p></list-item><list-item><p id="P23"><underline>Cardiovascular and pulmonary effects</underline>. Reported effects include cough, chest tightness, dyspnea (shortness of breath), cyanosis (turning blue from lack of oxygen), cardiac arrhythmia and tachycardia, hemoptysis (spitting or coughing up blood), pulmonary edema (fluid in the lungs), apnea with secondary cardiac effects, and impaired lung function in asthmatics.</p></list-item></list><sec id="S8"><label>2.1</label><title>Health effects at high exposures</title><p id="P24">Short duration and high concentration exposures to H<sub>2</sub>S are a well-known health hazard, and are among the leading causes of sudden death in the workplace (<xref rid="R156" ref-type="bibr">NIOSH 1978</xref>). As mentioned, H<sub>2</sub>S is the second most common cause of fatal gas inhalation exposures in the workplace (<xref rid="R92" ref-type="bibr">Guidotti 2010</xref>). H<sub>2</sub>S exhibits an exceptionally sharp exposure-response curve for lethality (<xref rid="R40" ref-type="bibr">Cantox Environmental 2009</xref>; <xref rid="R234" ref-type="bibr">Zelensky 2009</xref>), which yields a very small margin of safety, in part due to rapid olfactory paralysis and the loss of consciousness, which reduces the chance of flight. For these reasons, escaping from H<sub>2</sub>S exposure can be exceptionally difficult (<xref rid="R93" ref-type="bibr">Guidotti 1996</xref>). Deaths from H<sub>2</sub>S inhalation have occurred in many different workplace and some non-workplace settings, e.g., sewers, animal processing plants, waste dumps, sludge plants, oil and gas well drilling sites, tanks, cesspools, basements, and bathrooms (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>). Confined spaces, where concentrations can reach high levels, are especially dangerous. Given the significance of the hazard, H<sub>2</sub>S awareness training in the workplace has become &#x02013; or should be &#x02013; a regular part of health and safety programs where this gas may be encountered. Brief but high exposure of H<sub>2</sub>S can cause other impacts, e.g., reactive airways distress syndrome (RADS), a variant of occupational asthma (<xref rid="R22" ref-type="bibr">Bardana 1999</xref>; <xref rid="R44" ref-type="bibr">CDC 1993</xref>).</p></sec><sec id="S9"><label>2.2</label><title>Mechanisms of toxicity</title><p id="P25">Mechanisms postulated for the toxicity for H<sub>2</sub>S have been reviewed by <xref rid="R123" ref-type="bibr">Knight and Presnell 2005</xref>; <xref rid="R16" ref-type="bibr">ATSDR 2006</xref>; <xref rid="R92" ref-type="bibr">Guidotti 2010</xref>, and others. One mechanism is direct inhibition of cellular enzymes, in particular, cytochrome c oxidase, the terminal enzyme of oxidative phosphorylation, which impairs aerobic metabolism and results in cellular anoxia and tissue hypoxia (<xref rid="R10" ref-type="bibr">Ammann 1986</xref>). This has been demonstrated by H<sub>2</sub>S concentrations in the range of 5 to 10 ppm, which in humans can cause a shift from aerobic to anaerobic respiration (<xref rid="R31" ref-type="bibr">Bhambhani et al. 1996</xref>; <xref rid="R32" ref-type="bibr">Bhambhani and Singh 1991</xref>). Several mechanisms have been proposed for neurotoxic effects: changes in the membrane and synaptic properties of dorsal raphe serotonergic cells, potentially due to an interaction with free thiols and disulfide bonds present in the membrane proteins; possible inhibition of monoamine oxidase that disrupts neurotransmission in brain stem nuclei controlling respiration (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>); and hypoxia-induced neuronal cell death attributable to cytochrome oxidase inhibition. <xref rid="R80" ref-type="bibr">Fiedler et al. (2008)</xref> notes toxicity due to cellular asphyxiation has been challenged by an animal model of H<sub>2</sub>S-induced apnea after &#x0201c;knockdown&#x0201d; caused by an afferent neural signal from the lung via the vagus nerve, which innervates the viscera and provides information about the state of the body&#x02019;s organs to the central nervous system, rather than a direct effect on the brain stem (<xref rid="R8" ref-type="bibr">Almeida and Guidotti 1999</xref>), and that the persistent neurologic effects among those experiencing acute H<sub>2</sub>S intoxication resulted from hypoxia secondary to respiratory insufficiency, rather than a direct toxic effect on the brain (<xref rid="R149" ref-type="bibr">Milby and Baselt 1999</xref>).</p><p id="P26">H<sub>2</sub>S is present in mammalian tissues at concentrations from the high nmol/L to low &#x003bc;mol/L range (<xref rid="R170" ref-type="bibr">Polhemus and Lefer, 2014</xref>), a result of endogenous production where it appears to serve a number of functions, probably acting as a neuromodulator and/or as an intracellular messenger or signaling molecule in the brain (<xref rid="R166" ref-type="bibr">Olson 2011</xref>; <xref rid="R172" ref-type="bibr">Qu et al. 2008</xref>; <xref rid="R212" ref-type="bibr">Varaksin and Puschina 2011</xref>). Although not currently used, a decreased concentration of H<sub>2</sub>S in expired air has been suggested as a biomarker of inflammation and asthma (<xref rid="R222" ref-type="bibr">Wang et al. 2011</xref>).</p><p id="P27">The details of the mechanisms and toxicity of H<sub>2</sub>S at high concentrations (and case reports and other literature) are beyond our present scope. In brief, however, we note that the most commonly reported nonlethal effect following an acute high concentration exposure is &#x0201c;knockdown&#x0201d;: unconsciousness followed by apparent recovery. While typically unmeasured, rough estimates of concentrations in such events are 500 ppm or more, and the exposure duration is short, typically less than 1 hr (<xref rid="R28" ref-type="bibr">Beauchamp et al. 1984</xref>). Following such exposures, common permanent or persistent neurological effects reported include headaches, poor concentration ability and attention span, short-term memory impairment, and impaired motor function. Brief exposure to still higher concentrations can result in respiratory arrest and/or pulmonary edema. Although exact mechanisms are unknown, rapid respiratory failure and possibly pulmonary edema are secondary contributors to the action of H<sub>2</sub>S on central nervous system depression or tissue hypoxia. Cardiovascular effects (e.g., cardiac arrhythmia and tachycardia) also have been reported following acute exposures. Extensive discussions of toxicity and effects at high concentrations are provided elsewhere (e.g., <xref rid="R16" ref-type="bibr">ATSDR 2006</xref>; <xref rid="R163" ref-type="bibr">OEHHA 2008</xref>; also see review papers cited previously). Interesting and detailed discussions of dose-response and lethality of H<sub>2</sub>S have been developed by Alberta&#x02019;s Energy Resource and Conservation Board (<xref rid="R40" ref-type="bibr">Cantox Environmental 2009</xref>; <xref rid="R234" ref-type="bibr">Zelensky 2009</xref>).</p></sec><sec id="S10"><label>2.3</label><title>Health effects at low and chronic exposures</title><p id="P28">In contrast to short-term (acute) high concentration exposures, it is much more difficult to evaluate effects of long-term (chronic) and low or medium concentration exposures (below 0.1 and 1 ppm, respectively), the focus of <xref rid="S62" ref-type="sec">Section 3</xref> of this report. Most epidemiological (or observational) studies have deficiencies in terms of exposure characterization, e.g., obtaining little if any information on individual-level exposures, exposure patterns, peak exposures, and co-exposures to other contaminants. The paucity and limitations of controlled chronic animal studies also lead to knowledge gaps of low level chronic exposures (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>). Controlled chronic human studies are neither feasible nor ethical. Thus, it is unsurprising that the earlier studies and reviews have inconsistent findings with respect to the nature and significance of chronic low level exposures, leading several reviews to conclude that there is &#x0201c;insufficient&#x0201d; evidence to link low level H<sub>2</sub>S exposures to significant health impacts (<xref rid="R134" ref-type="bibr">Lewis and Copley 2015</xref>; <xref rid="R136" ref-type="bibr">Lim et al. 2016</xref>; <xref rid="R164" ref-type="bibr">OEHHA 2000</xref>; <xref rid="R178" ref-type="bibr">Roth and Goodwin 2003</xref>).</p><p id="P29">A wide range of health effects at H<sub>2</sub>S concentrations below 10 ppm have been reported in both occupational and community settings. For example, <xref rid="R16" ref-type="bibr">ATSDR (2006)</xref> states: &#x0201c;Exposure to lower concentrations of hydrogen sulfide can result in less severe neurological and respiratory effects. Reported neurological effects include incoordination, poor memory, hallucinations, personality changes, and anosmia (loss of sense of smell); the respiratory effects include nasal symptoms, sore throat, cough, and dyspnea. Impaired lung function has also been observed in asthmatics acutely exposed to 2 ppm H<sub>2</sub>S; no alterations in lung function were observed in studies of nonasthmatic workers.&#x0201d; In contrast, <xref rid="R92" ref-type="bibr">Guidotti (2010)</xref> states: &#x0201c;Exposures on the order of 5 to 10 ppm are sometimes encountered in community settings, although they are more common as background in workplaces such as oil refineries. Levels above 1 ppm are very uncommon in the community, where concentrations above the odor threshold (generally above 0.05 ppm for most people) are normally unacceptable and prosecuted as a nuisance. It has been alleged that health effects may be observed at exposures below 1 ppm, but the evidence is weak.&#x0201d; The remainder of this section reviews the recent literature and discusses various health outcomes and symptoms, with the aim of clarifying the dichotomy regarding the occurrence of health effects from low and chronic H<sub>2</sub>S exposures.</p><sec id="S11"><label>2.3.1</label><title>Odor, nuisance and irritation</title><sec id="S12"><label>2.3.1.1</label><title>Odor classification</title><p id="P30">H<sub>2</sub>S is noted for its strong and offensive odor, which resembles rotten eggs. <xref rid="R226" ref-type="bibr">WHO (2006)</xref> and many others observe that H<sub>2</sub>S is often accompanied by other odorous compounds from the same source: kraft mills emit reduced sulfur compounds such as methyl mercaptan, dimethyl disulfide, dimethyl trisulfide, dimethyl sulfide and dimethyl monosulfide; the viscose industry emits carbon disulfide; and CAFOs emit reduced sulfur compounds, VOCs including phenyls (fresh sludge), ammonia (in the absence of H<sub>2</sub>S), dusts and bioaerosols (<xref rid="R34" ref-type="bibr">Blanes-vidal et al. 2009</xref>). Co-pollutants can change the odor quality of the mixture (<xref rid="R160" ref-type="bibr">NRC 1979</xref>).</p><p id="P31">It is important to distinguish between odor detection, odor recognition, odor threshold, olfactory fatigue, and olfactory paralysis. In community settings, the literature shows a degree of consistency with respect to odor detection and nuisance thresholds for acute exposures (30 min to 24 hr) at concentrations in the range of 0.0001 to 0.05 ppm.</p><list list-type="bullet" id="L6"><list-item><p id="P32"><underline>Odor detection threshold</underline>. Like other odors, inter-individual variation in sensitivity to H<sub>2</sub>S is large. A review of 26 studies showed average odor detection thresholds from 0.00007 to 1.4 ppm (0.10 to 2,100 &#x003bc;g/m<sup>3</sup>) (<xref rid="R11" ref-type="bibr">Amoore 1985</xref>); the geometric mean (GM) of these studies was 0.008 ppm (12 &#x003bc;g/m<sup>3</sup>) (<xref rid="R163" ref-type="bibr">OEHHA 2008</xref>). Other reviews note an odor detection threshold for H<sub>2</sub>S in pure form as low as 0.000013 to 0.0013 ppm (0.2 to 2.0 &#x003bc;g/m<sup>3</sup>), depending on purity (<xref rid="R211" ref-type="bibr">van Gemert and Nettenbreijer 1984</xref>; <xref rid="R231" ref-type="bibr">Winneke et al. 1979</xref>) to 7.3 ppm (11 &#x003bc;g/m<sup>3</sup>; <xref rid="R12" ref-type="bibr">Amoore and Hautala 1983</xref>). <xref rid="R164" ref-type="bibr">OEHHA (2000)</xref> states that at the reference exposure level (REL) of 0.0067 ppm (6.7 ppb = 10 &#x003bc;g/m<sup>3</sup>), H<sub>2</sub>S would be likely to be detectable by many people under ideal laboratory conditions, but it is &#x0201c;unlikely to be recognized or found annoying by more than a few.&#x0201d; <xref rid="R16" ref-type="bibr">ATSDR (2006)</xref> gives an odor detection threshold ranging from 0.0005 to 0.3 ppm. Odor responses summarized by <xref rid="R47" ref-type="bibr">Collins and Lewis (2000)</xref> and <xref rid="R232" ref-type="bibr">Woodall et al. (2005)</xref> list concentrations of 0.5, 2, 4, 8, and 30 ppb being recognized by 2, 14, 30, 50 and 83% of persons, respectively.</p></list-item><list-item><p id="P33"><underline>Odor recognition threshold</underline>. H<sub>2</sub>S is frequently assumed to have an odor recognition threshold that is three to four times higher than the odor detection threshold, as assumed for other compounds. The threshold for perception lies between 0.02 and 0.13 ppm (<xref rid="R49" ref-type="bibr">Costigan 2003</xref>).</p></list-item><list-item><p id="P34"><underline>Odor nuisance threshold</underline>. Odor nuisance occurs when an odor is perceived to be annoying. For H<sub>2</sub>S, this can occur due to aesthetic, behavioral or physiological responses, which can include nausea and headache (<xref rid="R11" ref-type="bibr">Amoore 1985</xref>; <xref rid="R176" ref-type="bibr">Reynolds and Kamper 1984</xref>). The annoyance threshold often is stated to be about five times greater than the odor detection threshold. Using the geometric mean odor detection threshold, the annoyance threshold is about 0.04 ppm (60 &#x003bc;g/m<sup>3</sup>) (<xref rid="R163" ref-type="bibr">OEHHA 2008</xref>). Slightly lower concentrations (0.03 ppm) have resulted in odor complaints and reports of nausea and headache near geyser emissions (<xref rid="R176" ref-type="bibr">Reynolds and Kamper 1984</xref>). These concentrations appear high for a guidance level, i.e., the California Ambient Air Quality Standard (CAAQS) is 0.03 ppm (<xref rid="R163" ref-type="bibr">OEHHA 2008</xref>). <xref rid="R226" ref-type="bibr">WHO (2006)</xref> states that on the &#x0201c;basis of the scientific literature, it is not possible to state a specific concentration at which odor nuisance starts to appear,&#x0201d; however, text supporting the WHO&#x02019;s Air Quality Guidelines indicate that a 30-min average concentration of 0.0047 ppm (7 &#x003bc;g/m<sup>3</sup>) is likely to produce substantial complaints (<xref rid="R226" ref-type="bibr">WHO 2006</xref>). The WHO guideline is based on two older citations (<xref rid="R137" ref-type="bibr">Lindvall 1970</xref>; <xref rid="R160" ref-type="bibr">NRC 1979</xref>). A recent and well-controlled clinical test suggests that at 0.05 ppm, the lowest H<sub>2</sub>S concentration tested, participants may not fully habituate to the smell, and that continuing exposure may prove to be annoying (<xref rid="R80" ref-type="bibr">Fiedler et al. 2008</xref>).</p></list-item><list-item><p id="P35"><underline>Olfactory fatigue</underline>. At concentrations above approximately 50 ppm (70 mg/m3), olfactory fatigue prevents detection of H<sub>2</sub>S odor (<xref rid="R163" ref-type="bibr">OEHHA 2008</xref>).</p></list-item><list-item><p id="P36"><underline>Olfactory paralysis</underline>. Neurotoxicity affecting the olfactory bulb and fibers may be followed by hyposmia or anosmia (permanent loss or reduction of the ability to perceive odor), which has been found in most men who recovered from severe and potentially lethal H<sub>2</sub>S exposure (<xref rid="R92" ref-type="bibr">Guidotti 2010</xref>).</p></list-item></list></sec><sec id="S13"><label>2.3.1.2</label><title>Odor and health</title><p id="P37">Odorant compounds can affect human health through several mechanisms (e.g., <xref rid="R185" ref-type="bibr">Schiffman et al. 2005</xref>; <xref rid="R230" ref-type="bibr">Wing et al. 2008</xref>; <xref rid="R232" ref-type="bibr">Woodall et al. 2005</xref>). Odor emissions, odor perception, and odor nuisance present quality of life issues that can cause individuals to modify certain physical and social activities (e.g., outdoor physical activity), which can then lead to other health-related issues. Odor perception is often associated with odor nuisance and complaints, and sometimes with psychological responses, e.g., headache, nausea, and loss of sleep. Ocular effects and nasal lesions are discussed in <xref rid="S17" ref-type="sec">Sections 2.3.2</xref> and <xref rid="S23" ref-type="sec">2.3.3</xref>, respectively. The <xref rid="R226" ref-type="bibr">WHO (2006)</xref> Air Quality Guidelines state that H<sub>2</sub>S levels should not exceed 0.005 ppm (7 &#x003bc;g/m<sup>3</sup>) over a 30-min period to avoid substantial complaints about odor annoyance. <xref rid="R163" ref-type="bibr">OEHHA (2008)</xref> in California makes the same statement but uses a higher exposure level, 0.03 ppm, developed in 1984 to reduce odors and physiological symptoms (headache and nausea) with a notation that this may need to be revisited. Several other studies have investigated odors and included H<sub>2</sub>S measurements around CAFOs and landfills with the following findings:
<list list-type="bullet" id="L8"><list-item><p id="P38">Irritation of the eyes, nose, and throat or other toxicological effects through properties of the odorous molecules and stimulation of the trigeminal nerve, typically at concentrations above the nuisance threshold. This is the &#x0201c;Type 1&#x0201d; classification of <xref rid="R232" ref-type="bibr">Woodall et al. (2005)</xref>, in which symptoms are produced by irritant properties, rather than being odor-induced, often with the odor providing a &#x0201c;warning&#x0201d; of potential adverse health effects.</p></list-item><list-item><p id="P39">Responses to non-odorant components that may be present in the airborne mixture, such as irritants or endotoxins in the case of CAFOs, which can induce inflammation and airflow obstruction. In this &#x0201c;Type 2&#x0201d; classification, a co-pollutant(s) in the mixture, not the odor itself, produces symptoms (<xref rid="R232" ref-type="bibr">Woodall et al. 2005</xref>).</p></list-item><list-item><p id="P40">Innate aversion, conditioning, and/or stress responses to the odor, which produces health effects and/or symptoms including nausea, vomiting, headaches, stress, negative mood, and a stinging sensation. This occurs at concentrations above the olfactory nerve threshold, that is, exceeding the odor recognition or nuisance threshold, but below the antrigeminal nerve threshold, which is associated with irritation. This &#x0201c;Type 3&#x0201d; classification (<xref rid="R232" ref-type="bibr">Woodall et al. 2005</xref>) can also include odor-related exacerbation of underlying conditions and odor-related stress-induced illness. Odor may also lead to an acute &#x0201c;stress&#x0201d; state among individuals who perceive that the odor source poses a health risk (<xref rid="R193" ref-type="bibr">Shusterman 2001</xref>).</p></list-item></list>
Because most facilities releasing H<sub>2</sub>S also emit other pollutants, studies based on odor perception alone cannot confirm the role between H<sub>2</sub>S exposure and health and psychological effects. Confirmation requires monitoring of H<sub>2</sub>S and potentially other components of the pollutant mixture. Still, at least one study suggests that H<sub>2</sub>S is often the predominant odor source. Using the threshold (dilution) olfactometry technique with a small human panel and 24 different slurry samples from swine operations, each tested for 35 gases (e.g., reduced sulfur compounds, phenyls, alcohols, ketones, acetic acid, ammonia), H<sub>2</sub>S explained 45 to 68% of odor concentration, with most of the remainder attributable to volatile organic compounds (<xref rid="R34" ref-type="bibr">Blanes-vidal et al., 2009</xref>). A review of five olfactory studies examining municipal wastewater odors also states the need to complement olfactometric measurements with other tools, e.g., portable H<sub>2</sub>S or SO<sub>2</sub> analyzers (<xref rid="R135" ref-type="bibr">Lewkowska et al., 2016</xref>). Unfortunately, relevant olfactometry studies identified in the literature are small, and few allow odor intensity to be correlated to the mixture&#x02019;s components. While more studies are examining co-pollutants associated with H<sub>2</sub>S sources, the lack of olfactometry studies that characterize co-pollutants remains a gap in the observational studies examining health effects associated with odor.</p></sec><sec id="S14"><label>2.3.1.3</label><title>Studies at livestock rearing systems</title><p id="P42">Livestock rearing systems include CAFOs as well as manure storage and treatment. As noted above, these facilities emit H<sub>2</sub>S and other odiferous co-pollutants, e.g., reduced sulfur compounds, phenyls, and ammonia; these facilities can also emit biological contaminants (e.g., endotoxins, fungi and bacteria), aerosols and particulate matter (e.g., entrained dust).</p><p id="P43">Many surveys have been conducted in communities with or near CAFOs where individuals experience chronic exposure to CAFO-related pollutants (<xref rid="R53" ref-type="bibr">Donham 2010</xref>). Occupational studies at CAFOs have documented health complaints, e.g., eye irritation, sinusitis, chronic bronchitis, nasal mucous membrane inflammation, nasal and throat irritation, headaches, and muscle aches and pains, as well as objective health effects, e.g., respiratory inflammation, cross-shift decline in lung function, and chronic respiratory impairment (<xref rid="R185" ref-type="bibr">Schiffman et al. 2005</xref>). Acute high level H<sub>2</sub>S exposure due to releases from agitated manure can lead to reactive airway distress syndrome (RADS), permanent neurologic damage, and death (<xref rid="R22" ref-type="bibr">Bardana 1999</xref>; <xref rid="R44" ref-type="bibr">CDC 1993</xref>). A review of health and social issues associated with CAFOs found over 70 papers addressing health issues affecting workers and communities (<xref rid="R56" ref-type="bibr">Donham et al. 2007</xref>). In reviewing health effects associated with airborne exposures at CAFOs, <xref rid="R100" ref-type="bibr">Heederik et al. (2007)</xref> noted the uncertainty regarding which effects were due to CAFO emissions; uncertainty also applies to attributing the effects to H<sub>2</sub>S as compared to other odiferous and irritation-causing CAFO-related pollutants. Below we examine studies since 2004 focusing on odors and nasal irritation from CAFOs. (Later sections address ocular, nasal lesions, respiratory, neurological, and immune effects associated with CAFOs).</p><p id="P44">The newer studies examining nasal irritation associated with livestock rearing systems follow:
<list list-type="bullet" id="L10"><list-item><p id="P45"><xref rid="R37" ref-type="bibr">Bullers (2005)</xref> studied residents living near hog farms in North Carolina, U.S. in 1998 and 1999 enrolled using snowball recruitment methods (n = 48), who were compared to a group without this exposure studied in 1999 enrolled using flyers (n = 34). The exposed group showed increases in 12 of 22 self-reported physical symptoms, including sinus problems. (Additional symptoms are discussed in subsequent sections.) The authors discussed theoretical models regarding effects of environmental stressors. Study limitations include a modest sample size, a non-random sample, lack of control of covariates, differences in interview protocols (interviews in-home, by telephone), payments to participants in the comparison group but not the exposed group, non-simultaneity of interview periods for the two groups, and the lack of objective health and exposure measures.</p></list-item><list-item><p id="P46"><xref rid="R185" ref-type="bibr">Schiffman et al. (2005)</xref> used well controlled exposure chamber tests and 48 self-selected human volunteers to evaluate physiologic and psychological responses to 1-hr exposures of dilute swine confinement air, stated to be equivalent to levels that could occur downwind of a swine facility, both within and beyond the property line. Concentrations measured during the exposure were 0.024 ppm (24 ppb) for H<sub>2</sub>S, 0.817 ppm (817 ppb) for ammonia, 24 &#x003bc;g/m<sup>3</sup> for particulate matter (PM), 7.4 EU/m<sup>3</sup> for endotoxin, and 56 D/T for odor (factor above the odor threshold). No association between H<sub>2</sub>S and nasal inflammation was found. To explain the dichotomy between this and other studies, the authors suggested that either additivity or synergy among the combined components may cause reported effects since no single component was present at sufficiently high concentration to be wholly responsible for symptoms, or that the self-reported &#x0201c;exposure- related avoidance&#x0201d; symptoms are innate or learned warning signals of potential health effects caused at higher concentrations or with prolonged exposure. Study limitations include the short exposure duration, use of healthy volunteers as compared to susceptible individuals (e.g., persons who are sensitized or have asthma) or individuals with involuntary and prolonged exposures, the inability to separate effects of H<sub>2</sub>S alone from the CAFO mixture, and differences between experimental tests and occupational or community settings with respect to stress and the resulting neuronal, hormonal and behavioral responses that might affect outcomes.</p></list-item><list-item><p id="P47">A longitudinal study of non-smoking adults (n=101) living within 1.5 miles of industrial hog operations in 16 neighborhoods in eastern North Carolina, U.S. collected survey (twice-daily odor diaries for approximately two weeks) and ambient H<sub>2</sub>S and PM<sub>10</sub> data from 2003 to 2005 (<xref rid="R106" ref-type="bibr">Horton et al. 2009</xref>). Typically, nine hog operations were within 2 miles of each community. In nine neighborhoods, odor was reported on &#x02265;50% of study days, and hog odors inside homes were reported on 12.5% of person-days. Odor ratings were strongest in the morning and evening, with higher temperature, humidity and PM<sub>10</sub> concentration, and both low and high (but not moderate) wind speeds. On 118 occasions, 34 participants reported that they altered activities due to hog odor. The authors concluded that malodor from swine operations was common in the studied communities, reported odors were related to objective environmental measurements, and that malodors interrupted the activities of daily life. Previously, odor was associated with stress levels for a subset of the same sample population (<xref rid="R105" ref-type="bibr">Horton 2007</xref>), while ethnographic interviews for another subset also found that malodor limited many daily physical and social activities that can reduce stress and promote health (<xref rid="R205" ref-type="bibr">Tajik et al. 2008</xref>).</p></list-item><list-item><p id="P48"><xref rid="R186" ref-type="bibr">Schinasi et al. (2011)</xref> tested associations between pollutants and odors near hog operations and acute physical symptoms using a longitudinal approach to help control the confounding possible in cross-sectional studies. The study used the same sample and monitoring approach described above (<xref rid="R106" ref-type="bibr">Horton et al. 2009</xref>). Participants were asked to spend 10 min outdoors twice a day at preselected times, assess odor, complete a symptom survey, and perform (unsupervised) spirometry. Simultaneously, ambient air monitoring was conducted for H<sub>2</sub>S, endotoxin and PM<sub>10</sub>, PM<sub>2.5</sub>, and PM<sub>2.5&#x02013;10</sub> in each community. Across the communities, the 1-hr H<sub>2</sub>S concentration averaged 0.00030 &#x000b1;0.00186 ppm (0.30 &#x000b1;1.86 ppb); 12-hr PM<sub>10</sub> averaged 19.4 &#x000b1; 11.8 &#x003bc;g/m<sup>3</sup>; and 12-hr PM<sub>2.5</sub> averaged 10.9 &#x000b1;5.7 &#x003bc;g/m<sup>3</sup>. Nasal irritation increased with general odor perception and ambient H<sub>2</sub>S (per 1 ppb increase). Study strengths include the repeated and objective exposure measures and the frequent outcome measurements. The authors note the small sample size and the possibility that emissions during the study were reduced.</p></list-item></list>
These investigations recognize that exposures from livestock related systems involve mixtures of pollutants. Identifying the effect of an individual component like H<sub>2</sub>S can be difficult, requiring characterization of the mixture by monitoring its major components at the source or in ambient air, ideally in the community or residence of study participants, and further, H<sub>2</sub>S levels must be shown to either dominate the health effect or be sufficiently non-collinear to separate effects of the mixture.</p></sec><sec id="S15"><label>2.3.1.4</label><title>Studies at landfills, compost, and wastewater facilities</title><p id="P50">We identified several newer studies conducted at landfills, compost and wastewater facilities. As noted earlier (<xref rid="S3" ref-type="sec">Section 1.2</xref>), these facilities produce H<sub>2</sub>S under anaerobic conditions, and thus emissions will include other reduced sulfur gases. In addition, VOCs and fugitive dust containing odiferous or irritating components may arise from active landfills (i.e., operating faces without grass or other cover) and composting facilities. The dispersal of dusts is likely to be limited to locations very near the source given the rapid settling and dust fall expected for larger particles, e.g., greater than 2.5 &#x003bc;m in diameter.
<list list-type="bullet" id="L12"><list-item><p id="P51">A community-based study in Pennsylvania, U.S. measured ambient and indoor levels of H<sub>2</sub>S at two elementary schools, one of which was located near a composting plant, in two seasons (spring and fall; <xref rid="R140" ref-type="bibr">Logue et al. 2001</xref>). School nurses recorded symptoms and medical history from 749 &#x0201c;exposed&#x0201d; and 518 &#x0201c;unexposed&#x0201d; students. At the control school, concentrations never exceeded 0.01 ppm (1-hr average); at the exposed school, concentrations exceeded 0.01 ppm on 9 days in autumn and 3 days in spring). H<sub>2</sub>S was not associated with irritation or olfactory symptoms. (Other outcomes from this study are discussed in later sections.) The negative results may have been due to the minimal exposure contrast between the schools, and other exposures that might have caused exposure misclassification.</p></list-item><list-item><p id="P52">Among studies of wastewater treatment plant (WWTP) workers, only <xref rid="R130" ref-type="bibr">Lee et al. (2007)</xref> assessed nasal irritation. In Iowa, 109 workers at WWTPs were compared to 66 workers at water treatment plants (WTP), a group with similar work duties and characteristics but without occupational H<sub>2</sub>S exposure. Objective measures of H<sub>2</sub>S were used, but odor perceptions were not evaluated. Most (95%) monitored concentrations of H<sub>2</sub>S were below 1 ppm, and the overall geometric mean concentration was 0.15 ppm (range from 0 to 42.5 ppm) in the WWTP group. The exposed group had a significantly higher risk of sinus problems. Skin and throat irritation were also found at higher rates in wastewater treatment workers, but these associations were not robust. (Additional outcomes in this study, e.g., neurological and respiratory symptoms are discussed later.) The authors suggested that the symptoms may be promoted due to synergistic or additive effects of the contaminant mixture.</p></list-item><list-item><p id="P53">A panel study of 23 adults in Orange County, North Carolina, U.S., living within 0.75 mile of landfills completed a questionnaire twice daily about odor intensity, alteration of daily activities, mood state, and health symptoms (<xref rid="R99" ref-type="bibr">Heaney et al. 2011</xref>). At a site between the landfill and community, monitored H<sub>2</sub>S levels averaged 0.00022 ppm (range: 0 to 0.0023 ppm), and were used as an indicator of a complex mixture of odorant chemicals. Conditional fixed effects models were used to associate odor perception to the alteration of daily activities, negative mood states, upper respiratory symptoms, mucous membrane irritation (burning eye, nose and throat), several neurological outcomes (dizziness, lightheadedness, &#x0201c;general ill feeling&#x0201d;), and other physical symptoms. The authors suggested that H<sub>2</sub>S concentrations, which were below odor detection thresholds, and were likely correlated with other (unmeasured) landfill pollutants, probably associated with fresh garbage. While odor, health and quality of life impacts were associated with landfills, the study has several limitations, e.g., possible reporting bias since both independent and dependent variables are based on diaries, a small sample size, an inability to separate effects of H<sub>2</sub>S from other odorous compounds, a lack of pollutant measurements other than H<sub>2</sub>S, and a lack of objective (e.g., clinical) outcome measures.</p></list-item></list>
As discussed in the prior section, identifying the effect of H<sub>2</sub>S at these facilities requires adequate characterization and separation of mixture components. This was probably a minor issue in the school study given limited penetration and filtering of particulate matter typical in most buildings; this study had negative results. Both the occupational and landfill panel studies monitored H<sub>2</sub>S but no other possible components of the exposure; the issue of co-exposure is particularly likely and limiting in the former study, as acknowledged by the authors.</p></sec><sec id="S16"><label>2.3.1.5</label><title>Summary of odor and irritation</title><p id="P55">Few controlled or occupational epidemiological studies have examined odor and/or irritation related to H<sub>2</sub>S. Several community-based studies have evaluated individuals living near H<sub>2</sub>S emitting facilities, however, comparisons and synthesis are impeded by the very different exposure assessment methods, which include perception-only studies (i.e., without H<sub>2</sub>S measures; <xref rid="R105" ref-type="bibr">Horton 2007</xref>), both indoor and ambient H<sub>2</sub>S measurements (<xref rid="R140" ref-type="bibr">Logue et al. 2001</xref>), ambient odor and ambient H<sub>2</sub>S measures (<xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>), and indoor odor and ambient H<sub>2</sub>S measures (<xref rid="R99" ref-type="bibr">Heaney et al. 2011</xref>; <xref rid="R106" ref-type="bibr">Horton et al. 2009</xref>). Simultaneous odor and H<sub>2</sub>S measures, collected both indoors and outdoors, are lacking, and information on individual-level exposures is also lacking. In studies using objective H<sub>2</sub>S measures, odor was associated with ambient H<sub>2</sub>S and nasal irritation, as has been shown in toxicological studies examining the irritant properties of H<sub>2</sub>S, however, other symptoms did not show robust associations. H<sub>2</sub>S odors may induce or exacerbate conditions such as stress or behavior modification. Importantly, studies using only odor as an exposure metric can be problematic for several reasons: they do not account for other pollutants that may be present; outcomes may be affected by response enhancement bias, i.e., an increase in reported symptoms since respondents are both aware of and potentially sensitized to the exposure (<xref rid="R79" ref-type="bibr">Farahat and Kishk 2010</xref>); odor thresholds among individuals vary enormously; and finally, odor perception can trigger a range of responses that may be contextual and difficult to assess.</p><p id="P56">In summary, odors associated with sources that emit H<sub>2</sub>S, including agricultural, waste, wastewater, and industrial facilities, are clearly associated with odor-triggered nuisance, complaints and physiological symptoms that can result in health and quality of life impacts. These impacts occur at concentrations above an individual&#x02019;s odor detection threshold, up to the odor nuisance threshold, at short-term H<sub>2</sub>S concentrations from roughly 0.001 to 0.050 ppm (<xref rid="R81" ref-type="bibr">Finnbjornsdottir et al. 2016</xref>; <xref rid="R99" ref-type="bibr">Heaney et al. 2011</xref>; <xref rid="R105" ref-type="bibr">Horton 2007</xref>; <xref rid="R226" ref-type="bibr">WHO 2006</xref>). Odor sensitivity to H<sub>2</sub>S varies greatly among individuals (by over four or more orders of magnitude), and some individuals can detect H<sub>2</sub>S at concentrations well below 0.001 ppm. Because the observational and community studies focus on waste management, industrial and agricultural facilities that emit a mixture of odiferous and irritation-causing pollutants, the reported health effects are not necessarily caused by H<sub>2</sub>S exposure alone. However, a recent study suggests that H<sub>2</sub>S may be the most important odorant at CAFOs, explaining 45 to 68% of the odor, with the remainder attributable to volatile organic compounds (<xref rid="R34" ref-type="bibr">Blanes-vidal et al. 2009</xref>). Given these and other study limitations noted above, the relationship between odor detection and harmful health effects has not been consistently found in epidemiological studies.</p></sec></sec><sec id="S17"><label>2.3.2</label><title>Ocular effects</title><p id="P57">Ocular effects of H<sub>2</sub>S have been recognized since at least the 18<sup>th</sup> century. <xref rid="R129" ref-type="bibr">Lambert et al. (2006)</xref> provides a lucid review. At moderate concentrations, H<sub>2</sub>S is an ocular irritant that affects the eyes in a condition that has been called &#x0201c;sore eye,&#x0201d; &#x0201c;gas eye&#x0201d; (<xref rid="R75" ref-type="bibr">EPA 2003</xref>), and &#x0201c;spinner&#x02019;s eye&#x0201d; (<xref rid="R87" ref-type="bibr">Glass 1990</xref>). In occupational studies, evidence on eye irritation has been called &#x0201c;inconsistent,&#x0201d; largely because effects have been reported over a wide concentration range and because several of the viscose-rayon studies likely involved co-exposures to sulfur dioxide, sulfuric acid, and carbon disulfide (<xref rid="R49" ref-type="bibr">Costigan 2003</xref>). More recent occupational epidemiology studies show eye irritation attributable to H<sub>2</sub>S (e.g., <xref rid="R115" ref-type="bibr">Kilburn 2012</xref>; <xref rid="R130" ref-type="bibr">Lee et al. 2007</xref>).</p><p id="P58">The older guidance and recommendations for threshold limit values (TLVs) for occupational exposure listed ocular toxicity at concentrations from 5 to 30 ppm, and <xref rid="R1" ref-type="bibr">ACGIH (2001)</xref> noted that a 1-hr 50 ppm exposure results in superficial inflammation and conjunctivitis with ocular pain, lacrimation, and photophobia, which can progress to keratoconjunctivitis and vesiculation of the corneal epithelium. The AIHA TLV guidance was based on ~10 studies from 1939 to 1969, which examined concentrations that generally are not relevant for community exposures (and thus omitted in this review). As discussed later (<xref rid="S81" ref-type="sec">Section 4.2.1</xref>), the TLV guidance was revised in 2010 and ocular effects are no longer considered a critical effect, i.e., the effect occurring at the lowest concentration that &#x0201c;drives&#x0201d; the TLV.</p><sec id="S18"><label>2.3.2.1</label><title>Studies at geothermal sources</title><p id="P59"><xref rid="R38" ref-type="bibr">Bustaffa et al. (2020)</xref> has recently reviewed the health effects associated with populations exposed to emissions from natural geothermal events and geothermal energy plants. Evidence of increased eye damage is based on a few studies that are all ecological in design and limited to a single area of New Zealand. <xref rid="R129" ref-type="bibr">Lambert et al. (2006)</xref> reviewed several ocular studies, including community studies in Finland and New Zealand (the latter are discussed in <xref rid="R38" ref-type="bibr">Bustaffa et al. (2020)</xref> and reviewed below), and concluded that in community settings, short-term H<sub>2</sub>S exposures of ~0.025 ppm appears to be the lowest concentration observed that irritates the eyes, and that chronic exposure is associated with serious ocular effects.</p><list list-type="bullet" id="L14"><list-item><p id="P60">The New Zealand studies examined communities in Rotorua, the largest naturally H<sub>2</sub>S-exposed population in the world, due to geothermal emissions (<xref rid="R24" ref-type="bibr">Bates et al. 1998</xref>). About a quarter of its population of 40,000 is routinely exposed to H<sub>2</sub>S at concentrations of at least 0.143 ppm (200 &#x003bc;g/m<sup>3</sup>); the highest 30-min concentrations exceed 1 ppm (1,500 &#x003bc;g/m<sup>3</sup>; <xref rid="R82" ref-type="bibr">Fisher 1999</xref>); the median concentration is 0.014 ppm (20 &#x003bc;g/m<sup>3</sup>); 35% of measurements exceed 0.05 ppm (70 &#x003bc;g/m<sup>3</sup>) and 10% exceed 0.286 ppm (400 &#x003bc;g/m<sup>3</sup>). Based on hospital discharge data from 1981 to 1990, standardized incidence rates of ocular disorders -- cataracts, diseases of the eye and adnexa (eyebrow, eyelids, and lacrimal apparatus), disorders of the conjunctiva, and disorders of the orbit -- were statistically higher than rates elsewhere in New Zealand (<xref rid="R24" ref-type="bibr">Bates et al. 1998</xref>). This ecological analysis did not address the sharp concentration gradients of H<sub>2</sub>S observed across the city (<xref rid="R107" ref-type="bibr">Horwell et al. 2005</xref>) or the differences between exposed and unexposed populations.</p></list-item><list-item><p id="P61"><xref rid="R26" ref-type="bibr">Bates et al. (2002)</xref> updated their earlier study with 1993 to 1996 morbidity data and grouped community exposures into three categories using exposure data based on passive air sampling of H<sub>2</sub>S. Again, Rotorua residents experienced significantly higher incidence of adnexa and eye disorders compared to residents elsewhere in the country, and exposure-response trends held across all four ethnicity&#x02013;gender categories. While improved in the updated study, the exposure assessment remained ecological in nature (individual exposure data were unavailable), and the authors acknowledge the lack of information on possible confounders, e.g., smoking and socio-economic status (SES), and possible selection bias.</p></list-item></list></sec><sec id="S19"><label>2.3.2.2</label><title>Studies at sulfate pulp mills and composting facilities</title><p id="P62">Pulp and paper production is the single largest source of H<sub>2</sub>S emissions (<xref rid="S3" ref-type="sec">Section 1.2</xref>). A series of Finnish studies have studied populations living near sulfate pulp mills.</p><list list-type="bullet" id="L16"><list-item><p id="P63">In Imatra, South Karelia, Finland, <xref rid="R94" ref-type="bibr">Haahtela et al. (1992)</xref> examined exposures to H<sub>2</sub>S and other reduced sulfides (methyl mercaptan, dimethyl sulfide, dimethyl disulfide). Local mills released an estimated 2,800 tons/year of H<sub>2</sub>S in 1989. During a plant upgrade in September 1987, emissions at one mill increased for two days, resulting in a maximum 4-hr concentration of 0.096 ppm (135 &#x003bc;g/m<sup>3</sup>) and 24-hr averages of 0.025 and 0.031 ppm (35 and 43 &#x003bc;g/m<sup>3</sup>) measured 1 km from the source; these levels are 4&#x02013;20 times higher than those during a reference period believed to be representative. During the 2-day event, sulfur dioxide (SO<sub>2</sub>) levels were low, but an intensive &#x0201c;catty&#x0201d; odor due to mesityl oxide was reported. Unfortunately, this unsaturated ketone, as well as reduced sulfur compounds other than H<sub>2</sub>S, were not measured; mesityl oxide is also an irritant to eyes and other tissues and has an acute Reference Exposure Level (REL) of 10 ppm (<xref rid="R165" ref-type="bibr">OEHHA 1999</xref>) and a US occupational Permissible Exposure Limit (PEL) for the time weighted average (TWA) of 25 ppm (<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>). (Occupational limits are discussed later in <xref rid="S80" ref-type="sec">Section 4.2</xref>.) Surveys distributed to persons (n=60) in the affected community shortly after the exposure event and in a subsequent reference period (n=66) showed that a statistically significant number of persons (22% of the sample) experienced direct irritative effect on mucous membranes and eye conjunctivitis, symptoms that corresponded to the physiological effects of acute H<sub>2</sub>S exposure.</p></list-item><list-item><p id="P64">A cross-sectional study by <xref rid="R145" ref-type="bibr">Marttila et al. (1994)</xref> evaluated ocular (and other symptoms) among children (n=134) under 15 years of age in three communities in South Karelia, Finland. The annual average H<sub>2</sub>S levels predicted using air quality dispersion models were 0.00067 and 0.0053 ppm (1 and 8 &#x003bc;g/m<sup>3</sup>) in the moderately and severely polluted communities, respectively, and the 24-hr maxima were 0.01 and 0.067 ppm (15 and 100 &#x003bc;g/m<sup>3</sup>); the available monitoring data indicated lower levels. Parent&#x02019;s reports over the past 4 weeks and 12 months showed increases in the children&#x02019;s eye irritation over time, but changes were not statistically significant; the small sample size and issues in symptom ascertainment may have limited associations. Concentrations of other reduced sulfur compounds were not reported. SO<sub>2</sub> levels were low (averaging 2&#x02013;3 &#x003bc;g/m<sup>3</sup>) and not indicated as a significant confounder. As in the previous studies, several sulfur compounds were present, including methyl mercaptan (CH<sub>3</sub>SH; annual mean from 2 to 5 &#x003bc;g/m<sup>3</sup> [0.001 &#x02013; 0.0025 ppb]; maximum 24-h concentration of 150 &#x003bc;g/m<sup>3</sup> [0.075 ppm]; high exposure area). CH<sub>3</sub>SH has a low odor threshold (0.002 ppm), and the acute REL and PEL are 0.5 and 10 ppm, respectively. However, confounding was not expected given that the CH<sub>3</sub>SH irritation threshold was estimated to be two orders of magnitude higher than that for H<sub>2</sub>S. Still, the potential effects of both acute and chronic exposure CH<sub>3</sub>SH, as well as other sulfur compounds, over a long period of time should be considered.</p></list-item></list><list list-type="bullet" id="L18"><list-item><p id="P65"><xref rid="R144" ref-type="bibr">Marttila et al. (1995)</xref> carried out a longitudinal study of adults (n=81) in Lappeenranta, Finland living 1.5 km from a pulp mill. Baseline and six follow-up surveys were administered to the cohort, and pollutants (TRS, SO<sub>2</sub>, TSP, NO<sub>x</sub>) were monitored continuously in the community over 15 months. Large and statistically significant differences in symptom intensity were found between the reference, medium and high exposure periods, suggesting a dose-response relationship. The intensity of eye (and nasal and pharyngeal) symptoms was significantly higher during days when TRS levels exceeded 0.0067 ppm (10 &#x003bc;g/m<sup>3</sup>). H<sub>2</sub>S was estimated to account for two-thirds of the TRS released in the region; concentrations of other reduced sulfur compounds were not presented; and SO<sub>2</sub> levels were low (5 &#x02013; 50 &#x003bc;g/m<sup>3</sup>) and not considered to be a significant confounder. The authors concluded that relatively low daily concentrations of malodorous sulfur compounds, i.e., TRS exceeding 0.0067 ppm (10 &#x003bc;g/m<sup>3</sup>), can cause exposure related short-term adverse effects.</p></list-item></list><list list-type="bullet" id="L20"><list-item><p id="P66"><xref rid="R140" ref-type="bibr">Logue et al. (2001)</xref> carried out a community-based study of students at an elementary school near a composting plant located in southeastern Pennsylvania, U.S (described earlier in <xref rid="S15" ref-type="sec">Section 2.3.1.4</xref>). The 749 students from the H<sub>2</sub>S exposed school (where measured 1-hr H<sub>2</sub>S levels exceeded 0.010 ppm on 9 days) and 491 students from the control school (no such events) participated in the survey of symptoms and medical conditions. Associations between H<sub>2</sub>S and ocular symptoms were not statistically significant.</p></list-item></list></sec><sec id="S20"><label>2.3.2.3</label><title>Studies of livestock rearing systems</title><list list-type="bullet" id="L22"><list-item><p id="P67">In well-controlled chamber tests to a CAFO mixture described earlier in <xref rid="S14" ref-type="sec">Section 2.3.1.3</xref>, <xref rid="R185" ref-type="bibr">Schiffman et al. (2005)</xref> found increased prevalence of eye irritation. This mixture contained H<sub>2</sub>S (0.024 ppm), ammonia (0.817 ppm), total suspended particulates (0.0241 mg/m<sup>3</sup>), endotoxin (7.40 endotoxin units/m<sup>3</sup>), and odor (57 times above odor threshold).</p></list-item></list><list list-type="bullet" id="L24"><list-item><p id="P68"><xref rid="R115" ref-type="bibr">Kilburn (2012)</xref> compared 25 individuals living from 0.17 to 3 km (most within 0.9 km) of hog manure lagoons with 22 age- and gender-matched individuals living beyond 3 km in Paulding, Ohio (and also to 58 additional controls in Tennessee) for pulmonary performance in a 3-day period in April, 2003. (The main objective of this study was to evaluate neurological endpoints, as described later.) H<sub>2</sub>S levels in 12 homes averaged from 0 to 0.03 ppm (but reached 2.1 ppm and varied over 10-fold in one-day&#x02019;s spot check samples), and two outdoor samples exceeded 1.1 ppm; these high levels appear to be outliers. Other airborne constituents, e.g. ammonia, SO<sub>2</sub>, NO<sub>2</sub> and particulate matter, were not considered. Questionnaires asked about frequencies of 35 common health complaints, respiratory symptoms, occupational history, exposure history (chemicals, pesticides, tobacco, alcohol, drug use, etc.), and medical history. While outcomes were uncorrelated with distance to the lagoons, frequencies of 18 of 35 symptoms, including eye irritation, differed significantly between exposed and (local) control populations. (Other outcomes in this study are discussed elsewhere in the present report.) Many of the same (and some additional) differences were found between the exposed Ohio population and the Tennessee referent population. While a number of objective outcome measures and some H<sub>2</sub>S monitoring were utilized, the sample size was small, co-pollutant exposure was likely, and the exposure assessment was incomplete.</p></list-item></list><list list-type="bullet" id="L26"><list-item><p id="P69"><xref rid="R186" ref-type="bibr">Schinasi et al. (2011)</xref>, described earlier, reported increased acute eye irritation following 10 minutes outdoors with perception of odor, as well as correlation with 12-hour mean levels of H<sub>2</sub>S, PM<sub>2.5</sub> and PM<sub>10</sub>. The log odds of acute eye irritation following 10-min outdoor exposure increased by 0.15 per 1 ppb of H<sub>2</sub>S, by 0.84 per 10 &#x003bc;g/m<sup>3</sup> of PM<sub>2.5</sub>, and by 0.36 per 10 &#x003bc;g/m<sup>3</sup> of PM<sub>10</sub>.</p></list-item></list></sec><sec id="S21"><label>2.3.2.4</label><title>Studies at wastewater treatment plants</title><list list-type="bullet" id="L28"><list-item><p id="P70"><xref rid="R130" ref-type="bibr">Lee et al. (2007)</xref>, described previously, found that eye irritation was more commonly reported by WWTP workers exposed to mean H<sub>2</sub>S concentration of 0.15 ppm (range: 0 &#x02013; 42.5 ppm) compared to unexposed workers.</p></list-item></list></sec><sec id="S22"><label>2.3.2.5</label><title>Summary of ocular effects</title><p id="P71">The Finnish studies around pulp mills (<xref rid="R94" ref-type="bibr">Haahtela et al. 1992</xref>; <xref rid="R144" ref-type="bibr">Marttila et al. 1995</xref>, <xref rid="R145" ref-type="bibr">1994</xref>) addressed both acute and chronic exposures and showed statistically significant increases in eye symptoms at (24-hr) concentrations as low as 0.007 ppm. However, these are ecological studies using small populations that likely involve co-exposures to other sulfur gases. In the geothermal area of Rotorua, New Zealand, an ecological approach was also used by classifying the city into high, medium, or low H<sub>2</sub>S exposure areas (<xref rid="R26" ref-type="bibr">Bates et al. 2002</xref>, <xref rid="R24" ref-type="bibr">1998</xref>). These studies also involve co-exposures, but to different pollutants than the Finnish studies given the different (volcanic) H<sub>2</sub>S source. While ocular effects may be experienced at lower concentrations, as concluded by <xref rid="R129" ref-type="bibr">Lambert et al. (2006)</xref>, the evidence is more consistent that single or repeated short-term H<sub>2</sub>S concentrations in the range of 0.007 to 0.025 ppm can produce eye irritation. However, the available observational studies have limitations: they incompletely address the nature of ocular effects other than irritation, their exposure assessments provide limited detail regarding exposures (e.g., short-term but high concentration events are not characterized), and they do not address whether chronic low level H<sub>2</sub>S exposure causes irreversible effects on the eye.</p><p id="P72">In summary, concentrations from about 0.007 to 0.025 ppm correspond with the low end of the range that has been associated with eye irritation in the older cross-sectional studies examining short- and long-term exposures in Rotorua (<xref rid="R26" ref-type="bibr">Bates et al. 2002</xref>, <xref rid="R24" ref-type="bibr">1998</xref>) and Finland (<xref rid="R94" ref-type="bibr">Haahtela et al. 1992</xref>; <xref rid="R144" ref-type="bibr">Marttila et al. 1995</xref>, <xref rid="R145" ref-type="bibr">1994</xref>). Several recent community studies around CAFOs and similar facilities have reported eye irritation (<xref rid="R99" ref-type="bibr">Heaney et al. 2011</xref>; <xref rid="R115" ref-type="bibr">Kilburn 2012</xref>; <xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>), as have short-term controlled tests at 0.024 ppm as part of a CAFO mixture containing ammonia and other contaminants described earlier (<xref rid="R185" ref-type="bibr">Schiffman et al. 2005</xref>). However, a short-term controlled test of H<sub>2</sub>S alone at 0.05, 0.5 and 5 ppm H<sub>2</sub>S did not present eye irritation (<xref rid="R80" ref-type="bibr">Fiedler et al. 2008</xref>), which suggests the possible role of co-pollutants, rapid fluctuations in H<sub>2</sub>S concentrations (that are averaged out in sampling), or longer exposure periods. The available studies have limitations: they do not address the nature of ocular effects other than irritation (<xref rid="R129" ref-type="bibr">Lambert et al. 2006</xref>); the exposure assessments provide little spatio-temporal information; the exposure contrasts may be minimal; and the question of whether chronic low level H<sub>2</sub>S exposure causes irreversible effects on the eye is not approached.</p></sec></sec><sec id="S23"><label>2.3.3</label><title>Nasal lesions</title><p id="P73">The olfactory epithelium is vulnerable to H<sub>2</sub>S induced pathology due to cytochrome oxidase inhibition at lower concentrations than damage to the nasal respiratory epithelium, and thus this effect has formed the basis for both occupational and environmental exposure standards (<xref rid="R188" ref-type="bibr">Schroeter et al. 2006</xref>), including EPA&#x02019;s current RfC and the ATSDR&#x02019;s intermediate duration MRL (<xref rid="S77" ref-type="sec">Section 4.1.2</xref>). These guidelines were informed by <xref rid="R36" ref-type="bibr">Brenneman et al. (2000)</xref>, who exposed groups of 12 male Sprague-Dawley rats to 0, 10, 30 or 80 ppm H<sub>2</sub>S for 6 hr/day for 10 weeks with subsequent examination of nasal epithelium. No adverse changes in olfactory or respiratory epithelia were seen at 10 ppm (13.9 mg/m<sup>3</sup>), and thus this concentration became the current NOAEL. At higher concentrations (30 ppm), olfactory lesions and basal cell hyperplasia (a response to the olfactory lesions) occurred throughout the nose; these increased in extent at 80 ppm. As described below, the only updates in the literature pertaining to nasal lesions are dosimetry refinements for an animal study, and a small case-report occupational study (<xref rid="R36" ref-type="bibr">Brenneman et al. 2000</xref>; <xref rid="R155" ref-type="bibr">Mousa 2015</xref>; <xref rid="R188" ref-type="bibr">Schroeter et al. 2006</xref>).</p><sec id="S24"><label>2.3.3.1</label><title>Pharmacokinetic modeling</title><p id="P74">Using interspecies pharmacokinetic computational fluid dynamics (PK-CFD) models, <xref rid="R188" ref-type="bibr">Schroeter et al. (2006)</xref> derived a human NOAEL of 5 ppm by extrapolating the nasal lesion and extraction data observed in rats to humans. The modeling used a conservative physiologically-based dosimetric approach for interspecies extrapolation and differences in exposed nasal surface areas, airflows, partitioning, diffusivity and reaction kinetics. Although some data were lacking to support the extrapolation, modeling was consistent with interspecies clearance data, and results showed good correlation with the incidence of olfactory lesions in rats. An investigation of interhuman variability, which simulated H<sub>2</sub>S uptake on olfactory epithelium for 5 adults and 2 children using anatomically correct models of the olfactory region generated from magnetic resonance imaging (MRI) or computed tomography (CT) scan data and steady-state inspiratory airflows, showed similar dosimetry (within 20%) over a range in olfactory airflow (<xref rid="R187" ref-type="bibr">Schroeter et al. 2010</xref>). While the modeling may incompletely represent population variability, it suggests that differences in nasal anatomy and ventilation do not significantly affect H<sub>2</sub>S uptake in the olfactory region. Additional discussion regarding derivation of the NOAEL and modeling contrasting nasal airflows rat and human noses are given by <xref rid="R57" ref-type="bibr">Dorman (2004)</xref>.</p></sec><sec id="S25"><label>2.3.3.2</label><title>Occupational studies</title><p id="P75">A recent case-report assessed symptom frequencies of oil field workers (n=34) in Iraq exposed to a wide range of H<sub>2</sub>S levels (daily ambient average concentrations from 4 &#x02013; 50 ppm) and an unexposed comparison group (<xref rid="R155" ref-type="bibr">Mousa 2015</xref>). No median or interquartile range (IQR) for exposures was reported. 53% of the exposed workers experienced nasal bleeding, and a few experienced additional bleeding.</p></sec><sec id="S26"><label>2.3.3.3</label><title>Summary</title><p id="P76">The effect of the PK-CFD modeling used to extrapolate nasal lesions in rats to humans (<xref rid="R36" ref-type="bibr">Brenneman et al. 2000</xref>; <xref rid="R188" ref-type="bibr">Schroeter et al. 2006</xref>) would be to halve the current NOAEL of 10 ppm to 5 ppm. This modeling is consistent with observations, and the rat-to-human extrapolation reduces uncertainty compared to simpler dosimetric approaches. However, human data in this concentration range are insufficient for confirmation, and the NOAEL remains at 10 ppm. As discussed later in <xref rid="S74" ref-type="sec">Section 4</xref>, these studies are important as the risk of nasal lesions remains the basis for several H<sub>2</sub>S standards and guidelines.</p></sec></sec><sec id="S27"><label>2.3.4</label><title>Respiratory and allergic effects</title><p id="P77">This section first reviews several older controlled studies describing changes in lactate and oxygen levels in blood and muscle measured during H<sub>2</sub>S exposure, which remain important in the regulatory context, then proceeds to recent epidemiological studies examining effects of chronic exposure in community settings due to emissions from volcanos, CAFOs, and other sources, and lastly reviews several occupational studies.</p><sec id="S28"><label>2.3.4.1</label><title>Controlled experiments</title><p id="P78">Several controlled experiments examined biochemical markers of respiratory-related function during and after H<sub>2</sub>S exposure, most recently in the 1990s. The two studies discussed below (<xref rid="R31" ref-type="bibr">Bhambhani et al. 1996</xref>; <xref rid="R32" ref-type="bibr">Bhambhani and Singh 1991</xref>) were used to establish Occupational Exposure Limits (OELs) in the United Kingdom (<xref rid="R49" ref-type="bibr">Costigan 2003</xref>) and are cited in the REL documentation (<xref rid="R163" ref-type="bibr">OEHHA 2008</xref>). More recent studies on lactate or oxygen stress were not identified. The two studies involved short-term exposure to small numbers of healthy individuals, and they may be most relevant to occupational settings. They update an older controlled study by <xref rid="R112" ref-type="bibr">Jappinen et al. (1990)</xref>, which may be the first controlled study of H<sub>2</sub>S effects on respiratory function.</p><list list-type="bullet" id="L30"><list-item><p id="P79"><xref rid="R112" ref-type="bibr">Jappinen et al. (1990)</xref> tested 26 male pulp mill workers with typical exposures from 2 to 7 ppm, and 3 men and 7 women with mild or moderate asthma. (Individuals with severe asthma were excluded.) Among the 10 individuals with asthma, a 30-min exposure to 2 ppm H<sub>2</sub>S caused a marginally significant increase in airway resistance R<sub>aw</sub> (average 26% change), but no change in FEV<sub>1</sub>, FVC, FEF<sub>25&#x02013;75</sub>, or specific airway conductance (SG<sub>aw</sub>). In 2 of 10 subjects, both R<sub>aw</sub> and SG<sub>aw</sub> changed by &#x0003e;30%, a sign of bronchial obstruction.</p></list-item><list-item><p id="P80"><xref rid="R32" ref-type="bibr">Bhambhani and Singh (1991)</xref> used 16 healthy young male adults and oral exposures to 0 (control), 0.5, 2 and 5 ppm (7 mg/m3) H<sub>2</sub>S under conditions of exercise. Lactate in blood and oxygen uptake showed a graded response, and results at 5 ppm were statistically different from those in controls. The authors suggested that at H<sub>2</sub>S doses from 2 to 5 ppm with higher exercise rates, oxygen is being utilized to detoxify H<sub>2</sub>S and that the activity of the enzyme cytochrome oxidase is inhibited. Both processes increase dependency on anaerobic metabolism and thus elevate blood lactate levels.</p></list-item><list-item><p id="P81"><xref rid="R31" ref-type="bibr">Bhambhani et al. (1996)</xref> compared effects of 0 (control) and 5 ppm exposures on the biochemical properties of skeletal muscle in 25 healthy young subjects (13 men, 12 women), who underwent two 30-min tests a moderate level of exercise, after which biopsies of the vastus lateralis muscle (part of the quadriceps) were obtained and analyzed for markers of anaerobic and aerobic metabolism. In men, levels of citrate synthase decreased significantly with exposure; lactose and lactate dehydrogenase increased although not significantly, and cytochrome oxidase decreased. Although most aerobic enzymes did not have statistically significant changes, short-term H<sub>2</sub>S exposure affected aerobic metabolism in a large proportion of men and women tested. Furthermore, exposure at half of the (U.K.) occupational exposure limit (OEL) resulted in a shift from aerobic to anaerobic metabolism. The authors remarked on the need to examine a larger sample to account for variability, as well as longer duration and higher concentration exposures.</p></list-item><list-item><p id="P82">In a detailed review of the physiological, pharmacological and toxicological effects of H<sub>2</sub>S, <xref rid="R166" ref-type="bibr">Olson (2011)</xref> noted the classical hormesis relationship between H<sub>2</sub>S exposure and O<sub>2</sub> consumption: at low concentrations, H<sub>2</sub>S stimulates oxygen consumption (and may even result in net ATP production); while at elevated levels, H<sub>2</sub>S inhibits consumption. However, the H<sub>2</sub>S concentrations in tissues and blood that cause these effects have not been resolved. The few studies employing controlled H<sub>2</sub>S exposures to evaluate respiratory outcomes, which use small sample sizes and only very short exposure periods, are consistent in showing that short (30 min) exposures at or around 2 ppm cause changes in indicators related to respiratory function in both healthy and (mild-to-moderate) asthmatic adults.</p></list-item></list></sec><sec id="S29"><label>2.3.4.2</label><title>Community studies near geothermal and volcanic sources</title><p id="P83">Respiratory impacts of H<sub>2</sub>S are not limited to high exposures; low levels also increase the risks of respiratory symptoms, respiratory disease mortality, and anti-asthma drug use (<xref rid="R38" ref-type="bibr">Bustaffa et al. 2020</xref>) as shown by studies examining communities near geothermal and volcanic H<sub>2</sub>S sources including Reykjavik (Iceland), Rotorua (New Zealand), the Azores (Portugal), and Mt. Amiata (Italy). (Geothermal emissions and hazards have been reviewed by <xref rid="R38" ref-type="bibr">Bustaffa et al. (2020)</xref> and <xref rid="R97" ref-type="bibr">Hansell and Oppenheimer (2004)</xref>.) Portions of these communities experience chronic exposure to H<sub>2</sub>S, estimated to be between 0.02 and 1.0 ppm; <xref rid="R162" ref-type="bibr">Nuvolone et al. (2019)</xref> found a lower range of 0.0003 to 0.0224 ppm. Both the older and the newer studies have associated chronic exposure with noninfectious respiratory symptoms and disease. For example, in Rotorua, <xref rid="R63" ref-type="bibr">Durand and Wilson (2006)</xref> used improved exposure mapping to show greatly elevated risks of a variety of respiratory symptoms and diseases; in Furnas, <xref rid="R9" ref-type="bibr">Amaral and Rodrigues (2007)</xref> showed a greatly increased rate of chronic bronchitis with exposure; in Reykjavik, <xref rid="R41" ref-type="bibr">Carlsen et al. (2012)</xref> found adverse impacts on individuals with asthma at H<sub>2</sub>S concentrations in the range of 0.0067 ppm; and in Tuscany, <xref rid="R162" ref-type="bibr">Nuvolone et al. (2019)</xref> found that an increase of 0.0047 ppm (90-day avg) could have both harmful and beneficial respiratory effects, results that may be partly explained by not testing for multiple outcomes. These studies do not demonstrate causal linkages to H<sub>2</sub>S exposure given potential confounding with other pollutants and, in some cases, issues regarding the comparability of the populations. The Reykjavik study (<xref rid="R41" ref-type="bibr">Carlsen et al. 2012</xref>) appears the strongest given its multiyear time series analysis, large sample, inclusive population, and objective measures of H<sub>2</sub>S and other pollutants. Further details on these studies follow.</p><list list-type="bullet" id="L32"><list-item><p id="P84"><xref rid="R63" ref-type="bibr">Durand and Wilson (2006)</xref> investigated respiratory disease among residents in Rotorua, New Zealand, a city of 61,000 where H<sub>2</sub>S exposure occurs from geothermal emissions (including sulfur springs, soil gas, and fumaroles). An H<sub>2</sub>S mapping survey using passive samplers and several weeks of sampling showed considerable spatial variation in concentrations, which results from varying soil gas emissions and meteorological influences. The analysis used 11 years (1991&#x02013;2001) of hospital discharge morbidity data, a cross-sectional analysis with groupings that assigned residential census area units (CAUs) to low, medium or high exposure categories (typical H<sub>2</sub>S concentrations of 0.03 &#x02013; 0.04, 0.5 and 1.0 ppm, respectively), and ecological controls for age, ethnicity, smoking status and socioeconomic status (deprivation). Greatly elevated risks (2 to 5-fold) were seen for all respiratory diseases, chronic obstructive pulmonary disease (COPD), asthma, and respiratory and chest symptoms. Study strengths include the large sample size, control of several potential confounders, and a more detailed exposure mapping than previously available. Study limitations include a lack of individual identifiers, inability to identify repeat hospital visits by an individual, the ecological smoking and deprivation data (linked to the CAU) that is a particular issue for Maori women due to their very high smoking rates, possible exposure misclassification due to short-term temporal fluctuations in H<sub>2</sub>S levels, sharp spatial gradients of H<sub>2</sub>S levels (<xref rid="R107" ref-type="bibr">Horwell et al. 2005</xref>), the likelihood of indoor exposures (<xref rid="R61" ref-type="bibr">Durand and Scott 2005</xref>), and (unknown) exposures at work and other non-residential environments.</p></list-item><list-item><p id="P85"><xref rid="R9" ref-type="bibr">Amaral and Rodrigues (2007)</xref> investigated the risk of chronic bronchitis using a population-based retrospective cohort design that compared two areas in the Azores, Portugal: one with volcanic activity (Furnas) that emitted H<sub>2</sub>S as well as water vapor, carbon dioxide, SO<sub>2</sub>, and other gases; and a second area (Santa Maria) without volcanic emissions. H<sub>2</sub>S exposures were not quantified, but earlier reports measured SO<sub>2</sub> at average levels between 0.01 and 0.08 ppm in Furnas (<xref rid="R27" ref-type="bibr">Baxter et al. 1999</xref>). Age and sex-adjusted incidence rates of chronic bronchitis, based on local medical records and census data from 1991 to 2001, were elevated in the exposed area relative to international norms, and the (all age) relative risk was 4.0 for males and 10.7 for females, based on a comparison of exposed to unexposed areas. High rates of chronic bronchitis in Furnas were partially attributed to chronic H<sub>2</sub>S and SO<sub>2</sub> exposure in a very humid atmosphere; co-exposure with SO<sub>2</sub>, a known toxicant and bronchoconstrictor, is a potential confounder.</p></list-item><list-item><p id="P86">A population-based time-series study examined the daily number of adults (&#x0003e;18 years of age) in Iceland&#x02019;s capital Reykjavik and the surrounding municipalities who were dispensed anti-asthma drugs as a function of daily air pollution levels over a nearly 4-year period (<xref rid="R41" ref-type="bibr">Carlsen et al. 2012</xref>). Geothermal sites outside the city emit H<sub>2</sub>S concentrations producing long term concentrations that averaged 0.0058 ppm (8.7 &#x003bc;g m<sup>&#x02212;3</sup>; maximum of 0.062 ppm [93 &#x003bc;g m<sup>&#x02212;3</sup>; 24-hr average]), and 1-hr levels that averaged 0.021 ppm (32 &#x003bc;g m<sup>&#x02212;3</sup>; maximum of 0.345 ppm [518 &#x003bc;g m<sup>&#x02212;3</sup>]). Poisson regression models using 3-day moving H<sub>2</sub>S averages, typically lagged several days, along with other pollutants (PM<sub>10</sub>, NO<sub>2</sub> and O<sub>3</sub>) and covariates (e.g., temperature, humidity, pollen count, influenza season, day-of-week, time trend and seasonal trend) showed that a small increase in H<sub>2</sub>S levels, 0.0067 ppm (10 &#x003bc;g m<sup>&#x02212;3</sup>), was associated with a modest (2%) but statistically significant increases in the number of individuals dispensed anti-asthma drugs, specifically inhalant adrenergics (both long- and short-acting bronchodilators). The authors noted that this was the first study outside of occupational settings to associate short-term changes in H<sub>2</sub>S levels with health-related outcomes. Study strengths include capturing essentially all drug prescriptions and considering multiple pollutants; weaknesses include the ecological design, the use of a single monitoring site, the lack of PM<sub>2.5</sub> data, a large amount of missing data, the inability to identify individual or group risk factors, and the surrogate indicator used for asthma exacerbation. While other pollutants were monitored, SO<sub>2</sub>, a known respiratory irritant, was not mentioned. However, continuous monitoring in Reykjavik shows that SO<sub>2</sub> levels are low relative to 24-hr and annual average limit values (<xref rid="R200" ref-type="bibr">Sk&#x000fa;lad&#x000f3;ttir and &#x000de;&#x000f3;r&#x000f0;arson 2003</xref>).</p></list-item><list-item><p id="P87"><xref rid="R23" ref-type="bibr">Bates et al. (2013)</xref> assessed the effect of H<sub>2</sub>S on asthma among 1,637 adults in Rotorua City, New Zealand. Recruitment used a 2-stage stratified strategy with mail and phone calls to individuals selected from a centralized patient registry, who then visited the study clinic and completed a questionnaire and clinical tests. Participant age ranged from 18&#x02013;65 years; most (60%) were female; 50% were former or current smokers; and 24% reported a prior or current asthma diagnosis. A city-wide monitoring network, consisting of 50 passive samplers deployed for 2 weeks in summer and 53 samplers in winter of 2010, was spatially interpolated via kriging to estimate quartiles of ambient H<sub>2</sub>S levels at each participant&#x02019;s residence and workplace for the prior 30 years. Ambient levels ranged from 0 to 0.064 ppm (IQR: 0.011 &#x02013; 0.031 ppm). The H<sub>2</sub>S exposure groups were not associated with increased asthma risk or most symptoms, with exceptions of increased coughing in the third exposure quartile (overall not statistically significant) and slightly reduced wheeze in the fourth (highest) exposure quartile. The authors discuss possible issues including selection bias, survivor effect, confounding due particulate matter exposure due to wood smoke (modeled PM<sub>10</sub> levels were noted to fall below 100 &#x003bc;g/m<sup>3</sup> and were inversely related to H<sub>2</sub>S levels based), NO<sub>2</sub> and traffic pollutant levels (stated to be positively correlated with H<sub>2</sub>S). Only minor differences were noted in analyses using exposures at home or work. While participants were required to live in Rotorua for at least 3 years prior to the study, residential and workplace histories were not obtained (only current addresses were used) and participation was limited to city residents.</p></list-item><list-item><p id="P88">Effects of ambient H<sub>2</sub>S in Reykjavik also were reported by <xref rid="R81" ref-type="bibr">Finnbjornsdottir et al. (2016)</xref>. In regions near a geothermal power plant, the risk of an emergency hospital visit (also heart disease and stroke as discussed later) among the 151,095 residents was investigated using a time series model and daily H<sub>2</sub>S levels at residences of the 13,383 patients visiting the hospital (32961 visits) over the 7.5 year study period. H<sub>2</sub>S levels were estimated using a simple plume-type model, and 24-hr H<sub>2</sub>S levels ranged from 0 to 0.047 ppm (69.5 &#x003bc;g/m<sup>3</sup>; IQR: 0 &#x02013; 0.003 ppm). No association was found between H<sub>2</sub>S and respiratory-related emergency visits. An important limitation of this study concerns ascertainment of outcomes, which used only collective categories (heart disease, respiratory disease, stroke).</p></list-item><list-item><p id="P89"><xref rid="R162" ref-type="bibr">Nuvolone et al. (2019)</xref> studied 33,804 residents near Mt. Amiata, Tuscany, Italy, home to geothermal power plants. Risks of neoplasms, respiratory diseases, central nervous diseases, and cardiovascular diseases were calculated using mortality and hospital data (non-respiratory effects are discussed later). Individual H<sub>2</sub>S exposures (maximum 90-day moving average estimated using dispersion modeling and geocoded addresses) ranged from 0.00034 to 0.022 ppm (0.5 to 33.5 &#x003bc;g/m<sup>3</sup>; mean of 0.005 ppm, SD of 0.005 ppm). A 0.005 ppm (7 &#x003bc;g/m<sup>3</sup>) increase in H<sub>2</sub>S levels was associated with a 12% increase in respiratory mortality and a 27% increase in pneumonia hospitalizations, and with reduced risk respiratory disease hospitalizations. Lower mortality risks (protective effect) were observed for cardiovascular diseases. Other respiratory effects were found to be less robust. While using medicate records and successfully geocoding most addresses to obtain model-based exposure estimates, the residential cohort design did provide information on individual-level confounders, e.g., smoking, alcohol consumption and diet.</p></list-item></list></sec><sec id="S30"><label>2.3.4.3</label><title>Studies regarding livestock rearing systems</title><p id="P90">Respiratory effects associated with H<sub>2</sub>S emissions from livestock rearing systems, including CAFOs, have been investigated in a few controlled and occupational epidemiological studies. However, a number of community-based studies have suggested increased prevalence of respiratory and asthma symptoms and lung function impacts among children and adults experiencing chronic exposure. While designs of these studies vary considerably, as summarized below, all but one identified respiratory-related disease or health symptoms, including breathing difficulty, chest tightness, wheeze (<xref rid="R37" ref-type="bibr">Bullers 2005</xref>; <xref rid="R39" ref-type="bibr">Campagna et al. 2004</xref>; <xref rid="R151" ref-type="bibr">Mirabelli et al. 2006a</xref>, <xref rid="R152" ref-type="bibr">2006b</xref>; <xref rid="R174" ref-type="bibr">Radon et al. 2007</xref>; <xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>), increased asthma prevalence and/or aggravation (<xref rid="R39" ref-type="bibr">Campagna et al. 2004</xref>; <xref rid="R148" ref-type="bibr">Merchant et al. 2005</xref>; <xref rid="R174" ref-type="bibr">Radon et al. 2007</xref>; <xref rid="R194" ref-type="bibr">Sigurdarson and Kline 2006</xref>) lung function (PEF and FEV<sub>1</sub>) decrements (<xref rid="R174" ref-type="bibr">Radon et al. 2007</xref>; weakly in <xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>), and COPD (<xref rid="R64" ref-type="bibr">Eduard et al. 2009</xref>), though the latter association was weak and only present in in farmers with atopy. The single negative study, <xref rid="R214" ref-type="bibr">Villeneuve et al. (2009)</xref>, had significant limitations: it examined a relatively small farm, had a small sample size, and the &#x0201c;high&#x0201d; exposure group extended 3 km radius from the farm, longer than the distance usually considered for CAFO impacts. Many of these studies used residential proximity to livestock as an exposure surrogate, but several recent studies used objective air quality measurements. Other issues include selection bias, measurement error, and multiple exposures (<xref rid="S53" ref-type="sec">Section 2.4.3</xref>). Of particular note, H<sub>2</sub>S exposure due to livestock rearing systems can be accompanied with elevated levels of endotoxins, ammonia, and organic dusts, all of which are strongly implicated in the development of respiratory disease (<xref rid="R232" ref-type="bibr">Woodall et al. 2005</xref>). Two studies with objective pollutant measures used time series analyses to show increased rates of unscheduled hospital visits for aggravation of asthma and respiratory disease at 30-min H<sub>2</sub>S concentrations above 0.03 ppm in Nebraska (<xref rid="R39" ref-type="bibr">Campagna et al. 2004</xref>), and a dose-response relationship for breathing difficulty and wheeze with odor and H<sub>2</sub>S at mean levels of 0.0003 ppm in North Carolina (<xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>).</p><list list-type="bullet" id="L34"><list-item><p id="P91"><xref rid="R37" ref-type="bibr">Bullers (2005)</xref>, described previously (<xref rid="S14" ref-type="sec">Section 2.3.1.3</xref>), associated residential proximity to hog farms for 12 of 22 self-reported symptoms investigated, including respiratory problems.</p></list-item><list-item><p id="P92">A time series analysis examined daily unscheduled or emergency hospital visits (N=5009) for respiratory disease among residents of Dakota City and South Sioux City, Nebraska, U.S. from January 1998 to May 2000 (<xref rid="R39" ref-type="bibr">Campagna et al. 2004</xref>). This area contained 13 known reduced sulfur sources; the largest, a beef slaughter and leather tanning facility with a waste treatment complex, emitted an estimated 1,900 pounds/day of H<sub>2</sub>S. TRS and H<sub>2</sub>S were measured in the community at 3 and 14 sites, respectively, and daily levels were categorized as &#x0201c;high&#x0201d; if any 30-min rolling averages exceeded 0.03 ppm (30 ppb) and as &#x0201c;low&#x0201d; otherwise. Previous sampling identified H<sub>2</sub>S as the only sulfur contaminant present in sufficient concentrations to cause concern. High days occurred on ~25% of days in the study. For children less than 18 years of age (N=174 visits), asthma hospital visits were associated with 1-day lagged TRS levels, and hospital visits for all respiratory diseases were associated with 1-day lagged H<sub>2</sub>S and TRS levels. Adult asthma hospital visits (N=281 visits) also were associated with 1-day lagged H<sub>2</sub>S levels. The study included diagnostic controls (visits for digestive diseases), which was negative. Linkages between TRS and H<sub>2</sub>S with exacerbations of asthma and other respiratory diseases appear robust given the community-wide exposure monitoring and the near-complete capture of visits in the local hospitals. Study limitations include issues regarding the quality of exposure data, the lack of individual measures, possible outcome misclassification, and possible omission of residents treated outside the community.</p></list-item><list-item><p id="P93">In Iowa, U.S., children living on farms that raised swine had a very high prevalence rate of asthma-related outcomes (44.1%); children on farms that raise swine adding antibiotics to feed had an even higher rate (55.8%), despite generally lower rates of atopy and personal histories of allergy in farm populations (<xref rid="R148" ref-type="bibr">Merchant et al. 2005</xref>). No environmental measurements were conducted, although high occupational exposures to respirable and total dust, endotoxin, H<sub>2</sub>S and ammonia have been shown in other Iowa farm studies. Several asthma symptoms were attributable to these co-exposures.</p></list-item><list-item><p id="P94">The controlled study by <xref rid="R185" ref-type="bibr">Schiffman et al. (2005)</xref>, previously detailed (<xref rid="S14" ref-type="sec">Section 2.3.1.3</xref>), found no association between a CAFO mixture containing H<sub>2</sub>S at an average concentration of 0.024 ppm and lung function or vital signs.</p></list-item><list-item><p id="P95">In Saxony, Germany, <xref rid="R174" ref-type="bibr">Radon et al. (2007</xref>; <xref rid="R173" ref-type="bibr">2005)</xref> studied 3,131 individuals with farm contact and 2,425 individuals without farm contact living near CAFOs. Among the group without farm contact, odds for all respiratory symptoms and for physician-diagnosed asthma increased with increasing self-reported level of odor annoyance. Odds of self-reported wheeze increased for individuals living within 500 m of 5 or more animal houses, and FEV<sub>1</sub> decreased for those living within 500 m of 12 animal houses. Study strengths include a large sample size, the development of dose-response curves relating health impacts to the number of animal houses, and the exclusion of individuals with professional or private contact with farming environments; author-noted limitations include the surrogate exposure metric, specifically that the number of animal houses is a poor exposure indicator, and the lack of ammonia and endotoxin co-pollutant measurements that be confounders.</p></list-item><list-item><p id="P96"><xref rid="R151" ref-type="bibr">Mirabelli et al. (2006a</xref>; <xref rid="R152" ref-type="bibr">2006b)</xref> studied the prevalence of wheezing among children 12 to 14 years of age living in North Carolina, USA. Wheeze prevalence among children with allergies was 5% higher at schools located within 3 miles of swine feeding operation, and 24% higher at schools where livestock odor was noticeable indoors twice or more per month, compared to schools at further distances or without odors.</p></list-item><list-item><p id="P97"><xref rid="R194" ref-type="bibr">Sigurdarson and Kline (2006)</xref> conducted a cross-sectional study of children attending two elementary schools in Iowa, USA, one located within 0.5 mile from a CAFO (n=61) and the other distant from large scale agricultural operations (n=248). The former school had a much higher prevalence of physician-diagnosed asthma (19.7%) than the control school (7.3%). Although the two populations differed (e.g., parents in the study school were more likely to work on a farm and to smoke), adjusted models showed that children remained at risk (adjusted odds ratio = 5.71, p = 0.004). No exposure measurements were taken.</p></list-item><list-item><p id="P98">An occupational study by <xref rid="R64" ref-type="bibr">Eduard et al. (2009)</xref> examined associations between H<sub>2</sub>S and respiratory morbidity and mortality among 4,735 Norwegian farmers on crop-only, livestock-only, and crop-and-livestock farms. Based on personal air sampling, the median annual average exposure was 1.1 ppb (IQR: 0.2 &#x02013; 36 ppb). If H<sub>2</sub>S-related tasks and H<sub>2</sub>S odor were absent, levels were assumed to be 0 ppb. Cattle and swine farms had the highest H<sub>2</sub>S levels, 0.036 and 0.029 ppm (36 ppb and 29 ppb), respectively; sheep/goats and poultry farms both had levels of 0.0002 ppm (0.20 ppb), and crop-only farms had 0 ppm (0 ppb). A subset of 1,213 farmers with atopy showed a weakly elevated risk of COPD when comparing with high vs. low exposure groups. No dose-response relationship was observed, and H<sub>2</sub>S exposure was not associated with chronic bronchitis or lung function. While the study results were negative or inconclusive, the use of personal air sampling is unique among the studies and has the potential to reduce exposure measurement error.</p></list-item><list-item><p id="P99">A cross-sectional study in rural Sarsfield, Ottawa, Canada, found that self-reported respiratory health disease and symptoms (asthma, rhinitis, sinusitis, chronic bronchitis, allergies) of 723 adults and 285 children/adolescents were not associated with distance between residences and hog farm operations (<xref rid="R214" ref-type="bibr">Villeneuve et al. 2009</xref>). The authors noted the lack of direct exposure measures and possible biases from using self-reported health measures. (This study did find a higher prevalence of depression and lower health related quality of life measures.)</p></list-item><list-item><p id="P100"><xref rid="R186" ref-type="bibr">Schinasi et al. (2011)</xref>, described earlier (<xref rid="S14" ref-type="sec">Section 2.3.1.3</xref>), found that wheeze and breathing difficulty increased with general odor perception and ambient H<sub>2</sub>S levels in a dose-response fashion (per 1 ppb), and that cough increased with general odor perception. Pulmonary function (PEF and FEV<sub>1</sub>) was only weakly associated with odor and pollutant levels (not limited to H<sub>2</sub>S). A study limitation acknowledged by the authors is the low quality of lung function data.</p></list-item><list-item><p id="P101"><xref rid="R115" ref-type="bibr">Kilburn (2012)</xref>, discussed previously (<xref rid="S20" ref-type="sec">Section 2.3.2.3</xref>), found significant differences between exposed and (local) control populations for 18 of 35 symptoms, including chest tightness, palpitations, shortness of breath, dry cough, and several pulmonary function measures (FVC, FEV<sub>1</sub>).</p></list-item></list></sec><sec id="S31"><label>2.3.4.4</label><title>Studies near other industries</title><p id="P102">Health effects of H<sub>2</sub>S exposures have been examined in industrial settings other than CAFOs.</p><list list-type="bullet" id="L36"><list-item><p id="P103"><xref rid="R140" ref-type="bibr">Logue et al. (2001)</xref>, a community-based study detailed above (<xref rid="S15" ref-type="sec">Section 2.3.1.4</xref>), found no association between H<sub>2</sub>S and respiratory effects among children attending an elementary school near a composting facility.</p></list-item><list-item><p id="P104"><xref rid="R133" ref-type="bibr">Lewis et al. (2003)</xref> examined mortality and morbidity associated with H<sub>2</sub>S among 25,292 petroleum workers in Canada in an inception cohort from 1964 onwards. A job-exposure matrix (JEM) estimated cumulative lifetime occupational exposure, which were validated using workplace measures. The median annual H<sub>2</sub>S exposure was 0.07 ppm, the IQR was 0.01 &#x02013; 0.60 ppm, and the 95<sup>th</sup> percentile is 4.76 ppm. The study included estimates of possible exposure to cigarette smoke, hydrocarbons (solvents, fuels and lubricants), coke and catalysts. No association was found between H<sub>2</sub>S exposure and respiratory disease. (Results for additional endpoints (cancer, neurobehavior) are discussed elsewhere (<xref rid="S38" ref-type="sec">Sections 2.3.6.2</xref> and <xref rid="S39" ref-type="sec">2.3.6.3</xref>)</p></list-item><list-item><p id="P105"><xref rid="R150" ref-type="bibr">Mirabelli and Wing (2006)</xref> found that residential proximity within 10 miles to four pulp and paper mills in North Carolina, U.S. was weakly associated with elevated prevalence of daytime wheezing among students who reported using cigarettes or experiencing second-hand cigarette smoke exposure. The association is based on questionnaires provided by over 64,000 children attending public schools. Although associations attained marginal significance and exposures were not quantified, the study suggests the importance of considering interactions between environmental exposures and personal or household exposures, and possibly that children exposed to cigarette smoke may represent a particularly vulnerable population.</p></list-item><list-item><p id="P106"><xref rid="R130" ref-type="bibr">Lee et al. (2007)</xref>, discussed previously (<xref rid="S15" ref-type="sec">Section 2.3.1.4</xref>), found that workers exposed to H<sub>2</sub>S had higher risks of respiratory symptoms including dry cough, cough with phlegm, wheeze, chest tightness, and breathlessness.</p></list-item><list-item><p id="P107"><xref rid="R6" ref-type="bibr">Al-Batanony and El-Shafie (2011)</xref> analyzed effects of sulf-hemoglobin, used as a biomarker of H<sub>2</sub>S exposure, in 43 workers at a wastewater treatment plant (exposed) and 43 unexposed workers in Egypt. Respiratory symptoms and cardiovascular functioning were assessed using self-reported data and clinical tests. Sulf-hemoglobin levels were significantly higher among the exposed than unexposed workers (0.41&#x000b1;0.13% vs. 0.08&#x000b1;0.02%, p&#x0003c;0.001). No findings linking H<sub>2</sub>S exposure and respiratory function were reported. (Results for cardiovascular effects are discussed in the following section.) This is the only study reviewed that used sulf-hemoglobin as an exposure biomarker, however, the characteristics of this biomarker were not well defined.</p></list-item><list-item><p id="P108"><xref rid="R101" ref-type="bibr">Heldal et al. (2019)</xref> examined the respiratory function of 148 mostly male wastewater workers (121 exposed; 47 unexposed) using an exposure index derived from personal sampling that reflected the number and duration of H<sub>2</sub>S peaks above 0.1, 1, 5 and 10 ppm (<xref rid="R20" ref-type="bibr">Austigard et al. 2018</xref>). Airway symptoms were significantly higher in H<sub>2</sub>S-exposed workers than unexposed workers, however, H<sub>2</sub>S was not associated with FEV<sub>1</sub> or FVC. No interactions were seen between H<sub>2</sub>S and endotoxin, a common co-exposure. Nausea and fever were not significantly associated with H<sub>2</sub>S.</p></list-item></list></sec><sec id="S32"><label>2.3.4.5</label><title>Summary of respiratory and allergic effects</title><p id="P109">Most of the controlled studies examining acute H<sub>2</sub>S exposures are older studies that remain important in the regulatory context. Using 30-min exposures and H<sub>2</sub>S concentrations from 2 to 5 ppm, these studies show changes in several indicators of respiratory function in both healthy and (mild-to-moderate) asthmatic adults (<xref rid="R31" ref-type="bibr">Bhambhani et al. 1996</xref>; <xref rid="R32" ref-type="bibr">Bhambhani and Singh 1991</xref>; <xref rid="R112" ref-type="bibr">Jappinen et al. 1990</xref>). The only newer controlled study is <xref rid="R185" ref-type="bibr">Schiffman et al. (2005)</xref>, who used 1-hr exposures of dilute swine confinement with H<sub>2</sub>S at a concentration of 0.024 ppm to show increase prevalence of headache, eye irritation and nausea, but no significant effects on vital signs, lung function, nasal inflammation, salivary IgA, mood, attention or memory were found.</p><p id="P110">The recent epidemiological studies have examined chronic exposure near volcanic areas, CAFOs, and industrial sources, often extending on older studies. Community studies around geothermal and volcanic emission sources in Iceland, the Azores, Tuscany, and New Zealand tend to show higher prevalence rates of respiratory symptoms and disease. <xref rid="R41" ref-type="bibr">Carlsen et al. (2012)</xref>, the strongest of these studies, found exacerbation of asthma at H<sub>2</sub>S concentrations of 0.0067 ppm; <xref rid="R63" ref-type="bibr">Durand and Wilson (2006)</xref> and <xref rid="R9" ref-type="bibr">Amaral and Rodrigues (2007)</xref> showed greatly elevated risks of a range of respiratory symptoms and disease; while <xref rid="R162" ref-type="bibr">Nuvolone et al. (2019)</xref>, <xref rid="R23" ref-type="bibr">Bates et al. (2013)</xref> and <xref rid="R81" ref-type="bibr">Finnbjornsdottir et al. (2016)</xref> found weak or contradictory associations. A number of new studies examined CAFOs and similar sources, adding to some 70 earlier studies that examined these sources. These show many common impacts, including sore throat, cough, nasal irritation, difficulty of breathing, chest tightness, wheezing, increased asthma prevalence and/or aggravation, lung function decrements, and other impacts. Many of these studies use distance from emission facilities as a proxy for exposure, and the role of H<sub>2</sub>S cannot be isolated in most of the studies (<xref rid="S57" ref-type="sec">Sections 2.4.3.4</xref> and <xref rid="S58" ref-type="sec">2.4.3.5</xref>). Two studies are notable for their rigor and methodological contributions: <xref rid="R39" ref-type="bibr">Campagna et al. (2004)</xref> found statistically significant though small increases in unscheduled hospital visits for asthma aggravation and respiratory disease at 30-min H<sub>2</sub>S concentrations above 0.03 ppm; <xref rid="R186" ref-type="bibr">Schinasi et al. (2011)</xref> found a dose-response relationship between breathing difficulty and cough with odor and H<sub>2</sub>S at mean levels of 0.0003 ppm.</p><p id="P111">In addition, the recent epidemiology literature has suggested populations that are susceptible to chronic low level H<sub>2</sub>S exposure: <xref rid="R39" ref-type="bibr">Campagna et al. (2004)</xref> identified that individuals with asthma are more susceptible to respiratory disease aggravation; <xref rid="R64" ref-type="bibr">Eduard et al. (2009)</xref> found that farmers with atopy are more susceptible to increased prevalence of COPD; and <xref rid="R151" ref-type="bibr">Mirabelli et al. (2006a</xref>) remarks that children using cigarettes or experiencing second hand tobacco smoke are susceptible to increased prevalence of wheeze with H<sub>2</sub>S exposure. Such results are unsurprising given the increased sensitivity of individuals with asthma and/or allergies to odors and respiratory irritants (<xref rid="R68" ref-type="bibr">EPA 2017</xref>).</p><p id="P112">The community and occupational studies hint that industrial emission sources such as wastewater facilities may affect respiratory health (<xref rid="R130" ref-type="bibr">Lee et al. 2007</xref>), although evidence is severely lacking and scattered across many industries.</p></sec></sec><sec id="S33"><label>2.3.5</label><title>Cardiovascular and metabolic effects</title><p id="P113">Over the past several years, many studies have investigated the effects of H<sub>2</sub>S on the cardiovascular system using animal models. In large part, this is motivated by the therapeutic potential of H<sub>2</sub>S, which has been considered a &#x0201c;hot&#x0201d; new signaling molecule that seemingly affects all organ systems and biological processes, as discussed in several recent reviews (<xref rid="R166" ref-type="bibr">Olson 2011</xref>; <xref rid="R172" ref-type="bibr">Qu et al. 2008</xref>; <xref rid="R212" ref-type="bibr">Varaksin and Puschina 2011</xref>). On systemic blood vessels and other organ systems, H<sub>2</sub>S can have a vasodilatory effects via signaling and other mechanisms, although mechanisms remain unclear and may involve interactions between H<sub>2</sub>S, NO and CO. The cited reviews discuss multiple metabolic mechanisms and effects. For example, male mice exposed to H<sub>2</sub>S at 80 ppm for 6 hr showed marked but reversible cardiovascular abnormalities, including bradycardia (50% reduction in heart rate and irregular heart rate), lower cardiac output, lower core body temperature, lower respiratory rate, and reduced spontaneous physical activity, possibly due to inhibitory effects of H<sub>2</sub>S on metabolism, among other reasons (<xref rid="R215" ref-type="bibr">Volpato et al. 2008</xref>). <xref rid="R1" ref-type="bibr">ACGIH (2001)</xref> discusses metabolic changes in people exposed to H<sub>2</sub>S at 20 ppm and above (<xref rid="R33" ref-type="bibr">Blackstone et al. 2005</xref>), and similar studies and potential applications are discussed by <xref rid="R14" ref-type="bibr">Aslami et al. (2009)</xref>. Because studies are animal-based, typically use high concentrations, and are not intended to address concerns related to community exposures and public health, they are not further discussed in this report. The following summarizes epidemiological studies that have investigated cardiovascular effects of H<sub>2</sub>S at low concentrations in community and occupational settings.</p><list list-type="bullet" id="L38"><list-item><p id="P114">An occupational study by <xref rid="R6" ref-type="bibr">Al-Batanony and El-Shafie (2011)</xref>, detailed previously (<xref rid="S31" ref-type="sec">Section 2.3.4.4</xref>), assessed the relationship between sulf-hemoglobin, which they used as a biomarker for H<sub>2</sub>S exposure, and cardiovascular functioning. Overall, workers with higher exposure (higher percent sulf-hemoglobin) were more likely to have heart problems but the sample size was very small (n = 12) and no additional statistical tests were conducted.</p></list-item><list-item><p id="P115">A previously-described study (<xref rid="S29" ref-type="sec">Section 2.3.4.2</xref>) by (<xref rid="R81" ref-type="bibr">Finnbjornsdottir et al. 2016</xref>) assessed the relationship between ambient H<sub>2</sub>S and risk of emergency hospital visits due to heart disease and stroke. H<sub>2</sub>S concentrations exceeding 0.005 ppm (7 &#x003bc;g/m<sup>3</sup>) were associated with a slight increase in same-day emergency hospital visits with heart disease as the primary diagnosis. This association with heart disease was higher among males and among those 73 years and older. Associations were weaker when analyzing H<sub>2</sub>S measurements from days prior to hospital admittance. H<sub>2</sub>S was not associated with stroke.</p></list-item><list-item><p id="P116">A community-based study by <xref rid="R162" ref-type="bibr">Nuvolone et al. (2019)</xref>, described previously (<xref rid="S29" ref-type="sec">Section 2.3.4.2</xref>), concluded that a 0.005 ppm (7 &#x003bc;g/m<sup>3</sup>) increase in H<sub>2</sub>S was associated with an increased risk of hospitalizations for heart failure and vein/lymphatic disease, but also a lower risk of ischemic heart disease mortality. Other effects were suggested with weaker associations.</p></list-item></list><sec id="S34"><label>2.3.5.1</label><title>Studies regarding livestock rearing systems.</title><p id="P117">Livestock rearing systems have been studied in relation to various health effects, as discussed earlier. Only one study by <xref rid="R115" ref-type="bibr">Kilburn (2012)</xref> has evaluated possible cardiovascular effects associated with proximity to CAFO facilities. <xref rid="R115" ref-type="bibr">Kilburn (2012)</xref>, described in <xref rid="S20" ref-type="sec">Section 2.3.2.3</xref>, found significant differences between exposed and control populations for 18 of 35 symptoms, including chest tightness and palpitations.</p></sec><sec id="S35"><label>2.3.5.2</label><title>Summary of cardiovascular and metabolic effects.</title><p id="P118">Epidemiological studies of cardiovascular effects are inconclusive, suggesting both weak positive and negative associations with outcomes such as ischemic heart disease mortality, acute myocardial infarction mortality, and vein or lymphatic disease hospitalization among others. The studies assessing additional cardiovascular outcomes generally found no significant effects.</p></sec></sec><sec id="S36"><label>2.3.6</label><title>Neurological and neurobehavioral effects</title><p id="P119">In animals, chronic medium level H<sub>2</sub>S exposure (6.7 ppm) has been shown to adversely affect myelination of the central nervous system (<xref rid="R202" ref-type="bibr">Solnyshkova 2003</xref>; <xref rid="R203" ref-type="bibr">Solnyshkova and Shakhlamov 2002</xref>). Earlier human studies of low-to-medium level exposures suggested many neurological/neurobehavioral symptoms, e.g., memory defects, lack of concentration, depression, and other cognitive and sensory defects. These studies have highlighted a lack of understanding regarding H<sub>2</sub>S toxicity and the pathophysiological mechanisms affecting brain function, and they reinforce the need for larger and better controlled studies (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>; <xref rid="R80" ref-type="bibr">Fiedler et al. 2008</xref>; <xref rid="R103" ref-type="bibr">Hirsch 2002</xref>). Many of these studies can be criticized given the general lack of objective measures of cognitive performance, imprecise and highly variable exposure estimates, and the mixture of pollutants involved in most cases. Exceptions are the controlled study by <xref rid="R80" ref-type="bibr">Fiedler et al. (2008)</xref>, a community study by <xref rid="R110" ref-type="bibr">Inserra et al. (2004)</xref>, and the newer studies by <xref rid="R117" ref-type="bibr">Kilburn (1999</xref>, <xref rid="R115" ref-type="bibr">2012)</xref>; <xref rid="R121" ref-type="bibr">Kilburn and Warshaw (1995)</xref>.</p><sec id="S37"><label>2.3.6.1</label><title>Controlled studies</title><p id="P120">Two recent controlled studies examined neurological and neurobehavioral effects:</p><list list-type="bullet" id="L40"><list-item><p id="P121"><xref rid="R185" ref-type="bibr">Schiffman et al. (2005)</xref>, previously described (<xref rid="S14" ref-type="sec">Section 2.3.1.3</xref>), positively associated H<sub>2</sub>S exposure with the prevalence of headache and nausea; associations were not found with mood, memory, or attention.</p></list-item><list-item><p id="P122"><xref rid="R80" ref-type="bibr">Fiedler et al. (2008)</xref> exposed 74 adults to concentrations of 0.05, 0.5 and 5 ppm H<sub>2</sub>S in 2-hour periods over three consecutive weeks; the subjects completed ratings and tests before and during the final hour. The subjects were relatively young (mean of 24.7 &#x000b1; 4.2 years of age), highly educated (16.5 &#x000b1; 2.4 years), and healthy. A broad set of symptoms were investigated, and included physical (headache, fatigue, lightheaded, drowsy, nausea), cognitive (difficulty concentrating, disoriented/confused, dizzy), eye irritation (burning, dryness, itching, runny/watery eyes), anxiety (feel jittery in body, feel nervous, heart palpitations, feel tense, worried), upper respiratory (sneeze, nasal congestion, choking, throat irritation, nose irritation), lower respiratory (shortness of breath, wheezy, chest tightening, chest pain, coughing, somatic control (skin irritation or dryness, stomach ache, numbness, ear ringing, leg cramps, back pain, sweating, body aches), environmental quality (light intensity, ventilation, air movement, air quality, noise level, room temperature, humidity, odor level), and odor ratings (irritation, intensity, pleasantness). Dose&#x02013;response relationships were observed for odor intensity, irritation and unpleasantness, but not for sensory or cognitive measures. While the total symptom severity was not significantly elevated for any exposure condition, anxiety symptoms significantly increased at 5 ppm compared to 0.05-ppm; verbal learning was also affected. The authors concluded that while exposure increased several symptoms, the magnitude of the changes was relatively minor, and that increased anxiety was due to irritation associated with odor. They also noted the need for further investigation to confirm effects on verbal learning, which could represent a threshold effect of H<sub>2</sub>S, fatigue, or some other factor, and issues in generalizing results to communities or workers who are chronically exposed with a range of health conditions and ages.</p></list-item></list></sec><sec id="S38"><label>2.3.6.2</label><title>Occupational studies</title><p id="P123">A number of occupational studies have investigated neurological endpoints associated with mostly acute H<sub>2</sub>S exposures above 10 ppm. Headaches have been associated with acute (30 &#x02013; 60 min) and high (240 &#x02013; 500 ppm) H<sub>2</sub>S exposures, followed by neuropsychiatric clinical disorders, unconsciousness, and respiratory failure (<xref rid="R103" ref-type="bibr">Hirsch 2002</xref>; <xref rid="R119" ref-type="bibr">Kilburn 1993</xref>; <xref rid="R197" ref-type="bibr">Sjaastad and Bakketeig 2006</xref>). In a survey of residents of V&#x000e5;g&#x000e5;, Norway, <xref rid="R197" ref-type="bibr">Sjaastad and Bakketeig (2006)</xref> found 2 cases of &#x0201c;hydrogen sulphide headaches&#x0201d; among 1,838 WWTP workers exposed to at least 100 ppm, but no individuals in the (mostly soapstone) mining industry reported such headaches. <xref rid="R113" ref-type="bibr">Kangas et al. (1984)</xref> reported headaches at 20 ppm. More commonly, headaches are reported following acute exposures at concentrations of 300 &#x02013; 500 ppm (<xref rid="R197" ref-type="bibr">Sjaastad and Bakketeig 2006</xref>). In addition to headaches, earlier studies have investigated neurobehavioral function among acutely exposed workers (n = 16) in several industries in Texas, Louisiana, and elsewhere, among residents living downwind of oil fields in Kentucky and Texas (<xref rid="R118" ref-type="bibr">Kilburn 1997</xref>), and among highly exposed individuals (n = 19) in several states and Canada (<xref rid="R116" ref-type="bibr">Kilburn 2003</xref>).</p><p id="P124">The following studies have examined chronic, low-level exposure in occupational settings.</p><list list-type="bullet" id="L42"><list-item><p id="P125"><xref rid="R121" ref-type="bibr">Kilburn and Warshaw (1995)</xref> found that H<sub>2</sub>S-exposed workers (n = 13) at and residents (n = 22) living near an oil refinery in California, U.S. had different neurophysiological outcomes (e.g., reaction time, balance, color discrimination, digit symbol, immediate recall) and mood state scores than controls, which consisted of residents drawn randomly from towns free of known contamination (N=359). H<sub>2</sub>S exposures averaged 0.01 ppm (1-week average) and peaks reached 0.1 ppm at neighboring homes and 8.8 ppm (24-hr average) at the refinery. Other pollutants measured included carbonyl sulfide (2.6 &#x02013; 52.1 ppm) and mercaptans (1 &#x02013; 21.1 ppm; 24-hr averages). Workers and exposed residents were combined into one &#x0201c;exposed&#x0201d; group, which increased power but reduced the exposure contrast and precluded the opportunity to observe a potential dose-response relationship. The petroleum refinery, which included coking units and a desulfurization plant, likely emitted a number of pollutants in addition to H<sub>2</sub>S, e.g., mercaptans, carbonyl sulfide, combustion-related gases, particulate matter, and VOCs, that were not characterized in this early study.</p></list-item><list-item><p id="P126"><xref rid="R133" ref-type="bibr">Lewis et al. (2003)</xref>, described earlier (<xref rid="S31" ref-type="sec">Section 2.3.4.4</xref>), examined the relationship between H<sub>2</sub>S exposure and potentially neurological-related outcomes, including accidental falls and transportation accidents. For workers exposed to a (median) lifetime H<sub>2</sub>S concentration of 0.07 ppm (IQR: 0.01 &#x02013; 0.60 ppm), males showed no association between H<sub>2</sub>S and neurological-related mortality or death due to accidental falls, but a slight positive association was shown for mortality due to transportation accidents when comparing upper and lower exposure tertiles (&#x02265;1.5 versus &#x0003c;0.1 ppm-years). The median cumulative concentration was 0.17 ppm after adjustments for employment duration (average 8.8 years). This study has a small sample size (n = 15) and lacks a dose-response relationship. More recent assessments note that individuals with underlying neurological conditions or temporary impairment to motor functioning, cognition, or vision may be at greater risk to adverse neurological outcomes from H<sub>2</sub>S exposure (<xref rid="R139" ref-type="bibr">Lococo et al. 2018</xref>; <xref rid="R225" ref-type="bibr">WHO 2018</xref>).</p></list-item><list-item><p id="P127">In the study of 175 WWTP and WTP workers in Iowa, U.S. discussed earlier (<xref rid="S15" ref-type="sec">Section 2.3.1.4</xref>), workers with H<sub>2</sub>S exposure had higher prevalence of neurological symptoms (headache, dizziness, memory or concentration difficulties, tiredness), and higher rates of depression (<xref rid="R130" ref-type="bibr">Lee et al. 2007</xref>).</p></list-item><list-item><p id="P128">In Egypt, H<sub>2</sub>S exposure was associated with cognitive impairment among sewer maintenance workers (n = 33) compared to an unexposed group (n = 30) matched for age, education and socio-economic status (<xref rid="R79" ref-type="bibr">Farahat and Kishk 2010</xref>). H<sub>2</sub>S levels measured in and around manhole openings ranged from 9 to 11 ppm (12 &#x02013; 15 mg/m<sup>3</sup>) and 5 to 7 ppm (7 &#x02013; 9 mg/m<sup>3</sup>), respectively. The exposed group had higher rates of non-specific neurological symptoms (headache, memory defects, lack of concentration), prolonged reaction time, delayed P300 latency, and poorer performance on most neuropsychological tests. As noted earlier, a H<sub>2</sub>S biomarker of exposure, urinary thiosulfate, was elevated among exposed workers, although no quantitative relationship was found between this marker, H<sub>2</sub>S exposure, and neurological outcomes. Possibly the most significant outcome was delayed P300 latency, suggesting slowing of cognitive function, in contrast to the non-specific symptoms (<xref rid="R92" ref-type="bibr">Guidotti 2010</xref>). The authors noted that sewer workers are exposed to multiple chemical and biological hazards, as well as occasionally high levels of H<sub>2</sub>S, although levels are normally low during routine work, and that their results are generally supported by other studies of sewer workers, e.g., in Sweden (<xref rid="R207" ref-type="bibr">Thorn et al. 2002</xref>).</p></list-item></list></sec><sec id="S39"><label>2.3.6.3</label><title>Community studies</title><p id="P129">Neurological symptoms and outcomes in community settings were examined in a number of older studies, mostly using self-reported questionnaires. For example, <xref rid="R168" ref-type="bibr">Partti-Pellinen et al. (1996)</xref> used a cross-sectional design and a self-administered questionnaire to examine central nervous system symptoms (as well as eye irritation and respiratory-tract symptoms) in adults (n=336) living near a pulp mill and an unpolluted reference community (n = 380) in South Karelia, Finland. In the exposed community, TRS levels averaged approximately 0.001 &#x02013; 0.002 ppm (2 &#x02013; 3 &#x003bc;g/m<sup>3</sup>) and 24-hr levels ranged from 0 to 0.038 ppm (0 &#x02013; 56 &#x003bc;g/m<sup>3</sup>) and SO<sub>2</sub> averaged 1 &#x003bc;g/m<sup>3</sup> and 24-hr levels ranged from 0 &#x02013; 24 &#x003bc;g/m<sup>3</sup>; TRS levels were below 0.0007 ppm (1 &#x003bc;g/m<sup>3</sup>) in the reference community. An elevated risk of headache was found in the exposed community for the prior 4 week and 12 month periods. (Risk of cough also increased for the preceding 12-month period.)</p><p id="P130">The newer studies examining neurological outcomes in community settings are diverse.</p><list list-type="bullet" id="L44"><list-item><p id="P131">Portions of Khozestan Province, Iran experience leakage of natural &#x0201c;sour gas&#x0201d; that contains up to 40% H<sub>2</sub>S. <xref rid="R182" ref-type="bibr">Saadat et al. (2006)</xref> evaluated exposed (n = 64) and unexposed adults (n = 64) matched by sex, age, and educational levels for depression and hopelessness using Beck&#x02019;s depression inventory (BDI) and Beck&#x02019;s hopelessness (BHS) questionnaires. Airborne reactive sulfur compounds in the exposed areas are reported as 0.023 &#x000b1; 0.002 ppm of SO<sub>2</sub> equivalents; unfortunately this metric is difficult to interpret. Exposed individuals had elevated risk of depression and hopelessness, supporting earlier findings of increased rates of suicide attempts and suicide in the same area (<xref rid="R181" ref-type="bibr">Saadat et al. 2004</xref>).</p></list-item><list-item><p id="P132"><xref rid="R120" ref-type="bibr">Kilburn et al. (2010)</xref> contrasted neurotoxic effects among 49 adults in three towns located in sour gas/oil areas in New Mexico and 42 unexposed adults in Arizona, U.S. H<sub>2</sub>S exposures occurred resulted due to emissions from several oil refineries, a gas desulphurization facility, and a WWTP. Short-term (grab) samples showed 2 &#x02013; 74 ppm at the WWTP and H<sub>2</sub>S odors were detected at the other sites; few other measurements were available. An earlier study in this area showed daily H<sub>2</sub>S levels from 0 to 0.014 ppm (0 &#x02013; 14 ppb) (<xref rid="R60" ref-type="bibr">Dubyk and Mustafa 2002</xref>). H<sub>2</sub>S exposure was associated with higher rates of neurological and cognitive dysfunction (e.g., vocabulary, short- but not long-term recall memory, attention/coordination), neurophysiological indicators (e.g., reaction time, balance, hearing, grip strength), and mood state (e.g., tension, vigor, anger, confusion, fatigue). Findings for the three exposure groups were consistent for impairment of neurobehavioral function, mood disturbance, and increased frequencies of irritative, indigestion, respiratory, mood, sleep, balance, memory and limbic system symptoms. Study limitations include a small sample, the likelihood of both acute and chronic exposures in each town (due to episodic releases associated with malfunctions at the WWTP), and the lack of exposure data.</p></list-item><list-item><p id="P133"><xref rid="R175" ref-type="bibr">Reed et al. (2014)</xref> examined cognitive function among adults in Rotorua City, New Zealand exposed to H<sub>2</sub>S, using the same study population and design as <xref rid="R23" ref-type="bibr">Bates et al. (2013)</xref>. No effect was seen for visual and verbal episodic memory, attention, fine motor skills, psychomotor speed, or mood.</p></list-item><list-item><p id="P134"><xref rid="R81" ref-type="bibr">Finnbjornsdottir et al. (2016)</xref>, described earlier, found no association between ambient H<sub>2</sub>S at concentrations up to 0.047 ppm (69.5 &#x003bc;g/m<sup>3</sup>; IQR: 0 &#x02013; 0.003 ppm) in the Reykjavik capital area and the risk of emergency hospital visits due to stroke.</p></list-item><list-item><p id="P135">In Rotorua City, New Zealand, <xref rid="R171" ref-type="bibr">Pope et al. (2017)</xref> examined peripheral nerve function using the same study design and almost-identical study population (n = 1,635) as <xref rid="R175" ref-type="bibr">Reed et al. (2014)</xref> and <xref rid="R23" ref-type="bibr">Bates et al. (2013)</xref>. H<sub>2</sub>S concentrations ranged from 0 to 57.9 ppb (IQR: 5.6 &#x02013; 18.4 ppb). Peripheral nerve function was not associated with H<sub>2</sub>S.</p></list-item><list-item><p id="P136">In the community-based study by <xref rid="R162" ref-type="bibr">Nuvolone et al. (2019)</xref>, discussed earlier, a 0.005 ppm (7 &#x003bc;g/m<sup>3</sup>) increase in H<sub>2</sub>S was associated with an increased risk of hospitalizations for peripheral nervous system, as well of suggestions of additional effects. They did not account for the problem of multiple testing, which may have led to spurious findings.</p></list-item></list></sec><sec id="S40"><label>2.3.6.4</label><title>Community studies of livestock rearing systems</title><p id="P137">Recent studies examining neurological and neurobehavioral effects potentially associated with exposures due to livestock rearing systems are discussed below.</p><list list-type="bullet" id="L46"><list-item><p id="P138"><xref rid="R37" ref-type="bibr">Bullers (2005)</xref>, described previously (<xref rid="S14" ref-type="sec">Section 2.3.1.3</xref>), found an association between residential proximity to hog farms and 12 of 22 self-reported symptoms including nausea.</p></list-item><list-item><p id="P139">In Dakota City, Nebraska, U.S., <xref rid="R110" ref-type="bibr">Inserra et al. (2004)</xref> used computer-assisted standardized neurobehavioral tests to investigate differences among residents (n = 171; &#x02265;16 years of age) living in an area with repeated H<sub>2</sub>S exposure due to emissions from a beef slaughter/leather tanning facility and wastewater lagoon and a reference population (n = 164) with comparable demographic characteristics and health conditions. An exposure map was generated using the monthly highest 1-hr H<sub>2</sub>S concentration measured at 14 residential locations, which was then classified into exposed (&#x02265;0.09 ppm) and comparison (&#x0003c;0.05 ppm) areas (<xref rid="R109" ref-type="bibr">Inserra et al. 2002</xref>); these classifications were consistent with odor complaints. A battery of 14 tests was administered to study participants that addressed sensory (vision, vibration, grip strength, fatigue), affect (health and physical functioning), cognitive (complex function, memory, attention), and motor (response speed, coordination) domains. H<sub>2</sub>S exposure was associated with sensory function (increased vibration sensitivity), motor skills (lower hand grip strength), cognitive (memory) function (match to sample score, and 8-s delay test of match to sample). Of the 28 neurobehavioral tests, 21 showed no adverse relationship with residence area (the H<sub>2</sub>S exposure surrogate), after adjustment for potential confounders. Overall, the authors concluded the two groups showed similar or only marginal differences. This study&#x02019;s strengths include the use of standardized tests (potentially reducing measurement error), standardized protocols (reducing interviewer bias), random sampling of participants (reducing selection bias), and standardized protocols including &#x0201c;blinded&#x0201d; examiners (reducing interviewer bias); its limitations include the possibility of exposure misclassification, uncontrolled occupational exposures, and modest participation rate (&#x0003c;75%).</p></list-item><list-item><p id="P140"><xref rid="R106" ref-type="bibr">Horton et al. (2009)</xref>, described earlier (<xref rid="S14" ref-type="sec">Section 2.3.1.3</xref>), associated CAFO emissions (malodor, H<sub>2</sub>S concentrations, and semi-volatile PM<sub>10</sub> concentrations) with stress and negative mood states, e.g., being stressed or annoyed, nervous or anxious, gloomy and angry). In this study, participants spent 10 min outdoors before returning indoors to complete surveys; these assessments were made repeatedly. The study obtained objective measurements of pollutants including H<sub>2</sub>S, which averaged from 0.00001 to 0.0015 ppm (0.01 to 1.5 ppb) and ranged to 0.09 ppm (90 ppb) (averaging time not specified). The contemporaneous and subjective assessment of both exposure and outcome is susceptible to response enhancement bias that can increase reports of symptoms since respondents are aware of and potentially sensitized to their exposure (<xref rid="R79" ref-type="bibr">Farahat and Kishk 2010</xref>), however, this potential bias should not affect associations with H<sub>2</sub>S.</p></list-item><list-item><p id="P141">A cross-sectional Canadian study, discussed previously (<xref rid="S30" ref-type="sec">Section 2.3.4.3</xref>), found a higher prevalence of depression (18.2%) among people who lived within 3 km of farms relative to those who lived more than 9 km distant (8.0%; <xref rid="R214" ref-type="bibr">Villeneuve et al. 2009</xref>). Individuals living near farms were more likely to worry about environmental issues (water quality, outdoor and indoor smells, air pollution) and had lower health-related quality of life scores. No associations were observed with migraines. This study&#x02019;s strengths included a relatively large sample and the use of a standardized instrument; limitations were modest participation rates, differences in socioeconomic characteristics among the groups, and the lack of direct exposure measures.</p></list-item><list-item><p id="P142"><xref rid="R115" ref-type="bibr">Kilburn (2012)</xref>, detailed previously (<xref rid="S20" ref-type="sec">Section 2.3.2.3</xref>), found significant differences between exposed and control populations for 18 of 35 symptoms, including headaches, dizziness, and lightheadedness.</p></list-item></list></sec><sec id="S41"><label>2.3.6.5</label><title>Summary of neurological and neurobehavioral effects</title><p id="P143">Memory and learning impairment lead complaints that are associated with H<sub>2</sub>S exposure (<xref rid="R167" ref-type="bibr">Partlo et al. 2001</xref>), although a broader set of persistent neurological effects (e.g., headaches, poor concentration ability and attention span, impaired short-term memory, and impaired motor function) have been reported in persons recovering from H<sub>2</sub>S-induced unconsciousness resulting from very high concentration exposure (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>). Animal studies have demonstrated effects on brain function, e.g., rats exposed to 125 ppm for 4 hours/day, 5 days/week for 5 consecutive weeks showed impaired performance and learning of spatial tasks (<xref rid="R167" ref-type="bibr">Partlo et al. 2001</xref>), findings stated to have relevance for humans (<xref rid="R232" ref-type="bibr">Woodall et al. 2005</xref>). Other animal studies with H<sub>2</sub>S inhalation exposure suggest decreased motor activity and task response rates from which a LOAEL of 80 ppm for 3 hr/day for 5 days has been derived (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>). Biochemical changes include decreased brain stem total lipids and phospholipids shown in guinea pigs exposed to 20 ppm H<sub>2</sub>S for 1 hr/day for 11 days (<xref rid="R95" ref-type="bibr">Haider et al. 1980</xref>), and harmful CNS myelination after chronic exposure to 6.7 ppm (<xref rid="R202" ref-type="bibr">Solnyshkova 2003</xref>; <xref rid="R203" ref-type="bibr">Solnyshkova and Shakhlamov 2002</xref>). Still, the NOAEL for impaired performance in rats remains 100 ppm for 2 hr (<xref rid="R65" ref-type="bibr">Elovaara et al. 1978</xref>). No new animal studies on learning relevant to this review were identified.</p><p id="P144">We identified two recent controlled studies of humans. <xref rid="R185" ref-type="bibr">Schiffman et al. (2005)</xref> used 1-hr exposures of dilute swine confinement with H<sub>2</sub>S at 0.024 ppm and showed increased prevalence of headaches, eye irritation, and nausea. <xref rid="R80" ref-type="bibr">Fiedler et al. (2008)</xref> used 2-hr exposures of H<sub>2</sub>S alone at 0.05, 0.5 and 5 ppm and found dose&#x02013;response relationships for odor intensity, irritation and unpleasantness; compromised verbal learning was shown without a dose-response relationship. A small and older controlled study reported headaches among 3 of 10 asthmatics exposed to 2 ppm H<sub>2</sub>S for 30 min (<xref rid="R112" ref-type="bibr">Jappinen et al. 1990</xref>). Additional neurobehavioral effects in humans and animals include alterations in balance, reaction time, visual field, and verbal recall, with effect severity depending on exposure duration and concentration (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>). While the few controlled human studies have shown odor, irritation and nuisance symptoms, e.g., irritation and headache, neurological or neurobehavioral affects have not been observed. However, many of the studies examined a single acute exposure event with a small number of healthy individuals, and the ability to capture subtle neurological impairments may be limited (<xref rid="R71" ref-type="bibr">EPA 2011</xref>). Additionally, these studies may not be generalizable to other populations, e.g., communities and workers experiencing chronic exposure, or individuals that have greater susceptibility due to their health conditions and age (<xref rid="R80" ref-type="bibr">Fiedler et al. 2008</xref>).</p><p id="P145">The observational studies, both occupational and environmental, complement the controlled studies, but can be challenging to evaluate and synthesize. In comparison to community conditions, both the controlled and occupational epidemiological studies tend to reflect higher concentrations, as do the case reports. Further, all of the observational studies have significant limitations in their exposure assessments that preclude an understanding of potential dose-response relationships pertinent to neurological and neurobehavioral outcomes. As has been noted (and see <xref rid="S57" ref-type="sec">Sections 2.4.3.4</xref> and <xref rid="S58" ref-type="sec">2.4.3.5</xref>), other pollutants often accompany H<sub>2</sub>S in community and occupational settings, and isolating effects of H<sub>2</sub>S in a mixture can be challenging. In addition, objective evaluation of many neurological and neurobehavioral outcomes can be difficult for due to their linkage to educational attainment and other factors, the potential of measurement bias, the likely wide range of sensitivity among individuals, the influence of psychological responses to odor, irritation and nuisance perceptions accompanying H<sub>2</sub>S exposure (e.g., headache and nausea), and the flight response, though such biases in outcome ascertainments can be controlled using blinded assessments, objective tests, and other means. Additional issues in cross-sectional studies include generally modest sample sizes, the comparability of groups, and adequate control of potential covariates and confounders. Several of the newer epidemiological studies, which tend to better address these issues, highlight behavioral and neurological effects at low but chronic exposure, and often report similar outcomes as earlier studies. The older studies show, for example: persistent cognitive impairment (reaction time delay, neurological and neurobehavioral deficits) in individuals acutely exposed to high but unknown concentrations of H<sub>2</sub>S, but unremarkable neurological and physical examinations (<xref rid="R223" ref-type="bibr">Wasch et al. 1989</xref>); reduced perceptual motor speed, impaired verbal recall and remote memory, visual field performance decrements, and abnormal mood status was found in subjects (n = 16) referred for evaluation of effects of reduced sulfur gas exposure compared to referents (n = 353; <xref rid="R118" ref-type="bibr">Kilburn 1997</xref>); differences in neurophysiological outcomes (reaction time; balance, color discrimination, digit symbol, immediate recall) and mood state scores (<xref rid="R121" ref-type="bibr">Kilburn and Warshaw 1995</xref>); and some memory impairment (<xref rid="R117" ref-type="bibr">Kilburn 1999</xref>). Among the newer studies, <xref rid="R162" ref-type="bibr">Nuvolone et al. (2019)</xref> assessed a variety of neurological-related mortality and hospitalization diagnoses, but a dose-response effect was seen only for peripheral nervous system hospitalizations (per 0.0047 ppm increase in ambient H<sub>2</sub>S); and <xref rid="R131" ref-type="bibr">Legator et al. (2001)</xref> reported elevated risks of self-reported central nervous symptoms (e.g., fatigue, headache, and difficulty sleeping) in Odessa, Texas (n = 126) and Puna, Hawaii (n = 97), two communities with H<sub>2</sub>S levels averaging from 0.007 to 0.027 ppm, compared to reference communities (n = 170); short-term H<sub>2</sub>S levels (1&#x02013;8 hr averages) were reported to reach 0.5 ppm. The effects observed in these and the other newer studies examining workplace and community populations are not well understood mechanistically, and some of the past literature has been criticized (<xref rid="R92" ref-type="bibr">Guidotti 2010</xref>).</p><p id="P146">Sixteen new observational studies evaluated a range of neurological and neurobehavioral effects among workers and communities in geothermally active regions or around CAFOs, sewer, oil and gas facilities. Three of these studies had negative findings for visual and verbal episodic memory, attention, fine motor skills, psychomotor speed, mood, peripheral nerve function, or stroke (<xref rid="R81" ref-type="bibr">Finnbjornsdottir et al. 2016</xref>; <xref rid="R171" ref-type="bibr">Pope et al. 2017</xref>; <xref rid="R175" ref-type="bibr">Reed et al. 2014</xref>); each of these studies employed spatially modeled estimates of ambient H<sub>2</sub>S exposure. A study using universal kriging to estimate residential exposure positively associated H<sub>2</sub>S and some neurological outcomes (<xref rid="R110" ref-type="bibr">Inserra et al. 2004</xref>). The dozen other studies with positive associations used a variety of designs and instruments, and showed a degree of agreement with respect to non-specific neurological symptoms (headache, memory defects, memory or concentration difficulties (<xref rid="R79" ref-type="bibr">Farahat and Kishk 2010</xref>; <xref rid="R110" ref-type="bibr">Inserra et al. 2004</xref>; <xref rid="R115" ref-type="bibr">Kilburn 2012</xref>; <xref rid="R120" ref-type="bibr">Kilburn et al. 2010</xref>; <xref rid="R130" ref-type="bibr">Lee et al. 2007</xref>; <xref rid="R168" ref-type="bibr">Partti-Pellinen et al. 1996</xref>), more objective neurophysiologic outcomes (e.g., peripheral sensation and discrimination; <xref rid="R110" ref-type="bibr">Inserra et al. 2004</xref>; <xref rid="R115" ref-type="bibr">Kilburn 2012</xref>; <xref rid="R121" ref-type="bibr">Kilburn and Warshaw 1995</xref>; <xref rid="R162" ref-type="bibr">Nuvolone et al. 2019</xref>), affect (<xref rid="R80" ref-type="bibr">Fiedler et al. 2008</xref>; <xref rid="R120" ref-type="bibr">Kilburn et al. 2010</xref>), and mood states or feelings of stress, hopelessness or depression (<xref rid="R37" ref-type="bibr">Bullers 2005</xref>; <xref rid="R106" ref-type="bibr">Horton et al. 2009</xref>; <xref rid="R120" ref-type="bibr">Kilburn et al. 2010</xref>; <xref rid="R121" ref-type="bibr">Kilburn and Warshaw 1995</xref>; <xref rid="R130" ref-type="bibr">Lee et al. 2007</xref>; <xref rid="R182" ref-type="bibr">Saadat et al. 2006</xref>; <xref rid="R214" ref-type="bibr">Villeneuve et al. 2009</xref>). The relatively few studies with robust H<sub>2</sub>S measures more commonly associated non-specific neurological symptoms and mood states than objective neurophysiologic outcomes (<xref rid="R79" ref-type="bibr">Farahat and Kishk 2010</xref>; <xref rid="R110" ref-type="bibr">Inserra et al. 2004</xref>; <xref rid="R120" ref-type="bibr">Kilburn et al. 2010</xref>; <xref rid="R121" ref-type="bibr">Kilburn and Warshaw 1995</xref>; <xref rid="R162" ref-type="bibr">Nuvolone et al. 2019</xref>; <xref rid="R168" ref-type="bibr">Partti-Pellinen et al. 1996</xref>). Finally, several community studies indicated health-related quality of life impacts on populations living within ~3.6 km (2 miles) of large-scale farming operations (e.g., <xref rid="R106" ref-type="bibr">Horton et al. 2009</xref>; <xref rid="R214" ref-type="bibr">Villeneuve et al. 2009</xref>), a finding which diverges from (short-term) controlled studies that show only irritation and anxiety (e.g., <xref rid="R80" ref-type="bibr">Fiedler et al. 2008</xref>). Full explanations for the dichotomy between controlled and observational studies, the identification of specific and plausible neurological and neurobehavioral mechanisms at play, and the dose-response relationships involved, all remain unresolved.</p></sec></sec><sec id="S42"><label>2.3.7</label><title>Reproductive and developmental effects</title><p id="P147">No new reproductive or developmental studies were identified. The existing literature is summarized here.</p><list list-type="bullet" id="L48"><list-item><p id="P148">Several animal studies found harmful neurodevelopmental effects from chronic H<sub>2</sub>S exposure at the following concentrations: 75 ppm (<xref rid="R98" ref-type="bibr">Hayden et al. 1990</xref>); 20 and 50 ppm (<xref rid="R179" ref-type="bibr">Roth et al. 1997</xref>; <xref rid="R198" ref-type="bibr">Skrajny et al. 1992</xref>); 25 and 75 ppm (<xref rid="R198" ref-type="bibr">Skrajny et al. 1992</xref>). All of these concentrations exceed 10 ppm, our cutoff for low-level exposure.</p></list-item><list-item><p id="P149"><xref rid="R16" ref-type="bibr">ATSDR&#x02019;s (2006)</xref> review notes that only limited human data links maternal or paternal exposure to H<sub>2</sub>S to an increased risk of spontaneous abortion among rayon textile, paper mill, or petrochemical workers (or spouses), although other hazardous chemicals present in these occupations may have contributed to the increased risk. The reproductive performance of rats exposed to between 10 and 80 ppm H<sub>2</sub>S for an intermediate duration was unaffected, and the available animal data suggest that H<sub>2</sub>S is not a developmental toxicant at concentrations below 80 ppm. <xref rid="R16" ref-type="bibr">ATSDR (2006)</xref> concludes that no structural anomalies, developmental delays, performance in developmental neurobehavioral tests, or impacts in brain histology were observed in a well-conducted rat study, and that while alterations in Purkinje cell (large neurons in the brain) growth was noted in offspring of rats exposed to 20 or 50 ppm H<sub>2</sub>S during gestation and lactation periods, the significance of this finding given unaltered neurobehavioral performance is unknown (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>).</p></list-item><list-item><p id="P150">California&#x02019;s <xref rid="R163" ref-type="bibr">OEHHA (2008)</xref> review highlights <xref rid="R233" ref-type="bibr">Xu et al. (1998)</xref>, a retrospective study examining spontaneous abortion among never-smoking married women (n = 2,853), 20 to 44 years of age who reported at least one pregnancy during employment at a large petrochemical complex in Beijing, China. Based on employment records, most (57%) workers had occupational exposure to petrochemicals during their first trimester. Comparisons within and across plants showed that frequent exposure to petrochemicals greatly increased the risk of spontaneous abortion. Similarly, increased risk of spontaneous abortion was found for the 106 women exposed to only H<sub>2</sub>S; unfortunately, this study did not report concentrations. Exposures at refineries can involve many pollutants, and this study is atypical given the stated exposure conditions.</p></list-item><list-item><p id="P151">Finally, a review of occupational, environmental and lifestyle factors associated with spontaneous abortion (<xref rid="R127" ref-type="bibr">Kumar 2011</xref>) discusses several additional studies, including an older Russian study examining effects of H<sub>2</sub>S exposure on menstrual function and the estrous cycle (<xref rid="R213" ref-type="bibr">Vasiljeva 1973</xref>).</p></list-item></list><sec id="S43"><label>2.3.7.1</label><title>Summary of reproductive and developmental effects.</title><p id="P152">Animal studies examining exposures above 10 ppm have not shown reproductive or developmental toxicity. Of the few human studies, several suggest that maternal or paternal exposure to H<sub>2</sub>S is associated with an increased risk of spontaneous abortion (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>; <xref rid="R233" ref-type="bibr">Xu et al. 1998</xref>), however, these studies likely are confounded by simultaneous exposures to multiple pollutants.</p></sec></sec><sec id="S44"><label>2.3.8</label><title>Carcinogenic effects</title><p id="P153">Inhalational exposure of H<sub>2</sub>S has not been consistently shown to cause cancer in humans, and its ability to cause cancer in animals has not been studied. For these reasons, H<sub>2</sub>S has not been classified in relation to cancer (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>). While clinical studies have linked sulfate-reducing bacteria or H<sub>2</sub>S in the colon with chronic disorders, e.g., ulcerative colitis and colorectal cancer, evidence remains circumstantial and underlying mechanisms undefined (<xref rid="R19" ref-type="bibr">Attene-Ramos et al. 2007</xref>). Several recent studies have evaluated potential carcinogenic effects of low-dose H<sub>2</sub>S exposure in community and occupational settings, including those reviewed by <xref rid="R38" ref-type="bibr">Bustaffa et al. (2020)</xref>:</p><list list-type="bullet" id="L50"><list-item><p id="P154"><xref rid="R133" ref-type="bibr">Lewis et al. (2003)</xref>, described earlier in <xref rid="S31" ref-type="sec">Section 2.3.4.4</xref>, found no evidence of increased risk of cancer with occupational exposure.</p></list-item><list-item><p id="P155"><xref rid="R126" ref-type="bibr">Kristbjornsdottir and Rafnsson (2012)</xref> examined cancer incidence among 74,806 Icelandic children and adults, contrasting rates among individuals living in geothermal and non-geothermal areas. Residing in a high temperature geothermal location was positively associated with increased risk of cancers (both individual cancer types and overall cancer risk); the greatest risks were found for pancreatic cancer followed by non-Hodgkin&#x02019;s lymphoma. The analysis stratified by age groups to control for possible biases, however full results were not reported and H<sub>2</sub>S was not measured, and thus the use of residence location may have resulted in exposure measurement error and confounding, particularly with radon.</p></list-item><list-item><p id="P156">A community-based study in Italy by <xref rid="R162" ref-type="bibr">Nuvolone et al. (2019)</xref>, described earlier in <xref rid="S29" ref-type="sec">Section 2.3.4.2</xref>, found that a 0.005 ppm (7 &#x003bc;g/m<sup>3</sup>) increase in H<sub>2</sub>S was associated with slightly reduced risk of malignant neoplasm mortality. The protective dose-response relationship was minimally significant and the analysis did not account for multiple testing.</p></list-item></list><sec id="S45"><label>2.3.8.1</label><title>Summary of carcinogenic effects.</title><p id="P157">Two of the three recent studies that examined cancer found some effect on the incidence of some cancers with H<sub>2</sub>S exposure, but each study had methodological weaknesses, including a lack of direct exposure measurements. The finding by <xref rid="R162" ref-type="bibr">Nuvolone et al. (2019)</xref> of a protective association between H<sub>2</sub>S and neoplasm(s) is likely spurious. The strong positive associations with risks of pancreatic cancer, breast cancer, basal cell carcinoma, and non-Hodgkin&#x02019;s lymphoma found by <xref rid="R126" ref-type="bibr">Kristbjornsdottir and Rafnsson (2012)</xref> might be explained by factors other than H<sub>2</sub>S. Overall, the literature on carcinogenic effects of H<sub>2</sub>S is inconclusive.</p></sec></sec><sec id="S46"><label>2.3.9</label><title>Immunological effects</title><list list-type="bullet" id="L52"><list-item><p id="P158">A review by <xref rid="R100" ref-type="bibr">Heederik et al. (2007)</xref> notes the limited evidence regarding changes in immunoglobulin A responses in individuals that have been associated with odor, which might result from psychophysiological changes related to stress and sensitization.</p></list-item><list-item><p id="P159"><xref rid="R101" ref-type="bibr">Heldal et al. (2019)</xref>, described earlier, investigated effects of H<sub>2</sub>S (and other wastewater workplace-related exposures) on inflammatory reactive markers (C-reactive protein; CRP), surfactant protein D (SpD), club cell protein 16 (CC16), interleukin 8 (IL-8), intercellular adhesion molecule 1 (ICAM-1), and macrophage inflammatory protein (MIP)-1alpha. The H<sub>2</sub>S exposure index was negatively associated with the level of ICAM-1, but not with CPR, SpD, CC16, IL-8, or MIP-1alpha.</p></list-item></list><sec id="S47"><label>2.3.9.1</label><title>Studies regarding livestock rearing systems.</title><p id="P160">Earlier sections of this review have discussed a variety of health endpoints associated with livestock rearing systems; here we focus on immune effects.</p><list list-type="bullet" id="L54"><list-item><p id="P161"><xref rid="R21" ref-type="bibr">Avery et al. (2004)</xref> investigated CAFO exposures and immune function suppression using secretory immunoglobulin A (sIgA) measurements obtained twice daily for 14 days from 15 adults living within 2.4 km of hog farming operations in North Carolina, USA, along with odor intensity perceptions. The longitudinal analysis suggested that odor intensity was associated with a decline in sIgA, although the association was not statistically significant and sIgA levels stayed within the normal range. The authors noted that salivary glands are largely under autonomic central nervous system control, are part of &#x0201c;stress&#x0201d; circuits and centers for homeostatic regulation, and that sIgA forms a response to invading microorganisms at mucosal surfaces. Like most of the CAFO studies, exposure to co-pollutants (especially endotoxin) can confound results. Additionally, H<sub>2</sub>S levels were not measured.</p></list-item><list-item><p id="P162"><xref rid="R185" ref-type="bibr">Schiffman et al. (2005)</xref>, described previously (<xref rid="S14" ref-type="sec">Section 2.3.1.3</xref>), found no association between H<sub>2</sub>S and salivary IgA.</p></list-item></list></sec><sec id="S48"><label>3.3.9.2</label><title>Summary of immunological effects.</title><p id="P163">Very few studies have examined immune effects of low-level H<sub>2</sub>S exposure. At higher exposure levels, an occupational study has associated H<sub>2</sub>S exposure with lower ICAM-1 levels although CPR, SpD, CC16, IL-8, and MIP-1 alpha levels were unchanged (<xref rid="R101" ref-type="bibr">Heldal et al. 2019</xref>). Other studies have not found significant results, and are limited by a lack of H<sub>2</sub>S measures, often using proximity or odor as an exposure proxy. Overall, the literature on the immunological impact of H<sub>2</sub>S is inconclusive.</p></sec></sec><sec id="S49"><label>2.3.10</label><title>Effects on livestock</title><p id="P164">While an analysis of the literature pertaining to environmental exposures of H<sub>2</sub>S on beef cows and other animals is beyond the scope of this report, we note several papers examining beef cattle in Alberta, Canada, a major oil and (sour) gas producing area, due to the study size (27,000 cattle in 207 herds), chronic low-level exposures, and data completeness (including exposure monitoring). The study methodology is presented by <xref rid="R217" ref-type="bibr">Waldner (2008a</xref>; <xref rid="R218" ref-type="bibr">2008b</xref>; <xref rid="R219" ref-type="bibr">2008c</xref>) and commented on by the study&#x02019;s Science Advisory Board co-chair (<xref rid="R91" ref-type="bibr">Guidotti 2009</xref>). H<sub>2</sub>S concentrations ranged from 0.00009 to 0.00033 ppm (0.09 to 0.33 ppb) (5th to 95th percentile). Results are summarized below.</p><list list-type="bullet" id="L56"><list-item><p id="P165"><xref rid="R220" ref-type="bibr">Waldner (2008d)</xref> found that SO<sub>2</sub>, H<sub>2</sub>S and VOC exposures during gestation were not associated with the odds of calf treatment in the first 3 months of life, however, exposure in the first month after calving was associated with a small increase in these odds after the first month of life (typically for diarrhea, pneumonia and umbilical infections), and that the H<sub>2</sub>S linkages were consistent with possible mechanisms.</p></list-item><list-item><p id="P166"><xref rid="R29" ref-type="bibr">Bechtel et al. (2009)</xref> found that VOC exposure was associated with an increase in CD4 T lymphocytopenia in cattle, showing modulation of the immune system, although the significance of the change is unclear. In addition, H<sub>2</sub>S exposure was associated with an increase in rabies antibody titer; the authors noted several discrepancies and stated that it was unlikely that this exposure would increase antibody production.</p></list-item><list-item><p id="P167"><xref rid="R216" ref-type="bibr">Waldner (2009)</xref> found no evidence that SO<sub>2</sub>, H<sub>2</sub>S and VOCs exposures affected abortions or still births in the beef herds.</p></list-item><list-item><p id="P168"><xref rid="R221" ref-type="bibr">Waldner and Clark (2009)</xref> found associations between VOCs (measured as benzene) and respiratory lesions for calves older than 3 weeks, and between SO<sub>2</sub> and lesions during gestation.</p></list-item></list></sec></sec><sec id="S50"><label>2.4</label><title>Synthesis of the studies</title><sec id="S51"><label>2.4.1</label><title>Weight of the evidence</title><p id="P169">We start with a general &#x0201c;weight of the evidence&#x0201d; discussion to provide context and a conceptual framework for evaluating study strengths and weaknesses. Discussions pertaining to weight of the evidence are presented elsewhere (e.g., <xref rid="R74" ref-type="bibr">EPA 2005</xref>; <xref rid="R165" ref-type="bibr">OEHHA 1999</xref>), and typically involve both qualitative and qualitative assessments, a summary narrative encompassing the individual lines of evidence, and a critique often using (Austin Bradford) &#x0201c;Hill&#x02019;s Criteria.&#x0201d; These nine well-known &#x0201c;criteria for causation&#x0201d; date from a 1965 article on smoking and include consistency of association, strength of association, dose-response, temporality, experimentation, specificity, biologic plausibility, coherence, and analogy. Key issues in the weight of evidence discussions include the following:
<list list-type="order" id="L58"><list-item><p id="P170">The <underline>strength</underline> of associated adverse health effect with a chemical exposure can be measured in terms of high observed effect incidence or high relative risk, statistical significance of differences between control and exposed groups, and a positive dose-response relationship.</p></list-item><list-item><p id="P171">The <underline>consistency</underline> of associated adverse health effect with a chemical exposure is noted by the similarity of effects found in different studies and among different populations and/or species.</p></list-item><list-item><p id="P172">The <underline>specificity</underline> of associated adverse health effect to an exposure strengthens the case for causality; however, it is well-recognized that such highly specific associations are rare.</p></list-item><list-item><p id="P173">The <underline>temporal association</underline> between the adverse health effect should occur at a time following exposure that is consistent with the nature of the effect, e.g., respiratory irritation immediately following H<sub>2</sub>S exposure is temporally consistent, as would be tumor development that involve a latency period of months or years.</p></list-item><list-item><p id="P174">The <underline>coherence</underline> of the adverse health effect with the exposure reflects the scientific plausibility of the association, which is based on an understanding of the pharmacokinetics and mechanism of action.</p></list-item><list-item><p id="P175">Results utilizing <underline>human</underline> data are most relevant to assessing human health effects. Sources of human data, i.e., epidemiological studies, controlled exposure experiments, and case reports, can each provide important information, but each has strengths and weaknesses.</p></list-item></list>
As an example of the application of weight-of-evidence considerations, <xref rid="R165" ref-type="bibr">OEHHA&#x02019;s (1999)</xref> evaluation of acute RELs emphasized dose-response relationship, reproducibility of findings, mechanism of action, and consistency with other studies. More recent thinking for causality consolidate and refine the necessary criteria to four factors: the strength of association (including analysis of plausible confounding); temporality; plausibility (addressing articulate mediation and interaction); and experimental support (including implications of study design on exchangeability) (<xref rid="R192" ref-type="bibr">Shimonovich et al., 2021</xref>).</p><p id="P177">As noted earlier, while hazards and risks from high concentrations of H<sub>2</sub>S are well known, information pertaining to low level human exposure remains relatively scarce and more difficult to interpret. In the following, we discuss key weight-of-the-evidence issues that pertain to many or most of the studies.</p></sec><sec id="S52"><label>2.4.2</label><title>Definition and scope of adverse effects</title><p id="P178">Definitions of adverse effects vary. <xref rid="R165" ref-type="bibr">OEHHA (1999)</xref> cited <xref rid="R78" ref-type="bibr">EPA (1989)</xref> in defining adverse effects: &#x0201c;A biochemical change, functional impairment, or pathological lesion that either singularly or in combination adversely affects the performance of the whole organism or reduces an organism&#x02019;s ability to respond to an additional environmental challenge.&#x0201d; Thus, the perception of even an objectionable odor was not necessarily considered as an adverse health effect unless accompanied by other symptoms or signs, e.g., nausea and vomiting, or by actions or behaviors that affected quality of life. Similarly, odor complaints to city or state departments do not constitute a permit violation, although they may trigger an inspection of a facility. Because self-reports of symptoms (and exposure) can be influenced by many factors, including odor, socioeconomic status and interviewer bias (e.g., <xref rid="R174" ref-type="bibr">Radon et al. 2007</xref>), the general preference is to control for such factors using objective outcome measures and not to rely on symptoms, although odors may affect quality-of-life issues. Temporary and reversible impacts, including odor, also are sometimes excluded, especially in occupational settings. <xref rid="R229" ref-type="bibr">WHO&#x02019;s (1948)</xref> well-known definition of health, &#x0201c;a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity,&#x0201d; encompasses a broader view of adverse effects that would include odors and symptoms that might affect mental and social well-being. Inclusion of odor impacts as an adverse effect is further supported given that objectionable H<sub>2</sub>S odors can inhibit outdoor activity of individuals, including exercise that can contribute to their well-being, as noted in several studies (<xref rid="R35" ref-type="bibr">Brancher et al. 2017</xref>; <xref rid="R99" ref-type="bibr">Heaney et al. 2011</xref>; <xref rid="R209" ref-type="bibr">Uluta&#x0015f; et al. 2021</xref>).</p><p id="P179">Adverse effects investigated in the H<sub>2</sub>S literature are predominantly morbidity outcomes, mostly ocular, respiratory, and neurological/neurobehavioral symptoms and disease. Only one study has examined mortality due to chronic, low-level H<sub>2</sub>S exposure (<xref rid="R25" ref-type="bibr">Bates et al. 1997</xref>), and only few older studies were identified that examined immunological, reproductive or pregnancy outcomes in humans.</p></sec><sec id="S53"><label>2.4.3</label><title>Nature and characterization of exposure</title><p id="P180">Many of the observational studies of H<sub>2</sub>S are limited with respect to the exposure assessments, and addressing and minimizing adverse effects of <italic toggle="yes">exposure measurement error</italic> is important to obtain credible results. These errors can result from multiple factors, e.g., the difficulty of differentiating acute from chronic exposure, estimating exposure using distance proxies or spatial models, and multi-pollutant mixtures, among other challenges. <italic toggle="yes">Reporting or awareness bias</italic>, noted earlier, also can affect self-reported exposures. Such concerns are particularly pertinent to community-based studies of livestock rearing operations and geothermal sources that use non-objective or proxy measures of H<sub>2</sub>S exposure, often due to difficulties of collecting samples at or near emission sources, or due to a focus on generating hypotheses that might explain observations in a region known for a particular industry, e.g., hog farms in North Carolina, U.S., or geothermal plants in Tuscany, Italy. The following discusses challenges in characterizing exposure, addressing biological monitoring, duration of exposure, spatial variation, pollutant mixtures, and cumulative effects.</p><p id="P181">Measurements (or validated estimates) of H<sub>2</sub>S concentrations are needed to develop dose-response information relevant for establishing air quality guidelines and standards, comparing results among studies, confirming exposure estimates, and other purposes. A growing number of community-based and occupational epidemiology studies have included concentration measurements. Organized by health effect investigated, objective measures of H<sub>2</sub>S were used in studies investigating odor and sinus irritation (<xref rid="R99" ref-type="bibr">Heaney et al. 2011</xref>; <xref rid="R106" ref-type="bibr">Horton et al. 2009</xref>; <xref rid="R130" ref-type="bibr">Lee et al. 2007</xref>; <xref rid="R140" ref-type="bibr">Logue et al. 2001</xref>; <xref rid="R185" ref-type="bibr">Schiffman et al. 2005</xref>; <xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>); ocular effects (<xref rid="R26" ref-type="bibr">Bates et al. 2002</xref>, <xref rid="R24" ref-type="bibr">1998</xref>; <xref rid="R82" ref-type="bibr">Fisher 1999</xref>; <xref rid="R94" ref-type="bibr">Haahtela et al. 1992</xref>; <xref rid="R115" ref-type="bibr">Kilburn, 2012</xref>; <xref rid="R130" ref-type="bibr">Lee et al., 2007</xref>; <xref rid="R140" ref-type="bibr">Logue et al., 2001</xref>; <xref rid="R144" ref-type="bibr">Marttila et al., 1995</xref>, <xref rid="R145" ref-type="bibr">1994</xref>; <xref rid="R185" ref-type="bibr">Schiffman et al., 2005</xref>; <xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>); nasal lesions (<xref rid="R155" ref-type="bibr">Mousa 2015</xref>); respiratory health (<xref rid="R23" ref-type="bibr">Bates et al. 2013</xref>; <xref rid="R39" ref-type="bibr">Campagna et al. 2004</xref>; <xref rid="R41" ref-type="bibr">Carlsen et al. 2012</xref>; <xref rid="R63" ref-type="bibr">Durand and Wilson 2006</xref>; <xref rid="R64" ref-type="bibr">Eduard et al. 2009</xref>; <xref rid="R79" ref-type="bibr">Farahat and Kishk 2010</xref>; <xref rid="R81" ref-type="bibr">Finnbjornsdottir et al. 2016</xref>; <xref rid="R101" ref-type="bibr">Heldal et al. 2019</xref>; <xref rid="R115" ref-type="bibr">Kilburn 2012</xref>; <xref rid="R130" ref-type="bibr">Lee et al. 2007</xref>; <xref rid="R140" ref-type="bibr">Logue et al. 2001</xref>; <xref rid="R162" ref-type="bibr">Nuvolone et al. 2019</xref>; <xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>); cardiovascular health (<xref rid="R81" ref-type="bibr">Finnbjornsdottir et al. 2016</xref>; <xref rid="R115" ref-type="bibr">Kilburn 2012</xref>; <xref rid="R162" ref-type="bibr">Nuvolone et al. 2019</xref>); neurological and neurobehavioral health (<xref rid="R23" ref-type="bibr">Bates et al. 2013</xref>; <xref rid="R60" ref-type="bibr">Dubyk and Mustafa 2002</xref>; <xref rid="R79" ref-type="bibr">Farahat and Kishk 2010</xref>; <xref rid="R106" ref-type="bibr">Horton et al. 2009</xref>; <xref rid="R109" ref-type="bibr">Inserra et al. 2002</xref>, <xref rid="R110" ref-type="bibr">2004</xref>; <xref rid="R115" ref-type="bibr">Kilburn 2012</xref>; <xref rid="R120" ref-type="bibr">Kilburn et al. 2010</xref>; <xref rid="R121" ref-type="bibr">Kilburn and Warshaw 1995</xref>; <xref rid="R130" ref-type="bibr">Lee et al. 2007</xref>; <xref rid="R162" ref-type="bibr">Nuvolone et al. 2019</xref>; <xref rid="R168" ref-type="bibr">Partti-Pellinen et al. 1996</xref>; <xref rid="R171" ref-type="bibr">Pope et al. 2017</xref>; <xref rid="R175" ref-type="bibr">Reed et al. 2014</xref>); immune (<xref rid="R101" ref-type="bibr">Heldal et al. 2019</xref>; <xref rid="R185" ref-type="bibr">Schiffman et al. 2005</xref>); reproductive and developmental health (<xref rid="R213" ref-type="bibr">Vasiljeva 1973</xref>); and cancer (<xref rid="R162" ref-type="bibr">Nuvolone et al. 2019</xref>). Given that H<sub>2</sub>S is found as a component of a mixture of pollutants emitted from most sources of concern, other components in the mixture that might be associated with the health effect of interest must also be characterized to avoid confounding, as described below in <xref rid="S57" ref-type="sec">Section 2.4.3.4</xref>.</p><p id="P182">Studies without H<sub>2</sub>S measurements can serve several purposes. These include: helping to confirm and extend results of other studies, e.g., showing the prevalence of health issues; evaluating the effectiveness of interventions and emission controls, e.g., documenting reduced numbers of complaints or symptoms; generating hypotheses; and providing preliminary investigations.</p><sec id="S54"><label>2.4.3.1</label><title>Biological monitoring</title><p id="P183">In an attempt to better understand the relationship between external and internal exposure, H<sub>2</sub>S measures may be combined with biological monitoring of sulfhemoglobin or urinary thiosulfate. Several studies, noted above, lack H<sub>2</sub>S measurements and instead utilize biological monitoring. Depending on the circumstance, biomarkers in blood and urine may be more difficult to obtain than ambient or indoor air samples. However, if a biomarker is not specific to the compound of interest and data for potential confounding factors are not collected, the biomarker may not be useful in assessing true exposure.</p><p id="P184">Urinary thiosulfate is the most common biomarker of H<sub>2</sub>S exposure (<xref rid="R15" ref-type="bibr">ATSDR 2016</xref>). Thiosulfate is produced through oxidative metabolism of H<sub>2</sub>S. The process occurs in two steps, which may explain the delayed buildup of thiosulfate in the body following H<sub>2</sub>S exposure (<xref rid="R227" ref-type="bibr">WHO 2003</xref>). Urinary thiosulfate can be used to confirm low-level exposures, although the responsiveness of this biomarker to low-level exposures may vary significantly between individuals (<xref rid="R62" ref-type="bibr">Durand and Weinstein 2007</xref>). H<sub>2</sub>S can promote red blood cells (RBCs) to form sulfhemoglobin, a sulfheme protein complex (<xref rid="R128" ref-type="bibr">Kurzban et al. 1999</xref>; <xref rid="R177" ref-type="bibr">R&#x000ed;os-Gonz&#x000e1;lez et al. 2014</xref>). H<sub>2</sub>S is produced endogenously (see <xref rid="S72" ref-type="sec">Section 3.10</xref>) but at levels too low to form sulfhemoglobin, while exogenous H<sub>2</sub>S may occur at levels high enough to warrant the use of sulfhemoglobin to assess its presence in tissues and cells (<xref rid="R177" ref-type="bibr">R&#x000ed;os-Gonz&#x000e1;lez et al. 2014</xref>). However, blood sulfhemoglobin is not specific to H<sub>2</sub>S, and can be formed following exposure to drugs (e.g., phenacetin, dapsone, and sulfonamides) as well as other sulfur-containing agents (<xref rid="R86" ref-type="bibr">Gharahbaghian et al. 2009</xref>; <xref rid="R30" ref-type="bibr">Bhagavan 2002</xref>). If sulfhemoglobin accumulates, it can cause sulfhemoglobinemia and cyanosis, although these are rare conditions.</p><p id="P185">Biological monitoring of H<sub>2</sub>S in epidemiological studies is rare; exceptions are a few studies that measure urine thiosulfate (<xref rid="R79" ref-type="bibr">Farahat and Kishk 2010</xref>) or blood sulfhemoglobin (<xref rid="R6" ref-type="bibr">Al-Batanony and El-Shafie 2011</xref>). Other studies have measured these biomarkers to assess exposure in humans (<xref rid="R66" ref-type="bibr">Ensabella et al. 2004</xref>; <xref rid="R183" ref-type="bibr">Saeedi et al. 2015</xref>) and animals (<xref rid="R58" ref-type="bibr">Drewnoski et al. 2012</xref>). In Italy, <xref rid="R66" ref-type="bibr">Ensabella et al. (2004)</xref> used ambient workplace H<sub>2</sub>S measures to verify blood sulfhemoglobin as a reliable measure of individual worker exposure to environmental H<sub>2</sub>S. In contrast, <xref rid="R183" ref-type="bibr">Saeedi et al. (2015)</xref> found that workers exposed to higher levels of H<sub>2</sub>S had lower mean sulfhemoglobin levels, yet these results are largely inconclusive due to the study&#x02019;s minimal exposure contrast and the limited statistical analysis. <xref rid="R58" ref-type="bibr">Drewnoski et al. (2012)</xref> investigated cattle exposed to environmental sulfate, which is converted to H<sub>2</sub>S in the rumen of cattle, by measuring both urine thiosulfate and blood sulfhemoglobin. To date, use of H<sub>2</sub>S biomarkers is uncommon, and all of the human biological monitoring studies discussed occurred in occupational settings. Validation of H<sub>2</sub>S biomarkers for low level exposures in community settings must consider sources of H<sub>2</sub>S &#x02013; endogenous or exogenous, clearance rates, sensitivity, and other factors to avoid exposure measurement error. Thus, at present, it would be prudent to collect ambient or personal H<sub>2</sub>S air samples in addition to urine thiosulfate or blood sulfhemoglobin. Further, the invasiveness and inconvenience of conventional blood draws may limit the use of biomonitoring in community studies to clinical settings, however, this may change as techniques evolve that allow convenient and minimally invasive (e.g., finger prick) sampling and analytical techniques.</p></sec><sec id="S55"><label>2.4.3.2</label><title>Duration of exposure: acute, intermediate, and chronic</title><p id="P186">Exposure to H<sub>2</sub>S (and other chemicals) in community and occupational settings will involve both acute and chronic exposures. In practice, these terms are not well defined. Acute exposure events, vary in concentration, length of exposure period, and their periodicity. For many pollutants including H<sub>2</sub>S, acute exposures are characterized as the maximum 15-min, 1-hr, or 24-hr average concentration. (<xref rid="S74" ref-type="sec">Section 4</xref> discusses the form of standards and guidelines that utilize different averaging periods.) Additionally, acute exposures can be a once-in-a-lifetime event, e.g., a result of a rare natural disaster or major industrial failure. In contrast, chronic exposures result from repeated exposure events over multiple years, and sometimes from a continuous or an ongoing release. Chronic exposures also vary in concentration, and are usually represented as an annual average concentration. For some pollutants (e.g., lead), intermediate durations are also sometimes used, e.g., a 3-month average.</p><p id="P187">Real-world H<sub>2</sub>S exposures can include both acute events, e.g., one or few events in a lifetime, intermediate or intermittent exposures, e.g., multiple events in a week or month, and chronic exposures, e.g., occurring on nearly a daily basis due to occupational exposures or proximity to emission sources.</p><p id="P188">Exposures in community settings near H<sub>2</sub>S emission sources (e.g., volcanoes, CAFOs, oil and gas facilities) will likely include intermediate duration and chronic exposures, although acute exposures also may occur. For example, upsets due to malfunctions at an industrial source may greatly increase levels over the chronic exposure normally expected, as documented by <xref rid="R94" ref-type="bibr">Haahtela et al. (1992)</xref>. More generally, for pollutants like H<sub>2</sub>S that are primarily emitted by localized outdoor sources, community exposures will be time varying due to the combined effects of: (1) the emission rate, which changes depending on activity, temperature, and other factors; (2) meteorological influences on dispersion, which is determined by winds, insolation, atmospheric stability, boundary layer height, precipitation, landscape features, and other factors; (3) sheltering or attenuation of H<sub>2</sub>S concentrations in buildings and other &#x0201c;microcompartments&#x0201d;, which are affected by air change rates, mixing, filtration, etc.; and (4) an individual&#x02019;s activity patterns (movement between microcompartments), breathing rate, and other individual-level factors. A key point in community settings is that time-averaged concentrations of H<sub>2</sub>S are likely to be low, but occasional concentration spikes at much higher levels for periods of minutes to hours may occur. High pollutant events lasting several days can occur if sufficient H<sub>2</sub>S emissions are released and if certain meteorological conditions that inhibit dispersion are persistent, e.g., prolonged subsidence inversion. These factors produce considerable spatial and temporal variation in H<sub>2</sub>S concentrations, including daily and seasonal patterns, that affect both occupational or environmental exposures, discussed further the following section.</p><p id="P189">The time-varying (dynamic) behavior of pollutant concentrations can be captured with fast-response real-time instruments, which are available for H<sub>2</sub>S and some other pollutants (e.g., SO<sub>2</sub>, CO, PM<sub>2.5</sub>, O<sub>3</sub>), but not for other pollutants (e.g., endotoxin). Several studies have used continuous monitors for H<sub>2</sub>S at locations designed to reflect population exposure, and several studies have used (short-term) indoor measurements in residences. Unlike the low-cost PM<sub>2.5</sub> sensors now being widely deployed across the world, low-cost (less than say $200) H<sub>2</sub>S sensors that operate reliably at low concentrations (0.001 &#x02013; 0.1 ppm) are unavailable.</p><p id="P190">The use of biomarkers or personal exposure monitoring, the &#x0201c;gold standard&#x0201d; in exposure assessment, has not been attempted in community studies of H<sub>2</sub>S. As described earlier (<xref rid="S54" ref-type="sec">Section 2.4.3.1</xref>), H<sub>2</sub>S biomarkers have limitations, and personal monitoring can involve substantial cost, logistical and participant burden impacts. As noted, only a subset of studies reviewed employed monitoring for H<sub>2</sub>S and other pollutants. In the studies that did use monitoring, there was little discussion of the temporal nature of exposures. Because different averaging times were used, it can be difficult to compare studies examining acute impacts. Generally, temporal fluctuations of H<sub>2</sub>S levels in a community would be expected to be similar to that of other pollutants arising from localized outdoor sources. <italic toggle="yes">A recommendation is to collect and analyze long-term (ideally &#x02265;1 year) continuous monitoring records of H</italic><sub><italic toggle="yes">2</italic></sub><italic toggle="yes">S at sites representative of population exposure around various types of sources</italic>. Such data for several other pollutants exist in both public and industry-operated ambient air quality monitoring networks in the U.S., Canada and elsewhere. Occasionally, citizen complaints or permit violations may initiate such monitoring for a limited period, in the U.S. most typically conducted by the U.S. ATSDR, states or industry as part of a exposure and health assessment, e.g., <xref rid="R147" ref-type="bibr">MDHHS (2023)</xref>. While primarily used to compare community exposure to reference levels (discussed in <xref rid="S75" ref-type="sec">Section 4.1</xref>), such initiatives rarely yield peer-reviewed publications that advance epidemiology, possibly a missed opportunity.</p><p id="P191">Ideally, data with 5-min or higher time resolution would be obtained and used to analyze concentration distributions at 5-min, 10-min, 30-min, 1-hr, and 24-hr averaging periods. In recent years, new technology has enabled the measurement of H<sub>2</sub>S with ppb precision e.g., cavity ring-down technology with high performance.</p></sec><sec id="S56"><label>2.4.3.3</label><title>Spatial variation of community exposure</title><p id="P192">For mostly the same reasons just discussed, ambient H<sub>2</sub>S concentrations in a community will vary from place to place. Spatial variation will always occur from localized outdoor sources and can lead to measurement error. Issues of cost and logistics generally preclude the use of a sufficient number of monitors to fully understand spatial variation across a community, although reasonable estimates can be made with a small set of monitors. Several (Finnish) epidemiological studies have used dispersion models to attempt to &#x0201c;fill-in&#x0201d; the inevitable data gaps from monitoring data (<xref rid="R96" ref-type="bibr">H&#x000e4;kkinen et al. 1985</xref>; <xref rid="R145" ref-type="bibr">Marttila et al. 1994</xref>; <xref rid="R226" ref-type="bibr">WHO 2006)</xref>, an approach which is reasonable if data exist to confirm (&#x0201c;ground-truth&#x0201d;) model predictions. Using measured or modeled concentrations, researchers may divide a region or city into zones based on concentration levels (i.e., high, medium, and low). The definition of cut-off points for exposure categories should consider climate factors such as wind direction and good characterization of background levels. For example, in the geothermally active city of Rotorua, New Zealand, the main emission sources of H<sub>2</sub>S are spatially clustered and thus not all residents are equally exposed; three zones were defined as high (~1 ppm), medium (0.5 ppm), and low/background levels (0 &#x02013; 0.04 ppm) (<xref rid="R26" ref-type="bibr">Bates et al. 2002</xref>). Considering the lack of standardized exposure category definitions, it is vital to consider each study&#x02019;s definition of exposure and exposure groups. The use of spatially-defined groups or zones (defined by monitoring, modeling, proximity, or other data) in an cross-section epidemiological study design requires careful consideration and control of covariates to avoid potential bias and confounding..</p><p id="P193">The majority of community studies around geothermal sources or livestock rearing operations used indirect proxy exposure measures, most often residential or school proximity to a facility or the number of facilities in the community (<xref rid="R38" ref-type="bibr">Bustaffa et al. 2020</xref>). Such indirect measures do not capture differences among sources and emissions, effects of meteorology and terrain on contaminant dispersion, impacts from other emission sources, and other factors that affect exposure (<xref rid="R108" ref-type="bibr">Huang and Batterman 2000</xref>). Thus, it is not expected that concentrations will be proportional to inverse distance from the source, or radially symmetric around the source, assumptions that have been used in the literature. Urban/rural differences are additional spatial challenges in studying the health effects of environmental exposures around geothermal plants or CAFOs. Urban and rural populations may differ with respect to sensitization and acclimatization to CAFO pollutants, e.g., a potential bias may result due to the lower prevalence of respiratory allergies sometimes seen among populations with early farm-animal contact (<xref rid="R174" ref-type="bibr">Radon et al. 2007</xref>).</p><p id="P194">Exposure assessments for H<sub>2</sub>S are just beginning to use the hybrid approaches that have become common in air pollution epidemiology for pollutants like PM<sub>2.5</sub> and NO<sub>2</sub>. These approaches synthesize a variety of data sources (satellite and remote sensing, <italic toggle="yes">in situ</italic> or ambient monitoring, land use features, emission inventories, chemical transport modeling, and sometimes housing features) to improve accuracy in comparison to any single approach. These techniques are particularly applicable to obtaining intermediate to long-term (e.g., weekly to annual) concentration estimates over large areas with high spatial resolution. A recent pilot study couples <italic toggle="yes">in situ</italic> and satellite data to estimate concentrations and emissions of several pollutants (CO<sub>2</sub>, CH<sub>4</sub>, H<sub>2</sub>S, and NH<sub>3</sub>) from a California dairy (<xref rid="R132" ref-type="bibr">Leifer et al., 2020</xref>), an approach that may have considerable value when linked to health data.</p></sec><sec id="S57"><label>2.4.3.4</label><title>Pollutant mixtures</title><p id="P195">Air pollution exposures experienced in communities and often workplaces involve mixtures of many chemicals. Measurement error can occur in trying to characterize exposure to an individual pollutant without considering potential co-pollutants. Both the components in the mixture, and the relative concentrations of components in the mixture depend on emission sources that are present. Thus, the &#x0201c;typical&#x0201d; exposure can vary considerably between individuals and between studies. As examples, H<sub>2</sub>S exposures from oil and gas facilities will likely include other reduced sulfur compounds and combustion-related compounds like SO<sub>2</sub> and CO; H<sub>2</sub>S exposures associated with CAFOs and manure management will likely be accompanied with other gases such as ammonia, mercaptans, sulfides, and ketones, and may also include particulate matter containing organic dusts containing bioactive substances (endotoxins, glucans, fungi and molds) (<xref rid="R53" ref-type="bibr">Donham 2010</xref>; <xref rid="R158" ref-type="bibr">NRC 2003</xref>). In addition, the composition and rate (strength or intensity) of emissions from most sources (e.g., oil and gas facilities, geothermal plants, or CAFOs) will differ among facilities and during different operations. For example, emissions may increase during hot weather and during manure spraying, an intermittent activity. Thus, the composition and concentration of exposures in community settings will vary in time and space, and the correlation among mixture components will also vary.</p><p id="P196">Ideally, each individual pollutant would be separately and objectively measured, otherwise effects of individual pollutants will be difficult to disentangle. Of the newer community-based livestock rearing studies identified, only five measured H<sub>2</sub>S (<xref rid="R39" ref-type="bibr">Campagna et al. 2004</xref>; <xref rid="R64" ref-type="bibr">Eduard et al. 2009</xref>; <xref rid="R110" ref-type="bibr">Inserra et al. 2004</xref>; <xref rid="R115" ref-type="bibr">Kilburn 2012</xref>; <xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>). Even fewer measured additional co-pollutants likely to confound observed health effects (<xref rid="R39" ref-type="bibr">Campagna et al. 2004</xref>; <xref rid="R64" ref-type="bibr">Eduard et al. 2009</xref>; <xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>); these may provide the best dose-response information for setting air quality standards. In their controlled exposure study, <xref rid="R185" ref-type="bibr">Schiffman et al. (2005)</xref> opines that while individual components of the mixture at low concentrations were not expected to produce health effects, the observed health effects may represent a combined and potentially synergistic effect. To date, no attempt has yet been made to evaluate health effects of components isolated from real CAFO mixtures, although this is technically possible. For example, subjects could be exposed only to CAFO-related gases by using filters to remove particulate matter and microorganisms. However, for practical reasons, controlled chamber studies are limited to short-term exposures and small sample sizes. Although exposure to the entire mixture may be more relevant to community exposure, such tests could be useful in demonstrating the effectiveness of occupational interventions e.g., N95 masks for workers and mechanical ventilation with particulate filtration for facilities. The results of both controlled and observational studies suggest the need for or desirability of a multipollutant approach to control emissions from livestock-related and potentially other types of facilities. Thus, controls should include both regulation of individual pollutants and broader technology or performance requirements. This approach would be more responsive to health impacts resulting from additive or synergistic effect of multiple pollutants from H<sub>2</sub>S sources.</p><p id="P197">The presence of pollutant mixtures is a real-world condition. In observational studies it may be difficult to discern effects of an individual pollutant when present in a mixture, however, effects may still be discerned despite spatial, temporal, and compositional variability if a study involves a sufficiently large sample of subjects, large geographic domain, sufficient duration, and appropriate pollutant measurements. Moreover, observational studies usually are the only practical approach to examine chronic and low-level exposures, to investigate potential synergies between mixture components and host factors like susceptibility, and to study large populations. The nascent but evolving hybrid models noted in the prior section may be valuable to provide exposure estimates for these studies.</p><p id="P198">If multiple pollutants are present and reasonably likely to influence a particular health outcome due to their concentration and toxicity, then ideally each pollutant should be objectively measured. It may be sufficient to screen for co-pollutants, or use the threshold olfactory technique (<xref rid="S13" ref-type="sec">Section 2.3.1.2</xref>) in certain studies, to target the exposure assessment. Otherwise, effects of an individual pollutant in the mixture may be difficult or impossible to disentangle. Given information regarding the major components of the mixture, then controlled, occupational and community studies can utilize a variety of experimental and statistical techniques to understand effects of individual components, including potential interactions (e.g., synergies) with other mixture components, as discussed in the next section.</p></sec><sec id="S58"><label>2.4.3.5</label><title>Cumulative effects of multiple chemical exposures</title><p id="P199">The term &#x0201c;cumulative effects&#x0201d; refers to the overall impact of concomitant exposures to multiple chemicals and other stressors in a particular condition or scenario. For exposure to chemical mixtures, this can include effects that are equal to (additive), less than (antagonistic), or greater than (synergistic) predictions based on the effects observed with exposures to individual chemicals.</p><p id="P200">As discussed above, H<sub>2</sub>S exposures often occur with exposures to other pollutants. Of the current literature, few studies provided information that can shed light on cumulative effects. <xref rid="R185" ref-type="bibr">Schiffman et al. (2005)</xref> addressed CAFO emissions, which involve a mixture of H<sub>2</sub>S, other reduced sulfur compounds, endotoxin and dust that may act on the same target tissues. One of few controlled human studies, it offers some evidence that the mixture may increase the hazard of H<sub>2</sub>S at low concentrations (documented as headaches, eye irritation, and nausea), since no single component was present at sufficiently high concentration to be wholly responsible for these symptoms (H<sub>2</sub>S levels were only 0.024 ppm) (<xref rid="R185" ref-type="bibr">Schiffman et al. 2005</xref>). <xref rid="R130" ref-type="bibr">Lee et al. (2007)</xref> also opined that symptoms observed may result from synergistic or additive effects of the mixture components; they found WWTP workers to have higher risks of respiratory symptoms (dry cough, cough with phlegm, wheeze, chest tightness, breathlessness), although H<sub>2</sub>S concentrations averaged 0.15 ppm and 95% of measurements were below 1 ppm (although the maximum value was high, 42.5 ppm). Finally, <xref rid="R151" ref-type="bibr">Mirabelli et al. (2006a</xref>) suggested that children using cigarettes or experiencing secondhand tobacco smoke were susceptible to increased prevalence of wheeze, suggesting co-exposure to environmental exposure as an additional risk factor.</p><p id="P201">Although more complex than investigating a single component, multipollutant studies are needed to provide the most meaningful approach to deal with actual exposures and health effects from pollutant mixtures (<xref rid="R52" ref-type="bibr">Dominici et al. 2010</xref>; <xref rid="R90" ref-type="bibr">Greenbaum and Shaikh 2010</xref>; <xref rid="R146" ref-type="bibr">Mauderly et al. 2010</xref>). Multipollutant approaches may lead to better management strategies because real world H<sub>2</sub>S exposures often occur with other toxic pollutants.</p></sec></sec><sec id="S59"><label>2.4.4</label><title>At-risk populations and susceptibility</title><p id="P202">Three definitions are intended to provide some consistency in the discussion, although these terms are often comingled in the literature.</p><list list-type="bullet" id="L60"><list-item><p id="P203">The term &#x0201c;susceptibility&#x0201d; or &#x0201c;susceptible population&#x0201d; has been used to recognize groups that are at greater risk than the general population for health risk(s) from a specific pollutant, generally due to <underline>biological</underline> or <underline>intrinsic</underline> factors (e.g., life stage, gender, health and preexisting disease/conditions, nutritional status, and effects of exposure to other toxic substances such as cigarette smoke). A susceptible population would exhibit a different or enhanced response to a pollutant (like H<sub>2</sub>S) than most persons with the same exposure, and detoxification or excretion of the pollutant, organ function or other processes may be reduced or compromised (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>).</p></list-item><list-item><p id="P204">The term &#x0201c;vulnerability&#x0201d; or &#x0201c;vulnerable population&#x0201d; typically refers to <underline>nonbiological</underline> or <underline>extrinsic</underline> factors (e.g., socioeconomic factors, limited access to health care, lower quality housing located near emission sources). Vulnerability may affect susceptibility, and thus these terms are often comingled.</p></list-item><list-item><p id="P205">Finally, the term &#x0201c;at-risk&#x0201d; or &#x0201c;at-risk population&#x0201d; refers to groups more that are likely to have higher risk of health effects than the general population, potentially a result of separate or combined influences from susceptibility, vulnerability, and higher exposure. (Populations with unusually high exposure to H<sub>2</sub>S are discussed in <xref rid="S62" ref-type="sec">Section 3</xref>.)</p></list-item></list><p id="P206">Generally, the scope of the H<sub>2</sub>S studies available permits limited insight with respect to susceptibility, and only to some health outcomes. Few studies examined potential effect modifiers that might identify more susceptible or vulnerable populations. Given the malodor of H<sub>2</sub>S, it is reasonable to anticipate that individuals with asthma, who show increased sensitivity to odors, would have a worsening of their condition upon exposure (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>). Strong supporting evidence of asthmatic vulnerability is provided by <xref rid="R41" ref-type="bibr">Carlsen et al. (2012)</xref> who studied a population exposed to volcanic emissions with daily H<sub>2</sub>S averages of 0.006 ppm and daily peaks of 0.062 ppm (1-hr averages of 0.021 ppm and 1-hr peaks of 0.345 ppm), and by <xref rid="R39" ref-type="bibr">Campagna et al. (2004)</xref> who studied a population around CAFOs with 30-min concentrations above 0.030 ppm. Earlier, controlled 30-min tests with 2 ppm H<sub>2</sub>S of a small group of subjects with mild-to-moderate asthma noted some sensitivity by increased airway resistance and decreased specific airway conductance, implying bronchial obstruction; however, this study excluded individuals who may be most susceptible, specifically, severe asthmatics and children (<xref rid="R112" ref-type="bibr">Jappinen et al. 1990</xref>). <xref rid="R81" ref-type="bibr">Finnbjornsdottir et al. (2016)</xref> found a weak association between H<sub>2</sub>S and heart disease in adults that increased slightly among those 73 years and older. Besides underlying conditions such as asthma, environmental and social factors have been evaluated as potential effect modifiers. Being raised on a farm may increase a child&#x02019;s risk of asthma, even after accounting for atopy and allergy (<xref rid="R148" ref-type="bibr">Merchant et al. 2005</xref>). Children may be more susceptible to a broader range of respiratory diseases than adults (<xref rid="R39" ref-type="bibr">Campagna et al. 2004</xref>). Children who smoke cigarettes or experience secondhand smoke have higher risk of wheezing than children who do not (<xref rid="R150" ref-type="bibr">Mirabelli and Wing 2006</xref>). However, not all studies that stratified health risk by susceptibility factors have found significant effects. <xref rid="R214" ref-type="bibr">Villeneuve et al. (2009)</xref> found no difference in health effects between children/adolescents and adults. <xref rid="R194" ref-type="bibr">Sigurdarson and Kline (2006)</xref> noted that children with parents who farmed and smoked were not more likely to have asthma than children of parents who did not.</p><p id="P207">The broader literature points to several groups that are at-risk for morbidity and mortality effects from air pollutants. Examples for two pollutants are given. For particulate matter (PM<sub>2.5</sub>), susceptible and at risk groups include children and older adults, individuals with pre-existing heart and lung disease, and persons with lower socioeconomic status and with genetic differences. Emerging though still limited evidence exists for additional potentially at-risk populations, including individuals with diabetes, people who are obese, pregnant women, and the developing fetus (<xref rid="R70" ref-type="bibr">EPA 2012</xref>). For sulfur dioxide (SO<sub>2</sub>), at-risk groups include those with pre-existing respiratory disease, children and older adults (but possibly not adolescents), and people who spend extended periods of time outdoors and/or at elevated ventilation rates (<xref rid="R68" ref-type="bibr">EPA 2017</xref>). EPA concluded that large portions of the US population are likely to be at increased risk from these pollutants, and health-protective standards were set based on the at-risk groups. Clearly, a very large number of individuals are exposed and affected by air pollutants PM<sub>2.5</sub> and ozone. Over the past four decades, SO<sub>2</sub> emissions, concentrations, and the numbers of individuals affected have likely dropped considerably e.g., in 2021, nonattainment areas for SO<sub>2</sub> included 26 areas with a population of 2.13 million persons (<xref rid="R73" ref-type="bibr">EPA 2010b</xref>). In this report, the number of individuals affected by high concentrations of H<sub>2</sub>S is not estimated, however considering the many facilities that routinely or intermittently release H<sub>2</sub>S across the nation (e.g., refineries, CAFOs, wastewater facilities, etc.), the population exposed or potentially exposed may be substantial.</p></sec><sec id="S60"><label>2.4.5</label><title>Potential biases in observational studies</title><p id="P208">While observational studies provide opportunities to examine chronic low-level exposures, results of these and other epidemiological studies can be limited by several types of biases. <italic toggle="yes">Reporting or awareness bias</italic> can affect self-reported symptom assessments, potentially important for H<sub>2</sub>S considering its odor that may make subjects more aware and likely to report effects and symptoms. Reporting bias also occurs for other reasons, e.g., economic interests associated with industry and study participants. <italic toggle="yes">Recall bias</italic> is a second potential issue in symptom studies, particularly for longer recall periods. A third bias is the <italic toggle="yes">sensitization &#x02013;</italic> or conversely <italic toggle="yes">tolerance bias</italic> &#x02013; to exposures and odors; this bias also may affect results of experimental (chamber) investigations. <xref rid="R185" ref-type="bibr">Schiffman et al. (2005)</xref>, for example, discusses possible differences in responses obtained from volunteers in chamber studies compared to those who are chronically and involuntarily exposed, however, the literature is equivocal on this topic, showing that repeated exposure can increase sensitivity to an odor (especially among women), but that some workers appear tolerant of swine confinement air.</p><p id="P209">Other types of biases in observational studies, particularly in community-based studies, include <italic toggle="yes">selection bias</italic> (e.g., the need for a randomly selected case population and, in case-control studies, an appropriately selected comparison population), the possibility of <italic toggle="yes">confounders</italic> (including co-pollutants), and <italic toggle="yes">effect modifiers</italic> (e.g., due to urban/rural differences) (<xref rid="R53" ref-type="bibr">Donham 2010</xref>; <xref rid="R100" ref-type="bibr">Heederik et al. 2007</xref>; <xref rid="R174" ref-type="bibr">Radon et al. 2007</xref>).</p><p id="P210"><xref rid="S53" ref-type="sec">Section 2.4.3</xref> earlier discussed issues and weaknesses in exposure estimates used in the observational studies. Exposure measurement error or misclassification is a topic that has received considerable attention in the epidemiological literature (<xref rid="R42" ref-type="bibr">Carroll et al. 2006</xref>). <italic toggle="yes">Exposure measurement error,</italic> that is, differences between the measured (or predicted) exposure used in the analysis compared to the underlying or true exposure, or <italic toggle="yes">exposure misclassification,</italic> the analogous term for a categorical exposure variable, can lead to incorrect inference, specifically, biased and/or imprecisely estimated effect coefficients that may be serious enough to invalidate the inference regarding the effect of H<sub>2</sub>S on health (<xref rid="R191" ref-type="bibr">Sheppard et al. 2012</xref>). The framework for exposure measurement or misclassification error refers to standard categories: <italic toggle="yes">classical measurement error</italic> due to random errors resulting when the true exposure is measured but with noise, which causes biased effect estimates as well as higher or lower standard errors; <italic toggle="yes">Berkson measurement error</italic> when only part of the true exposure or aggregated exposure is measured, which causes unbiased but more variable exposure-response (effect) estimates; <italic toggle="yes">Berkson-like measurement error</italic> due to smoothing the exposure surface; and <italic toggle="yes">classical-like measurement error</italic> when noise is not independent (<xref rid="R204" ref-type="bibr">Szpiro and Paciorek 2013</xref>). Related classifications of errors due to spatial issues include: the <italic toggle="yes">modifiable areal unit problem</italic> (MAUP), which can bias outcomes when a point-based measure (e.g., H<sub>2</sub>S level measured at a site) is assumed to apply to a district (e.g., census tracts) and lead to the so-called ecological fallacy (<xref rid="R85" ref-type="bibr">Ganguly et al. 2015</xref>; <xref rid="R190" ref-type="bibr">Shafran-Nathan et al. 2017</xref>); <italic toggle="yes">location-based covariate measurement error</italic>, e.g., when proximity to a H<sub>2</sub>S source like a CAFO is used to define exposure; and differences between <italic toggle="yes">ambient and personal exposures</italic> (<xref rid="R122" ref-type="bibr">Kioumourtzoglou et al. 2014</xref>). Finally, studies investigating chronic disease can be susceptible to <italic toggle="yes">exposure timing bias</italic>, e.g., the use of current exposure conditions that may have limited relevance for a disease that developed years or decades earlier (<xref rid="R138" ref-type="bibr">Lipfert and Wyzga 2008</xref>).</p></sec><sec id="S61"><label>2.4.6</label><title>Summary of the studies</title><p id="P211"><xref rid="T1" ref-type="table">Table 1</xref> summarizes many of the health effects associated with H<sub>2</sub>S. Only a subset of studies that measured or estimated H<sub>2</sub>S levels are included. Estimates listed of H<sub>2</sub>S exposure levels, durations, and co-pollutants are approximate. The case reports and the available epidemiologic and toxicological literature clearly indicate that the high H<sub>2</sub>S concentrations that sometimes occur in occupational settings such as viscose rayon and pulp manufacture, and oil, gas and geothermal energy production have the potential to produce morbidity and death. The dose-response relationship for mortality is well understood. However, the literature does not include any large occupational epidemiological studies that address morbidity or mortality due to chronic occupational exposures. Such studies are recommended and could shed light on the low-level exposures that are the focus of this report. There is also a paucity of large studies addressing chronic low level H<sub>2</sub>S exposures occurring in community settings. Such studies are needed to evaluate the potential of H<sub>2</sub>S to cause health effects on susceptible and vulnerable individuals. In addition, although there are numerous reports of adverse effects, many involve concurrent exposures and the data and/or analyses do not quantitatively link effects with H<sub>2</sub>S exposure for this and other reasons (<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>).</p><p id="P212">The newer literature includes several medium-sized studies using (daily) time-series analyses and objective measures of both pollutants and respiratory-related symptoms and disease. Unscheduled hospital visits for aggravation of asthma and respiratory disease increased at H<sub>2</sub>S concentrations above 0.03 ppm in Nebraska (<xref rid="R39" ref-type="bibr">Campagna et al. 2004</xref>); irritation (nose and eye), odor, difficulty of breathing and cough was associated with higher H<sub>2</sub>S concentrations or odor in North Carolina (<xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>); and exacerbation of existing asthma at H<sub>2</sub>S concentrations of 0.0067 ppm was indicated by (increased) dispersal of anti-asthma drugs in Reykjavik (<xref rid="R41" ref-type="bibr">Carlsen et al. 2012</xref>). The latter study has the strength that multiple pollutants were considered, which due to differences in pollutant emissions may have had greater influence on the CAFO-oriented studies (i.e., <xref rid="R39" ref-type="bibr">Campagna et al. 2004</xref>; <xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>). These studies strongly suggest that short-term (30 min to 24-hr) H<sub>2</sub>S concentrations in the range of 0.007 to 0.03 ppm, roughly around the odor detection/nuisance threshold, can significantly exacerbate asthma. Individuals with asthma are highly susceptible to air pollutants, and thus this finding is consistent with the literature for other pollutants. Although findings in these studies appear robust, ecological designs (and typically a single monitoring site) were used, which limits the ability to identify and control for individual or group risk factors (effect modifiers and covariates).</p><p id="P213">Many of the other studies discussed in this review show elevated risks for other symptoms and diseases, including ocular symptoms, sore throat, cough, nasal irritation, nasal lesions, difficulty of breathing, chest tightness, wheezing, increased asthma prevalence and/or aggravation, lung function decrements, depression, neurological and neurobehavioral changes among individuals in communities and workplaces where H<sub>2</sub>S concentrations are elevated or likely to be elevated. In particular, eye irritation may result at concentrations starting in the range of 0.007 to 0.025 ppm. The modeling by <xref rid="R187" ref-type="bibr">Schroeter et al. (2010</xref>; <xref rid="R188" ref-type="bibr">2006</xref>) had the effect of changing the NOAEL for nasal lesions. In community settings, odor-triggered nuisance, complaints and physiological symptoms are expected with short-term concentrations in the range of 0.001 to 0.050 ppm, and odor nuisance thresholds are in the range from 0.03 to 0.05 ppm or lower. The newer observational studies document neurological and neurobehavioral abnormalities in community settings around H<sub>2</sub>S sources, but the identification of the causal mechanisms and the dose-response relationships remains unresolved.</p><p id="P214">Exposure assessment limitations in these studies just mentioned, including a lack of objective monitoring, preclude establishments of dose-response relationships. Exposure assessments continue to represent a significant weakness of H<sub>2</sub>S studies (<xref rid="R165" ref-type="bibr">OEHHA 1999</xref>); this is a common problem in air pollution epidemiology. Additionally, results of some studies may have been affected by co-pollutants, biases in participant recruitment/selection, symptom ascertainment (especially when self-reported), occupation and exposure history, and other factors. Many studies used cross-sectional designs that have a high likelihood of bias due to the difficulty of accounting for covariates and confounding variables. Good discussions of methodological limitations are provided by <xref rid="R174" ref-type="bibr">Radon et al. (2007)</xref> and (<xref rid="R164" ref-type="bibr">OEHHA 2000</xref>) for the H<sub>2</sub>S studies, and by <xref rid="R88" ref-type="bibr">G&#x000f6;tschi et al. (2008)</xref> for air pollutants in general.</p><p id="P215">There is a large divergence between experimental animal and human studies with respect to the concentrations that are associated with adverse effects. These types of studies typically employ different types of health effect measures (<xref rid="R164" ref-type="bibr">OEHHA 2000</xref>). Moreover, animal and controlled human exposures are typically very short-term in nature, likely to miss health effects with long latency periods, rarely evaluate effects relevant to susceptible individuals (including children, the elderly, and persons with preexisting medical conditions), and may not reflect other factors important to actual exposures and real-world conditions. However, experimental studies represent an essential criterion in causality determinations (<xref rid="S51" ref-type="sec">Section 2.4.1</xref>)</p><p id="P216">As in most of the epidemiological literature, it is difficult to assess publication bias in the H<sub>2</sub>S literature. Few studies with exclusively null findings were identified, although <xref rid="R110" ref-type="bibr">Inserra et al. (2004)</xref> and <xref rid="R214" ref-type="bibr">Villeneuve et al. (2009)</xref> reported largely negative findings. The lack of negative studies and the preponderance of smaller studies suggest that publication bias is likely (<xref rid="R88" ref-type="bibr">G&#x000f6;tschi et al. 2008</xref>).</p></sec></sec></sec><sec id="S62"><label>3</label><title>Exposure to H<sub>2</sub>S</title><p id="P217">A short discussion is provided of populations exposed to H<sub>2</sub>S. Elevated levels and exposures of H<sub>2</sub>S occur near several types of air pollution sources.</p><list list-type="bullet" id="L62"><list-item><p id="P218"><underline>Industry</underline>. H<sub>2</sub>S is emitted more or less continuously in certain industries. These include natural gas production, shale oil industry, petroleum refining, petrochemical synthesis, municipal sewage pumping and treatment plants, landfills, swine containment and manure handling (including confined animal confinement facilities or CAFOs), pulp and paper production, construction in wetlands, asphalt roofing, pelt processing, animal slaughter facilities, tanneries, coke production plants, viscose rayon manufacture, sulfur production, iron smelting, ocean fishing, and food and meat processing, pulp and paper mills, oil refineries, hot springs and geothermal energy installations, Superfund and other waste sites, and chemical (and other) waste lagoons (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>, <xref rid="R17" ref-type="bibr">2002</xref>; <xref rid="R87" ref-type="bibr">Glass 1990</xref>).</p></list-item><list-item><p id="P219"><underline>Accidental releases</underline>. H<sub>2</sub>S can be emitted in large amounts resulting in acute exposures due to industrial accidents, pipeline failures, and geothermal sources. Based on a multistate surveillance program, 637 H<sub>2</sub>S events occurred from 1993 to 2001, resulting in 63 public evacuations and 185 people injured (<xref rid="R17" ref-type="bibr">ATSDR 2002</xref>). In Alberta, Canada, 357 sour gas incidents occurred from 1990 to 2005 along pipelines, including hits, leaks, releases and ruptures (<xref rid="S70" ref-type="sec">Section 3.8</xref>).</p></list-item><list-item><p id="P220"><underline>Natural sources</underline> include volcanoes, sulfur springs, undersea vents, swamps and stagnant bodies of water and in crude petroleum and natural gas. Additionally, bacteria, fungi, and actinomycetes release H<sub>2</sub>S during the decomposition of sulfur-containing proteins and by the direct reduction of sulfate (SO<sub>4</sub><sup>2-</sup>; <xref rid="R16" ref-type="bibr">ATSDR 2006</xref>).</p></list-item></list><p id="P221">Typically, background levels (away from industrial or strong natural sources) are low, falling below 0.001 ppm (1 ppb), while proximity to strong natural sources or industries emitting H<sub>2</sub>S can produce much higher concentrations that often exceed 0.09 ppm (90 ppb) (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>).</p><p id="P222">This section emphasizes exposures of H<sub>2</sub>S reported in the scientific literature relevant to community exposure. It does not include the &#x0201c;gray literature,&#x0201d; which potentially includes a large number of exposure assessments that sometimes result from citizen complaints, regulatory requirements, or permit violations that are conducted by the U.S. ATSDR, states, and industry (e.g., <xref rid="R147" ref-type="bibr">MDHHS 2023</xref>).</p><sec id="S63"><label>3.1</label><title>General urban levels</title><p id="P223">In one report, the average ambient H<sub>2</sub>S level was estimated at 0.0002 ppm (0.3 &#x003bc;g/m<sup>3</sup>). In north-west London, over a period of 2.5 years, air levels of H<sub>2</sub>S were generally &#x0003c;0.0001 ppm (0.1 ppb; 0.15 &#x003bc;g/m<sup>3</sup>) under clear conditions (<xref rid="R226" ref-type="bibr">WHO 2006</xref>, <xref rid="R228" ref-type="bibr">1981</xref>). <xref rid="R16" ref-type="bibr">ATSDR (2006)</xref> reports that ambient air concentrations from natural sources range between 0.00011 and 0.00033 ppm (0.11 and 0.33 ppb), and that levels in urban areas are generally below 0.001 ppm (1 ppb).</p></sec><sec id="S64"><label>3.2</label><title>Geothermal sources</title><p id="P224">H<sub>2</sub>S has been continuously monitored in the city of Rotorua, New Zealand, where geothermal activity is sufficient to cause odors and where studies of mortality (<xref rid="R25" ref-type="bibr">Bates et al. 1997</xref>), cancer (<xref rid="R24" ref-type="bibr">Bates et al. 1998</xref>), morbidity (<xref rid="R26" ref-type="bibr">Bates et al. 2002</xref>), respiratory disease (<xref rid="R63" ref-type="bibr">Durand and Wilson 2006</xref>) and cognitive function (<xref rid="R175" ref-type="bibr">Reed et al. 2014</xref>) have been performed. H<sub>2</sub>S concentrations exceeded 0.05 ppm (80 &#x003bc;g/m<sup>3</sup>) over 55% of the time in the mid-winter months (<xref rid="R226" ref-type="bibr">WHO 2006</xref>, <xref rid="R228" ref-type="bibr">1981</xref>). <xref rid="R107" ref-type="bibr">Horwell et al. (2005)</xref> mapped levels in the city using passive samplers and indicated that maximum 8-hr levels in the center city may reach 1 ppm regularly, while 10-min peaks may be order of magnitude higher. Other studies in Rotorua have detected similarly low levels: a range of 0.03 to 1.0 ppm (<xref rid="R63" ref-type="bibr">Durand and Wilson 2006</xref>); IQR of 0.0056 to 0.184 ppm (<xref rid="R171" ref-type="bibr">Pope et al. 2017</xref>); IQR of 0.011 to 0.031 ppm (<xref rid="R23" ref-type="bibr">Bates et al. 2013</xref>); median of 0.014 ppm (<xref rid="R26" ref-type="bibr">Bates et al. 2002</xref>, <xref rid="R24" ref-type="bibr">1998</xref>). Different sampling techniques and spatial variation in concentrations due to soil gas emission fluxes and meteorological influences could explain the differences in measured ambient levels (<xref rid="R63" ref-type="bibr">Durand and Wilson 2006</xref>). <xref rid="R61" ref-type="bibr">Durand and Scott (2005)</xref> reported on levels inside nine buildings in Rotorua and discussed the lack of effectiveness of preventative measures, such as under-laying of concrete floors with a gas-proof butanol seal, under-floor ventilation systems, and positive-pressure air conditioning.</p><p id="P225">Reykajavik, Iceland is also known for high geothermal activity with ambient H<sub>2</sub>S at concentrations averaging 0.0058 (<xref rid="R41" ref-type="bibr">Carlsen et al. 2012</xref>). According to <xref rid="R81" ref-type="bibr">Finnbjornsdottir et al. (2016)</xref>, the interquartile range (IQR) of H<sub>2</sub>S levels is 0 to 0.003 ppm. In another geothermal &#x0201c;hotspot,&#x0201d; Mt. Amiata, Tuscany, ambient H<sub>2</sub>S concentrations averaged 0.0003 to 0.022 ppm (<xref rid="R162" ref-type="bibr">Nuvolone et al. 2019</xref>).</p></sec><sec id="S65"><label>3.3</label><title>Oil and gas production facilities, including sour gas wells and pipelines</title><p id="P226">H<sub>2</sub>S is both routinely and episodically released at sour gas wells, gas and crude oil batteries, gas and oil processing plants, oil refineries, and tar sands mining operations. Possibly the most extensive H<sub>2</sub>S monitoring has been performed in Alberta, Canada. <xref rid="R7" ref-type="bibr">Alberta Environment (2004)</xref> provides statistics from about 80 monitoring stations in Alberta over a three-year period at sites potentially affected by oil and gas exploration and production facilities. The three highest (1 hr) concentrations ranged to 3 ppm; excluding these values, the average concentration was 0.006 ppm (6 ppb or 8.5 &#x003bc;g/m<sup>3</sup>). Alberta Environment also summarized pipeline incidents, including hits, leaks, releases and ruptures, reports 10 to 41 sour gas incidents per year (total 357 from 1990 to 2005), most of which were attributed to corrosion (<xref rid="R3" ref-type="bibr">AEUB 2007</xref>). The overall rate of sour gas pipeline incidents ranges from 1.2 to 3.2 incidents per year per 1000 km, and a declining trend is noted across the Province of Alberta. Pipeline accident rates are typically expressed in terms of number of incidents per year per km of pipeline, and rates can vary significantly in different regions. A health study of Canadian petroleum workers did not directly measure H<sub>2</sub>S but used a job-exposure matrix to back-estimate lifetime occupational median exposures of 0.07 ppm (<xref rid="R133" ref-type="bibr">Lewis et al. 2003</xref>).</p><p id="P227">The US EPA conducted some monitoring around the Gulf Coast in the aftermath of the BP oil spill (<xref rid="R2" ref-type="bibr">AER 2022</xref>). Based on website notes, most sites had levels below detection limits (0.1 ppm); some levels exceeded 0.5 ppm in Venice, Alabama, and typical values at Chalmette, Louisiana (some 50 miles from Venice) were 0.002 to 0.004 ppm (<xref rid="R69" ref-type="bibr">EPA 2016</xref>). <xref rid="R141" ref-type="bibr">Lusk and Kraft (2010)</xref> reported on H<sub>2</sub>S monitoring (and an avian risk assessment) in oil and gas production facilities in New Mexico and found that most peak levels were below 6 ppm; the maximum peak level was 33 ppm. Another occupational study of oil/sour gas facilities in New Mexico found levels ranging from 0 to 0.014 ppm (<xref rid="R60" ref-type="bibr">Dubyk and Mustafa 2002</xref>).</p><p id="P228">Natural gas venting during well testing and development, as well as testing and maintenance of other energy infrastructure, can be a short-term source of H<sub>2</sub>S emissions and exposure. This appears to have become more common in the past decade due to the expansion of hydraulic fracturing and natural gas fields in North America, e.g., sour gas fields in Alberta, Canada. Typically, venting during well tests and other non-routine activities has been limited to a maximum duration of three days, and monitoring and modeling may be required to ensure that ambient H<sub>2</sub>S concentrations (and SO<sub>2</sub> concentrations if flaring is used) do not cause odors (1-hour level H<sub>2</sub>S level below 0.01 ppm) or exceed standards (<xref rid="R2" ref-type="bibr">AER 2022</xref>; <xref rid="R4" ref-type="bibr">AH 2020</xref>). Venting typically would not be utilized subsequently, e.g., during well operation.</p></sec><sec id="S66"><label>3.4</label><title>Pulp and paper mills</title><p id="P229">Emissions from pulp and paper mills can include a mixture of particles, sulfur dioxide and several malodorous compounds including H<sub>2</sub>S, methyl mercaptan, and methyl sulfides, which are often measured and reported as total reduced sulfur (TRS). H<sub>2</sub>S can constitute a variable form of TRS, e.g., <xref rid="R111" ref-type="bibr">Jaakkola et al. (1990)</xref> indicate 70%. Some of the studies reporting concentrations around these facilities are listed below.</p><list list-type="bullet" id="L64"><list-item><p id="P230">Peak concentrations up to 0.13 ppm (200 &#x003bc;g/m<sup>3</sup>) were measured near a pulp and paper-mill in California (<xref rid="R226" ref-type="bibr">WHO 2006</xref>, <xref rid="R228" ref-type="bibr">1981</xref>).</p></list-item><list-item><p id="P231">In an occupational survey of H<sub>2</sub>S and other sulfides at six kraft mills in Finland, concentrations ranged from below 0.05 ppm (75 &#x003bc;g/m<sup>3</sup>) to 20 ppm (30,000 &#x003bc;g/m<sup>3</sup>), the highest concentrations being found near vacuum pumps (<xref rid="R113" ref-type="bibr">Kangas et al. 1984</xref>; <xref rid="R226" ref-type="bibr">WHO 2006</xref>).</p></list-item><list-item><p id="P232">In a Finnish town with two sulfate pulp mills (annual emissions of 1993 and 794 T/year of H<sub>2</sub>S, respectively), dispersion models estimated average annual concentrations up to 0.037 ppm (55 &#x003bc;g/m<sup>3</sup>), monthly average concentrations up to 0.067 ppm (100 &#x003bc;g/m<sup>3</sup>), 24-hr concentrations up to 0.36 ppm (540 &#x003bc;g/m<sup>3</sup>), and 1-hr concentrations up to 1.07 ppm (1600 &#x003bc;g/m<sup>3</sup>) (<xref rid="R96" ref-type="bibr">H&#x000e4;kkinen et al. 1985</xref>; <xref rid="R226" ref-type="bibr">WHO 2006</xref>).</p></list-item><list-item><p id="P233">Observational health studies of communities near sulfate pulp mills in South Karelia, Finland reported average concentrations of 0.00067 to 0.0053 ppm (<xref rid="R145" ref-type="bibr">Marttila et al. 1994</xref>) and 0.001 to 0.002 ppm (<xref rid="R168" ref-type="bibr">Partti-Pellinen et al. 1996</xref>).</p></list-item><list-item><p id="P234">Monitoring data near five kraft mills in Alberta, Canada is reported by <xref rid="R7" ref-type="bibr">Alberta Environment (2004)</xref>.</p></list-item><list-item><p id="P235"><xref rid="R125" ref-type="bibr">Korhonen et al. (2004)</xref> summarized occupational exposures in the paper industry across 12 countries; however, relative few measurements of H<sub>2</sub>S are reported.</p></list-item><list-item><p id="P236"><xref rid="R150" ref-type="bibr">Mirabelli and Wing (2006)</xref> reported odors near four pulp and paper mills in North Carolina, but exposures are not quantified.</p></list-item><list-item><p id="P237">H<sub>2</sub>S monitoring in seven localities near around Ru&#x0017e;omberok, Slovakia, a polluted area containing a kraft pulp mill, showed long-term average concentrations (2002 through 2004) up to 0.004 ppm (5.8 &#x003bc;g/m<sup>3</sup>) and maximum levels of 0.014 ppm (21 &#x003bc;g/m<sup>3</sup>) (<xref rid="R59" ref-type="bibr">Drimal et al. 2010</xref>). Using the 95th percentile 24-hr samples as a worst-case, a RfC of 0.001 ppm (2 &#x003bc;g/m<sup>3</sup>) (<xref rid="R75" ref-type="bibr">EPA 2003</xref>), the authors report hazard quotients up to 7. This represents the first air monitoring of H<sub>2</sub>S in Slovakia.</p></list-item></list></sec><sec id="S67"><label>3.5</label><title>Viscose rayon mills</title><p id="P238">Near a viscose rayon mill in Finland, H<sub>2</sub>S concentrations were measured and predicted using a dispersion model (<xref rid="R83" ref-type="bibr">FNBH 1982</xref>; <xref rid="R226" ref-type="bibr">WHO 2006</xref>). For a 55 m high smokestack, average annual concentrations exceeded 0.007 ppm (10 &#x003bc;g/m<sup>3</sup>), 24-hr concentrations were approximately 0.134 ppm (200 &#x003bc;g/m<sup>3</sup>), and hourly concentrations reached 0.302 ppm (450 &#x003bc;g/m<sup>3</sup>). A higher smokestack reduced maximum annual, 24-hr and hourly concentrations to 0.003, 0.023, and 0.054 ppm, respectively (4, 35 and 80 &#x003bc;g/m<sup>3</sup>). A Japanese survey of 18 viscose rayon plants showed very high occupational exposures of H<sub>2</sub>S, which ranged from 0.3 to 7.8 ppm (450 to 11,700 &#x003bc;g/m<sup>3</sup>), with a mean of 3 ppm (4,500 &#x003bc;g/m<sup>3</sup>) (<xref rid="R102" ref-type="bibr">Higashi et al. 1983</xref>; <xref rid="R226" ref-type="bibr">WHO 2006</xref>).</p></sec><sec id="S68"><label>3.6</label><title>Livestock rearing systems</title><p id="P239">Livestock rearing systems include confined animal feeding systems (CAFOs) and manure storage and treatment. H<sub>2</sub>S is the main toxic emission from livestock rearing systems with liquid manure storage; other emissions can include ammonia, mercaptans, sulfides, ketones and particulate matter, which can include organic dusts with endotoxins, glucans, fungi, molds and other microbes. A very complete review of emissions, with recommendations, is provided by <xref rid="R158" ref-type="bibr">NRC (2003)</xref>. Acute exposures have been reviewed by <xref rid="R54" ref-type="bibr">Donham et al. (1982)</xref>, and updated reviews of community and occupational concerns are given by the same team (<xref rid="R53" ref-type="bibr">Donham 2010</xref>; <xref rid="R56" ref-type="bibr">Donham et al. 2007</xref>). An increasing number of studies are examining odors and contaminants in communities near CAFOs.</p><list list-type="bullet" id="L66"><list-item><p id="P240">H<sub>2</sub>S and TRS measurements at multiple indoor and outdoor locations in Dakota City and South Sioux City, Nebraska, an area affected by a large animal waste treatment facility and other sources, exceeded 0.030 ppm (30 ppb) about a quarter of the time (<xref rid="R18" ref-type="bibr">ATSDR 1997</xref>; <xref rid="R39" ref-type="bibr">Campagna et al. 2004</xref>; <xref rid="R109" ref-type="bibr">Inserra et al. 2002</xref>; <xref rid="R224" ref-type="bibr">White et al. 1999</xref>).</p></list-item><list-item><p id="P241"><xref rid="R55" ref-type="bibr">Donham et al. (2006)</xref> measured H<sub>2</sub>S outside 35 homes located near swine farms in three regions -- those with CAFO facilities, hoop structure facilities, or crop-only production (control) -- in the Upper Midwest, U.S. The time weighted average concentrations of H<sub>2</sub>S (8.42 ppb) was higher (p = 0.047) in the CAFO area than the control area (3.48 ppb). The concentration of H<sub>2</sub>S exceeded the ATSDR limit (30 ppb) for chronic exposure at two of the 12 homes in the CAFO area (17%). Average H<sub>2</sub>S levels exceeded the EPA recommended community standards (0.7 ppb) in all three regions.</p></list-item><list-item><p id="P242"><xref rid="R230" ref-type="bibr">Wing et al. (2008)</xref> measured odors, H<sub>2</sub>S and PM<sub>10</sub> at 16 neighborhoods in eastern North Carolina, US that had between one and 16 CAFOs within a radius of 2 miles. Monitoring periods in each neighborhood were at least 2 wks. Average H<sub>2</sub>S concentrations ranged from 0.00 to 0.00148 ppm (0.00 to 1.48 ppb), and 15-min levels reached 0.090 ppm (90 ppb). Odor ratings made by 101 participants during 10-min periods of sitting outside twice a day were associated with weather conditions and concentrations of H<sub>2</sub>S and PM<sub>10</sub> (<xref rid="R106" ref-type="bibr">Horton et al. 2009</xref>; <xref rid="R230" ref-type="bibr">Wing et al. 2008</xref>).</p></list-item><list-item><p id="P243"><xref rid="R64" ref-type="bibr">Eduard et al. (2009)</xref> used personal air monitors to measure individual-level H<sub>2</sub>S exposure among 4,735 Norwegian livestock farmers. The authors reported levels ranging from 0.0002 ppm (sheep, goat, poultry farms) to 0.036 ppm (cattle farms).</p></list-item><list-item><p id="P244"><xref rid="R208" ref-type="bibr">Thorne et al. (2009)</xref> collected measurements of toxicants upwind, downwind and in barns of swine facilities in central Iowa, U.S., including PM<sub>2.5</sub>, endotoxin, odor threshold, H<sub>2</sub>S, bacteria, fungi and airborne microbes. H<sub>2</sub>S measurements averaged 0.0024 to 0.0032 ppm at a distance of 160 m from the barn; indoor measurements averaged between 0.020 and 0.146 ppm, depending on the type of confinement building. H<sub>2</sub>S levels were low compared to earlier literature, in part as the facilities studied were relatively small, and site activities (e.g., manure pumping) and meteorological conditions were noted to affect the downwind concentrations.</p></list-item><list-item><p id="P245">Across 16 communities in eastern North Carolina, U.S., 12-hr H<sub>2</sub>S concentration averaged 0.00030 &#x000b1;0.00186 ppm, 12-hr PM<sub>10</sub> averaged 19.4 &#x000b1; 11.8 &#x003bc;g/m<sup>3</sup>, and 12-hr PM<sub>2.5</sub> averaged 10.9 &#x000b1;5.7 &#x003bc;g/m<sup>3</sup> (<xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>).</p></list-item><list-item><p id="P246"><xref rid="R115" ref-type="bibr">Kilburn (2012)</xref> reports some measurements in and outside of homes within 3 km of hog manure lagoons in Paulding, Ohio, U.S. Average H<sub>2</sub>S levels in 12 homes ranged from 0 to 0.03 ppm (but reached 2.1 ppm in one home and varied over 10-fold in one-day&#x02019;s spot check samples). Two outdoor samples exceeded 1.1 ppm.</p></list-item><list-item><p id="P247">In Iowa, U.S., <xref rid="R169" ref-type="bibr">Pavilonis et al. (2013)</xref> measured ambient H<sub>2</sub>S near (&#x0003c;40 m) a single, medium sized swine CAFO over 7 months to determine the temporal and spatial variability of H<sub>2</sub>S, near two schools over a 2 weeks period, and near 13 CAFOs also over a 2-week period. Near the single CAFO, concentrations ranged from 0.0002 to 0.0486 ppm, depending on the sampling period and proximity to a lagoon on the property. 2-week concentrations near the schools were below 0.001 ppm, and 2-week concentrations near the 13 CAFOs were 0.001 to 0.043 ppm, although several measurements exceeded the state&#x02019;s ambient limit of 30 ppb (24-hr average).</p></list-item><list-item><p id="P248">Additional community-based health studies have assessed odor but not H<sub>2</sub>S (<xref rid="R21" ref-type="bibr">Avery et al. 2004</xref>; <xref rid="R173" ref-type="bibr">Radon et al. 2005</xref>).</p></list-item></list><p id="P249">It is significant to note that the <xref rid="R158" ref-type="bibr">NRC (2003)</xref> expert panel made management recommendations for H<sub>2</sub>S: &#x0201c;For air emissions important on a local scale (hydrogen sulfide [H<sub>2</sub>S], particulate matter [PM], and odor), the aim is to control ambient concentrations at the farm boundary and/or nearest occupied dwelling. Standards applicable to the farm boundary and/or nearest occupied dwelling must be developed.&#x0201d;</p></sec><sec id="S69"><label>3.7</label><title>Sewage and waste treatment facilities</title><p id="P250">H<sub>2</sub>S exposure is a well know hazard for WWTP workers. <xref rid="R104" ref-type="bibr">Ho et al. (2008)</xref> reviewed a number of H<sub>2</sub>S sources associated with wastewater facilities. A study of WWTPs in Iowa, U.S. found the average H<sub>2</sub>S level typically below 1 ppm (95% of samples were below this value), an overall geometric mean of 0.15 ppm, and a range from 0 to 42.5 ppm (<xref rid="R130" ref-type="bibr">Lee et al. 2007</xref>). A study of wastewater pump stations in Tianjin, China, measured 15 volatile organic compounds (VOCs) including H<sub>2</sub>S and found that it occurred at levels higher than other VOCs, with a geometric mean of 0.020 ppm (29.42 &#x003bc;g/m<sup>3</sup>) and range of non-detect to 0.059 ppm (87.50 &#x003bc;g/m<sup>3</sup>); researchers then used modeling to predict that at these levels, H<sub>2</sub>S would confer non-carcinogenic health risks, most likely olfactory mucosa damage, with a hazard quotients of 1.14 and 1.13 for the mean and median exposures, respectively (<xref rid="R157" ref-type="bibr">Niu et al. 2014</xref>). Additional occupational studies of wastewater workers have found concentrations ranging from 0.4 to 13.1 ppm (<xref rid="R20" ref-type="bibr">Austigard et al. 2018</xref>); from 5 to 11 ppm (<xref rid="R79" ref-type="bibr">Farahat and Kishk 2010</xref>); and from 2 to 74 ppm (<xref rid="R120" ref-type="bibr">Kilburn et al. 2010</xref>). Exposure to H<sub>2</sub>S from wastewater plants may extend beyond the industrial setting into nearby communities.</p><p id="P251">Attention has been increasing with respect to H<sub>2</sub>S levels from municipal and other solid waste management facilities, possibly due to the development of nearby or adjoining residential development. A study of residential exposure nearby a landfill found average ambient levels of 0.00022 ppm with a range from 0 to 0.0023 ppm (<xref rid="R99" ref-type="bibr">Heaney et al. 2011</xref>). <xref rid="R124" ref-type="bibr">Ko et al. (2015)</xref> measured levels of H<sub>2</sub>S at and near landfills and evaluated technologies to control H<sub>2</sub>S emissions at landfills; <xref rid="R48" ref-type="bibr">Col&#x000f3;n et al. (2017)</xref> focused levels within waste processing plants in Spain using mechanical-biological waste treatment designed to reduce the biodegradable fraction and stabilize municipal wastes. The highest H<sub>2</sub>S concentrations (1.85 ppm) were found in a mechanical-biological treatment facility for municipal solid waste in Portugal, followed by a biofiltration unit (0.546 ppm), over the landfill (0.022 ppm) and then a composting treatment hall (0.019 ppm); this paper also summarizes H<sub>2</sub>S levels found at eight other landfills or waste processing facilities (<xref rid="R161" ref-type="bibr">Nunes et al. 2021</xref>).</p></sec><sec id="S70"><label>3.8</label><title>Accidental exposures</title><p id="P252">During accidental exposures, concentrations from 100 ppm (150 mg/m<sup>3</sup>) to 12,000 ppm (18,000 mg/m<sup>3</sup>) have been reported (<xref rid="R228" ref-type="bibr">WHO 1981</xref>). Accidental releases can have severe effects. For example, the malfunction of an oil field flare in the small community of Poza Rica, Mexico resulted in a H<sub>2</sub>S release that caused 320 people to be hospitalized and 22 deaths; H<sub>2</sub>S levels were not measured (<xref rid="R228" ref-type="bibr">WHO 1981</xref>). <xref rid="R94" ref-type="bibr">Haahtela et al. (1992)</xref> presents an epidemiological study of short-term upset at a paper mill that greatly increased exposures for several days. Leaks in sour gas pipelines, discussed earlier (<xref rid="S65" ref-type="sec">Section 3.3</xref>), are another potential source of accidental exposure, although the number of individuals affected appears small in most cases.</p><p id="P253">Failures of flares, a rudimentary emission control system, and other controls used at industrial sources of H<sub>2</sub>S and other pollutants can produce periods of high emissions and high exposures. Emergency, process and production flaring at refineries, sour gas processing facilities, and gas extraction well development normally convert H<sub>2</sub>S, if present in the waste stream, to SO<sub>2</sub>, which is considerably less toxic and odiferous. (In developed countries, process flaring would not normally be utilized to control H<sub>2</sub>S given concerns over SO<sub>2</sub> emissions and exposures.) There are no known statistics on flare failure rates that have led to sizable H<sub>2</sub>S emissions and such events are rarely documented in the scientific literature, although such incidents have led to community exposure in multiple settings.</p></sec><sec id="S71"><label>3.9</label><title>Other exposures</title><p id="P254">H<sub>2</sub>S exposure can result from other environmental and industrial sources, including production of pesticides and intermediates, in particular, sodium tetrathiocarbonate (STTC), and a need for more studies on co-exposure to CS<sub>2</sub> (another by-product) and H<sub>2</sub>S has been expressed (<xref rid="R195" ref-type="bibr">Silva 2013</xref>).</p><p id="P255">H<sub>2</sub>S exposure can result from mining activities, including underground and surface mining, as well as the injection of waste slurry into abandoned underground mines. These activities can generate large quantities of sulfate, which under anaerobic conditions in the presence of carbon, can be reduced to sulfide by naturally occurring bacteria; some of the sulfide will remain dissolved in groundwater (<xref rid="R196" ref-type="bibr">Simonton and King 2013</xref>). In mining regions in West Virginia, U.S., <xref rid="R196" ref-type="bibr">Simonton and King (2013)</xref> found sulfate in all 73 residential drinking water wells tested and observed rotten-egg odor in all homes, however, H<sub>2</sub>S concentrations were not measured. Further studies of mining related H<sub>2</sub>S exposure are needed to quantify levels and temporal and spatial variability.</p></sec><sec id="S72"><label>3.10</label><title>Endogenous production</title><p id="P256">Exposure to H<sub>2</sub>S occurs endogenously, that is, from the production of H<sub>2</sub>S in the body, in addition to the external sources discussed previously. In brief, most endogenous production results from the metabolism of sulfhydryl-containing amino acids by bacteria in the intestinal tract and the mouth, and some is produced in the brain and several smooth muscles by enzymes in these tissues (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>). In the mouth, H<sub>2</sub>S is a component of halitosis, and concentrations between 0.001 and 0.1 ppm (1&#x02013;100 ppb) have been measured in mouth air. In the large intestine, H<sub>2</sub>S can be generated by bacterial reduction of inorganic sulfate and sulfite, and by fermentation of sulfur-containing amino acids. H<sub>2</sub>S can compose up to 10% of intestinal gases, and mean concentrations range in flatus are between 1 and 4 ppm, although levels reaching 18 ppm have been recorded among individuals on a normal diet. In the brain, H<sub>2</sub>S produced from reactions catalyzed by the cystathionine &#x003b2;-synthase enzyme from the desulfhydration of cysteine acts as a neuromodulator, enhancing the N-methyl-D-asparate (NMDA) receptor-mediated response, facilitating the induction of hippocampal long-term potentiation, and serving as a widely distributing signaling or messenger molecule (<xref rid="S9" ref-type="sec">Section 2.2</xref>).</p></sec><sec id="S73"><label>3.11</label><title>Summary of exposure sources</title><p id="P257">This section has focused on airborne emissions of H<sub>2</sub>S from various types of sources that produce on-site (occupational) and off-site (downwind community) exposures. In communities near pulp and paper mills, the largest source of airborne emissions, H<sub>2</sub>S concentrations can vary widely, e.g., a Slovakian study (<xref rid="R59" ref-type="bibr">Drimal et al. 2010</xref>) reported a long-term average of 0.004 ppm and maximum concentrations up to 0.014 ppm, while a Finnish study (<xref rid="R96" ref-type="bibr">H&#x000e4;kkinen et al. 1985</xref>; <xref rid="R226" ref-type="bibr">WHO 2006</xref>) showed annual average concentrations up to 0.037 ppm (annual average) and 1-hr peaks up to 1.07 ppm). Typically, much higher levels are found in occupational settings, e.g., up to 20 ppm in kraft mills in Finland (<xref rid="R96" ref-type="bibr">H&#x000e4;kkinen et al. 1985</xref>; <xref rid="R226" ref-type="bibr">WHO 2006</xref>), and 42.5 ppm at sewage and waste treatment facilities in Iowa, U.S. (<xref rid="R130" ref-type="bibr">Lee et al. 2007</xref>). Yet greater differences between community and occupational exposures have been found at viscose rayon mills (<xref rid="R83" ref-type="bibr">FNBH 1982</xref>; <xref rid="R102" ref-type="bibr">Higashi et al. 1983</xref>; <xref rid="R226" ref-type="bibr">WHO 2006</xref>). Oil and gas production facilities, the next largest H<sub>2</sub>S emission category, include a diverse set of sources, e.g., sour gas wells, pipelines, gas and crude oil batteries, processing plants, and refineries. These facilities may routinely (e.g., continuously) release H<sub>2</sub>S that produce generally modest concentrations and exposures in community settings, but more widespread and sometimes much higher exposures may result from facility startup or testing activities, e.g., well-development, and sometimes from upsets and accidents, e.g., spills and pipeline leaks. As examples: across 80 monitoring sites in communities with sour gas facilities in Alberta, Canada, H<sub>2</sub>S concentrations averaged 0.006 ppm and 1-hr peaks reached 3 ppm (<xref rid="R7" ref-type="bibr">Alberta Environment 2004</xref>); and concentrations in coastal communities following the large BP oil spill Louisiana, US were mostly below 0.1 ppm (<xref rid="R69" ref-type="bibr">EPA 2016</xref>). The third largest emission category, livestock rearing systems including CAFOs, has had the largest number of studies. These have reported some of the higher H<sub>2</sub>S concentrations in community settings, e.g., short-term measurements exceeding 1 ppm in and outside of near swine facilities in Iowa, U.S. (<xref rid="R115" ref-type="bibr">Kilburn 2012</xref>). However, these levels appear atypical and long-term average concentrations generally average well below 0.1 ppm and often much lower, below 0.01 ppm (<xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>; <xref rid="R208" ref-type="bibr">Thorne et al. 2009</xref>). Other potentially important H<sub>2</sub>S sources can include water and waste processing facilities. Finally, community exposures to volcanic and geothermal sources of H<sub>2</sub>S, have received attention in Portugal, Iceland, New Zealand and Italy; community monitoring shows great variability with long term averages typically below 0.1 ppm but occasional short term peaks that may reach one to two orders of magnitude higher (<xref rid="S64" ref-type="sec">Section 3.2</xref>).</p><p id="P258">Emissions of H<sub>2</sub>S from industrial and agricultural sources can be controlled or further controlled to protect workers and community members, unlike the volcanic or geothermal sources. It is notable that H<sub>2</sub>S emissions &#x02013; in comparison to on-site or environmental concentrations &#x02013; are rarely measured, and the reliability of the existing emission data is unknown.</p></sec></sec><sec id="S74"><label>4</label><title>Exposure recommendations and regulatory levels</title><p id="P259">H<sub>2</sub>S exposure limits recommended for workers and the general population range over several orders of magnitude, differing for a number of reasons including the literature that was available and selected as relevant and meaningful, the type of endpoint or critical effect considered, the duration of exposure, the populations considered, the degree of protection desired, and the adjustment, safety and uncertainty factors applied. Guidelines and limits may differ among agencies even though the same study may be used to define the critical effect, reflecting the agency&#x02019;s assessment of the evidence, attitudes towards risk averseness, and agency practices and policies. This concern is particularly relevant for community standards and guidelines developed from occupational, controlled human or animal studies given the need to protect susceptible and vulnerable populations. Adjustment and uncertainty factors (sometimes called safety factors) reflect animal-to-human (or other) dosimetry issues, as well as the recognition that community exposure can occur to susceptible and vulnerable populations who are not adequately represented in the underlying studies. To date, guidelines and limits for H<sub>2</sub>S have not utilized approaches or adjustment factors that consider H<sub>2</sub>S as a surrogate for the toxicity of a mixture of co-pollutants emitted from the same source.</p><sec id="S75"><label>4.1</label><title>Community standards and guidelines</title><p id="P260">Existing community guidelines in the U.S. are summarized in <xref rid="T2" ref-type="table">Table 2</xref> and discussed below. Several European guidelines are discussed later in the text.</p><sec id="S76"><label>4.1.1</label><title>U.S. Reference concentration (RfC)</title><p id="P261">The EPA defines the inhalation RfC as an estimate (with uncertainty spanning perhaps an order of magnitude) of a daily inhalation exposure of the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects during a lifetime. It is based on the assumption that a concentration or exposure <italic toggle="yes">threshold</italic> exist for certain toxic effects such that no adverse effect will occur below a given exposure. The inhalation RfC considers toxic effects for both the respiratory system (portal-of-entry) and for effects peripheral to the respiratory system (extra-respiratory effects). The current RfC for H<sub>2</sub>S (<xref rid="R75" ref-type="bibr">EPA 2003</xref>) is derived from a no-adverse-effect level (NOAEL) of 10 ppm based on a controlled exposure of rats by <xref rid="R36" ref-type="bibr">Brenneman et al. (2000)</xref> described in Section 3.3.3. The RfC was derived following EPA guidance, which adjustments for a continuous exposure concentration (factor of 4), dosimetric and physiological adjustments for differences between rats and humans (factor of 5), and standard uncertainty factors for interspecies extrapolation, sensitive populations and subchronic exposure (factors of 3, 10 and 10, respectively), resulting in a RfC of 0.0013 ppm (2 &#x003bc;g/m<sup>3</sup>). The product of the uncertainty factors is 300, the highest among agency standards and guidelines reviewed. As noted in Section 3.3.3, <xref rid="R188" ref-type="bibr">Schroeter et al. (2006)</xref> derived a NOAEL of 5 ppm for this effect using data from <xref rid="R36" ref-type="bibr">Brenneman et al. (2000)</xref>, which would have the effect of changing the dosimetric and physiological adjustment (formerly 5) to a factor of 2, thus increasing the RfC to 0.0033 ppm.</p></sec><sec id="S77"><label>4.1.2</label><title>Minimal risk level (MRL)</title><p id="P262">The MRL is an estimate of daily human exposure to a substance that is likely to be without an appreciable risk of adverse effects (noncarcinogenic) over a specified duration of exposure (<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>). MRLs are derived when reliable and sufficient data exist to identify the target organ(s) of effect or the most sensitive health effect(s) for a specific duration within a given route of exposure. They do not consider carcinogenic effects. MRLs can be derived for acute, intermediate, and chronic duration exposures for inhalation and oral routes. Although methods have been established to derive these levels, uncertainties are associated with these techniques. Furthermore, ATSDR acknowledges additional uncertainties inherent in the application of the procedures to derive less than lifetime MRLs. As an example, acute inhalation MRLs may not be protective for health effects that are delayed in development or are acquired following repeated acute insults, such as hypersensitivity reactions, asthma, or chronic bronchitis. As these kinds of health effects data become available and methods to assess levels of significant human exposure improve, MRLs will be revised.</p><p id="P263">Several estimates of MRLs have been made for H<sub>2</sub>S (derivation shown detailed in <xref rid="R16" ref-type="bibr">ATSDR 2006</xref>). The following summarizes ATSDR&#x02019;s discussion.</p><list list-type="bullet" id="L68"><list-item><p id="P264"><underline>Acute MRL</underline>: <xref rid="R16" ref-type="bibr">ATSDR (2006)</xref> has set an inhalation MRL of 0.067 ppm (100 &#x003bc;g/m<sup>3</sup>) for acute exposure duration (&#x02264; 14 days) based on suggestive evidence of bronchial obstruction among asthmatics exposed to 2 ppm H<sub>2</sub>S for 30 min (<xref rid="R112" ref-type="bibr">Jappinen et al. 1990</xref>). This concentration was considered a minimally adverse effect level because changes in airway resistance and specific airway conductance were observed in only 2 of 10 subjects. The MRL was calculated by dividing the unadjusted LOAEL by an uncertainty factor of 27 (3 for use of a minimal LOAEL, 3 for human variability, and 3 for database deficiencies). The LOAEL from <xref rid="R112" ref-type="bibr">Jappinen et al. (1990)</xref> is supported by the LOAEL of 5 ppm for increased blood lactate levels observed in exercising subjects (<xref rid="R31" ref-type="bibr">Bhambhani et al. 1996</xref>). As noted, the J&#x000e4;ppinen study excluded individuals with severe asthma.</p></list-item><list-item><p id="P265"><underline>Intermediate duration MRL</underline>. An MRL of 0.02 ppm has been derived for intermediate-duration inhalation exposure to H<sub>2</sub>S (15 &#x02013; 364 days). ATSDR noted the limited data on the toxicity of H<sub>2</sub>S in humans following intermediate-duration exposure. Acute- and chronic-duration studies suggest that the respiratory tract and nervous system are sensitive targets of H<sub>2</sub>S. Like the <xref rid="R75" ref-type="bibr">EPA (2003)</xref>, the <xref rid="R36" ref-type="bibr">Brenneman et al. (2000)</xref> study was selected as the basis of the intermediate-duration inhalation MRL, and the critical effect was nasal lesions. The MRL was derived using the NOAEL/LOAEL approach, utilizing an uncertainty factor of 30 (3 for extrapolation from animals using dosimetric adjustments and 10 for human variability), adjusting for duration, and adjusting for regional gas dose ratio for the extra thoracic region. The same limitations, noted above, would apply to the MRL.</p></list-item><list-item><p id="P266"><underline>Chronic MRL</underline>. ATSDR cites several human studies that have examined the chronic toxicity of inhaled hydrogen sulfide dating from 1951 to 1990, including <xref rid="R111" ref-type="bibr">Jaakkola et al. (1990)</xref>, <xref rid="R112" ref-type="bibr">Jappinen et al. (1990)</xref> and <xref rid="R113" ref-type="bibr">Kangas et al. (1984)</xref> in the present review, plus several others. Most of these studies reported increases in the occurrence of subjective symptoms of respiratory irritation in workers or residents living near paper mills. However, due to limitations including poor exposure characterization (including the lack of information on peak exposure levels), co-exposures to other chemicals, and the lack of animal studies examining chronic toxicity, a chronic-duration inhalation MRL was not derived.</p></list-item></list></sec><sec id="S78"><label>4.1.3</label><title>California reference exposure level (REL)</title><p id="P267">Similar to the EPA RfC, <xref rid="R165" ref-type="bibr">OEHHA (1999)</xref> defines the REL as the concentration level at or below which no adverse health effects are anticipated for a specified exposure duration. RELs are based on the most sensitive, relevant, adverse health effect reported in the medical and toxicological literature and are designed to protect the most sensitive individuals in the population by the inclusion of margins of safety. Since margins of safety are incorporated to address data gaps and uncertainties, exceeding the REL does not automatically indicate an adverse health impact. A chronic inhalation REL of 0.0067 ppm (10 &#x003bc;g/m<sup>3</sup>) was established by <xref rid="R164" ref-type="bibr">OEHHA (2000)</xref> on the basis of histopathological inflammatory changes in the nasal mucosa of mice study (<xref rid="R46" ref-type="bibr">CIIT 1983</xref>). Adjustments to human exposures included a subchronic uncertainty factor of 3, interspecies uncertainty factor of 3, intraspecies uncertainty factor of 10, and cumulative uncertainty factor of 100. It was noted that 50% of the population would be able to detect the odor of H<sub>2</sub>S under controlled conditions, but only 5% would find it annoying at this level. An acute REL of 0.028 ppm (42 &#x003bc;g/m<sup>3</sup>) for 1 hr was established by <xref rid="R163" ref-type="bibr">OEHHA (2008)</xref> on the basis of headache, nausea, and other physiological responses to odor.</p></sec><sec id="S79"><label>4.1.4</label><title>WHO Air Quality Guidelines</title><p id="P268"><xref rid="R226" ref-type="bibr">WHO (2006)</xref> Air Quality Guidelines provide a value of 0.1 ppm (0.15 mg/m<sup>3</sup>) with an averaging time of 24 hr based on ocular damage. WHO also states that to avoid substantial complaints about odor annoyance. H<sub>2</sub>S concentrations should not be allowed to exceed 0.0046 ppm (7 &#x003bc;g/m<sup>3</sup>) with a 30-min averaging period.</p></sec></sec><sec id="S80"><label>4.2</label><title>Occupational standards and guidelines</title><p id="P269">There are several widely used occupational standards and guidelines. As pointed out specifically for H<sub>2</sub>S by <xref rid="R149" ref-type="bibr">Milby and Baselt (1999)</xref>, acceptable air levels in workplace environments are based on very different considerations than acceptable levels in community air. In brief, persons in the workplace are assumed to be in reasonably good health, generally remain in the workplace environment for no more than 8 hr/day and 40 hr/wk, and generally are exposed to a limited number of agents. In contrast, community residents comprise all ages and all states of health and may be physically present in the community for most or all of any 24-hr period or longer. Residents also tend to have a reasonable expectation that their community air will be generally free of noxious substances that create health or nuisance problems. Thus, while H<sub>2</sub>S levels possibly as high as 10 ppm have been considered acceptable for workplace settings (but see the new TLVs below), much lower concentrations (well below 0.1 ppm) can create unacceptable health and nuisance conditions in community settings (<xref rid="T1" ref-type="table">Table 1</xref>). For example, community health assessments performed by state agencies have used the US EPA RfC (<xref rid="S76" ref-type="sec">Section 4.1.1</xref>) of 0.0015 ppb as a long-term level that might result in an increased risk of nasal irritation (<xref rid="R147" ref-type="bibr">MDHHS 2023</xref>).</p><sec id="S81"><label>4.2.1</label><title>U.S. threshold limit values (TLV)</title><p id="P270">The TLV-TWA is defined as &#x0201c;the time-weighted average concentration for a conventional 8-hr workday and a 40-hr work week, to which it is believed that nearly all workers may be repeatedly exposed, day after day, without adverse effect&#x0201d; (<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>). The TLV recommendations are widely used in occupational settings throughout the world. Since 1966, <xref rid="R1" ref-type="bibr">ACGIH (2001)</xref> has recommended a TLV-TWA (time weighted average) of 10 ppm and a TLV-STEL (short-term exposure limit) of 15 ppm for H<sub>2</sub>S to protection against significant health risks of sudden death, eye irritation, neurasthenic symptoms such as fatigue, headache, dizziness, and irritability, or permanent central nervous system effects that may result from acute, subchronic, or chronic exposure. In part, the basis was a number of studies indicating that 10 ppm exposure will not cause eye irritation, the most commonly reported adverse physical effect of exposure to H<sub>2</sub>S at concentrations of 50 to 100 ppm.</p><p id="P271">In 2010, ACGIH revised the exposure limits to 1 ppm (TWA) and 5 ppm (STEL) (<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>). The basis and rationale for the changes is to be protective of upper respiratory tract irritation and central nervous system impairment. The TLV documentation cites that 1 ppm should be sufficient to protect against all the unwanted effects of H<sub>2</sub>S and that peak exposures of 5 ppm may produce minor irritation and a brief change in oxygen uptake but would not be expected to produce more serious effects on the respiratory, central nervous or cardiovascular system. Cited studies supporting this conclusion included <xref rid="R31" ref-type="bibr">Bhambhani et al. (1996)</xref>, <xref rid="R32" ref-type="bibr">Bhambhani and Singh (1991)</xref>, <xref rid="R33" ref-type="bibr">Blackstone et al. (2005)</xref>, <xref rid="R36" ref-type="bibr">Brenneman et al. (2000)</xref>, <xref rid="R57" ref-type="bibr">Dorman et al. (2004)</xref>, and <xref rid="R80" ref-type="bibr">Fiedler et al. (2008)</xref>, among others. <xref rid="R1" ref-type="bibr">ACGIH (2001)</xref> also notes that it may be necessary to control exposures below the TLV to prevent complaints of odor.</p></sec><sec id="S82"><label>4.2.2</label><title>U.S. Occupational Safety and Health Administration (OSHA) permissible exposure limits (PELs) and National Institute for Occupational Safety and Health (NIOSH) recommended exposure limits (RELs)</title><p id="P272">OSHA has a Ceiling Limit of 20 ppm, Short-Term Exposure Limit (STEL) of 50 ppm (maximum 10-min peak per 8-hr shift), and a TWA of 10 ppm (vacated in 1989). These levels date back to 1978 (<xref rid="R156" ref-type="bibr">NIOSH 1978</xref>). The NIOSH REL is a ceiling of 10 ppm and an Immediately Dangerous to Life and Health (IDLH) limit of 100 ppm.</p></sec><sec id="S83"><label>4.2.3</label><title>U.K. Occupational Exposure Standards (OES)</title><p id="P273">In the U.K., OES were set in 2002 at 5 ppm for the 8-hr TWA and 10 ppm for the STEL. The basis for these levels are studies on young, fit, and healthy adult human volunteers undergoing maximal and submaximal exercise which demonstrated that brief periods (15 &#x02013; 30 min) of exposure to 5 and 10 ppm, respectively, caused a shift towards anaerobic respiration (<xref rid="R31" ref-type="bibr">Bhambhani et al. 1996</xref>; <xref rid="R32" ref-type="bibr">Bhambhani and Singh 1991</xref>; <xref rid="R49" ref-type="bibr">Costigan 2003</xref>).</p></sec><sec id="S84"><label>4.2.4</label><title>Scientific Committee on Occupational Exposure Limits (SCOEL)</title><p id="P274">Following the UK OES, in 2007 the European SCOEL recommended setting the 8-hr TWA and the STEL to 5 and 10 ppm, respectively, based on experimental studies of nasal lesions in rats (<xref rid="R189" ref-type="bibr">SCOEL 2007</xref>). Their report discussed studies examining eye irritation and lung function impairment, but concluded that workers in the occupational studies examined were also exposed to CS<sub>2</sub> gas, and that effects could not be attributed to H<sub>2</sub>S alone at levels below 20 ppm.</p></sec><sec id="S85"><label>4.2.5</label><title>Dutch Expert Committee on Occupational Standards (DECOS)</title><p id="P275">The Dutch set standards in 2006 (<xref rid="R51" ref-type="bibr">DECOS 2006</xref>) and 2010 (<xref rid="R50" ref-type="bibr">DECOS 2010</xref>) at 1.6 ppm for long-term exposure to H<sub>2</sub>S, substantially below the UK OES and European SCOEL. No recommendations were made for a short-term standard. Again, nasal lesions in rats served as the critical effect with a NOAEL of 10 ppm. The DECOS added an additional safety factor after considering the potential for differences among people, specifically pregnant women and asthmatics who may be more sensitive to exposure.</p></sec><sec id="S86"><label>4.2.6</label><title>German maximum workplace concentration (MAK)</title><p id="P276">In 2006, the German review committee recommended a Maximum Workplace Concertation (MAK) of 5 ppm, stipulated as the highest concentration assessed that will not interfere with occupational activity or cause adverse effects. This recommendation was based on a review of toxicity data (including <xref rid="R16" ref-type="bibr">ATSDR 2006</xref>; <xref rid="R51" ref-type="bibr">DECOS 2006</xref>), and included studies on skin irritation, lung function impairment, and cardiovascular effects.</p></sec></sec><sec id="S87"><label>4.3</label><title>U.S. Emergency response guidelines</title><p id="P277">Like the occupational limits, emergency response guidelines are not intended as general community standards. Several sets of guidelines are listed here for completeness and reference.</p><sec id="S88"><label>4.3.1</label><title>Emergency Response Planning Guidelines</title><p id="P278">Existing short-term exposure guidelines include the American Industrial Hygiene Association (<xref rid="R5" ref-type="bibr">AIHA 1991</xref>) Emergency Response Planning Guidelines (ERPGs), which are defined as concentration ranges where adverse health effects could be observed. Three ERPGs are available for many substances, with the definitions are provided below (<xref rid="R43" ref-type="bibr">Cavender et al. 2008</xref>).</p><list list-type="bullet" id="L70"><list-item><p id="P279">The ERPG-1 is the maximum airborne concentration below which nearly all individuals could be exposed for 1 hr without experiencing other than mild transient adverse health effects or perceiving a clearly defined, objectionable odor, which is set to 0.1 ppm for H<sub>2</sub>S (60 min peak).</p></list-item><list-item><p id="P280">The ERPG-2 is the maximum airborne concentration below which nearly all individuals could be exposed for 1 hr without experiencing or developing irreversible or other severe health effects which could impair an individual&#x02019;s ability to take protective action, which is 30 ppm (60 min peak).</p></list-item><list-item><p id="P281">The ERPG-3 is the maximum airborne concentration below which nearly all individuals could be exposed for 1 hr without experiencing or developing life-threatening health effects, which is 100 ppm (60 min peak).</p></list-item></list></sec><sec id="S89"><label>4.3.2</label><title>U.S. Acute Exposure Guideline Levels (AEGLs).</title><p id="P282">AEGLs are a second set of emergency response guidelines developed through a collaborative and worldwide effort involving the public and private sectors. AEGLs describe risks to humans resulting from once-in-a-lifetime, or rare, exposure to airborne chemicals. The National Advisory Committee for the Development of Acute Exposure Guideline Levels for Hazardous Substances (AEGL Committee) is involved in developing these guidelines to help both national and local authorities, as well as private companies, deal with emergencies involving spills, or other catastrophic exposures (<xref rid="R159" ref-type="bibr">NRC 2001</xref>). AEGLs represent threshold exposure limits for the general public and are applicable to emergency exposure periods ranging from 10 min to 8 hrs.</p><p id="P283">AEGLs are used for emergency planning and response, often in combination with computer-assisted air dispersion models to estimate &#x0201c;vulnerability zones&#x0201d; associated with releases of chemical substances, e.g., as stipulated under the U.S. EPA Risk Management Program (section 112(r) of the Clean Air Act Amendments for eligible sources (<xref rid="S4" ref-type="sec">Section 1.3</xref>). Then, human health risks associated with a chemical release can be estimated by comparing the projected airborne concentrations of the chemical with the exposed populations and AEGL values to determine appropriate responses. Three levels (AEGL-1, AEGL-2 and AEGL-3) have been developed for each of five exposure periods (10 and 30 min, 1 hr, 4 hr, and 8 hr) and are distinguished by varying degrees of severity of toxic effects. The three AEGLs are defined as follows:</p><list list-type="bullet" id="L72"><list-item><p id="P284">AEGL-1 is the airborne concentration of a substance above which it is predicted that the general population, including susceptible individuals, could experience notable discomfort, irritation, or certain asymptomatic, non-sensory effects. However, the effects are not disabling and are transient and reversible upon cessation of exposure. AEGL-1 ranges from 0.33 ppm to 0.75 ppm for averaging times ranging from 8 hr to 10 min, respectively. These values are derived from a human study of headaches among asthmatics (<xref rid="R112" ref-type="bibr">Jappinen et al. 1990</xref>).</p></list-item><list-item><p id="P285">AEGL-2 is the airborne concentration above which it is predicted that the general population, including susceptible individuals, could experience irreversible or other serious, long-lasting adverse health effects or an impaired ability to escape. AEGL-2 ranges from 17 ppm to 41 ppm for averaging times ranging from 8 hr to 10 min, respectively. These values are derived from rat studies of perivascular edema (<xref rid="R114" ref-type="bibr">Khan et al.1991</xref>; Green et al. 1991).</p></list-item><list-item><p id="P286">AEGL-3 is the airborne concentration of a substance above which it is predicted that the general population, including susceptible individuals, could experience life-threatening health effects or death. AEGL-3 ranges from 31 ppm to 76 ppm for averaging times ranging from 8 hr to 10 min, respectively. These values are derived from a rat study of mortality following a 1-hour exposure (<xref rid="R143" ref-type="bibr">MacEwen and Vernot 1972</xref>).</p></list-item></list><p id="P287">As the AEGL program notes, &#x0201c;AEGLs have been developed primarily to provide guidance in situations where there can be a rare, typically accidental exposure to a particular chemical that can involve the general public. They, therefore, differ from PELs, TLVs, WEELs, RELs or MAK values, etc. in that they are based primarily on acute toxicology data and not subchronic or chronic data. The guidance therefore does not reflect the effects that could result from frequent exposure. Also, they are designed to protect the general population including the elderly and children, groups that are generally not considered in the development of workplace exposure levels.&#x0201d; An advantage of AEGLs is that they account for exposure time. AEGL values represent threshold levels for the <underline>general public</underline>, including susceptible subpopulations, such as infants, children, the elderly, persons with asthma, and those with other illnesses. It is recognized that individuals, subject to unique or idiosyncratic responses, could experience the effects described at concentrations below the corresponding AEGL.</p><p id="P288">The current AEGLs for H<sub>2</sub>S were published on April 11, 2002, and remained &#x0201c;interim&#x0201d; AEGLs until 2012 when they were accepted by the AEGL Subcommittee to become &#x0201c;Final&#x0201d; for use by public and private organizations. The Subcommittee states that interim AEGLs represent &#x0201c;the best efforts of the AEGL Committee to establish exposure limits, and the values are available for use as deemed appropriate on an interim basis by federal and state regulatory agencies and the private sector&#x0201d; (<xref rid="R159" ref-type="bibr">NRC 2001</xref>). Shortly after approving the AEGLs, the Subcommittee disbanded. The AEGLs have not been revised subsequently.</p></sec></sec><sec id="S90"><label>4.4</label><title>Summary of Exposure Recommendations and Regulatory Levels</title><p id="P289">Guidelines and standards for continuous exposure to H<sub>2</sub>S in community and occupational settings address short-term, intermediate, and long-term duration of exposure to a range of concentrations that, for the most part, exceed the background levels that communities experience on a regular basis. For shorter term exposures, the ATSDR has recommended a MRL of 0.07 ppm with a LOAEL of 2 ppm for exposures lasting &#x02264;14 days and the WHO published a guidance value of 0.1 ppm with a LOAEL of 15 ppm for exposures lasting 24 hrs. For intermediate exposure duration (15 &#x02013; 365 days), the ATSDR set a MRL of 0.02 ppm with a NOAEL of 30.5 ppm. For long-term, even lifetime, exposure duration, the EPA set an RfC of 0.0015 ppm with a LOAEL of 30 ppm and a NOAEL of 10 ppm. The California OEHHA set an inhalation REL of 0.008 ppm with a NOAEL of 30.5 ppm. In terms of occupational guidelines and standards, STELs of 5 ppm, 10 ppm, and 50 ppm were established by ACGIH, U.K. OES, and OSHA, respectively; TWAs of 1 ppm, 5 ppm, and 10 ppm were set by ACGIH, U.K. OES, and OSHA, respectively; Ceilings of 10 ppm and 20 ppm were established by OSHA and NIOSH, respectively. The OSHA exposure limits are higher than those set by other agencies and have not been updated in 40 years. Additional standards for emergency response situations (AEGLs and ERPGs) exist but are not intended to address chronic, low-level exposures. As previously discussed, occupational and community air standards are different for valid reasons. Workers are, on average, healthier and exposed to less toxic agents than would be a community member. Protective community standards must consider people of all ages with underlying health conditions, odor sensitivities, or other vulnerabilities, and who are likely exposed to a more complex mixture of agents.</p><p id="P290">For short, intermediate, and long-term exposures, community standards identify exposure to H<sub>2</sub>S concentrations between 0.0015 and 0.1 ppm and above as potentially dangerous to human health. At first glance, a long term community standard set in the vicinity of 0.01 ppm may seem protective of public health given the H<sub>2</sub>S levels reported in most of the epidemiological studies that used objective measures of H<sub>2</sub>S concentrations. Most of these studies used an averaging period of at least one year, notably longer than the time period considered by all of the occupational standards, as well as by most of the community standards. However, local sources of H<sub>2</sub>S in community settings that result in low (&#x0003c;0.01 ppm) long term exposure can and frequently do produce much higher concentration short-term peaks (lasting minutes to hours); these peaks may far exceed the odor detection threshold and may be associated with irritation and other adverse health effects. This highlights the need for both chronic and acute exposure limits.</p><p id="P291">Finally, as noted throughout this review, community exposure to H<sub>2</sub>S typically occurs as a mixture of pollutants that depends on the source (e.g., CAFO, wastewater, landfill, oil and gas facility). Given the difficulty and expense of monitoring all components in the mixture, the H<sub>2</sub>S (or total reduced sulfur) concentration may serve as a surrogate or indicator of exposure. While this does not affect the H<sub>2</sub>S-health response relationship, it may require additional interpretation and adjustment as a community standard. Specifically, a lower standard may be required if the co-pollutants in the mixture have synergistic effects or increase the toxicity when H<sub>2</sub>S is at low levels. Unfortunately, relatively few studies adequately characterize co-pollutants, much less their interactions.</p></sec></sec><sec id="S91"><label>5</label><title>Conclusion</title><p id="P292">Increased large scale food production and shifts in the fossil fuel sector, specifically the development and expansion of CAFOs and hydraulic fracturing, have spurred the growth of industries that emit H<sub>2</sub>S. In turn, elevated emissions of H<sub>2</sub>S in the U.S. and elsewhere has increased the likelihood of low level but widespread and chronic community exposure to this toxic gas. Acute exposure to high H<sub>2</sub>S concentrations can produce morbidity and death with a well-understood dose-response relationship, based primarily on a large body of occupational studies. In contrast, effects of chronic and low-level exposure of H<sub>2</sub>S, defined here as concentrations below 0.1 ppm, in both occupational and community settings is much less well understood.</p><p id="P293">This review has synthesized the literature since 2004, which includes over 100 studies addressing toxicology, controlled human studies, and observational human studies, with a focus on community impacts. We have not attempted a risk assessment of H<sub>2</sub>S exposure. Most of the recent literature continues to focus on naturally occurring geothermal and volcanic H<sub>2</sub>S sources and on industrial sources such as CAFOs, pulp and paper mills, and wastewater treatment facilities. The epidemiological studies in these settings are limited by several challenges. First, the exposure assessments have frequently used spatial proxies of H<sub>2</sub>S, or spatially and temporally sparse point measurements, both with potentially large and generally unknown exposure measurement error. This is significant given considerable uncertainty and variability in H<sub>2</sub>S emissions and concentrations, perhaps especially around CAFOs. Second, H<sub>2</sub>S emitted by both natural and industrial sources typically occurs as part of a mixture with other pollutants; this mixture can include other reduced sulfur compounds released from many sources, as well as ammonia, dust, bacteria, insecticides, and mold from CAFOs, and SO<sub>2</sub>, other combustion products and VOCs from industrial sources such as paper and pulp mills and oil and gas facilities. This leads to the potential for confounding by co-pollutants, particularly in chronic studies where the spatial and temporal variation of exposures is large. Third, the epidemiological literature is not conducive to formal meta-analyses given its diversity in terms of population studied, exposure conditions, and study design. However, it is primarily the potential for exposure measurement errors and confounding that limits the strength of the association between low level H<sub>2</sub>S exposure and adverse health effects. Despite such limitations, chronic community exposure to H<sub>2</sub>S at average concentrations below 0.01 ppm and peak (short-term) exposures roughly an order of magnitude higher has been associated with a spectrum of adverse health effects, most notably odor aversion, irritation, and ocular, nasal, respiratory, and neurological effects. It is likely that susceptible and vulnerable populations, including individuals with underlying health conditions such as asthma, may be particularly at risk. Several of the observational studies, particularly those with larger sample sizes and longitudinal designs, have greater sensitivity and have shown effects for changes in H<sub>2</sub>S levels in the 0.001 ppm range. While the possibility of confounding by co-pollutants cannot be completely ruled out in each study, effects of low level chronic exposure are seen in different settings and across H<sub>2</sub>S sources (CAFOs, landfills, geothermal, volcanic, pulp mills) where pollutant mixtures will vary significantly. Collectively, the epidemiological evidence supports the finding that adverse health impacts are caused by exposure to H<sub>2</sub>S at low levels, defined here as below 0.1 ppm.</p><p id="P294">Our findings should be confirmed and extended by larger and more comprehensive epidemiological studies that incorporate susceptible populations, address a wider variety of industrial sectors, and assess multiple outcomes, including neurological, cardiovascular, reproductive/developmental, immune, and carcinogenic endpoints. These studies should be methodologically robust, measuring co-pollutants, accounting for multicollinearity, and employing objective exposure assessment techniques that include long-term continuous sampling to determine annual, daily and hourly average H<sub>2</sub>S concentrations, mapping of exposures, hybrid modeling. Study designs using larger samples sizes, longitudinal models with repeated observations or using case-crossover techniques may prove particularly sensitive and robust. In addition, researchers should consider measuring indoor air concentrations or individual exposures using personal air monitors, while weighing the feasibility of associated costs and participant burdens.</p><p id="P295">To date, few studies have focused on the oil and gas extractive industries, or the chemical and petroleum industries, which collectively emit about one-third of total U.S. H<sub>2</sub>S emissions. Understanding the health impacts of fracking is particularly important given its recent and rapid growth and its potential to emit significant levels of H<sub>2</sub>S during well development and potentially other phases, though we recognize the potential for co-exposure to diesel particulate matter, NO<sub>x</sub> and potentially other pollutants in such studies. National or state H<sub>2</sub>S emissions tracking programs can help to identify the relative contributions of industrial sectors and the potential impact of imposing stricter regulations. Industry emissions data can help inform the design of community-based exposure assessment and health studies, although these data may not be adequate and reliable.</p><p id="P296">Long-term epidemiological studies with large sample sizes and objective exposure measures also are needed to confirm and expand upon findings of neurological effects starting at long-term mean concentrations of 0.007 ppm, and eye irritation, nasal irritation and harmful respiratory effects starting at 0.0003 ppm. As research expands to include susceptible populations and a wide range of adverse health effects, agencies will need to ensure that their guidelines are sufficiently protective of community-wide releases of H<sub>2</sub>S.</p><p id="P297">The adverse health impacts associated with low-level chronic exposure shown in many of the reviewed studies, combined with the continuing and possibly increasing emissions in some sectors, suggest the need for additional emission standards, administrative and/or engineering controls on agricultural and industrial facilities, and enforcement of protective exposure standards or guidelines. In the USA, community guidelines of 0.0015 and 0.020 ppm were set by the EPA (RfC) and ATSDR (Intermediate MRL) in 2003 and 2006, respectively. The lower EPA guideline is more protective in part as it considers subchronic and lifetime exposures; the intermediate ATSDR guideline considers exposure durations up to one year. Although both agencies stated that these levels consider sensitive populations, they were developed from rat inhalation studies that may not be sufficiently protective to protect susceptible populations, even after adjusting for uncertainty factors. Further, these guidelines do not account for odor aversion, irritation, and ocular, nasal, respiratory and neurological effects that epidemiological studies suggest can occur at low exposure levels. Compared to community guidelines, occupational guidelines permit considerably higher exposure concentrations, namely, 1 and 10 ppm, as established by the ACGIH (TLV-TWA) and OSHA (PEL-TWA) in 2010 and 1989, respectively, and should not be applied as community guidelines.</p></sec></body><back><ack id="S92"><title>Acknowledgement</title><p id="P298">We thank Craig Segall for providing the initial impetus and motivation for this work, Neil Carmen, Andrew Hoover and Albert Shim for their input and assistance, and the anonymous reviewers who provided many constructive suggestions. This work was supported in part by the National Institute of Environmental Health Sciences, National Institutes of Health under Grants P30ES017885 and T32ES007062. It is dedicated to Sheldon Batterman who died suddenly in the midst of writing of this report, who reminds us to live honestly, to the highest principles, and to advocate for those less well off.</p><sec id="S93"><title>Funding Sources:</title><p id="P299">Support for this research was provided by grants P30ES017885 and T32ES007062 from the National Institute of Environmental Health Sciences, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p></sec></ack><fn-group><fn fn-type="COI-statement" id="FN1"><p id="P300">Declaration of Interest</p></fn><fn fn-type="COI-statement" id="FN2"><p id="P301">The authors declare that they have no known competing financial interests or relationships. The authors have not participated in and do not anticipate participation in any legal, regulatory, or advocacy proceedings related to the contents of the paper.</p></fn></fn-group><glossary><title>List of abbreviations and acronyms</title><p id="P302">This report uses the following abbreviations:</p><def-list><def-item><term>ACGIH</term><def><p id="P303">American Conference of Governmental Industrial Hygienists</p></def></def-item><def-item><term>AEGL</term><def><p id="P304">Acute Exposure Guideline Level</p></def></def-item><def-item><term>AER</term><def><p id="P305">Alberta Energy Regulator</p></def></def-item><def-item><term>AEUB</term><def><p id="P306">Alberta Energy and Utility Board</p></def></def-item><def-item><term>AH</term><def><p id="P307">Alberta Health</p></def></def-item><def-item><term>AIHA</term><def><p id="P308">American Industrial Hygiene Association</p></def></def-item><def-item><term>ATSDR</term><def><p id="P309">Agency for Toxic Substances and Disease Registry</p></def></def-item><def-item><term>BDI</term><def><p id="P310">Beck&#x02019;s depression inventory</p></def></def-item><def-item><term>BHS</term><def><p id="P311">Beck&#x02019;s hopelessness</p></def></def-item><def-item><term>CAAQS</term><def><p id="P312">California Ambient Air Quality Standard</p></def></def-item><def-item><term>CAFO</term><def><p id="P313">confined animal feeding operation</p></def></def-item><def-item><term>CC16</term><def><p id="P314">club cell protein 16</p></def></def-item><def-item><term>CDC</term><def><p id="P315">Centers for Disease Control and Prevention</p></def></def-item><def-item><term>CIIT</term><def><p id="P316">Chemical Industry Institute of Toxicology</p></def></def-item><def-item><term>COPD</term><def><p id="P317">chronic obstructive pulmonary disease</p></def></def-item><def-item><term>CRP</term><def><p id="P318">C-reactive protein</p></def></def-item><def-item><term>CT</term><def><p id="P319">computed tomography</p></def></def-item><def-item><term>EPA</term><def><p id="P320">Environmental Protection Agency</p></def></def-item><def-item><term>EPCRA</term><def><p id="P321">Emergency Planning and Community Right-to-Know Act</p></def></def-item><def-item><term>ERPG</term><def><p id="P322">emergency response planning guideline</p></def></def-item><def-item><term>FEV<sub>1</sub></term><def><p id="P323">forced expiratory volume</p></def></def-item><def-item><term>FNBH</term><def><p id="P324">Finnish National Board of Health</p></def></def-item><def-item><term>FR</term><def><p id="P325">Federal Register</p></def></def-item><def-item><term>FVC</term><def><p id="P326">forced vital capacity (measure of lung volume)</p></def></def-item><def-item><term>H<sub>2</sub>S</term><def><p id="P327">hydrogen sulfide (gaseous air pollutant)</p></def></def-item><def-item><term>HEC</term><def><p id="P328">human equivalent concentration</p></def></def-item><def-item><term>ICAM-1</term><def><p id="P329">intercellular adhesion molecule 1</p></def></def-item><def-item><term>IDLH</term><def><p id="P330">Immediately Dangerous to Life and Health</p></def></def-item><def-item><term>IL-8</term><def><p id="P331">interleukin 8</p></def></def-item><def-item><term>IQR</term><def><p id="P332">interquartile range</p></def></def-item><def-item><term>JEM</term><def><p id="P333">job-exposure matrix</p></def></def-item><def-item><term>LOAEL</term><def><p id="P334">lowest observed effects level</p></def></def-item><def-item><term>MIP</term><def><p id="P335">macrophage inflammatory protein</p></def></def-item><def-item><term>MRI</term><def><p id="P336">magnetic resonance imaging</p></def></def-item><def-item><term>MRL</term><def><p id="P337">minimal risk levels</p></def></def-item><def-item><term>NIOSH</term><def><p id="P338">National Institute for Occupational Safety and Health</p></def></def-item><def-item><term>NOAEL</term><def><p id="P339">no observed adverse effects level</p></def></def-item><def-item><term>NO<sub>x</sub></term><def><p id="P340">nitrogen oxides (gaseous air pollutant)</p></def></def-item><def-item><term>NRC</term><def><p id="P341">National Research Council</p></def></def-item><def-item><term>O<sub>3</sub></term><def><p id="P342">ozone</p></def></def-item><def-item><term>OEHHA</term><def><p id="P343">California Office of Environmental Health Hazard Assessment</p></def></def-item><def-item><term>OEL</term><def><p id="P344">Occupational Exposure Limit</p></def></def-item><def-item><term>OES</term><def><p id="P345">Occupational Exposure Standard</p></def></def-item><def-item><term>OR</term><def><p id="P346">odds ratio</p></def></def-item><def-item><term>OSHA</term><def><p id="P347">Occupational Safety and Health Administration</p></def></def-item><def-item><term>PEL</term><def><p id="P348">permissible exposure limit</p></def></def-item><def-item><term>PK-CFD</term><def><p id="P349">pharmacokinetic computational fluid dynamics</p></def></def-item><def-item><term>PM<sub>2.5</sub></term><def><p id="P350">particulate matter under 2.5 &#x003bc;m dia. Also, PM<sub>10</sub> for 10 &#x003bc;m diameter</p></def></def-item><def-item><term>ppb</term><def><p id="P351">parts per billion (volume-type pollutant concentration unit)</p></def></def-item><def-item><term>ppm</term><def><p id="P352">parts per million (volume-type pollutant concentration unit)</p></def></def-item><def-item><term>R<sub>aw</sub></term><def><p id="P353">airway resistance</p></def></def-item><def-item><term>RADS</term><def><p id="P354">reactive airways distress syndrome</p></def></def-item><def-item><term>RBC</term><def><p id="P355">red blood cell</p></def></def-item><def-item><term>REF</term><def><p id="P356">reference exposure level</p></def></def-item><def-item><term>REL</term><def><p id="P357">reference exposure levels (used by State of California)</p></def></def-item><def-item><term>RfC</term><def><p id="P358">reference concentration</p></def></def-item><def-item><term>SG<sub>aw</sub></term><def><p id="P359">specific airway conductance</p></def></def-item><def-item><term>sIgA</term><def><p id="P360">secretory immunoglobulin A</p></def></def-item><def-item><term>SO<sub>2</sub></term><def><p id="P361">sulfur dioxide (gaseous air pollutant)</p></def></def-item><def-item><term>SpD</term><def><p id="P362">surfactant protein D</p></def></def-item><def-item><term>TLV</term><def><p id="P363">Threshold Limit Values</p></def></def-item><def-item><term>TRI</term><def><p id="P364">Toxic Release Inventory, part of the Emergency Planning and Community Right-to-Know Act (EPCRA) Section 313 toxic chemical release reporting requirements</p></def></def-item><def-item><term>TRS</term><def><p id="P365">total reduced sulfur (gaseous air pollutant)</p></def></def-item><def-item><term>TSP</term><def><p id="P366">total suspended particulate (particulate air pollutant)</p></def></def-item><def-item><term>TWA</term><def><p id="P367">time weighted average</p></def></def-item><def-item><term>&#x003bc;g/m<sup>3</sup></term><def><p id="P368">micrograms per cubic meter (density type pollutant concentration unit)</p></def></def-item><def-item><term>WHO</term><def><p id="P369">World Health Organization</p></def></def-item><def-item><term>WTP</term><def><p id="P370">water treatment plant</p></def></def-item><def-item><term>WWTP</term><def><p id="P371">wastewater treatment plant</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="R1"><mixed-citation publication-type="book"><collab>ACGIH American Conference of Governmental Industrial Hygienists</collab>, <year>2001</year>. <source>Threshold Limit Values for Chemical Substances and Physical Agents &#x00026; Biological Exposure Indices, Hydrogen Sulfide</source> (<comment>7783-06-4</comment>). <publisher-loc>Cincinnati, OH</publisher-loc>, <comment>2010.</comment> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.acgih.org/science/tlv-bei-guidelines/" ext-link-type="uri">https://www.acgih.org/science/tlv-bei-guidelines/</ext-link>.</comment></mixed-citation></ref><ref id="R2"><mixed-citation publication-type="book"><collab>AER Alberta Energy Regulator</collab>, <year>2022</year>. <source>Directive 60: Upstream Petroleum Industry Flaring, Incinerating, and Venting</source>; <publisher-loc>Calgary, AB</publisher-loc>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.aer.ca/documents/directives/Directive060_2020.pdf" ext-link-type="uri">https://www.aer.ca/documents/directives/Directive060_2020.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R3"><mixed-citation publication-type="book"><collab>AEUB Alberta Energy and Utility Board</collab>, <year>2007</year>. <source>Pipeline Performance in Alberta, 1990&#x02013;2005</source>
<publisher-loc>Alberta, Canada</publisher-loc>: <publisher-name>Alberta Energy and Utility Board</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://static.aer.ca/prd/documents/reports/r2007-A.pdf" ext-link-type="uri">https://static.aer.ca/prd/documents/reports/r2007-A.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R4"><mixed-citation publication-type="webpage"><collab>AH Alberta Health</collab>, <year>2020</year>. <source>Odor Thresholds in Emergency Management: A jurisdictional Review</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://open.alberta.ca/publications/9781460147368" ext-link-type="uri">https://open.alberta.ca/publications/9781460147368</ext-link>.</comment></mixed-citation></ref><ref id="R5"><mixed-citation publication-type="book"><collab>AIHA American Industrial Hygiene Association</collab>, <year>1991</year>. <source>Emergency Response Planning Guidelines for Hydrogen Sulfide</source>
<publisher-loc>Akron, OH</publisher-loc>: <publisher-name>AIHA Press</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.aiha.org/get-involved/aiha-guideline-foundation/erpgs" ext-link-type="uri">https://www.aiha.org/get-involved/aiha-guideline-foundation/erpgs</ext-link>.</comment></mixed-citation></ref><ref id="R6"><mixed-citation publication-type="journal"><name><surname>Al-Batanony</surname><given-names>MA</given-names></name>, <name><surname>El-Shafie</surname><given-names>MK</given-names></name>, <year>2011</year>. <article-title>Work-related health effects among wastewater treatment plants workers</article-title>. <source>Int. J. Occup. Environ. Med</source>
<volume>2</volume>, <fpage>237</fpage>&#x02013;<lpage>244</lpage>.<pub-id pub-id-type="pmid">23022842</pub-id></mixed-citation></ref><ref id="R7"><mixed-citation publication-type="book"><collab>Environment Alberta</collab>, <year>2004</year>. <source>Assessment Report on Reduced Sulphur Compounds for Developing and Ambient Air Quality Objectives</source>. <publisher-loc>Alberta, Canada</publisher-loc>: <publisher-name>Alberta Environment</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://open.alberta.ca/publications/0778532062" ext-link-type="uri">https://open.alberta.ca/publications/0778532062</ext-link>.</comment></mixed-citation></ref><ref id="R8"><mixed-citation publication-type="journal"><name><surname>Almeida</surname><given-names>AF</given-names></name>, <name><surname>Guidotti</surname><given-names>TL</given-names></name>, <year>1999</year>. <article-title>Differential sensitivity of lung and brain to sulfide exposure: A peripheral mechanism for apnea</article-title>. <source>Toxicol. Sci</source>
<volume>50</volume>, <fpage>287</fpage>&#x02013;<lpage>293</lpage>.<pub-id pub-id-type="pmid">10478866</pub-id></mixed-citation></ref><ref id="R9"><mixed-citation publication-type="journal"><name><surname>Amaral</surname><given-names>AFS</given-names></name>, <name><surname>Rodrigues</surname><given-names>AS</given-names></name>, <year>2007</year>. <article-title>Chronic exposure to volcanic environments and chronic bronchitis incidence in the Azores</article-title>, <source>Portugal. Environ. Res</source>
<volume>103</volume>, <fpage>419</fpage>&#x02013;<lpage>423</lpage>.<pub-id pub-id-type="pmid">16916511</pub-id></mixed-citation></ref><ref id="R10"><mixed-citation publication-type="journal"><name><surname>Ammann</surname><given-names>HM</given-names></name>, <year>1986</year>. <article-title>A new look at physiologic respiratory response to H<sub>2</sub>S poisoning</article-title>. <source>J. Hazard. Mater</source>
<volume>13</volume>, <fpage>369</fpage>&#x02013;<lpage>374</lpage>.</mixed-citation></ref><ref id="R11"><mixed-citation publication-type="journal"><name><surname>Amoore</surname><given-names>JE</given-names></name>, <year>1985</year>. <article-title>The Perception of Hydrogen Sulfide Odor in Relation to Setting an Ambient Standard</article-title>. <source>Prepared for California Air Resources Board ARB</source>
<comment>Contract A4-046-33.</comment> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="http://www.arb.ca.gov/research/apr/past/a4-046-33.pdf" ext-link-type="uri">http://www.arb.ca.gov/research/apr/past/a4-046-33.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R12"><mixed-citation publication-type="journal"><name><surname>Amoore</surname><given-names>JE</given-names></name>, <name><surname>Hautala</surname><given-names>E</given-names></name>, <year>1983</year>. <article-title>Odor as an ald to chemical safety: Odor thresholds compared with threshold limit values and volatilities for 214 industrial chemicals in air and water dilution</article-title>. <source>J. Appl. Toxicol</source>
<volume>3</volume>, <fpage>272</fpage>&#x02013;<lpage>290</lpage>.<pub-id pub-id-type="pmid">6376602</pub-id></mixed-citation></ref><ref id="R13"><mixed-citation publication-type="journal"><name><surname>Armstrong</surname><given-names>SR</given-names></name>, <name><surname>Ames</surname><given-names>MR</given-names></name>, <name><surname>Green</surname><given-names>LC</given-names></name>, <year>2004</year>. <source>Is ambient hydrogen sulfide a risk to human health? Presented at the WEF/A&#x00026;WMA Odors and Air Emissions Conference</source>, <month>April</month>
<comment>2004</comment>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="http://cambridgeenvironmental.com/blog/wp-content/uploads/2011/11/Hydrogen%20Sulfide%20Ambient%20Air%20Health%20Risk.pdf" ext-link-type="uri">http://cambridgeenvironmental.com/blog/wp-content/uploads/2011/11/Hydrogen%20Sulfide%20Ambient%20Air%20Health%20Risk.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R14"><mixed-citation publication-type="journal"><name><surname>Aslami</surname><given-names>H</given-names></name>, <name><surname>Schultz</surname><given-names>M</given-names></name>, <name><surname>Juffermans</surname><given-names>N</given-names></name>, <year>2009</year>. <article-title>Potential Applications of Hydrogen Sulfide-Induced Suspended Animation</article-title>. <source>Curr. Med. Chem</source>
<volume>16</volume>, <fpage>1295</fpage>&#x02013;<lpage>1303</lpage>.<pub-id pub-id-type="pmid">19355886</pub-id></mixed-citation></ref><ref id="R15"><mixed-citation publication-type="book"><collab>ATSDR Agency for Toxic Substances and Disease Registry</collab>, <year>2016</year>. <source>Toxicological Profile for Hydrogen Sulfide and Carbonyl Sulfide</source>
<publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>Agency for Toxic Substances and Disease Registry</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.atsdr.cdc.gov/toxprofiles/tp114.pdf" ext-link-type="uri">https://www.atsdr.cdc.gov/toxprofiles/tp114.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R16"><mixed-citation publication-type="book"><collab>ATSDR Agency for Toxic Substances and Disease Registry</collab>, <year>2006</year>. <source>Toxicological Profile for Hydrogen Sulfide</source>
<publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>Agency for Toxic Substances and Disease Registry</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="http://www.atsdr.cdc.gov/toxprofiles/index.asp" ext-link-type="uri">http://www.atsdr.cdc.gov/toxprofiles/index.asp</ext-link>.</comment></mixed-citation></ref><ref id="R17"><mixed-citation publication-type="book"><collab>ATSDR Agency for Toxic Substances and Disease Registry</collab>, <year>2002</year>. <source>Hazardous Substances Emergency Events Surveillance Database</source>
<publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>Agency for Toxic Substances and Disease Registry</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.atsdr.cdc.gov/hs/hsees/public_use_file.html" ext-link-type="uri">https://www.atsdr.cdc.gov/hs/hsees/public_use_file.html</ext-link>.</comment></mixed-citation></ref><ref id="R18"><mixed-citation publication-type="book"><collab>ATSDR Agency for Toxic Substances and Disease Registry</collab>, <year>1997</year>. <source>Exposure Investigation for Dakota City/South Sioux City: Hydrogen sulfide in Ambient Air</source>
<publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>Agency for Toxic Substances and Disease Registry</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="http://www.atsdr.cdc.gov/HAC/PHA/dakcity/dak_toc.html" ext-link-type="uri">http://www.atsdr.cdc.gov/HAC/PHA/dakcity/dak_toc.html</ext-link>.</comment></mixed-citation></ref><ref id="R19"><mixed-citation publication-type="journal"><name><surname>Attene-Ramos</surname><given-names>MS</given-names></name>, <name><surname>Wagner</surname><given-names>ED</given-names></name>, <name><surname>Gaskins</surname><given-names>HR</given-names></name>, <name><surname>Plewa</surname><given-names>MJ</given-names></name>, <year>2007</year>. <article-title>Hydrogen sulfide induces direct radical-associated DNA damage</article-title>. <source>Mol. Cancer Res</source>
<volume>5</volume>, <fpage>455</fpage>&#x02013;<lpage>459</lpage>.<pub-id pub-id-type="pmid">17475672</pub-id></mixed-citation></ref><ref id="R20"><mixed-citation publication-type="journal"><name><surname>Austigard</surname><given-names>&#x000c5;D</given-names></name>, <name><surname>Svendsen</surname><given-names>K</given-names></name>, <name><surname>Heldal</surname><given-names>KK</given-names></name>, <year>2018</year>. <article-title>Hydrogen sulphide exposure in waste water treatment</article-title>. <source>J. Occup. Med. Toxicol</source>
<volume>13</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">29321805</pub-id></mixed-citation></ref><ref id="R21"><mixed-citation publication-type="journal"><name><surname>Avery</surname><given-names>RC</given-names></name>, <name><surname>Wing</surname><given-names>S</given-names></name>, <name><surname>Marshall</surname><given-names>SW</given-names></name>, <name><surname>Schiffman</surname><given-names>SS</given-names></name>, <year>2004</year>. <article-title>Odor from industrial hog farming operations and mucosal immune function in neighbors</article-title>. <source>Arch. Environ. Health</source>
<volume>59</volume>, <fpage>101</fpage>&#x02013;<lpage>108</lpage>.<pub-id pub-id-type="pmid">16075904</pub-id></mixed-citation></ref><ref id="R22"><mixed-citation publication-type="journal"><name><surname>Bardana</surname><given-names>EJ</given-names></name>, <year>1999</year>. <article-title>Reactive airways dysfunction syndrome (RADS): Guidelines for diagnosis and treatment and insight into likely prognosis</article-title>. <source>Ann. Allergy, Asthma Immunol</source>
<volume>83</volume>, <fpage>583</fpage>&#x02013;<lpage>586</lpage>.<pub-id pub-id-type="pmid">10619325</pub-id></mixed-citation></ref><ref id="R23"><mixed-citation publication-type="journal"><name><surname>Bates</surname><given-names>MN</given-names></name>, <name><surname>Garrett</surname><given-names>N</given-names></name>, <name><surname>Crane</surname><given-names>J</given-names></name>, <name><surname>Balmes</surname><given-names>JR</given-names></name>, <year>2013</year>. <article-title>Associations of ambient hydrogen sulfide exposure with self-reported asthma and asthma symptoms</article-title>. <source>Environ. Res</source>
<volume>122</volume>, <fpage>81</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">23453847</pub-id></mixed-citation></ref><ref id="R24"><mixed-citation publication-type="journal"><name><surname>Bates</surname><given-names>MN</given-names></name>, <name><surname>Garrett</surname><given-names>N</given-names></name>, <name><surname>Graham</surname><given-names>B</given-names></name>, <name><surname>Read</surname><given-names>D</given-names></name>, <year>1998</year>. <article-title>Cancer incidence, morbidity and geothermal air pollution in Rotorua, New Zealand</article-title>. <source>Int. J. Epidemiol</source>
<volume>27</volume>, <fpage>10</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">9563687</pub-id></mixed-citation></ref><ref id="R25"><mixed-citation publication-type="journal"><name><surname>Bates</surname><given-names>MN</given-names></name>, <name><surname>Garrett</surname><given-names>N</given-names></name>, <name><surname>Graham</surname><given-names>B</given-names></name>, <name><surname>Read</surname><given-names>D</given-names></name>, <year>1997</year>. <article-title>Air pollution and mortality in the Rotorua geothermal area</article-title>. <source>Aust. N. Z. J. Public Health</source>
<volume>21</volume>, <fpage>581</fpage>&#x02013;<lpage>586</lpage>.<pub-id pub-id-type="pmid">9470262</pub-id></mixed-citation></ref><ref id="R26"><mixed-citation publication-type="journal"><name><surname>Bates</surname><given-names>MN</given-names></name>, <name><surname>Garrett</surname><given-names>N</given-names></name>, <name><surname>Shoemack</surname><given-names>P</given-names></name>, <year>2002</year>. <article-title>Investigation of Health Effects of Hydrogen Sulfide from a Geothermal Source</article-title>. <source>Arch. Environ. Health</source>
<volume>57</volume>, <fpage>405</fpage>&#x02013;<lpage>411</lpage>.<pub-id pub-id-type="pmid">12641180</pub-id></mixed-citation></ref><ref id="R27"><mixed-citation publication-type="journal"><name><surname>Baxter</surname><given-names>PJ</given-names></name>, <name><surname>Baubron</surname><given-names>J-C</given-names></name>, <name><surname>Coutinho</surname><given-names>R</given-names></name>, <year>1999</year>. <article-title>Health hazards and disaster potential of ground gas emissions at Furnas volcano, S&#x000e3;o Miguel, Azores</article-title>. <source>J. Volcanol. Geotherm. Res</source>
<volume>92</volume>, <fpage>95</fpage>&#x02013;<lpage>106</lpage>.</mixed-citation></ref><ref id="R28"><mixed-citation publication-type="journal"><name><surname>Beauchamp</surname><given-names>RO</given-names></name>, <name><surname>Bus</surname><given-names>JS</given-names></name>, <name><surname>Popp</surname><given-names>JA</given-names></name>, <name><surname>Boreiko</surname><given-names>CJ</given-names></name>, <name><surname>Andjelkovich</surname><given-names>DA</given-names></name>, <name><surname>Leber</surname><given-names>P</given-names></name>, <year>1984</year>. <article-title>A critical review of the literature on hydrogen sulfide toxicity</article-title>. <source>Crit. Rev. Toxicol</source>
<volume>13</volume>, <fpage>25</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">6378532</pub-id></mixed-citation></ref><ref id="R29"><mixed-citation publication-type="journal"><name><surname>Bechtel</surname><given-names>D</given-names></name>, <name><surname>Waldner</surname><given-names>C</given-names></name>, <name><surname>Wickstrom</surname><given-names>M</given-names></name>, <year>2009</year>. <article-title>Associations between immune function in yearling beef cattle and airborne emissions of sulfur dioxide, hydrogen sulfide, and VOCs from oil and natural gas facilities</article-title>. <source>Arch. Environ. Occup. Heal</source>
<volume>64</volume>, <fpage>73</fpage>&#x02013;<lpage>86</lpage>.</mixed-citation></ref><ref id="R30"><mixed-citation publication-type="book"><name><surname>Bhagavan</surname><given-names>NV</given-names></name>, <year>2002</year>. <source>Medical Biochemistry</source>, <edition>4th ed.</edition>
<publisher-loc>London</publisher-loc>: <publisher-name>Academic Press</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.elsevier.com/books/medical-biochemistry/bhagavan/978-0-12-095440-7" ext-link-type="uri">https://www.elsevier.com/books/medical-biochemistry/bhagavan/978-0-12-095440-7</ext-link>.</comment></mixed-citation></ref><ref id="R31"><mixed-citation publication-type="journal"><name><surname>Bhambhani</surname><given-names>Y</given-names></name>, <name><surname>Burnham</surname><given-names>R</given-names></name>, <name><surname>Snydmiller</surname><given-names>G</given-names></name>, <name><surname>MacLean</surname><given-names>I</given-names></name>, <name><surname>Martin</surname><given-names>T</given-names></name>, <year>1996</year>. <article-title>Effects of 5 ppm Hydrogen Sulfide Inhalation on Biochemical Properties of Skeletal Muscle in Exercising Men and Women</article-title>. <source>Am. Ind. Hyg. Assoc. J</source>
<volume>57</volume>, <fpage>464</fpage>&#x02013;<lpage>468</lpage>.<pub-id pub-id-type="pmid">8638517</pub-id></mixed-citation></ref><ref id="R32"><mixed-citation publication-type="journal"><name><surname>Bhambhani</surname><given-names>Y</given-names></name>, <name><surname>Singh</surname><given-names>M</given-names></name>, <year>1991</year>. <article-title>Physiological effects of hydrogen sulfide inhalation during exercise in healthy men</article-title>. <source>J. Appl. Physiol</source>
<volume>71</volume>, <fpage>1872</fpage>&#x02013;<lpage>1877</lpage>.<pub-id pub-id-type="pmid">1761485</pub-id></mixed-citation></ref><ref id="R33"><mixed-citation publication-type="journal"><name><surname>Blackstone</surname><given-names>E</given-names></name>, <name><surname>Morrison</surname><given-names>M</given-names></name>, <name><surname>Roth</surname><given-names>MB</given-names></name>, <year>2005</year>. <article-title>H<sub>2</sub>S Induces a Suspended Animation-Like State in Mice</article-title>. <source>Science</source>
<volume>308</volume>, <fpage>518</fpage>.<pub-id pub-id-type="pmid">15845845</pub-id></mixed-citation></ref><ref id="R34"><mixed-citation publication-type="journal"><name><surname>Blanes-vidal</surname><given-names>V</given-names></name>, <name><surname>Hansen</surname><given-names>MN</given-names></name>, <name><surname>Adamsen</surname><given-names>APS</given-names></name>, <name><surname>Feilberg</surname><given-names>A</given-names></name>, <name><surname>Petersen</surname><given-names>SO</given-names></name>, <name><surname>Jensen</surname><given-names>BB</given-names></name>, <year>2009</year>. <article-title>Characterization of odor released during handling of swine slurry&#x0202f;: Part I. Relationship between odorants and perceived odor concentrations</article-title>. <source>Atmos. Environ</source>
<volume>43</volume>, <fpage>2997</fpage>&#x02013;<lpage>3005</lpage>.</mixed-citation></ref><ref id="R35"><mixed-citation publication-type="journal"><name><surname>Brancher</surname><given-names>M</given-names></name>, <name><surname>Griffiths</surname><given-names>KD</given-names></name>, <name><surname>Franco</surname><given-names>D</given-names></name>, <name><surname>de Melo Lisboa</surname><given-names>H</given-names></name>, <year>2017</year>. <article-title>A review of odour impact criteria in selected countries around the world</article-title>. <source>Chemosphere</source>
<volume>168</volume>, <fpage>1531</fpage>&#x02013;<lpage>1570</lpage>.<pub-id pub-id-type="pmid">27939667</pub-id></mixed-citation></ref><ref id="R36"><mixed-citation publication-type="journal"><name><surname>Brenneman</surname><given-names>KA</given-names></name>, <name><surname>James</surname><given-names>RA</given-names></name>, <name><surname>Gross</surname><given-names>EA</given-names></name>, <name><surname>Dorman</surname><given-names>DC</given-names></name>, <year>2000</year>. <article-title>Olfactory neuron loss in adult male cd rats following subchronic inhalation exposure to hydrogen sulfide</article-title>. <source>Toxicol. Pathol</source>
<volume>28</volume>, <fpage>326</fpage>&#x02013;<lpage>333</lpage>.<pub-id pub-id-type="pmid">10805151</pub-id></mixed-citation></ref><ref id="R37"><mixed-citation publication-type="journal"><name><surname>Bullers</surname><given-names>S</given-names></name>, <year>2005</year>. <article-title>Environmental stressors, perceived control, and health: The case of residents near large-scale hog farms in Eastern North Carolina</article-title>. <source>Hum. Ecol</source>
<volume>33</volume>, <fpage>1</fpage>&#x02013;<lpage>16</lpage>.</mixed-citation></ref><ref id="R38"><mixed-citation publication-type="journal"><name><surname>Bustaffa</surname><given-names>E</given-names></name>, <name><surname>Cori</surname><given-names>L</given-names></name>, <name><surname>Manzella</surname><given-names>A</given-names></name>, <name><surname>Nuvolone</surname><given-names>D</given-names></name>, <name><surname>Minichilli</surname><given-names>F</given-names></name>, <name><surname>Bianchi</surname><given-names>F</given-names></name>, <name><surname>Gorini</surname><given-names>F</given-names></name>, <year>2020</year>. <article-title>The health of communities living in proximity of geothermal plants generating heat and electricity: A review</article-title>. <source>Sci. Total Environ</source>
<volume>706</volume>, <fpage>135998</fpage>.<pub-id pub-id-type="pmid">31862594</pub-id></mixed-citation></ref><ref id="R39"><mixed-citation publication-type="journal"><name><surname>Campagna</surname><given-names>D</given-names></name>, <name><surname>Kathman</surname><given-names>SJ</given-names></name>, <name><surname>Pierson</surname><given-names>R</given-names></name>, <name><surname>Inserra</surname><given-names>SG</given-names></name>, <name><surname>Phifer</surname><given-names>BL</given-names></name>, <name><surname>Middleton</surname><given-names>DC</given-names></name>, <name><surname>Zarus</surname><given-names>GM</given-names></name>, <name><surname>White</surname><given-names>MC</given-names></name>, <year>2004</year>. <article-title>Ambient hydrogen sulfide, total reduced sulfur, and hospital visits for respiratory diseases in northeast Nebraska, 1998&#x02013;2000</article-title>. <source>J. Expo. Anal. Environ. Epidemiol</source>
<volume>14</volume>, <fpage>180</fpage>&#x02013;<lpage>187</lpage>.<pub-id pub-id-type="pmid">15014549</pub-id></mixed-citation></ref><ref id="R40"><mixed-citation publication-type="journal"><collab>Cantox Environmental</collab>, <year>2009</year>. <article-title>ERCBH2S: A Model for Calculating Emergency Response and Planning Zones for Sour Gas Facilities</article-title>. Vol. <volume>2</volume>: <source>Emergency Response Planning Endpoints</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://static.aer.ca/prd/documents/directives/ERCBH2S_VOLUME_2.pdf" ext-link-type="uri">https://static.aer.ca/prd/documents/directives/ERCBH2S_VOLUME_2.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R41"><mixed-citation publication-type="journal"><name><surname>Carlsen</surname><given-names>HK</given-names></name>, <name><surname>Zo&#x000eb;ga</surname><given-names>H</given-names></name>, <name><surname>Valdimarsd&#x000f3;ttir</surname><given-names>U</given-names></name>, <name><surname>G&#x000ed;slason</surname><given-names>T</given-names></name>, <name><surname>Hrafnkelsson</surname><given-names>B</given-names></name>, <year>2012</year>. <article-title>Hydrogen sulfide and particle matter levels associated with increased dispensing of anti-asthma drugs in Iceland&#x02019;s capital</article-title>. <source>Environ. Res</source>
<volume>113</volume>, <fpage>33</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">22264878</pub-id></mixed-citation></ref><ref id="R42"><mixed-citation publication-type="journal"><name><surname>Carroll</surname><given-names>RJ</given-names></name>, <name><surname>Ruppert</surname><given-names>D</given-names></name>, <name><surname>Stefanski</surname><given-names>LA</given-names></name>, <name><surname>Crainiceanu</surname><given-names>CM</given-names></name>, <year>2006</year>. <article-title>Measurement error in nonlinear models: a modern perspective</article-title>. <edition>2nd ed.</edition>
<source>Boca Raton, Florida: Chapman and Hall/CRC</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <pub-id pub-id-type="doi">10.1201/9781420010138</pub-id>.</mixed-citation></ref><ref id="R43"><mixed-citation publication-type="journal"><name><surname>Cavender</surname><given-names>F</given-names></name>, <name><surname>Phillips</surname><given-names>S</given-names></name>, <name><surname>Holland</surname><given-names>M</given-names></name>, <year>2008</year>. <article-title>Development of Emergency Response Planning Guidelines (ERPGs)</article-title>. <source>J. Med. Toxicol</source>
<volume>4</volume>, <fpage>127</fpage>&#x02013;<lpage>131</lpage>.<pub-id pub-id-type="pmid">18570174</pub-id></mixed-citation></ref><ref id="R44"><mixed-citation publication-type="journal"><collab>CDC Centers for Disease Control and Prevention</collab>, <year>1993</year>. <article-title>Fatalities attributed to entering manure waste pits, Minnesota, 1992</article-title>. <source>JAMA</source>
<volume>269</volume>, <fpage>3098</fpage>&#x02013;<lpage>3102</lpage>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00020468.htm" ext-link-type="uri">https://www.cdc.gov/mmwr/preview/mmwrhtml/00020468.htm</ext-link>.</comment><pub-id pub-id-type="pmid">8505805</pub-id></mixed-citation></ref><ref id="R45"><mixed-citation publication-type="journal"><name><surname>Chastain</surname><given-names>JP</given-names></name>, <name><surname>Henry</surname><given-names>S</given-names></name>, <year>2002</year>. <article-title>Chepter 4: Management of lagoons and storage structures for swine manure</article-title>. <source>Clemson Univerisity. In Cooperative Extension. In Livestock and forage. In CAMM, In swine training manual</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.clemson.edu/extension/camm/manuals/swine/sch4_03.pdf" ext-link-type="uri">https://www.clemson.edu/extension/camm/manuals/swine/sch4_03.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R46"><mixed-citation publication-type="book"><collab>CIIT Chemical Industry Institute of Toxicology</collab>, <year>1983</year>. <source>90-Day vapor inhalation toxicity study of hydrogen sulfide in B6C3F1 mice. EPA/OTS 0883&#x02013;0255. Chemical Industry Institute of Toxicology</source>, <publisher-loc>Research Triangle Park, NC</publisher-loc>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="http://www.ciit.org/AboutCIIT/About" ext-link-type="uri">http://www.ciit.org/AboutCIIT/About</ext-link>.</comment></mixed-citation></ref><ref id="R47"><mixed-citation publication-type="webpage"><name><surname>Collins</surname><given-names>J</given-names></name>, <name><surname>Lewis</surname><given-names>D</given-names></name>, <year>2000</year>. <source>Hydrogen sulfide: evaluation of current California air quality standards with respect to protection of children, Air Toxicology and Epidemiology Section, California Office of Environmental Health Hazard Assessment., Air Toxicology and Epidemiology Section, California Office of Environmental Health Hazard Assessment</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.arborhillsmonitoring.com/References/REF_CAL-EPA%20OEHHA%202000.pdf" ext-link-type="uri">https://www.arborhillsmonitoring.com/References/REF_CAL-EPA%20OEHHA%202000.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R48"><mixed-citation publication-type="journal"><name><surname>Col&#x000f3;n</surname><given-names>J</given-names></name>, <name><surname>Alvarez</surname><given-names>C</given-names></name>, <name><surname>Vinot</surname><given-names>M</given-names></name>, <name><surname>Lafuente</surname><given-names>FJ</given-names></name>, <name><surname>Pons&#x000e1;</surname><given-names>S</given-names></name>, <name><surname>S&#x000e1;nchez</surname><given-names>A</given-names></name>, <name><surname>Gabriel</surname><given-names>D</given-names></name>, <year>2017</year>. <article-title>Characterization of odorous compounds and odor load in indoor air of modern complex MBT facilities</article-title>. <source>Chem. Eng. J</source>
<volume>313</volume>, <fpage>1311</fpage>&#x02013;<lpage>1319</lpage>.</mixed-citation></ref><ref id="R49"><mixed-citation publication-type="journal"><name><surname>Costigan</surname><given-names>MG</given-names></name>, <year>2003</year>. <article-title>Hydrogen sulfide: UK occupational exposure limits</article-title>. <source>Occup. Environ. Med</source>
<volume>60</volume>, <fpage>918</fpage>&#x02013;<lpage>928</lpage>.<pub-id pub-id-type="pmid">14634182</pub-id></mixed-citation></ref><ref id="R50"><mixed-citation publication-type="webpage"><collab>DECOS Dutch Expert Committee on Occupational Standards</collab>, <year>2010</year>. <source>Health Council of the Netherlands. Presentation of Advisory Letter: Comparison of Recommended Exposure Limits for Hydrogen Sulphide</source> [<comment>accessed</comment>
<date-in-citation>2023 Mar 28</date-in-citation>]. <comment><ext-link xlink:href="https://www.healthcouncil.nl/documents/advisory-reports/2010/07/15/comparison-of-recommended-exposure-limits-for-hydrogen-sulphide" ext-link-type="uri">https://www.healthcouncil.nl/documents/advisory-reports/2010/07/15/comparison-of-recommended-exposure-limits-for-hydrogen-sulphide</ext-link>.</comment></mixed-citation></ref><ref id="R51"><mixed-citation publication-type="webpage"><collab>DECOS Dutch Expert Committee on Occupational Standards</collab>, <year>2006</year>. <source>Health Council of the Netherlands, Hydrogen Sulphide. Health-Based Recommended Occupational Exposure Limit in The Netherlands</source> [<comment>accessed</comment>
<date-in-citation>2023 Mar 28</date-in-citation>]. <comment><ext-link xlink:href="http://werkgroepterlinden.be/H2SC.pdf" ext-link-type="uri">http://werkgroepterlinden.be/H2SC.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R52"><mixed-citation publication-type="journal"><name><surname>Dominici</surname><given-names>F</given-names></name>, <name><surname>Peng</surname><given-names>RD</given-names></name>, <name><surname>Barr</surname><given-names>CD</given-names></name>, <name><surname>Bell</surname><given-names>ML</given-names></name>, <year>2010</year>. <article-title>Protecting human health from air pollution: Shifting from a single-pollutant to a multipollutant approach</article-title>. <source>Epidemiology</source>
<volume>21</volume>, <fpage>187</fpage>&#x02013;<lpage>194</lpage>.<pub-id pub-id-type="pmid">20160561</pub-id></mixed-citation></ref><ref id="R53"><mixed-citation publication-type="journal"><name><surname>Donham</surname><given-names>KJ</given-names></name>, <year>2010</year>. <article-title>Community and occupational health concerns in pork production: a review</article-title>. <source>J. Anim. Sci</source>
<volume>88</volume>, <fpage>102</fpage>&#x02013;<lpage>111</lpage>.<pub-id pub-id-type="pmid">19820064</pub-id></mixed-citation></ref><ref id="R54"><mixed-citation publication-type="journal"><name><surname>Donham</surname><given-names>KJ</given-names></name>, <name><surname>Knapp</surname><given-names>LW</given-names></name>, <name><surname>Monson</surname><given-names>R</given-names></name>, <name><surname>Kim</surname><given-names>Gustafson</given-names></name>, <year>1982</year>. <article-title>Acute toxic exposure to gases from liquid manure</article-title>. <source>J. Occup. Med</source>
<volume>24</volume>, <fpage>142</fpage>&#x02013;<lpage>145</lpage>.<pub-id pub-id-type="pmid">7057283</pub-id></mixed-citation></ref><ref id="R55"><mixed-citation publication-type="journal"><name><surname>Donham</surname><given-names>KJ</given-names></name>, <name><surname>Lee</surname><given-names>JA</given-names></name>, <name><surname>Thu</surname><given-names>K</given-names></name>, <name><surname>Reynolds</surname><given-names>SJ</given-names></name>, <year>2006</year>. <article-title>Assessment of air quality at neighbor residences in the vicinity of swine production facilities</article-title>. <source>J. Agromedicine</source>
<volume>11</volume>, <fpage>15</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">19274894</pub-id></mixed-citation></ref><ref id="R56"><mixed-citation publication-type="journal"><name><surname>Donham</surname><given-names>KJ</given-names></name>, <name><surname>Wing</surname><given-names>S</given-names></name>, <name><surname>Osterberg</surname><given-names>D</given-names></name>, <name><surname>Flora</surname><given-names>JL</given-names></name>, <name><surname>Hodne</surname><given-names>C</given-names></name>, <name><surname>Thu</surname><given-names>KM</given-names></name>, <name><surname>Thorne</surname><given-names>PS</given-names></name>, <year>2007</year>. <article-title>Community health and socioeconomic issues surrounding concentrated animal feeding operations</article-title>. <source>Environ. Health Perspect</source>
<volume>115</volume>, <fpage>317</fpage>&#x02013;<lpage>320</lpage>.<pub-id pub-id-type="pmid">17384786</pub-id></mixed-citation></ref><ref id="R57"><mixed-citation publication-type="journal"><name><surname>Dorman</surname><given-names>DC</given-names></name>, <name><surname>Struve</surname><given-names>MF</given-names></name>, <name><surname>Gross</surname><given-names>EA</given-names></name>, <name><surname>Brenneman</surname><given-names>KA</given-names></name>, <year>2004</year>. <article-title>Respiratory tract toxicity of inhaled hydrogen sulfide in Fischer-344 rats, Sprague-Dawley rats, and B6C3F1 mice following subchronic (90-day) exposure</article-title>. <source>Toxicol. Appl. Pharmacol</source>
<volume>198</volume>, <fpage>29</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">15207646</pub-id></mixed-citation></ref><ref id="R58"><mixed-citation publication-type="journal"><name><surname>Drewnoski</surname><given-names>ME</given-names></name>, <name><surname>Richter</surname><given-names>EL</given-names></name>, <name><surname>Hansen</surname><given-names>SL</given-names></name>, <year>2012</year>. <article-title>Dietary sulfur concentration affects rumen hydrogen sulfide concentrations in feed-lot steers during transition and finishing</article-title>. <source>J. Anim. Sci</source>
<volume>90</volume>, <fpage>4478</fpage>&#x02013;<lpage>4486</lpage>.<pub-id pub-id-type="pmid">23255818</pub-id></mixed-citation></ref><ref id="R59"><mixed-citation publication-type="journal"><name><surname>Drimal</surname><given-names>M</given-names></name>, <name><surname>Koppov&#x000e1;</surname><given-names>K</given-names></name>, <name><surname>Kl&#x000f6;slov&#x000e1;</surname><given-names>Z</given-names></name>, <name><surname>Fabi&#x000e1;nov&#x000e1;</surname><given-names>E</given-names></name>, <year>2010</year>. <article-title>Environmental exposure to hydrogen sulfide in central Slovakia (Ru&#x0017e;omberok area) in context of health risk assessment</article-title>. <source>Cent. Eur. J. Public Health</source>
<volume>18</volume>, <fpage>224</fpage>&#x02013;<lpage>229</lpage>.<pub-id pub-id-type="pmid">21361108</pub-id></mixed-citation></ref><ref id="R60"><mixed-citation publication-type="journal"><name><surname>Dubyk</surname><given-names>ST</given-names></name>, <name><surname>Mustafa</surname><given-names>S</given-names></name>, <year>2002</year>. <article-title>Trip Report: H2S Survey, March 18&#x02013;22, 2002</article-title>. <source>State of New Mexico: Environment Department 38</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.env.nm.gov/air-quality/" ext-link-type="uri">https://www.env.nm.gov/air-quality/</ext-link>.</comment></mixed-citation></ref><ref id="R61"><mixed-citation publication-type="journal"><name><surname>Durand</surname><given-names>M</given-names></name>, <name><surname>Scott</surname><given-names>BJ</given-names></name>, <year>2005</year>. <article-title>Geothermal ground gas emissions and indoor air pollution in Rotorua, New Zealand</article-title>. <source>Sci. Total Environ</source>
<volume>345</volume>, <fpage>69</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">15919529</pub-id></mixed-citation></ref><ref id="R62"><mixed-citation publication-type="journal"><name><surname>Durand</surname><given-names>M</given-names></name>, <name><surname>Weinstein</surname><given-names>P</given-names></name>, <year>2007</year>. <article-title>Thiosulfate in human urine following minor exposure to hydrogen sulfide: Implications for forensic analysis of poisoning</article-title>. <source>Forensic Toxicol</source>
<volume>25</volume>, <fpage>92</fpage>&#x02013;<lpage>95</lpage>.</mixed-citation></ref><ref id="R63"><mixed-citation publication-type="journal"><name><surname>Durand</surname><given-names>M</given-names></name>, <name><surname>Wilson</surname><given-names>JG</given-names></name>, <year>2006</year>. <article-title>Spatial analysis of respiratory disease on an urbanized geothermal field</article-title>. <source>Environ. Res</source>
<volume>101</volume>, <fpage>238</fpage>&#x02013;<lpage>245</lpage>.<pub-id pub-id-type="pmid">16169550</pub-id></mixed-citation></ref><ref id="R64"><mixed-citation publication-type="journal"><name><surname>Eduard</surname><given-names>W</given-names></name>, <name><surname>Pearce</surname><given-names>N</given-names></name>, <name><surname>Douwes</surname><given-names>J</given-names></name>, <year>2009</year>. <article-title>Chronic bronchitis, COPD, and lung function in farmers: The role of biological agents</article-title>. <source>Chest</source>
<volume>136</volume>, <fpage>716</fpage>&#x02013;<lpage>725</lpage>.<pub-id pub-id-type="pmid">19318669</pub-id></mixed-citation></ref><ref id="R65"><mixed-citation publication-type="journal"><name><surname>Elovaara</surname><given-names>E</given-names></name>, <name><surname>Tossavainen</surname><given-names>A</given-names></name>, <name><surname>Savolainen</surname><given-names>H</given-names></name>, <year>1978</year>. <article-title>Effects of subclinical hydrogen sulfide intoxication on mouse brain protein metabolism</article-title>. <source>Exp. Neurol</source>
<volume>62</volume>, <fpage>93</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">729679</pub-id></mixed-citation></ref><ref id="R66"><mixed-citation publication-type="journal"><name><surname>Ensabella</surname><given-names>F</given-names></name>, <name><surname>Spirito</surname><given-names>A</given-names></name>, <name><surname>Dupr&#x000e8;</surname><given-names>S</given-names></name>, <name><surname>Leoni</surname><given-names>V</given-names></name>, <name><surname>Schinina</surname><given-names>ME</given-names></name>, <name><surname>Strinati</surname><given-names>F</given-names></name>, <name><surname>Amiconi</surname><given-names>G</given-names></name>, <year>2004</year>. <article-title>Measurement of sulfhemoglobin (S-Hb) blood levels to determine individual hydrogen sulfide exposure in thermal baths in Italy</article-title>. <source>Ig. Sanita. Pubbl</source>
<volume>60</volume>, <fpage>201</fpage>&#x02013;<lpage>217</lpage>.<pub-id pub-id-type="pmid">15583709</pub-id></mixed-citation></ref><ref id="R67"><mixed-citation publication-type="webpage"><collab>EPA United States Environmental Protection Agency</collab>, <year>2020</year>. <source>Toxics Release Inventory (TRI) Program National Analysis: Releases of Chemicals</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.epa.gov/toxics-release-inventory-tri-program" ext-link-type="uri">https://www.epa.gov/toxics-release-inventory-tri-program</ext-link>.</comment></mixed-citation></ref><ref id="R68"><mixed-citation publication-type="webpage"><collab>EPA United States Environmental Protection Agency</collab>, <year>2017</year>. <source>Final Report of the Integrated Science Assessment (ISA) for Sulfur Oxides &#x02013; Health Criteria</source>
<comment>EPA/600/R-17/451.</comment> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.epa.gov/isa/integrated-science-assessment-isa-sulfur-oxides-health-criteria" ext-link-type="uri">https://www.epa.gov/isa/integrated-science-assessment-isa-sulfur-oxides-health-criteria</ext-link>.</comment></mixed-citation></ref><ref id="R69"><mixed-citation publication-type="webpage"><collab>EPA United States Environmental Protection Agency</collab>, <year>2016</year>. <source>Hydrogen Sulfide Monitoring on the Gulf Coastline. Web Archive</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://archive.epa.gov/emergency/bpspill/web/html/h2s.html" ext-link-type="uri">https://archive.epa.gov/emergency/bpspill/web/html/h2s.html</ext-link>.</comment></mixed-citation></ref><ref id="R70"><mixed-citation publication-type="webpage"><collab>EPA United States Environmental Protection Agency</collab>, <year>2012</year>. <source>National Ambient Air Quality Standards (NAAQS) for Particulate Matter (PM): Proposed Rule, 40 CFR Parts 50, 51, 52, 53 and 58</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.epa.gov/pm-pollution/2012-national-ambient-air-quality-standards-naaqs-particulate-matter-pm" ext-link-type="uri">https://www.epa.gov/pm-pollution/2012-national-ambient-air-quality-standards-naaqs-particulate-matter-pm</ext-link>.</comment></mixed-citation></ref><ref id="R71"><mixed-citation publication-type="book"><collab>EPA United States Environmental Protection Agency</collab>, <year>2011</year>. <part-title>Hydrogen Sulfide: Community Right to Know Toxic Chemical Release Reporting</part-title>. <source>40 CFR Part 372</source>, <publisher-name>U.S. Environmental Protection Agency, Federal Register</publisher-name>, <volume>76</volume>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.govinfo.gov/content/pkg/FR-2011-10-17/pdf/2011-23534.pdf" ext-link-type="uri">https://www.govinfo.gov/content/pkg/FR-2011-10-17/pdf/2011-23534.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R72"><mixed-citation publication-type="book"><collab>EPA United States Environmental Protection Agency</collab>, <year>2010a</year>. <part-title>Hydrogen Sulfide: Community Right to Know Toxic Chemical Release Reporting</part-title>. <source>40 CFR Part 372</source>, <publisher-name>U.S. Environmental Protection Agency, Federal Register</publisher-name>, <volume>75</volume>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.govinfo.gov/content/pkg/FR-2010-02-26/pdf/2010-4084.pdf" ext-link-type="uri">https://www.govinfo.gov/content/pkg/FR-2010-02-26/pdf/2010-4084.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R73"><mixed-citation publication-type="webpage"><collab>EPA United States Environmental Protection Agency</collab>, <year>2010b</year>. <source>Sulfur Dioxide (2010) Designated Area/State Information. Green Book</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.epa.gov/green-book/green-book-sulfur-dioxide-2010-area-information" ext-link-type="uri">https://www.epa.gov/green-book/green-book-sulfur-dioxide-2010-area-information</ext-link>.</comment></mixed-citation></ref><ref id="R74"><mixed-citation publication-type="webpage"><collab>EPA United States Environmental Protection Agency</collab>, <year>2005</year>. <source>Guidelines for Carcinogen Risk Assessment</source>
<comment>EPA/630/P-03/001B.</comment> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.epa.gov/sites/default/files/2013-09/documents/cancer_guidelines_final_3-25-05.pdf" ext-link-type="uri">https://www.epa.gov/sites/default/files/2013-09/documents/cancer_guidelines_final_3-25-05.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R75"><mixed-citation publication-type="journal"><collab>EPA United States Environmental Protection Agency</collab>, <year>2003</year>. <source>Toxicological Review of Hydrogen Sulfide in Support of Summary Information on the Integrated Risk Information System (IRIS)</source>
<comment>EPA/635/R-03/005.</comment> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://iris.epa.gov/static/pdfs/0061tr.pdf" ext-link-type="uri">https://iris.epa.gov/static/pdfs/0061tr.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R76"><mixed-citation publication-type="webpage"><collab>EPA United States Environmental Protection Agency</collab>, <year>1993a</year>. <source>Report to Congress on Hydrogen Sulfide Air Emissions Associated with the Extraction of Oil and Natural Gas</source> [<comment>accessed</comment>
<date-in-citation>2023 May 31</date-in-citation>]. <comment><ext-link xlink:href="https://www.energyindepth.org/wp-content/uploads/2011/03/EPA-H2S-Oil-and-Gas-Study-10-93.pdf" ext-link-type="uri">https://www.energyindepth.org/wp-content/uploads/2011/03/EPA-H2S-Oil-and-Gas-Study-10-93.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R77"><mixed-citation publication-type="book"><collab>EPA United States Environmental Protection Agency</collab>, <year>1993b</year>. <source>Health Assessment Document for Hydrogen Sulfide</source>
<comment>EPA/600/8&#x02013;86/026F.</comment>
<publisher-loc>Research Triangle Park, NC</publisher-loc>:. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://nepis.epa.gov/Exe/ZyPDF.cgi/30001FYP.PDF?Dockey=30001FYP.pdf" ext-link-type="uri">https://nepis.epa.gov/Exe/ZyPDF.cgi/30001FYP.PDF?Dockey=30001FYP.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R78"><mixed-citation publication-type="book"><collab>EPA United States Environmental Protection Agency</collab>, <year>1989</year>. <source>Glossary of Terms Related to Health, Exposure, and Risk Assessment</source>. <comment>EPA/450/3&#x02013;88/016.</comment>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>U.S. Environmental Protection Agency, Air Risk Information Support Center</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://nepis.epa.gov/Exe/ZyPDF.cgi/00002F5S.PDF?Dockey=00002F5S.pdf" ext-link-type="uri">https://nepis.epa.gov/Exe/ZyPDF.cgi/00002F5S.PDF?Dockey=00002F5S.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R79"><mixed-citation publication-type="journal"><name><surname>Farahat</surname><given-names>SA</given-names></name>, <name><surname>Kishk</surname><given-names>NA</given-names></name>, <year>2010</year>. <article-title>Cognitive functions changes among Egyptian sewage network workers</article-title>. <source>Toxicol. Ind. Health</source>
<volume>26</volume>, <fpage>229</fpage>&#x02013;<lpage>238</lpage>.<pub-id pub-id-type="pmid">20237195</pub-id></mixed-citation></ref><ref id="R80"><mixed-citation publication-type="journal"><name><surname>Fiedler</surname><given-names>N</given-names></name>, <name><surname>Kipen</surname><given-names>H</given-names></name>, <name><surname>Ohman-Strickland</surname><given-names>P</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Weisel</surname><given-names>C</given-names></name>, <name><surname>Laumbach</surname><given-names>R</given-names></name>, <name><surname>Kelly-McNeil</surname><given-names>K</given-names></name>, <name><surname>Olejeme</surname><given-names>K</given-names></name>, <name><surname>Lioy</surname><given-names>P</given-names></name>, <year>2008</year>. <article-title>Sensory and cognitive effects of acute exposure to hydrogen sulfide</article-title>. <source>Environ. Health Perspect</source>
<volume>116</volume>, <fpage>78</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">18197303</pub-id></mixed-citation></ref><ref id="R81"><mixed-citation publication-type="journal"><name><surname>Finnbjornsdottir</surname><given-names>RG</given-names></name>, <name><surname>Carlsen</surname><given-names>HK</given-names></name>, <name><surname>Thorsteinsson</surname><given-names>T</given-names></name>, <name><surname>Oudin</surname><given-names>A</given-names></name>, <name><surname>Lund</surname><given-names>SH</given-names></name>, <name><surname>Gislason</surname><given-names>T</given-names></name>, <name><surname>Rafnsson</surname><given-names>V</given-names></name>, <year>2016</year>. <article-title>Association between daily hydrogen sulfide exposure and incidence of emergency hospital visits: A population-based study</article-title>. <source>PLoS One</source>
<volume>11</volume>, <fpage>1</fpage>&#x02013;<lpage>19</lpage>.</mixed-citation></ref><ref id="R82"><mixed-citation publication-type="journal"><name><surname>Fisher</surname><given-names>GW</given-names></name>, <year>1999</year>. <article-title>Natural levels of hydrogen sulphide in New Zealand</article-title>. <source>Atmos. Environ</source>
<volume>33</volume>, <fpage>3078</fpage>&#x02013;<lpage>3079</lpage>.</mixed-citation></ref><ref id="R83"><mixed-citation publication-type="journal"><collab>FNBH Finnish National Board of Health</collab>, <year>1982</year>. <article-title>Valkeankosken ilma ja terveys. Epidemiologinen tutkimus yhdyskuntailman ja terveyden v&#x000e4;lisist&#x000e4; suhteista rekistereist&#x000e4; saatavien tietojen valossa [Ambient air and health status in Valkeankoski]</article-title>. <source>Helsinki, Government Printing Centre</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://nepis.epa.gov/Exe/ZyPDF.cgi/00002F5S.PDF?Dockey=00002F5S.pdf" ext-link-type="uri">https://nepis.epa.gov/Exe/ZyPDF.cgi/00002F5S.PDF?Dockey=00002F5S.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R84"><mixed-citation publication-type="journal"><name><surname>Fuller</surname><given-names>DC</given-names></name>, <name><surname>Suruda</surname><given-names>AJ</given-names></name>, <year>2000</year>. <article-title>Occupationally Related Hydrogen Sulfide Deaths in the United States From 1984 to 1994</article-title>. <source>J. Occup. Environ. Med</source>
<volume>42</volume>, <fpage>939</fpage>&#x02013;<lpage>942</lpage>.<pub-id pub-id-type="pmid">10998771</pub-id></mixed-citation></ref><ref id="R85"><mixed-citation publication-type="journal"><name><surname>Ganguly</surname><given-names>R</given-names></name>, <name><surname>Batterman</surname><given-names>S</given-names></name>, <name><surname>Isakov</surname><given-names>V</given-names></name>, <name><surname>Snyder</surname><given-names>M</given-names></name>, <name><surname>Breen</surname><given-names>M</given-names></name>, <name><surname>Brakefield-Caldwell</surname><given-names>W</given-names></name>, <year>2015</year>. <article-title>Effect of geocoding errors on traffic-related air pollutant exposure and concentration estimates</article-title>. <source>J. Expo. Sci. Environ. Epidemiol</source>
<volume>25</volume>, <fpage>490</fpage>&#x02013;<lpage>498</lpage>.<pub-id pub-id-type="pmid">25670023</pub-id></mixed-citation></ref><ref id="R86"><mixed-citation publication-type="journal"><name><surname>Gharahbaghian</surname><given-names>L</given-names></name>, <name><surname>Massoudian</surname><given-names>B</given-names></name>, <name><surname>Dimassa</surname><given-names>G</given-names></name>, <year>2009</year>. <article-title>Methemoglobinemia and sulfhemoglobinemia in two pediatric patients after ingestion of hydroxylamine sulfate</article-title>. <source>West. J. Emerg. Med</source>
<volume>10</volume>, <fpage>197</fpage>&#x02013;<lpage>201</lpage>.<pub-id pub-id-type="pmid">19718385</pub-id></mixed-citation></ref><ref id="R87"><mixed-citation publication-type="journal"><name><surname>Glass</surname><given-names>DC</given-names></name>, <year>1990</year>. <article-title>A review of the health effects of hydrogen sulphide exposure</article-title>. <source>Ann. Occup. Hyg</source>
<volume>34</volume>, <fpage>323</fpage>.<pub-id pub-id-type="pmid">2196846</pub-id></mixed-citation></ref><ref id="R88"><mixed-citation publication-type="journal"><name><surname>G&#x000f6;tschi</surname><given-names>T</given-names></name>, <name><surname>Heinrich</surname><given-names>J</given-names></name>, <name><surname>Sunyer</surname><given-names>J</given-names></name>, <name><surname>K&#x000fc;nzli</surname><given-names>N</given-names></name>, <year>2008</year>. <article-title>Long-term effects of ambient air pollution on lung function: A review</article-title>. <source>Epidemiology</source>
<volume>19</volume>, <fpage>690</fpage>&#x02013;<lpage>701</lpage>.<pub-id pub-id-type="pmid">18703932</pub-id></mixed-citation></ref><ref id="R89"><mixed-citation publication-type="journal"><name><surname>Grant</surname><given-names>RH</given-names></name>, <name><surname>Boehm</surname><given-names>MT</given-names></name>, <name><surname>Lawrence</surname><given-names>AJ</given-names></name>, <name><surname>Heber</surname><given-names>AJ</given-names></name>, <year>2013</year>. <article-title>Hydrogen Sulfide Emissions from Sow Farm Lagoons across Climates Zones</article-title>. <source>J. Environ. Qual</source>
<volume>42</volume>, <fpage>1674</fpage>&#x02013;<lpage>1683</lpage>.<pub-id pub-id-type="pmid">25602408</pub-id></mixed-citation></ref><ref id="R90"><mixed-citation publication-type="journal"><name><surname>Greenbaum</surname><given-names>D</given-names></name>, <name><surname>Shaikh</surname><given-names>R</given-names></name>, <year>2010</year>. <article-title>First steps toward multipollutant science for air quality decisions</article-title>. <source>Epidemiology</source>
<volume>21</volume>, <fpage>195</fpage>&#x02013;<lpage>197</lpage>.<pub-id pub-id-type="pmid">20160562</pub-id></mixed-citation></ref><ref id="R91"><mixed-citation publication-type="journal"><name><surname>Guidotti</surname><given-names>T</given-names></name>, <year>2009</year>. <article-title>The western Canada study: Effective management of a high-profile study of risk</article-title>. <source>Arch. Environ. Occup. Heal</source>
<volume>64</volume>, <fpage>3</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="R92"><mixed-citation publication-type="journal"><name><surname>Guidotti</surname><given-names>TL</given-names></name>, <year>2010</year>. <article-title>Hydrogen sulfide: Advances in understanding human toxicity</article-title>. <source>Int. J. Toxicol</source>
<volume>29</volume>, <fpage>569</fpage>&#x02013;<lpage>581</lpage>.<pub-id pub-id-type="pmid">21076123</pub-id></mixed-citation></ref><ref id="R93"><mixed-citation publication-type="journal"><name><surname>Guidotti</surname><given-names>TL</given-names></name>, <year>1996</year>. <article-title>Hydrogen sulfide</article-title>. <source>Occup. Med</source>
<volume>46</volume>, <fpage>367</fpage>&#x02013;<lpage>371</lpage>.</mixed-citation></ref><ref id="R94"><mixed-citation publication-type="journal"><name><surname>Haahtela</surname><given-names>T</given-names></name>, <name><surname>Marttila</surname><given-names>O</given-names></name>, <name><surname>Vikka</surname><given-names>V</given-names></name>, <name><surname>Jappinen</surname><given-names>P</given-names></name>, <name><surname>Jaakkola</surname><given-names>JJK</given-names></name>, <year>1992</year>. <article-title>The South Karelia air pollution study: Acute health effects of malodorous sulfur air pollutants released by a pulp mill</article-title>. <source>Am. J. Public Health</source>
<volume>82</volume>, <fpage>603</fpage>&#x02013;<lpage>605</lpage>.<pub-id pub-id-type="pmid">1546787</pub-id></mixed-citation></ref><ref id="R95"><mixed-citation publication-type="journal"><name><surname>Haider</surname><given-names>SS</given-names></name>, <name><surname>Hasan</surname><given-names>M</given-names></name>, <name><surname>Islam</surname><given-names>F</given-names></name>, <year>1980</year>. <article-title>Effect of air pollutant hydrogen sulfide on the levels of total lipids, phospholipids &#x00026; cholesterol in different regions of the guineapig brain</article-title>. <source>Indian J. Exp. Biol</source>
<volume>18</volume>, <fpage>418</fpage>&#x02013;<lpage>420</lpage>.<pub-id pub-id-type="pmid">7399614</pub-id></mixed-citation></ref><ref id="R96"><mixed-citation publication-type="book"><name><surname>H&#x000e4;kkinen</surname><given-names>AJ</given-names></name>, <name><surname>Jokinen</surname><given-names>J</given-names></name>, <name><surname>Kauppinen</surname><given-names>H</given-names></name>, <year>1985</year>. <source>Imatran ilman rikkidioksidin ja keskeisten hajurikkiyhdisteiden pitoisuustasot sek&#x000e4; alueen havupuuvauriot. Ilmatieteen laitos. [Concentration levels of sulfur dioxide and main odorous sulfur compounds in Imatra, and damage to the coniferous trees of the area]</source>
<publisher-loc>Helsinki, Finland</publisher-loc>: <publisher-name>Meteorological Institute</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://en.ilmatieteenlaitos.fi/" ext-link-type="uri">https://en.ilmatieteenlaitos.fi/</ext-link>.</comment></mixed-citation></ref><ref id="R97"><mixed-citation publication-type="journal"><name><surname>Hansell</surname><given-names>A</given-names></name>, <name><surname>Oppenheimer</surname><given-names>C</given-names></name>, <year>2004</year>. <article-title>Health Hazards from Volcanic Gases: A Systematic Literature Review</article-title>. <source>Arch. Environ. Health</source>
<volume>59</volume>, <fpage>628</fpage>&#x02013;<lpage>639</lpage>.<pub-id pub-id-type="pmid">16789471</pub-id></mixed-citation></ref><ref id="R98"><mixed-citation publication-type="journal"><name><surname>Hayden</surname><given-names>LJ</given-names></name>, <name><surname>Goeden</surname><given-names>H</given-names></name>, <name><surname>Roth</surname><given-names>SH</given-names></name>, <year>1990</year>. <article-title>Growth and development in the rat during sub-chronic exposure to low levels of hydrogen sulfide</article-title>. <source>Toxicol. Ind. Health</source>
<volume>6</volume>, <fpage>389</fpage>&#x02013;<lpage>401</lpage>.<pub-id pub-id-type="pmid">2237925</pub-id></mixed-citation></ref><ref id="R99"><mixed-citation publication-type="journal"><name><surname>Heaney</surname><given-names>CD</given-names></name>, <name><surname>Wing</surname><given-names>S</given-names></name>, <name><surname>Campbell</surname><given-names>RL</given-names></name>, <name><surname>Caldwell</surname><given-names>D</given-names></name>, <name><surname>Hopkins</surname><given-names>B</given-names></name>, <name><surname>Richardson</surname><given-names>D</given-names></name>, <name><surname>Yeatts</surname><given-names>K</given-names></name>, <year>2011</year>. <article-title>Relation between malodor, ambient hydrogen sulfide, and health in a community bordering a landfill</article-title>. <source>Environ. Res</source>
<volume>111</volume>, <fpage>847</fpage>&#x02013;<lpage>852</lpage>.<pub-id pub-id-type="pmid">21679938</pub-id></mixed-citation></ref><ref id="R100"><mixed-citation publication-type="journal"><name><surname>Heederik</surname><given-names>D</given-names></name>, <name><surname>Sigsgaard</surname><given-names>T</given-names></name>, <name><surname>Thorne</surname><given-names>PS</given-names></name>, <name><surname>Kline</surname><given-names>JN</given-names></name>, <name><surname>Avery</surname><given-names>R</given-names></name>, <name><surname>B&#x000f8;nl&#x000f8;kke</surname><given-names>JH</given-names></name>, <name><surname>Chrischilles</surname><given-names>EA</given-names></name>, <name><surname>Dosman</surname><given-names>JA</given-names></name>, <name><surname>Duchaine</surname><given-names>C</given-names></name>, <name><surname>Kirkhorn</surname><given-names>SR</given-names></name>, <name><surname>Kulhankova</surname><given-names>K</given-names></name>, <name><surname>Merchant</surname><given-names>JA</given-names></name>, <year>2007</year>. <article-title>Health effects of airborne exposures from concentrated animal feeding operations</article-title>. <source>Environ. Health Perspect</source>
<volume>115</volume>, <fpage>298</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="pmid">17384782</pub-id></mixed-citation></ref><ref id="R101"><mixed-citation publication-type="journal"><name><surname>Heldal</surname><given-names>KK</given-names></name>, <name><surname>Austigard</surname><given-names>&#x000c5;D</given-names></name>, <name><surname>Svendsen</surname><given-names>KH</given-names></name>, <name><surname>Einarsdottir</surname><given-names>E</given-names></name>, <name><surname>Goffeng</surname><given-names>LO</given-names></name>, <name><surname>Sikkeland</surname><given-names>LI</given-names></name>, <name><surname>Nordby</surname><given-names>KC</given-names></name>, <year>2019</year>. <article-title>Endotoxin and Hydrogen Sulphide Exposure and Effects on the Airways among Waste Water Workers in Sewage Treatment Plants and Sewer Net System</article-title>. <source>Ann. Work Expo. Heal</source>
<volume>63</volume>, <fpage>437</fpage>&#x02013;<lpage>447</lpage>.</mixed-citation></ref><ref id="R102"><mixed-citation publication-type="journal"><name><surname>Higashi</surname><given-names>TM</given-names></name>, <name><surname>Kazuyuki</surname><given-names>T</given-names></name>, <name><surname>Toyama</surname><given-names>N</given-names></name>, <name><surname>Sakurai</surname><given-names>HT</given-names></name>, <name><surname>Medicine</surname><given-names>P</given-names></name>, <name><surname>Health</surname><given-names>P</given-names></name>, <name><surname>August</surname><given-names>R</given-names></name>, <year>1983</year>. <source>School of Medicine, Keio University</source>, <volume>35</volume>
<fpage>281</fpage>&#x02013;<lpage>292</lpage>.</mixed-citation></ref><ref id="R103"><mixed-citation publication-type="journal"><name><surname>Hirsch</surname><given-names>AR</given-names></name>, <year>2002</year>. <article-title>Hydrogen sulfide exposure without loss of consciousness: Chronic effects in four cases</article-title>. <source>Toxicol. Ind. Health</source>
<volume>18</volume>, <fpage>51</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">12868793</pub-id></mixed-citation></ref><ref id="R104"><mixed-citation publication-type="journal"><name><surname>Ho</surname><given-names>C-FH</given-names></name>, <name><surname>Jolis</surname><given-names>D</given-names></name>, <name><surname>Tansel</surname><given-names>B</given-names></name>, <year>2008</year>. <article-title>Gaseous Emissions from Wastewater Facilities</article-title>. <source>Water Environ. Res</source>
<volume>80</volume>, <fpage>1262</fpage>&#x02013;<lpage>1280</lpage>.</mixed-citation></ref><ref id="R105"><mixed-citation publication-type="book"><name><surname>Horton</surname><given-names>R</given-names></name>, <year>2007</year>. <source>Malodor from industrial hog operations, stress, negative mood, and secretory immune function nearby residents</source>
<publisher-loc>Chapel Hill, NC</publisher-loc>: <publisher-name>University of North Carolina-Chapel Hill</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://core.ac.uk/reader/210598950" ext-link-type="uri">https://core.ac.uk/reader/210598950</ext-link>.</comment></mixed-citation></ref><ref id="R106"><mixed-citation publication-type="journal"><name><surname>Horton</surname><given-names>RA</given-names></name>, <name><surname>Wing</surname><given-names>S</given-names></name>, <name><surname>Marshall</surname><given-names>SW</given-names></name>, <name><surname>Brownley</surname><given-names>KA</given-names></name>, <year>2009</year>. <article-title>Malodor as a trigger of stress and negative mood in neighbors of industrial hog operations</article-title>. <source>Am. J. Public Health</source>
<volume>99</volume> Suppl <issue>3</issue>, <fpage>610</fpage>&#x02013;<lpage>615</lpage>.</mixed-citation></ref><ref id="R107"><mixed-citation publication-type="journal"><name><surname>Horwell</surname><given-names>CJ</given-names></name>, <name><surname>Patterson</surname><given-names>JE</given-names></name>, <name><surname>Gamble</surname><given-names>JA</given-names></name>, <name><surname>Allen</surname><given-names>AG</given-names></name>, <year>2005</year>. <article-title>Monitoring and mapping of hydrogen sulphide emissions across an active geothermal field: Rotorua, New Zealand</article-title>. <source>J. Volcanol. Geotherm. Res</source>
<volume>139</volume>, <fpage>259</fpage>&#x02013;<lpage>269</lpage>.</mixed-citation></ref><ref id="R108"><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>YL</given-names></name>, <name><surname>Batterman</surname><given-names>S</given-names></name>, <year>2000</year>. <article-title>Residence location as a measure of environmental exposure: A review of air pollution epidemiology studies</article-title>. <source>J. Expo. Anal. Environ. Epidemiol</source>
<volume>10</volume>, <fpage>66</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">10703849</pub-id></mixed-citation></ref><ref id="R109"><mixed-citation publication-type="journal"><name><surname>Inserra</surname><given-names>S</given-names></name>, <name><surname>Phifer</surname><given-names>B</given-names></name>, <name><surname>Pierson</surname><given-names>R</given-names></name>, <name><surname>Campagna</surname><given-names>D</given-names></name>, <year>2002</year>. <article-title>Community-based exposure estimate for hydrogen sulfide</article-title>. <source>J. Expo. Anal. Environ. Epidemiol</source>
<volume>12</volume>, <fpage>124</fpage>&#x02013;<lpage>129</lpage>.<pub-id pub-id-type="pmid">11965529</pub-id></mixed-citation></ref><ref id="R110"><mixed-citation publication-type="journal"><name><surname>Inserra</surname><given-names>SG</given-names></name>, <name><surname>Phifer</surname><given-names>BL</given-names></name>, <name><surname>Anger</surname><given-names>WK</given-names></name>, <name><surname>Lewin</surname><given-names>M</given-names></name>, <name><surname>Hilsdon</surname><given-names>R</given-names></name>, <name><surname>White</surname><given-names>MC</given-names></name>, <year>2004</year>. <article-title>Neurobehavioral evaluation for a community with chronic exposure to hydrogen sulfide gas</article-title>. <source>Environ. Res</source>
<volume>95</volume>, <fpage>53</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">15068930</pub-id></mixed-citation></ref><ref id="R111"><mixed-citation publication-type="journal"><name><surname>Jaakkola</surname><given-names>JJ</given-names></name>, <name><surname>Vilkka</surname><given-names>V</given-names></name>, <name><surname>Marttila</surname><given-names>O</given-names></name>, <name><surname>J&#x000e4;ppinen</surname><given-names>P</given-names></name>, <name><surname>Haahtela</surname><given-names>T</given-names></name>, <year>1990</year>. <article-title>The South Karelia Air Pollution Study: the effects of malodorous sulfur compounds from pulp mills on respiratory and other symptoms</article-title>. <source>Am. Rev. Resp. Dis</source>
<volume>142</volume>, <fpage>1344</fpage>&#x02013;<lpage>1350</lpage>.<pub-id pub-id-type="pmid">2252252</pub-id></mixed-citation></ref><ref id="R112"><mixed-citation publication-type="journal"><name><surname>Jappinen</surname><given-names>P</given-names></name>, <name><surname>Vilkka</surname><given-names>V</given-names></name>, <name><surname>Marttila</surname><given-names>O</given-names></name>, <name><surname>Haahtela</surname><given-names>T</given-names></name>, <year>1990</year>. <article-title>Exposure to hydrogen sulphide and respiratory function</article-title>. <source>Br. J. Ind. Med</source>
<volume>47</volume>, <fpage>824</fpage>&#x02013;<lpage>828</lpage>.<pub-id pub-id-type="pmid">2271389</pub-id></mixed-citation></ref><ref id="R113"><mixed-citation publication-type="journal"><name><surname>Kangas</surname><given-names>J</given-names></name>, <name><surname>J&#x000e4;ppinen</surname><given-names>P</given-names></name>, <name><surname>Savolainen</surname><given-names>H</given-names></name>, <year>1984</year>. <article-title>Exposure to hydrogen sulphide, mercaptans and sulphur dioxide in pulp industry</article-title>. <source>Am. Ind. Hyg. Assoc. J</source>
<volume>45</volume>, <fpage>787</fpage>&#x02013;<lpage>790</lpage>.<pub-id pub-id-type="pmid">6517022</pub-id></mixed-citation></ref><ref id="R114"><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>AA</given-names></name>, <name><surname>Yong</surname><given-names>S</given-names></name>, <name><surname>Prior</surname><given-names>MG</given-names></name>, <name><surname>Lillie</surname><given-names>LE</given-names></name>, <year>1991</year>. <article-title>Cytotoxic effects of hydrogen sulfide on pulmonary alveolar macrophages in rats</article-title>. <source>J. Toxicol. Environ. Health</source>
<volume>33</volume>, <fpage>57</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">2033644</pub-id></mixed-citation></ref><ref id="R115"><mixed-citation publication-type="journal"><name><surname>Kilburn</surname><given-names>KH</given-names></name>, <year>2012</year>. <article-title>Human impairment from living near confined animal (Hog) feeding operations</article-title>. <source>J. Environ. Public Health</source>
<volume>2012</volume>, <fpage>565690</fpage>.<pub-id pub-id-type="pmid">22496706</pub-id></mixed-citation></ref><ref id="R116"><mixed-citation publication-type="journal"><name><surname>Kilburn</surname><given-names>KH</given-names></name>, <year>2003</year>. <article-title>Effects of hydrogen sulfide on neurobehavioral function</article-title>. <source>South. Med. J</source>
<volume>96</volume>, <fpage>639</fpage>&#x02013;<lpage>646</lpage>.<pub-id pub-id-type="pmid">12940311</pub-id></mixed-citation></ref><ref id="R117"><mixed-citation publication-type="journal"><name><surname>Kilburn</surname><given-names>KH</given-names></name>, <year>1999</year>. <article-title>Evaluating health effects from exposure to hydrogen sulfide: central nervous system dysfunction</article-title>. <source>Environ. Epidemiol. Toxicol</source>
<volume>1</volume>, <fpage>207</fpage>&#x02013;<lpage>216</lpage>.</mixed-citation></ref><ref id="R118"><mixed-citation publication-type="journal"><name><surname>Kilburn</surname><given-names>KH</given-names></name>, <year>1997</year>. <article-title>Exposure to reduced sulfur gases impairs neurobehavioral function</article-title>. <source>South. Med. J</source>
<volume>90</volume>, <fpage>997</fpage>&#x02013;<lpage>1006</lpage>.<pub-id pub-id-type="pmid">9347810</pub-id></mixed-citation></ref><ref id="R119"><mixed-citation publication-type="journal"><name><surname>Kilburn</surname><given-names>KH</given-names></name>, <year>1993</year>. <article-title>Case report: profound neurobehavioral deficit in an oil field worker overcome by hydrogen sulfide</article-title>. <source>Am. J. Med. Sci</source>
<volume>306</volume>, <fpage>301</fpage>&#x02013;<lpage>305</lpage>.<pub-id pub-id-type="pmid">8238084</pub-id></mixed-citation></ref><ref id="R120"><mixed-citation publication-type="journal"><name><surname>Kilburn</surname><given-names>KH</given-names></name>, <name><surname>Thrasher</surname><given-names>JD</given-names></name>, <name><surname>Gray</surname><given-names>MR</given-names></name>, <year>2010</year>. <article-title>Low-level hydrogen sulfide and central nervous system dysfunction</article-title>. <source>Toxicol. Ind. Health</source>
<volume>26</volume>, <fpage>387</fpage>&#x02013;<lpage>405</lpage>.<pub-id pub-id-type="pmid">20504829</pub-id></mixed-citation></ref><ref id="R121"><mixed-citation publication-type="journal"><name><surname>Kilburn</surname><given-names>KH</given-names></name>, <name><surname>Warshaw</surname><given-names>RH</given-names></name>, <year>1995</year>. <article-title>Hydrogen sulfide and reduced-sulfur gases adversely affect neurophysiological functions</article-title>. <source>Toxicol. Ind. Health</source>
<volume>11</volume>, <fpage>185</fpage>&#x02013;<lpage>197</lpage>.<pub-id pub-id-type="pmid">7491634</pub-id></mixed-citation></ref><ref id="R122"><mixed-citation publication-type="journal"><name><surname>Kioumourtzoglou</surname><given-names>MA</given-names></name>, <name><surname>Spiegelman</surname><given-names>D</given-names></name>, <name><surname>Szpiro</surname><given-names>AA</given-names></name>, <name><surname>Sheppard</surname><given-names>L</given-names></name>, <name><surname>Kaufman</surname><given-names>JD</given-names></name>, <name><surname>Yanosky</surname><given-names>JD</given-names></name>, <name><surname>Williams</surname><given-names>R</given-names></name>, <name><surname>Laden</surname><given-names>F</given-names></name>, <name><surname>Hong</surname><given-names>B</given-names></name>, <name><surname>Suh</surname><given-names>H</given-names></name>, <year>2014</year>. <article-title>Exposure measurement error in PM2.5 health effects studies: A pooled analysis of eight personal exposure validation studies</article-title>. <source>Environ. Heal. A Glob. Access Sci. Source</source>
<volume>13</volume>, <fpage>1</fpage>&#x02013;<lpage>11</lpage>.</mixed-citation></ref><ref id="R123"><mixed-citation publication-type="journal"><name><surname>Knight</surname><given-names>LD</given-names></name>, <name><surname>Presnell</surname><given-names>SE</given-names></name>, <year>2005</year>. <article-title>Death by sewer gas: Case report of a double fatality and review of the literature</article-title>. <source>Am. J. Forensic Med. Pathol</source>
<volume>26</volume>, <fpage>181</fpage>&#x02013;<lpage>185</lpage>.<pub-id pub-id-type="pmid">15894856</pub-id></mixed-citation></ref><ref id="R124"><mixed-citation publication-type="journal"><name><surname>Ko</surname><given-names>JH</given-names></name>, <name><surname>Xu</surname><given-names>Q</given-names></name>, <name><surname>Jang</surname><given-names>YC</given-names></name>, <year>2015</year>. <article-title>Emissions and Control of Hydrogen Sulfide at Landfills: A Review</article-title>. <source>Crit. Rev. Environ. Sci. Technol</source>
<volume>45</volume>, <fpage>2043</fpage>&#x02013;<lpage>2083</lpage>.</mixed-citation></ref><ref id="R125"><mixed-citation publication-type="journal"><name><surname>Korhonen</surname><given-names>K</given-names></name>, <name><surname>Liukkonen</surname><given-names>T</given-names></name>, <name><surname>Ahrens</surname><given-names>W</given-names></name>, <name><surname>Astrakianakis</surname><given-names>G</given-names></name>, <name><surname>Boffetta</surname><given-names>P</given-names></name>, <name><surname>Burdorf</surname><given-names>A</given-names></name>, <name><surname>Heederik</surname><given-names>D</given-names></name>, <name><surname>Kauppinen</surname><given-names>T</given-names></name>, <name><surname>Kogevinas</surname><given-names>M</given-names></name>, <name><surname>Osvoll</surname><given-names>P</given-names></name>, <name><surname>Rix</surname><given-names>BA</given-names></name>, <name><surname>Saalo</surname><given-names>A</given-names></name>, <name><surname>Sunyer</surname><given-names>J</given-names></name>, <name><surname>Szadkowska-Stanczyk</surname><given-names>I</given-names></name>, <name><surname>Teschke</surname><given-names>K</given-names></name>, <name><surname>Westberg</surname><given-names>H</given-names></name>, <name><surname>Widerkiewicz</surname><given-names>K</given-names></name>, <year>2004</year>. <article-title>Occupational exposure to chemical agents in the paper industry</article-title>. <source>Int. Arch. Occup. Environ. Health</source>
<volume>77</volume>, <fpage>451</fpage>&#x02013;<lpage>460</lpage>.<pub-id pub-id-type="pmid">15368059</pub-id></mixed-citation></ref><ref id="R126"><mixed-citation publication-type="journal"><name><surname>Kristbjornsdottir</surname><given-names>A</given-names></name>, <name><surname>Rafnsson</surname><given-names>V</given-names></name>, <year>2012</year>. <article-title>Incidence of cancer among residents of high temperature geothermal areas in Iceland: A census based study 1981 to 2010</article-title>. <source>Environ. Heal. A Glob. Access Sci. Source</source>
<volume>11</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage>.</mixed-citation></ref><ref id="R127"><mixed-citation publication-type="journal"><name><surname>Kumar</surname><given-names>S</given-names></name>, <year>2011</year>. <article-title>Occupational, environmental and lifestyle factors associated with spontaneous abortion</article-title>. <source>Reprod. Sci</source>
<volume>18</volume>, <fpage>915</fpage>&#x02013;<lpage>930</lpage>.<pub-id pub-id-type="pmid">21960507</pub-id></mixed-citation></ref><ref id="R128"><mixed-citation publication-type="journal"><name><surname>Kurzban</surname><given-names>GP</given-names></name>, <name><surname>Chu</surname><given-names>L</given-names></name>, <name><surname>Ebersole</surname><given-names>JL</given-names></name>, <name><surname>Holt</surname><given-names>SC</given-names></name>, <year>1999</year>. <article-title>Sulfhemoglobin formation in human erythrocytes by cystalysin, an L-cysteine desulfhydrase from Treponema denticola</article-title>. <source>Oral Microbiol. Immunol</source>
<volume>14</volume>, <fpage>153</fpage>&#x02013;<lpage>164</lpage>.<pub-id pub-id-type="pmid">10495709</pub-id></mixed-citation></ref><ref id="R129"><mixed-citation publication-type="journal"><name><surname>Lambert</surname><given-names>TW</given-names></name>, <name><surname>Goodwin</surname><given-names>VM</given-names></name>, <name><surname>Stefani</surname><given-names>D</given-names></name>, <name><surname>Strosher</surname><given-names>L</given-names></name>, <year>2006</year>. <article-title>Hydrogen sulfide (H2S) and sour gas effects on the eye. A historical perspective</article-title>. <source>Sci. Total Environ</source>
<volume>367</volume>, <fpage>1</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">16650463</pub-id></mixed-citation></ref><ref id="R130"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>JA</given-names></name>, <name><surname>Thorne</surname><given-names>PS</given-names></name>, <name><surname>Reynolds</surname><given-names>SJ</given-names></name>, <name><surname>O&#x02019;Shaughnessy</surname><given-names>PT</given-names></name>, <year>2007</year>. <article-title>Monitoring risks in association with exposure levels among wastewater treatment plant workers</article-title>. <source>J. Occup. Environ. Med</source>
<volume>49</volume>, <fpage>1235</fpage>&#x02013;<lpage>1248</lpage>.<pub-id pub-id-type="pmid">17993928</pub-id></mixed-citation></ref><ref id="R131"><mixed-citation publication-type="journal"><name><surname>Legator</surname><given-names>MS</given-names></name>, <name><surname>Morris</surname><given-names>DL</given-names></name>, <name><surname>Philips</surname><given-names>DL</given-names></name>, <name><surname>Singleton</surname><given-names>CR</given-names></name>, <year>2001</year>. <article-title>Health Effects from Chronic Low-Level Exposure to Hydrogen Sulfide</article-title>. <source>Arch. Environ. Health</source>
<volume>56</volume>, <fpage>123</fpage>&#x02013;<lpage>131</lpage>.<pub-id pub-id-type="pmid">11339675</pub-id></mixed-citation></ref><ref id="R132"><mixed-citation publication-type="journal"><name><surname>Leifer</surname><given-names>I</given-names></name>, <name><surname>Melton</surname><given-names>C</given-names></name>, <name><surname>Tratt</surname><given-names>DM</given-names></name>, <name><surname>Buckland</surname><given-names>KN</given-names></name>, <name><surname>Chang</surname><given-names>CS</given-names></name>, <name><surname>Clarisse</surname><given-names>L</given-names></name>, <name><surname>Franklin</surname><given-names>M</given-names></name>, <name><surname>Hall</surname><given-names>JL</given-names></name>, <name><surname>Brian Leen</surname><given-names>J</given-names></name>, <name><surname>Lundquist</surname><given-names>T</given-names></name>, <name><surname>Van Damme</surname><given-names>M</given-names></name>, <name><surname>Vigil</surname><given-names>S</given-names></name>, <name><surname>Whitburn</surname><given-names>S</given-names></name>, <year>2020</year>. <article-title>Estimating exposure to hydrogen sulfide from animal husbandry operations using satellite ammonia as a proxy: Methodology demonstration</article-title>. <source>Sci. Total Environ</source>
<volume>709</volume>, <fpage>134508</fpage>.<pub-id pub-id-type="pmid">31927425</pub-id></mixed-citation></ref><ref id="R133"><mixed-citation publication-type="journal"><name><surname>Lewis</surname><given-names>RJ</given-names></name>, <name><surname>Schnatter</surname><given-names>AR</given-names></name>, <name><surname>Drummond</surname><given-names>I</given-names></name>, <name><surname>Murray</surname><given-names>N</given-names></name>, <name><surname>Thompson</surname><given-names>FS</given-names></name>, <name><surname>Katz</surname><given-names>AM</given-names></name>, <name><surname>Jorgensen</surname><given-names>G</given-names></name>, <name><surname>Nicolich</surname><given-names>MJ</given-names></name>, <name><surname>Dahlman</surname><given-names>D</given-names></name>, <name><surname>Theriault</surname><given-names>G</given-names></name>, <year>2003</year>. <article-title>Mortality and cancer morbidity in a cohort of Canadian petroleum workers</article-title>. <source>Occup. Environ. Med</source>
<volume>60</volume>, <fpage>918</fpage>&#x02013;<lpage>929</lpage>.<pub-id pub-id-type="pmid">14634182</pub-id></mixed-citation></ref><ref id="R134"><mixed-citation publication-type="journal"><name><surname>Lewis</surname><given-names>RJ</given-names></name>, <name><surname>Copley</surname><given-names>GB</given-names></name>, <year>2015</year>. <article-title>Chronic low-level hydrogen sulfide exposure and potential effects on human health: A review of the epidemiological evidence</article-title>. <source>Crit. Rev. Toxicol</source>
<volume>45</volume>, <fpage>93</fpage>&#x02013;<lpage>123</lpage>.<pub-id pub-id-type="pmid">25430508</pub-id></mixed-citation></ref><ref id="R135"><mixed-citation publication-type="journal"><name><surname>Lewkowska</surname><given-names>P</given-names></name>, <name><surname>Cie&#x0015b;lik</surname><given-names>B</given-names></name>, <name><surname>Dymerski</surname><given-names>T</given-names></name>, <name><surname>Konieczka</surname><given-names>P</given-names></name>, <name><surname>Namie&#x0015b;nik</surname><given-names>J</given-names></name>, <year>2016</year>. <article-title>Characteristics of odors emitted from municipal wastewater treatment plant and methods for their identification and deodorization techniques</article-title>. <source>Environ. Res</source>
<volume>151</volume>, <fpage>573</fpage>&#x02013;<lpage>586</lpage>.<pub-id pub-id-type="pmid">27591529</pub-id></mixed-citation></ref><ref id="R136"><mixed-citation publication-type="journal"><name><surname>Lim</surname><given-names>E</given-names></name>, <name><surname>Mbowe</surname><given-names>O</given-names></name>, <name><surname>Lee</surname><given-names>ASW</given-names></name>, <name><surname>Davis</surname><given-names>J</given-names></name>, <year>2016</year>. <article-title>Effect of environmental exposure to hydrogen sulfide on central nervous system and respiratory function: a systematic review of human studies</article-title>. <source>Int. J. Occup. Environ. Health</source>
<volume>22</volume>, <fpage>80</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">27128692</pub-id></mixed-citation></ref><ref id="R137"><mixed-citation publication-type="journal"><name><surname>Lindvall</surname><given-names>T</given-names></name>, <year>1970</year>. <article-title>On sensory evaluation of odorous air pollutant intensities. Measurements of odor intensity in the laboratory and in the field, with special reference to effluents of sulfate pulp factories</article-title>. <source>Nord. Hyg. Tidskr</source>
<volume>51</volume>, <fpage>36</fpage>&#x02013;<lpage>39</lpage>.</mixed-citation></ref><ref id="R138"><mixed-citation publication-type="journal"><name><surname>Lipfert</surname><given-names>FW</given-names></name>, <name><surname>Wyzga</surname><given-names>RE</given-names></name>, <year>2008</year>. <article-title>On exposure and response relationships for health effects associated with exposure to vehicular traffic</article-title>. <source>J. Expo. Sci. Environ. Epidemiol</source>
<volume>18</volume>, <fpage>588</fpage>&#x02013;<lpage>599</lpage>.<pub-id pub-id-type="pmid">18322450</pub-id></mixed-citation></ref><ref id="R139"><mixed-citation publication-type="book"><name><surname>Lococo</surname><given-names>KH</given-names></name>, <name><surname>Staplin</surname><given-names>L</given-names></name>, <name><surname>Schultz</surname><given-names>MW</given-names></name>, <year>2018</year>. <source>The effects of medical conditions on driving performance: A literature review and synthesis</source>
<comment>Report No. DOT HS 812 526.</comment>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Highway Traffic Safety Administration</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://rosap.ntl.bts.gov/view/dot/38687" ext-link-type="uri">https://rosap.ntl.bts.gov/view/dot/38687</ext-link>.</comment></mixed-citation></ref><ref id="R140"><mixed-citation publication-type="journal"><name><surname>Logue</surname><given-names>JN</given-names></name>, <name><surname>Ramaswamy</surname><given-names>K</given-names></name>, <name><surname>Hersh</surname><given-names>JH</given-names></name>, <year>2001</year>. <article-title>Investigation of illness associated with exposure to hydrogen sulfide among Pennsylvania school students</article-title>. <source>J. Environ. Heal</source>
<volume>63</volume>, <fpage>9</fpage>&#x02013;<lpage>13</lpage>.</mixed-citation></ref><ref id="R141"><mixed-citation publication-type="book"><name><surname>Lusk</surname><given-names>JD</given-names></name>, <name><surname>Kraft</surname><given-names>WA</given-names></name>, <year>2010</year>. <source>Hydrogen Sulfide Monitoring Near Oil and Gas Production Facilities in Southeastern New Mexico and Potential Effects of Hydrogen Sulfide to Migratory Birds and Other Wildlife</source>
<publisher-loc>Albuquerque NM</publisher-loc>: <publisher-name>U.S. Fish &#x00026; Wildlife Service, New Mexico Ecological Services and Field Offices. Project identifier FFS</publisher-name>
<volume>2</volume>, <fpage>F41</fpage>&#x02013;<lpage>200220006</lpage>.</mixed-citation></ref><ref id="R142"><mixed-citation publication-type="book"><name><surname>Ma</surname><given-names>X</given-names></name>, <name><surname>Zheng</surname><given-names>G</given-names></name>, <name><surname>Liang</surname><given-names>M</given-names></name>, <name><surname>Xie</surname><given-names>D</given-names></name>, <name><surname>Martinelli</surname><given-names>G</given-names></name>, <name><surname>Sajjad</surname><given-names>W</given-names></name>, <name><surname>Xu</surname><given-names>W</given-names></name>, <name><surname>Fan</surname><given-names>Q</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Du</surname><given-names>L</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <year>2019</year>. <source>Occurrence and origin of H<sub>2</sub>S from volcanic reservoirs in niudong area of the Santanghu Basin, NW China.</source>
<publisher-name>Geofluids</publisher-name>
<comment>2019</comment>.</mixed-citation></ref><ref id="R143"><mixed-citation publication-type="book"><name><surname>MacEwen</surname><given-names>JD</given-names></name>, <name><surname>Vernot</surname><given-names>EH</given-names></name>, <year>1972</year>. <source>Toxic Hazards Research Unit Annual Technical Report: 1972. AMRL-TR-72-62</source>
<publisher-loc>Wright-Patterson AFB, OH</publisher-loc>: <publisher-name>Aerospace Medical Research Laboratory</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://apps.dtic.mil/sti/citations/AD0755358" ext-link-type="uri">https://apps.dtic.mil/sti/citations/AD0755358</ext-link>.</comment></mixed-citation></ref><ref id="R144"><mixed-citation publication-type="journal"><name><surname>Marttila</surname><given-names>O</given-names></name>, <name><surname>Jaakkola</surname><given-names>JJK</given-names></name>, <name><surname>Partti-Pellinen</surname><given-names>K</given-names></name>, <name><surname>Vilkka</surname><given-names>V</given-names></name>, <name><surname>Haahtela</surname><given-names>T</given-names></name>, <year>1995</year>. <article-title>South Karelia air pollution study: Daily symptom intensity in relation to exposure levels of malodorous sulfur compounds from pulp mills</article-title>. <source>Environ. Res</source>
<volume>71</volume>, <fpage>122</fpage>&#x02013;<lpage>127</lpage>.<pub-id pub-id-type="pmid">8977620</pub-id></mixed-citation></ref><ref id="R145"><mixed-citation publication-type="journal"><name><surname>Marttila</surname><given-names>O</given-names></name>, <name><surname>Jaakkola</surname><given-names>JJK</given-names></name>, <name><surname>Vilkka</surname><given-names>V</given-names></name>, <name><surname>J&#x000e4;ppinen</surname><given-names>P</given-names></name>, <name><surname>Haahtela</surname><given-names>T</given-names></name>, <year>1994</year>. <article-title>The south karelia air pollution study: The effects of malodorous sulfur compounds from pulp mills on respiratory and other symptoms in children</article-title>. <source>Environ. Res</source>
<volume>66</volume>, <fpage>152</fpage>&#x02013;<lpage>159</lpage>.<pub-id pub-id-type="pmid">8055837</pub-id></mixed-citation></ref><ref id="R146"><mixed-citation publication-type="journal"><name><surname>Mauderly</surname><given-names>JL</given-names></name>, <name><surname>Burnett</surname><given-names>RT</given-names></name>, <name><surname>Castillejos</surname><given-names>M</given-names></name>, <name><surname>&#x000d6;zkaynak</surname><given-names>H</given-names></name>, <name><surname>Samet</surname><given-names>JM</given-names></name>, <name><surname>Stieb</surname><given-names>DM</given-names></name>, <name><surname>Vedal</surname><given-names>S</given-names></name>, <name><surname>Wyzga</surname><given-names>RE</given-names></name>, <year>2010</year>. <article-title>Is the air pollution health research community prepared to support a multipollutant air quality management framework</article-title>. <source>Inhal. Toxicol</source>
<volume>22</volume>, <fpage>1</fpage>&#x02013;<lpage>19</lpage>.</mixed-citation></ref><ref id="R147"><mixed-citation publication-type="webpage"><collab>MDHHS Michigan Department of Health and Human Services</collab>, <year>2023</year>. <source>Evaluation of Reduced Sulfur Compounds (RSCs) and Volatile Organic Compounds (VOCs) in Communities Near Graphic Packaging International, LLC. and Kalamazoo Water Reclamation Plant</source> [<comment>accessed</comment>
<date-in-citation>2023 May 31</date-in-citation>]. <comment><ext-link xlink:href="https://www.michigan.gov/mdhhs/-/media/Project/Websites/mdhhs/Safety-and-Injury-Prevention/Environmental-Health/Health-Assessments/Documents/Kalamazoo-Air-Quality-Health-Consultation.pdf" ext-link-type="uri">https://www.michigan.gov/mdhhs/-/media/Project/Websites/mdhhs/Safety-and-Injury-Prevention/Environmental-Health/Health-Assessments/Documents/Kalamazoo-Air-Quality-Health-Consultation.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R148"><mixed-citation publication-type="journal"><name><surname>Merchant</surname><given-names>JA</given-names></name>, <name><surname>Naleway</surname><given-names>AL</given-names></name>, <name><surname>Svendsen</surname><given-names>ER</given-names></name>, <name><surname>Kelly</surname><given-names>KM</given-names></name>, <name><surname>Burmeister</surname><given-names>LF</given-names></name>, <name><surname>Stromquist</surname><given-names>AM</given-names></name>, <name><surname>Taylor</surname><given-names>CD</given-names></name>, <name><surname>Thorne</surname><given-names>PS</given-names></name>, <name><surname>Reynolds</surname><given-names>SJ</given-names></name>, <name><surname>Sanderson</surname><given-names>WT</given-names></name>, <name><surname>Chrischilles</surname><given-names>EA</given-names></name>, <year>2005</year>. <article-title>Asthma and farm exposures in a cohort of rural Iowa children</article-title>. <source>Environ. Health Perspect</source>
<volume>113</volume>, <fpage>350</fpage>&#x02013;<lpage>356</lpage>.<pub-id pub-id-type="pmid">15743727</pub-id></mixed-citation></ref><ref id="R149"><mixed-citation publication-type="journal"><name><surname>Milby</surname><given-names>TH</given-names></name>, <name><surname>Baselt</surname><given-names>RC</given-names></name>, <year>1999</year>. <article-title>Hydrogen sulfide poisoning: Clarification of some controversial issues</article-title>. <source>Am. J. Ind. Med</source>
<volume>35</volume>, <fpage>192</fpage>&#x02013;<lpage>195</lpage>.<pub-id pub-id-type="pmid">9894543</pub-id></mixed-citation></ref><ref id="R150"><mixed-citation publication-type="journal"><name><surname>Mirabelli</surname><given-names>MC</given-names></name>, <name><surname>Wing</surname><given-names>S</given-names></name>, <year>2006</year>. <article-title>Proximity to pulp and paper mills and wheezing symptoms among adolescents in North Carolina</article-title>. <source>Environ. Res</source>
<volume>102</volume>, <fpage>96</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="pmid">16457803</pub-id></mixed-citation></ref><ref id="R151"><mixed-citation publication-type="journal"><name><surname>Mirabelli</surname><given-names>MC</given-names></name>, <name><surname>Wing</surname><given-names>S</given-names></name>, <name><surname>Marshall</surname><given-names>SW</given-names></name>, <name><surname>Wilcosky</surname><given-names>TC</given-names></name>, <year>2006a</year>. <article-title>Asthma symptoms among adolescents who attend public schools that are located near confined swine feeding operations</article-title>. <source>Pediatrics</source>
<volume>118</volume>, <fpage>66</fpage>&#x02013;<lpage>75</lpage>.</mixed-citation></ref><ref id="R152"><mixed-citation publication-type="journal"><name><surname>Mirabelli</surname><given-names>MC</given-names></name>, <name><surname>Wing</surname><given-names>S</given-names></name>, <name><surname>Marshall</surname><given-names>SW</given-names></name>, <name><surname>Wilcosky</surname><given-names>TC</given-names></name>, <year>2006b</year>. <article-title>Race, poverty, and potential exposure of middle-school students to air emissions from confined swine feeding operations</article-title>. <source>Environ. Health Perspect</source>
<volume>114</volume>, <fpage>591</fpage>&#x02013;<lpage>596</lpage>.<pub-id pub-id-type="pmid">16581551</pub-id></mixed-citation></ref><ref id="R153"><mixed-citation publication-type="journal"><name><surname>Morii</surname><given-names>D</given-names></name>, <name><surname>Miyagatani</surname><given-names>Y</given-names></name>, <name><surname>Nakamae</surname><given-names>N</given-names></name>, <name><surname>Murao</surname><given-names>M</given-names></name>, <name><surname>Taniyama</surname><given-names>K</given-names></name>, <year>2010</year>. <article-title>Japanese experience of hydrogen sulfide: The suicide craze in 2008</article-title>. <source>J. Occup. Med. Toxicol</source>
<volume>5</volume>, <fpage>2</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">20925908</pub-id></mixed-citation></ref><ref id="R154"><mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>J</given-names></name>, <year>1997</year>. <article-title>The Brimstone Battles; Lost Opportunity; EPA Had Its Chance to Regulate Hydrogen Sulfide</article-title>. <source>The Houston Chronicle</source>, <month>November</month>
<day>9</day>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="http://www.chron.com/chronicle/nationa/h2s/lostop.html" ext-link-type="uri">http://www.chron.com/chronicle/nationa/h2s/lostop.html</ext-link>.</comment></mixed-citation></ref><ref id="R155"><mixed-citation publication-type="journal"><name><surname>Mousa</surname><given-names>HAL</given-names></name>, <year>2015</year>. <article-title>Short-term effects of subchronic low-level hydrogen sulfide exposure on oil field workers</article-title>. <source>Environ. Health Prev. Med</source>
<volume>20</volume>, <fpage>12</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">25315268</pub-id></mixed-citation></ref><ref id="R156"><mixed-citation publication-type="book"><collab>NIOSH National Institute for Occupational Safety and Health</collab>, <year>1978</year>. <source>Occupational Health Guideline for Hydrogen Sulfide</source>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Institute for Occupational Safety and Health</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.cdc.gov/niosh/docs/81-123/pdfs/0337.pdf" ext-link-type="uri">https://www.cdc.gov/niosh/docs/81-123/pdfs/0337.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R157"><mixed-citation publication-type="journal"><name><surname>Niu</surname><given-names>ZG</given-names></name>, <name><surname>Xu</surname><given-names>SY</given-names></name>, <name><surname>Gong</surname><given-names>QC</given-names></name>, <year>2014</year>. <article-title>Health risk assessment of odors emitted from urban wastewater pump stations in Tianjin, China</article-title>. <source>Environ. Sci. Pollut. Res</source>
<volume>21</volume>, <fpage>10349</fpage>&#x02013;<lpage>10360</lpage>.</mixed-citation></ref><ref id="R158"><mixed-citation publication-type="book"><collab>NRC National Research Council</collab>, <year>2003</year>. <source>Air Emissions from Animal Feeding Operations: Current Knowledge, Future Needs</source>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>The National Academies Press</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://nap.nationalacademies.org/login.php?record_id=10586" ext-link-type="uri">https://nap.nationalacademies.org/login.php?record_id=10586</ext-link>.</comment></mixed-citation></ref><ref id="R159"><mixed-citation publication-type="book"><collab>NRC National Research Council</collab>, <year>2001</year>. <source>Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals</source>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>The National Academies Press</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://nap.nationalacademies.org/login.php?record_id=10122" ext-link-type="uri">https://nap.nationalacademies.org/login.php?record_id=10122</ext-link>.</comment></mixed-citation></ref><ref id="R160"><mixed-citation publication-type="book"><collab>NRC National Research Council</collab>, <year>1979</year>. <source>Odors from Stationary and Mobile Sources</source>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>The National Academies Press</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://nap.nationalacademies.org/login.php?record_id=19818" ext-link-type="uri">https://nap.nationalacademies.org/login.php?record_id=19818</ext-link>.</comment></mixed-citation></ref><ref id="R161"><mixed-citation publication-type="journal"><name><surname>Nunes</surname><given-names>MI</given-names></name>, <name><surname>Kalinowski</surname><given-names>C</given-names></name>, <name><surname>Godoi</surname><given-names>AFL</given-names></name>, <name><surname>Gomes</surname><given-names>AP</given-names></name>, <name><surname>Cerqueira</surname><given-names>M</given-names></name>, <year>2021</year>. <article-title>Hydrogen sulfide levels in the ambient air of municipal solid waste management facilities: A case study in Portugal</article-title>. <source>Case Stud. Chem. Environ. Eng</source>
<volume>4</volume>, <fpage>100152</fpage>.</mixed-citation></ref><ref id="R162"><mixed-citation publication-type="journal"><name><surname>Nuvolone</surname><given-names>D</given-names></name>, <name><surname>Petri</surname><given-names>D</given-names></name>, <name><surname>Pepe</surname><given-names>P</given-names></name>, <name><surname>Voller</surname><given-names>F</given-names></name>, <year>2019</year>. <article-title>Health effects associated with chronic exposure to low-level hydrogen sulfide from geothermoelectric power plants. A residential cohort study in the geothermal area of Mt. Amiata in Tuscany</article-title>. <source>Sci. Total Environ</source>
<volume>659</volume>, <fpage>973</fpage>&#x02013;<lpage>982</lpage>.<pub-id pub-id-type="pmid">31096427</pub-id></mixed-citation></ref><ref id="R163"><mixed-citation publication-type="book"><collab>OEHHA California Office of Environmental Health Hazard Assessment</collab>, <year>2008</year>. <source>Acute toxicity Summary: TSD for Noncancer RELs: Hydrogen Sulfide</source>
<publisher-loc>Sacramento, CA</publisher-loc>: <publisher-name>Office of Environmental Health Hazard Assessment</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://oehha.ca.gov/air/air-toxics-hot-spots" ext-link-type="uri">https://oehha.ca.gov/air/air-toxics-hot-spots</ext-link>.</comment></mixed-citation></ref><ref id="R164"><mixed-citation publication-type="book"><collab>OEHHA California Office of Environmental Health Hazard Assessment</collab>, <year>2000</year>. <source>Determination of Noncancer Chronic Reference Exposure Levels: Chronic Toxicity Summary: Hydrogen Sulfide</source>
<publisher-loc>Sacramento, CA</publisher-loc>: <publisher-name>Office of Environmental Health Hazard Assessment</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="http://www.oehha.ca.gov/air/chronic_rels/index.html" ext-link-type="uri">http://www.oehha.ca.gov/air/chronic_rels/index.html</ext-link>.</comment></mixed-citation></ref><ref id="R165"><mixed-citation publication-type="book"><collab>OEHHA California Office of Environmental Health Hazard Assessment</collab>, <year>1999</year>. <source>Determination of Acute Reference Exposure Levels for Airborne Toxicants</source>
<publisher-loc>Sacramento, CA</publisher-loc>: <publisher-name>Office of Environmental Health Hazard Assessment, Air Toxicology and Epidemiology Section</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://oehha.ca.gov/media/downloads/crnr/acuterel.pdf" ext-link-type="uri">https://oehha.ca.gov/media/downloads/crnr/acuterel.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R166"><mixed-citation publication-type="journal"><name><surname>Olson</surname><given-names>KR</given-names></name>, <year>2011</year>. <article-title>The therapeutic potential of hydrogen sulfide: Separating hype from hope</article-title>. <source>Am. J. Physiol. - Regul. Integr. Comp. Physiol</source>
<volume>301</volume>, <fpage>297</fpage>&#x02013;<lpage>312</lpage>.</mixed-citation></ref><ref id="R167"><mixed-citation publication-type="journal"><name><surname>Partlo</surname><given-names>LA</given-names></name>, <name><surname>Sainsbury</surname><given-names>RS</given-names></name>, <name><surname>Roth</surname><given-names>SH</given-names></name>, <year>2001</year>. <article-title>Effects of repeated hydrogen sulphide (H2S) exposure on learning and memory in the adult rat</article-title>. <source>Neurotoxicology</source>
<volume>22</volume>, <fpage>177</fpage>&#x02013;<lpage>189</lpage>.<pub-id pub-id-type="pmid">11405250</pub-id></mixed-citation></ref><ref id="R168"><mixed-citation publication-type="journal"><name><surname>Partti-Pellinen</surname><given-names>K</given-names></name>, <name><surname>Marttila</surname><given-names>O</given-names></name>, <name><surname>Vilkka</surname><given-names>V</given-names></name>, <name><surname>Jaakkola</surname><given-names>JJK</given-names></name>, <name><surname>J&#x000e4;ppinen</surname><given-names>P</given-names></name>, <name><surname>Haahtela</surname><given-names>T</given-names></name>, <year>1996</year>. <article-title>The south karelia air pollution study: Effects of low-level exposure to malodorous sulfur compounds on symptoms</article-title>. <source>Arch. Environ. Health</source>
<volume>51</volume>, <fpage>315</fpage>&#x02013;<lpage>320</lpage>.<pub-id pub-id-type="pmid">8757412</pub-id></mixed-citation></ref><ref id="R169"><mixed-citation publication-type="journal"><name><surname>Pavilonis</surname><given-names>BT</given-names></name>, <name><surname>O&#x02019;Shaughnessy</surname><given-names>PT</given-names></name>, <name><surname>Altmaier</surname><given-names>R</given-names></name>, <name><surname>Metwali</surname><given-names>N</given-names></name>, <name><surname>Thorne</surname><given-names>PS</given-names></name>, <year>2013</year>. <article-title>Passive monitors to measure hydrogen sulfide near concentrated animal feeding operations</article-title>. <source>Environ. Sci. Process. Impacts</source>
<volume>15</volume>, <fpage>1271</fpage>&#x02013;<lpage>1278</lpage>.<pub-id pub-id-type="pmid">23681048</pub-id></mixed-citation></ref><ref id="R170"><mixed-citation publication-type="journal"><name><surname>Polhemus</surname><given-names>DJ</given-names></name>, <name><surname>Lefer</surname><given-names>DJ</given-names></name>, <year>2014</year>. <article-title>Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease</article-title>. <source>Circ. Res</source>
<volume>114</volume>, <fpage>730</fpage>&#x02013;<lpage>737</lpage>.<pub-id pub-id-type="pmid">24526678</pub-id></mixed-citation></ref><ref id="R171"><mixed-citation publication-type="journal"><name><surname>Pope</surname><given-names>K</given-names></name>, <name><surname>So</surname><given-names>YT</given-names></name>, <name><surname>Crane</surname><given-names>J</given-names></name>, <name><surname>Bates</surname><given-names>MN</given-names></name>, <year>2017</year>. <article-title>Ambient geothermal hydrogen sulfide exposure and peripheral neuropathy</article-title>. <source>Neurotoxicology</source>
<volume>60</volume>, <fpage>10</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">28223159</pub-id></mixed-citation></ref><ref id="R172"><mixed-citation publication-type="journal"><name><surname>Qu</surname><given-names>K</given-names></name>, <name><surname>Lee</surname><given-names>SW</given-names></name>, <name><surname>Bian</surname><given-names>JS</given-names></name>, <name><surname>Low</surname><given-names>CM</given-names></name>, <name><surname>Wong</surname><given-names>PTH</given-names></name>, <year>2008</year>. <article-title>Hydrogen sulfide: Neurochemistry and neurobiology</article-title>. <source>Neurochem. Int</source>
<volume>52</volume>, <fpage>155</fpage>&#x02013;<lpage>165</lpage>.<pub-id pub-id-type="pmid">17629356</pub-id></mixed-citation></ref><ref id="R173"><mixed-citation publication-type="webpage"><name><surname>Radon</surname><given-names>K</given-names></name>, <name><surname>Schulze</surname><given-names>A</given-names></name>, <name><surname>van Strien</surname><given-names>R</given-names></name>, <name><surname>Ehrenstein</surname><given-names>V</given-names></name>, <name><surname>Praml</surname><given-names>G</given-names></name>, <name><surname>Nowak</surname><given-names>D</given-names></name>, <year>2005</year>. <source>Atemwegsgesundheit und Allergiestatus bei jungen Erwachsenen in l&#x000e4;ndlichen Regionen Niedersachsens [Respiratory health and allergy among young adults from rural areas of Lower Saxony], In: Proceedings of 50th Annual Meeting of the German Society for Medical Informatics, Biometrics and Epidemiology, Freiburg, Germany</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.thieme-connect.de/products/ejournals/html/10.1055/s-2005-915572" ext-link-type="uri">https://www.thieme-connect.de/products/ejournals/html/10.1055/s-2005-915572</ext-link>.</comment></mixed-citation></ref><ref id="R174"><mixed-citation publication-type="journal"><name><surname>Radon</surname><given-names>K</given-names></name>, <name><surname>Schulze</surname><given-names>A</given-names></name>, <name><surname>Ehrenstein</surname><given-names>V</given-names></name>, <name><surname>Van Strien</surname><given-names>RT</given-names></name>, <name><surname>Praml</surname><given-names>G</given-names></name>, <name><surname>Nowak</surname><given-names>D</given-names></name>, <year>2007</year>. <article-title>Environmental exposure to confined animal feeding operations and respiratory health of neighboring residents</article-title>. <source>Epidemiology</source>
<volume>18</volume>, <fpage>300</fpage>&#x02013;<lpage>308</lpage>.<pub-id pub-id-type="pmid">17435437</pub-id></mixed-citation></ref><ref id="R175"><mixed-citation publication-type="journal"><name><surname>Reed</surname><given-names>BR</given-names></name>, <name><surname>Crane</surname><given-names>J</given-names></name>, <name><surname>Garrett</surname><given-names>N</given-names></name>, <name><surname>Woods</surname><given-names>DL</given-names></name>, <name><surname>Bates</surname><given-names>MN</given-names></name>, <year>2014</year>. <article-title>Chronic ambient hydrogen sulfide exposure and cognitive function</article-title>. <source>Neurotoxicol. Teratol</source>
<volume>42</volume>, <fpage>68</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">24548790</pub-id></mixed-citation></ref><ref id="R176"><mixed-citation publication-type="book"><name><surname>Reynolds</surname><given-names>RL</given-names></name>, <name><surname>Kamper</surname><given-names>RL</given-names></name>, <year>1984</year>. <source>Review of the State of California Ambient Air Quality Standard for Hydrogen Sulfide (H2S)</source>
<publisher-loc>Lakeport, CA</publisher-loc>: <publisher-name>Lake County Air Quality Management District</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://ww2.arb.ca.gov/resources/california-ambient-air-quality-standards" ext-link-type="uri">https://ww2.arb.ca.gov/resources/california-ambient-air-quality-standards</ext-link>.</comment></mixed-citation></ref><ref id="R177"><mixed-citation publication-type="journal"><name><surname>R&#x000ed;os-Gonz&#x000e1;lez</surname><given-names>BB</given-names></name>, <name><surname>Rom&#x000e1;n-Morales</surname><given-names>EM</given-names></name>, <name><surname>Pietri</surname><given-names>R</given-names></name>, <name><surname>L&#x000f3;pez-Garriga</surname><given-names>J</given-names></name>, <year>2014</year>. <article-title>Hydrogen sulfide activation in hemeproteins: The sulfheme scenario</article-title>. <source>J. Inorg. Biochem</source>
<volume>133</volume>, <fpage>78</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">24513534</pub-id></mixed-citation></ref><ref id="R178"><mixed-citation publication-type="book"><name><surname>Roth</surname><given-names>S</given-names></name>, <name><surname>Goodwin</surname><given-names>V</given-names></name>, <year>2003</year>. <source>Health Effects of Hydrogen Sulphide: Knowledge Gaps</source>
<publisher-loc>Alberta, Canada</publisher-loc>: <publisher-name>Alberta Environment</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.osti.gov/etdeweb/biblio/20388483" ext-link-type="uri">https://www.osti.gov/etdeweb/biblio/20388483</ext-link>.</comment></mixed-citation></ref><ref id="R179"><mixed-citation publication-type="journal"><name><surname>Roth</surname><given-names>SH</given-names></name>, <name><surname>Skrajny</surname><given-names>B</given-names></name>, <name><surname>Bennington</surname><given-names>R</given-names></name>, <name><surname>Brookes</surname><given-names>J</given-names></name>, <year>1997</year>. <article-title>Neurotoxicity of hydrogen sulfide may result from inhibition of respiratory enzymes</article-title>. <source>Proc. West Pharmacol. Soc</source>
<volume>40</volume>, <fpage>41</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">9436209</pub-id></mixed-citation></ref><ref id="R180"><mixed-citation publication-type="journal"><name><surname>Rumsey</surname><given-names>IC</given-names></name>, <name><surname>Aneja</surname><given-names>VP</given-names></name>, <year>2014</year>. <article-title>Measurement and modeling of hydrogen sulfide lagoon emissions from a swine concentrated animal feeding operation</article-title>. <source>Environ. Sci. Technol</source>
<volume>48</volume>, <fpage>1609</fpage>&#x02013;<lpage>1617</lpage>.<pub-id pub-id-type="pmid">24387076</pub-id></mixed-citation></ref><ref id="R181"><mixed-citation publication-type="journal"><name><surname>Saadat</surname><given-names>M</given-names></name>, <name><surname>Bahaoddini</surname><given-names>A</given-names></name>, <name><surname>Mohabatkar</surname><given-names>H</given-names></name>, <name><surname>Noemani</surname><given-names>K</given-names></name>, <year>2004</year>. <article-title>High incidence of suicide by burning in Masjid-i-Sulaiman (southwest of Iran), a polluted area with natural sour gas leakage</article-title>. <source>Burns</source>
<volume>30</volume>, <fpage>829</fpage>&#x02013;<lpage>832</lpage>.<pub-id pub-id-type="pmid">15555796</pub-id></mixed-citation></ref><ref id="R182"><mixed-citation publication-type="journal"><name><surname>Saadat</surname><given-names>M</given-names></name>, <name><surname>Zendeh-Boodi</surname><given-names>Z</given-names></name>, <name><surname>Ali Goodarzi</surname><given-names>M</given-names></name>, <year>2006</year>. <article-title>Environmental exposure to natural sour gas containing sulfur compounds results in elevated depression and hopelessness scores</article-title>. <source>Ecotoxicol. Environ. Saf</source>
<volume>65</volume>, <fpage>288</fpage>&#x02013;<lpage>291</lpage>.<pub-id pub-id-type="pmid">16169081</pub-id></mixed-citation></ref><ref id="R183"><mixed-citation publication-type="journal"><name><surname>Saeedi</surname><given-names>A</given-names></name>, <name><surname>Najibi</surname><given-names>A</given-names></name>, <name><surname>Mohammadi-Bardbori</surname><given-names>A</given-names></name>, <year>2015</year>. <article-title>Effects of long-term exposure to hydrogen sulfide on human red blood cells</article-title>. <source>Int. J. Occup. Environ. Med</source>
<volume>6</volume>, <fpage>20</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">25588222</pub-id></mixed-citation></ref><ref id="R184"><mixed-citation publication-type="journal"><name><surname>Savolainen</surname><given-names>K</given-names></name>, <name><surname>Riihim&#x000e4;ki</surname><given-names>V</given-names></name>, <name><surname>Laine</surname><given-names>A</given-names></name>, <year>1982</year>. <article-title>Biphasic Effects of Inhaled Solvents on Human Equilibrium</article-title>. <source>Acta Pharmacol. Toxicol. (Copenh)</source>
<volume>51</volume>, <fpage>237</fpage>&#x02013;<lpage>242</lpage>.<pub-id pub-id-type="pmid">7136729</pub-id></mixed-citation></ref><ref id="R185"><mixed-citation publication-type="journal"><name><surname>Schiffman</surname><given-names>SS</given-names></name>, <name><surname>Studwell</surname><given-names>CE</given-names></name>, <name><surname>Landerman</surname><given-names>LR</given-names></name>, <name><surname>Berman</surname><given-names>K</given-names></name>, <name><surname>Sundy</surname><given-names>JS</given-names></name>, <year>2005</year>. <article-title>Symptomatic effects of exposure to diluted air sampled from a swine confinement atmosphere on healthy human subjects</article-title>. <source>Environ. Health Perspect</source>
<volume>113</volume>, <fpage>567</fpage>&#x02013;<lpage>576</lpage>.<pub-id pub-id-type="pmid">15866765</pub-id></mixed-citation></ref><ref id="R186"><mixed-citation publication-type="journal"><name><surname>Schinasi</surname><given-names>L</given-names></name>, <name><surname>Horton</surname><given-names>RA</given-names></name>, <name><surname>Guidry</surname><given-names>VT</given-names></name>, <name><surname>Wing</surname><given-names>S</given-names></name>, <name><surname>Marshall</surname><given-names>SW</given-names></name>, <name><surname>Morland</surname><given-names>K</given-names></name>, <year>2011</year>. <article-title>Air pollution, lung function, and physical symptoms in communities near concentrated swine feeding operations</article-title>. <source>Epidemiol</source>
<volume>22</volume>, <fpage>208</fpage>&#x02013;<lpage>215</lpage>.</mixed-citation></ref><ref id="R187"><mixed-citation publication-type="journal"><name><surname>Schroeter</surname><given-names>JD</given-names></name>, <name><surname>Garcia</surname><given-names>GJM</given-names></name>, <name><surname>Kimbell</surname><given-names>JS</given-names></name>, <year>2010</year>. <article-title>A computational fluid dynamics approach to assess interhuman variability in hydrogen sulfide nasal dosimetry</article-title>. <source>Inhal. Toxicol</source>
<volume>22</volume>, <fpage>277</fpage>&#x02013;<lpage>286</lpage>.<pub-id pub-id-type="pmid">20064104</pub-id></mixed-citation></ref><ref id="R188"><mixed-citation publication-type="journal"><name><surname>Schroeter</surname><given-names>JD</given-names></name>, <name><surname>Kimbell</surname><given-names>JS</given-names></name>, <name><surname>Andersen</surname><given-names>ME</given-names></name>, <name><surname>Dorman</surname><given-names>DC</given-names></name>, <year>2006</year>. <article-title>Use of a pharmacokinetic-driven computational fluid dynamics model to predict nasal extraction of hydrogen sulfide in rats and humans</article-title>. <source>Toxicol. Sci</source>
<volume>94</volume>, <fpage>359</fpage>&#x02013;<lpage>367</lpage>.<pub-id pub-id-type="pmid">16984956</pub-id></mixed-citation></ref><ref id="R189"><mixed-citation publication-type="journal"><collab>SCOEL Scientific Committee on Occupational Exposure Limits</collab>, <year>2007</year>. <source>Recommendation from the Scientific Committee on Occupational Exposure Limits for Hydrogen Sulphide</source> [<comment>accessed</comment>
<date-in-citation>2023 Mar 28</date-in-citation>]. <comment><ext-link xlink:href="https://ec.europa.eu/social/search.jsp?advSearchKey=hydrogen+sulphide&#x00026;mode=advancedSubmit&#x00026;langId=en" ext-link-type="uri">https://ec.europa.eu/social/search.jsp?advSearchKey=hydrogen+sulphide&#x00026;mode=advancedSubmit&#x00026;langId=en</ext-link>.</comment></mixed-citation></ref><ref id="R190"><mixed-citation publication-type="journal"><name><surname>Shafran-Nathan</surname><given-names>R</given-names></name>, <name><surname>Levy</surname><given-names>I</given-names></name>, <name><surname>Levin</surname><given-names>N</given-names></name>, <name><surname>Broday</surname><given-names>DM</given-names></name>, <year>2017</year>. <article-title>Ecological bias in environmental health studies: the problem of aggregation of multiple data sources</article-title>. <source>Air Qual. Atmos. Heal</source>
<volume>10</volume>, <fpage>411</fpage>&#x02013;<lpage>420</lpage>.</mixed-citation></ref><ref id="R191"><mixed-citation publication-type="journal"><name><surname>Sheppard</surname><given-names>L</given-names></name>, <name><surname>Burnett</surname><given-names>RT</given-names></name>, <name><surname>Szpiro</surname><given-names>AA</given-names></name>, <name><surname>Kim</surname><given-names>S</given-names></name>, <name><surname>Jerrett</surname><given-names>M</given-names></name>, <year>2012</year>. <article-title>Confounding and exposure measurement error in air pollution epidemiology</article-title>. <source>Air Qual. Atmos. Heal</source>
<volume>5</volume>, <fpage>203</fpage>&#x02013;<lpage>216</lpage>.</mixed-citation></ref><ref id="R192"><mixed-citation publication-type="journal"><name><surname>Shimonovich</surname><given-names>M</given-names></name>, <name><surname>Pearce</surname><given-names>A</given-names></name>, <name><surname>Thomson</surname><given-names>H</given-names></name>, <name><surname>Keyes</surname><given-names>K</given-names></name>, <name><surname>Katikireddi</surname><given-names>SV</given-names></name>, <year>2021</year>. <article-title>Assessing causality in epidemiology: revisiting Bradford Hill to incorporate developments in causal thinking</article-title>. <source>Eur. J. Epidemiol</source>
<volume>36</volume>, <fpage>873</fpage>&#x02013;<lpage>887</lpage>.<pub-id pub-id-type="pmid">33324996</pub-id></mixed-citation></ref><ref id="R193"><mixed-citation publication-type="journal"><name><surname>Shusterman</surname><given-names>D</given-names></name>, <year>2001</year>. <article-title>Odor-associated health complaints: Competing explanatory models</article-title>. <source>Chem. Senses</source>
<volume>26</volume>, <fpage>339</fpage>&#x02013;<lpage>343</lpage>.<pub-id pub-id-type="pmid">11287393</pub-id></mixed-citation></ref><ref id="R194"><mixed-citation publication-type="journal"><name><surname>Sigurdarson</surname><given-names>ST</given-names></name>, <name><surname>Kline</surname><given-names>JN</given-names></name>, <year>2006</year>. <article-title>School proximity to concentrated animal feeding operations and prevalence of asthma in students</article-title>. <source>Chest</source>
<volume>129</volume>, <fpage>1486</fpage>&#x02013;<lpage>1491</lpage>.<pub-id pub-id-type="pmid">16778265</pub-id></mixed-citation></ref><ref id="R195"><mixed-citation publication-type="journal"><name><surname>Silva</surname><given-names>M</given-names></name>, <year>2013</year>. <article-title>A Review of Developmental and Reproductive Toxicity of CS2 and H<sub>2</sub>S Generated by the Pesticide Sodium Tetrathiocarbonate. Birth Defects Res</article-title>. <source>Part B - Dev. Reprod. Toxicol</source>
<volume>98</volume>, <fpage>119</fpage>&#x02013;<lpage>138</lpage>.</mixed-citation></ref><ref id="R196"><mixed-citation publication-type="journal"><name><surname>Simonton</surname><given-names>DS</given-names></name>, <name><surname>King</surname><given-names>S</given-names></name>, <year>2013</year>. <article-title>Hydrogen Sulfide Formation and Potential Health Consequences in Coal Mining Regions</article-title>. <source>Water Qual. Expo. Heal</source>
<volume>5</volume>, <fpage>85</fpage>&#x02013;<lpage>92</lpage>.</mixed-citation></ref><ref id="R197"><mixed-citation publication-type="journal"><name><surname>Sjaastad</surname><given-names>O</given-names></name>, <name><surname>Bakketeig</surname><given-names>LS</given-names></name>, <year>2006</year>. <article-title>Hydrogen sulphide headache and other rare, global headaches: V&#x000e5;g&#x000e5; study</article-title>. <source>Cephalalgia</source>
<volume>26</volume>, <fpage>466</fpage>&#x02013;<lpage>476</lpage>.<pub-id pub-id-type="pmid">16556249</pub-id></mixed-citation></ref><ref id="R198"><mixed-citation publication-type="journal"><name><surname>Skrajny</surname><given-names>B</given-names></name>, <name><surname>Hannah</surname><given-names>RS</given-names></name>, <name><surname>Roth</surname><given-names>SH</given-names></name>, <year>1992</year>. <article-title>Low concentrations of hydrogen sulphide alter monoamine levels in the developing rat central nervous system</article-title>. <source>Can. J. Physiol. Pharmacol</source>
<volume>70</volume>, <fpage>1515</fpage>&#x02013;<lpage>1518</lpage>.<pub-id pub-id-type="pmid">1296865</pub-id></mixed-citation></ref><ref id="R199"><mixed-citation publication-type="book"><name><surname>Skrtic</surname><given-names>L</given-names></name>, <year>2006</year>. <source>Hydrogen sulfide, oil and gas, and people&#x02019;s health (MS Thesis)</source>
<publisher-loc>Berkeley, CA</publisher-loc>: <publisher-name>University of California., Energy</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://earthworks.org/files/publications/hydrogensulfide_oilgas_health.pdf" ext-link-type="uri">https://earthworks.org/files/publications/hydrogensulfide_oilgas_health.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R200"><mixed-citation publication-type="journal"><name><surname>Sk&#x000fa;lad&#x000f3;ttir</surname><given-names>B</given-names></name>, <name><surname>&#x000de;&#x000f3;r&#x000f0;arson</surname><given-names>H</given-names></name>, <year>2003</year>. <source>Environmental Evaluation of Air Quality Midterm report</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.iti.is/files/%7Bfa8f9b4d-c451-4b2e-9ca9-e78b536ffddb%7D_ectos_delivery7-enviro-midtermreport.pdf" ext-link-type="uri">https://www.iti.is/files/%7Bfa8f9b4d-c451-4b2e-9ca9-e78b536ffddb%7D_ectos_delivery7-enviro-midtermreport.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R201"><mixed-citation publication-type="journal"><name><surname>Snyder</surname><given-names>JW</given-names></name>, <name><surname>Safir</surname><given-names>EF</given-names></name>, <name><surname>Summerville</surname><given-names>GP</given-names></name>, <name><surname>Middleberg</surname><given-names>RA</given-names></name>, <year>1995</year>. <article-title>Occupational fatality and persistent neurological sequelae after mass exposure to hydrogen sulfide</article-title>. <source>Am. J. Emerg. Med</source>
<volume>13</volume>, <fpage>199</fpage>&#x02013;<lpage>203</lpage>.<pub-id pub-id-type="pmid">7893309</pub-id></mixed-citation></ref><ref id="R202"><mixed-citation publication-type="journal"><name><surname>Solnyshkova</surname><given-names>TG</given-names></name>, <year>2003</year>. <source>Demyelination of Nerve Fibers in the Central Nervous System Caused by Chronic</source>&#x02026; <volume>136</volume>, <fpage>328</fpage>&#x02013;<lpage>332</lpage>.</mixed-citation></ref><ref id="R203"><mixed-citation publication-type="journal"><name><surname>Solnyshkova</surname><given-names>TG</given-names></name>, <name><surname>Shakhlamov</surname><given-names>VA</given-names></name>, <year>2002</year>. <article-title>Ultrastructural and morphometric characteristics of nerve cells and myelinated fibers in the cerebral cortex after chronic exposure to natural gas containing hydrogen sulfide in low concentrations</article-title>. <source>Bull. Exp. Biol. Med</source>
<volume>134</volume>, <fpage>411</fpage>&#x02013;<lpage>413</lpage>.<pub-id pub-id-type="pmid">12533774</pub-id></mixed-citation></ref><ref id="R204"><mixed-citation publication-type="journal"><name><surname>Szpiro</surname><given-names>AA</given-names></name>, <name><surname>Paciorek</surname><given-names>CJ</given-names></name>, <year>2013</year>. <article-title>Measurement error in two-stage analyses, with application to air pollution epidemiology</article-title>. <source>Environmetrics</source>
<volume>24</volume>, <fpage>501</fpage>&#x02013;<lpage>517</lpage>.<pub-id pub-id-type="pmid">24764691</pub-id></mixed-citation></ref><ref id="R205"><mixed-citation publication-type="journal"><name><surname>Tajik</surname><given-names>M</given-names></name>, <name><surname>Muhammad</surname><given-names>N</given-names></name>, <name><surname>Lowman</surname><given-names>A</given-names></name>, <name><surname>Thu</surname><given-names>K</given-names></name>, <name><surname>Wing</surname><given-names>S</given-names></name>, <name><surname>Grant</surname><given-names>GR</given-names></name>, <year>2008</year>. <article-title>Impact of odor from industrial hog operations on daily living activities</article-title>. <source>New Solut</source>
<volume>18</volume>, <fpage>193</fpage>&#x02013;<lpage>205</lpage>.<pub-id pub-id-type="pmid">18511396</pub-id></mixed-citation></ref><ref id="R206"><mixed-citation publication-type="journal"><name><surname>Tenhunen</surname><given-names>R</given-names></name>, <name><surname>Savolainen</surname><given-names>H</given-names></name>, <name><surname>J&#x000e4;ppinen</surname><given-names>P</given-names></name>, <year>1983</year>. <article-title>Changes in haem synthesis associated with occupational exposure to organic and inorganic sulphides</article-title>. <source>Clin. Sci. (London, Engl. 1979)</source>
<volume>64</volume>, <fpage>187</fpage>&#x02013;<lpage>191</lpage>.</mixed-citation></ref><ref id="R207"><mixed-citation publication-type="journal"><name><surname>Thorn</surname><given-names>J</given-names></name>, <name><surname>Beijer</surname><given-names>L</given-names></name>, <name><surname>Rylander</surname><given-names>R</given-names></name>, <year>2002</year>. <article-title>Work related symptoms among sewage workers: A nationwide survey in Sweden</article-title>. <source>Occup. Environ. Med</source>
<volume>59</volume>, <fpage>562</fpage>&#x02013;<lpage>566</lpage>.<pub-id pub-id-type="pmid">12151615</pub-id></mixed-citation></ref><ref id="R208"><mixed-citation publication-type="journal"><name><surname>Thorne</surname><given-names>PS</given-names></name>, <name><surname>Ansley</surname><given-names>AC</given-names></name>, <name><surname>Perry</surname><given-names>SS</given-names></name>, <year>2009</year>. <article-title>Concentrations of bioaerosols, odors, and hydrogen sulfide inside and downwind from two types of swine livestock operations</article-title>. <source>J. Occup. Environ. Hyg</source>
<volume>6</volume>, <fpage>211</fpage>&#x02013;<lpage>220</lpage>.<pub-id pub-id-type="pmid">19177273</pub-id></mixed-citation></ref><ref id="R209"><mixed-citation publication-type="journal"><name><surname>Uluta&#x0015f;</surname><given-names>K</given-names></name>, <name><surname>Kaskun</surname><given-names>S</given-names></name>, <name><surname>Demir</surname><given-names>S</given-names></name>, <name><surname>Din&#x000e7;er</surname><given-names>F</given-names></name>, <name><surname>Pekey</surname><given-names>H</given-names></name>, <year>2021</year>. <article-title>Assessment of H<sub>2</sub>S and BTEX concentrations in ambient air using passive sampling method and the health risks</article-title>. <source>Environ. Monit. Assess</source>
<volume>193</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="R210"><mixed-citation publication-type="webpage"><collab>USDA United States Department of Agriculture</collab>, <year>2022</year>. <source>United States hog inventory down 2%</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.nass.usda.gov/Newsroom/2022/09-29-2022.php" ext-link-type="uri">https://www.nass.usda.gov/Newsroom/2022/09-29-2022.php</ext-link>.</comment></mixed-citation></ref><ref id="R211"><mixed-citation publication-type="book"><name><surname>van Gemert</surname><given-names>LJ</given-names></name>, <name><surname>Nettenbreijer</surname><given-names>AH</given-names></name>, <year>1984</year>. <source>Compilation of odour threshold values in air and water</source>. <publisher-loc>Zeist</publisher-loc>: <publisher-name>Central Institute for Nutrition and Food Research TNO</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://cir.nii.ac.jp/crid/1570854175609650304" ext-link-type="uri">https://cir.nii.ac.jp/crid/1570854175609650304</ext-link>.</comment></mixed-citation></ref><ref id="R212"><mixed-citation publication-type="journal"><name><surname>Varaksin</surname><given-names>AA</given-names></name>, <name><surname>Puschina</surname><given-names>EV</given-names></name>, <year>2011</year>. <article-title>Hydrogen sulfide as a regulator of systemic functions in vertebrates</article-title>. <source>Neurophysiology</source>
<volume>43</volume>, <fpage>62</fpage>&#x02013;<lpage>72</lpage>.</mixed-citation></ref><ref id="R213"><mixed-citation publication-type="journal"><name><surname>Vasiljeva</surname><given-names>IA</given-names></name>, <year>1973</year>. <article-title>Effect of low concentrations of carbon disulfide and hydrogen sulfide on the menstrual function in women and on the estrous cycle under experimental conditions</article-title>. <source>Gig Sanit</source>
<volume>38</volume>, <fpage>24</fpage>&#x02013;<lpage>27</lpage>.</mixed-citation></ref><ref id="R214"><mixed-citation publication-type="journal"><name><surname>Villeneuve</surname><given-names>PJ</given-names></name>, <name><surname>Ali</surname><given-names>A</given-names></name>, <name><surname>Challacombe</surname><given-names>L</given-names></name>, <name><surname>Hebert</surname><given-names>S</given-names></name>, <year>2009</year>. <article-title>Intensive hog farming operations and self-reported health among nearby rural residents in Ottawa, Canada</article-title>. <source>BMC Public Health</source>
<volume>9</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">19121216</pub-id></mixed-citation></ref><ref id="R215"><mixed-citation publication-type="journal"><name><surname>Volpato</surname><given-names>GP</given-names></name>, <name><surname>Searles</surname><given-names>R</given-names></name>, <name><surname>Yu</surname><given-names>B</given-names></name>, <name><surname>Scherrer-Crosbie</surname><given-names>M</given-names></name>, <name><surname>Bloch</surname><given-names>KD</given-names></name>, <name><surname>Ichinose</surname><given-names>F</given-names></name>, <name><surname>Zapol</surname><given-names>WM</given-names></name>, <year>2008</year>. <article-title>Inhaled hydrogen sulfide: A rapidly reversible inhibitor of cardiac and metabolic function in the mouse</article-title>. <source>Anesthesiology</source>
<volume>108</volume>, <fpage>659</fpage>&#x02013;<lpage>668</lpage>.<pub-id pub-id-type="pmid">18362598</pub-id></mixed-citation></ref><ref id="R216"><mixed-citation publication-type="journal"><name><surname>Waldner</surname><given-names>C</given-names></name>, <year>2009</year>. <article-title>Risk of abortion and stillbirth in cow-calf herds exposed to the oil and gas industry in western canada</article-title>. <source>Arch. Environ. Occup. Heal</source>
<volume>64</volume>, <fpage>29</fpage>&#x02013;<lpage>45</lpage>.</mixed-citation></ref><ref id="R217"><mixed-citation publication-type="journal"><name><surname>Waldner</surname><given-names>C</given-names></name>, <year>2008a</year>. <article-title>Western Canada study of animal health effects associated with exposure to emissions from oil and natural gas field facilities. Study design and data collection I. Herd performance records and management</article-title>. <source>Arch. Environ. Occup. Heal</source>
<volume>63</volume>, <fpage>167</fpage>&#x02013;<lpage>184</lpage>.</mixed-citation></ref><ref id="R218"><mixed-citation publication-type="journal"><name><surname>Waldner</surname><given-names>C</given-names></name>, <year>2008b</year>. <article-title>Western Canada study of animal health effects associated with exposure to emissions from oil and natural gas field facilities. Study design and data collection II. Location of study herds relative to the oil and gas industry in Western Canada</article-title>. <source>Arch. Environ. Occup. Heal</source>
<volume>63</volume>, <fpage>187</fpage>&#x02013;<lpage>199</lpage>.</mixed-citation></ref><ref id="R219"><mixed-citation publication-type="journal"><name><surname>Waldner</surname><given-names>C</given-names></name>, <year>2008c</year>. <article-title>Western Canada study of animal health effects associated with exposure to emissions from oil and natural gas field facilities. Study design and data collection III. Methods of assessing animal exposure to contaminants from the oil and gas industry</article-title>. <source>Arch. Environ. Occup. Heal</source>
<volume>63</volume>, <fpage>201</fpage>&#x02013;<lpage>219</lpage>.</mixed-citation></ref><ref id="R220"><mixed-citation publication-type="journal"><name><surname>Waldner</surname><given-names>C</given-names></name>, <year>2008d</year>. <article-title>The association between exposure to the oil and gas industry and beef calf mortality in Western Canada</article-title>. <source>Arch. Environ. Occup. Heal</source>
<volume>63</volume>, <fpage>220</fpage>&#x02013;<lpage>240</lpage>.</mixed-citation></ref><ref id="R221"><mixed-citation publication-type="journal"><name><surname>Waldner</surname><given-names>C</given-names></name>, <name><surname>Clark</surname><given-names>E</given-names></name>, <year>2009</year>. <article-title>Association between exposure to emissions from the oil and gas industry and pathology of the immune, nervous, and respiratory systems, and skeletal and cardiac muscle in beef calves</article-title>. <source>Arch. Environ. Occup. Heal</source>
<volume>64</volume>, <fpage>6</fpage>&#x02013;<lpage>27</lpage>.</mixed-citation></ref><ref id="R222"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>P</given-names></name>, <name><surname>Zhang</surname><given-names>G</given-names></name>, <name><surname>Wondimu</surname><given-names>T</given-names></name>, <name><surname>Ross</surname><given-names>B</given-names></name>, <name><surname>Wang</surname><given-names>R</given-names></name>, <year>2011</year>. <article-title>Hydrogen sulfide and asthma</article-title>. <source>Exp. Physiol</source>
<volume>96</volume>, <fpage>847</fpage>&#x02013;<lpage>852</lpage>.<pub-id pub-id-type="pmid">21666034</pub-id></mixed-citation></ref><ref id="R223"><mixed-citation publication-type="journal"><name><surname>Wasch</surname><given-names>HH</given-names></name>, <name><surname>Yip</surname><given-names>P</given-names></name>, <name><surname>Bowler</surname><given-names>R</given-names></name>, <name><surname>Cone</surname><given-names>JE</given-names></name>, <name><surname>Estrin</surname><given-names>WJ</given-names></name>, <year>1989</year>. <article-title>Prolongation of the P-300 Latency Associated With Hydrogen Sulfide Exposure</article-title>. <source>Arch. Neurol</source>
<volume>46</volume>, <fpage>902</fpage>&#x02013;<lpage>904</lpage>.<pub-id pub-id-type="pmid">2757531</pub-id></mixed-citation></ref><ref id="R224"><mixed-citation publication-type="journal"><name><surname>White</surname><given-names>MC</given-names></name>, <name><surname>Inserra</surname><given-names>SG</given-names></name>, <name><surname>Berger</surname><given-names>SA</given-names></name>, <name><surname>Campagna</surname><given-names>D</given-names></name>, <name><surname>Phifer</surname><given-names>BL</given-names></name>, <name><surname>Lybarber</surname><given-names>JA</given-names></name>, <year>1999</year>. <article-title>Health concerns for communities exposed to hydrogen sulfide. A perspective from two communities</article-title>. <source>Environ. Epidemiol. Toxicol</source>
<volume>1</volume>, <fpage>236</fpage>&#x02013;<lpage>240</lpage>.</mixed-citation></ref><ref id="R225"><mixed-citation publication-type="book"><collab>WHO World Health Organization</collab>, <year>2018</year>. <source>Falls: Key Facts</source>
<publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://www.who.int/news-room/fact-sheets/detail/falls" ext-link-type="uri">https://www.who.int/news-room/fact-sheets/detail/falls</ext-link>.</comment></mixed-citation></ref><ref id="R226"><mixed-citation publication-type="book"><collab>WHO World Health Organization</collab>, <year>2006</year>. <source>Hydrogen Sulfide. Chap. 6.6 in Air Quality Guidelines for Europe</source>
<edition>2nd ed.</edition>
<publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://apps.who.int/iris/bitstream/handle/10665/107335/9789289013581-eng.pdf?sequence=1&#x00026;isAllowed=y" ext-link-type="uri">https://apps.who.int/iris/bitstream/handle/10665/107335/9789289013581-eng.pdf?sequence=1&#x00026;isAllowed=y</ext-link>.</comment></mixed-citation></ref><ref id="R227"><mixed-citation publication-type="book"><collab>WHO World Health Organization</collab>, <year>2003</year>. <source>Hydrogen Sulfide: Human Health Aspects. Concise International Chemical Assessment Document 53</source>
<publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://apps.who.int/iris/bitstream/handle/10665/42638/9241530537.pdf?sequence=1&#x00026;isAllowed=y" ext-link-type="uri">https://apps.who.int/iris/bitstream/handle/10665/42638/9241530537.pdf?sequence=1&#x00026;isAllowed=y</ext-link>.</comment></mixed-citation></ref><ref id="R228"><mixed-citation publication-type="book"><collab>WHO World Health Organization</collab>, <year>1981</year>. <source>Environmental Health Criteria 19: Hydrogen Sulfide</source>
<publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://wedocs.unep.org/20.500.11822/29305" ext-link-type="uri">https://wedocs.unep.org/20.500.11822/29305</ext-link>.</comment></mixed-citation></ref><ref id="R229"><mixed-citation publication-type="webpage"><collab>WHO World Health Organization</collab>, <year>1948</year>. <source>Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19&#x02013;22 June, 1946&#x0202f;; signed on 22 July 1946 by the representatives of 61 States and entered into force on 7 April 1948</source> [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="http://www.who.int/governance/eb/whoconstitution_en.pdf" ext-link-type="uri">http://www.who.int/governance/eb/whoconstitution_en.pdf</ext-link>.</comment></mixed-citation></ref><ref id="R230"><mixed-citation publication-type="journal"><name><surname>Wing</surname><given-names>S</given-names></name>, <name><surname>Horton</surname><given-names>RA</given-names></name>, <name><surname>Marshall</surname><given-names>SW</given-names></name>, <name><surname>Thu</surname><given-names>K</given-names></name>, <name><surname>Tajik</surname><given-names>M</given-names></name>, <name><surname>Schinasi</surname><given-names>L</given-names></name>, <name><surname>Schiffman</surname><given-names>SS</given-names></name>, <year>2008</year>. <article-title>Air pollution and odor in communities near industrial swine operations</article-title>. <source>Environ. Health Perspect</source>
<volume>116</volume>, <fpage>1362</fpage>&#x02013;<lpage>1368</lpage>.<pub-id pub-id-type="pmid">18941579</pub-id></mixed-citation></ref><ref id="R231"><mixed-citation publication-type="journal"><name><surname>Winneke</surname><given-names>G</given-names></name>, <name><surname>Kotalik</surname><given-names>J</given-names></name>, <name><surname>Keldenich</surname><given-names>HO</given-names></name>, <name><surname>Kastka</surname><given-names>J</given-names></name>, <year>1979</year>. <article-title>Zur Wahrnehmung von Schwefelwasserstoff unter Labor-und Feldbedingungen [Determination of hydrogen sulfide in laboratory and field conditions]</article-title>. <source>Staub Reinh. der Luft</source>
<volume>39</volume>, <fpage>156</fpage>&#x02013;<lpage>159</lpage>.</mixed-citation></ref><ref id="R232"><mixed-citation publication-type="journal"><name><surname>Woodall</surname><given-names>GM</given-names></name>, <name><surname>Smith</surname><given-names>RL</given-names></name>, <name><surname>Granville</surname><given-names>GC</given-names></name>, <year>2005</year>. <article-title>Proceedings of the Hydrogen Sulfide Health Research and Risk Assessment Symposium, October 31-November 2, 2000</article-title>. <source>Inhal. Toxicol</source>
<volume>17</volume>, <fpage>593</fpage>&#x02013;<lpage>639</lpage>.<pub-id pub-id-type="pmid">16033755</pub-id></mixed-citation></ref><ref id="R233"><mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>X</given-names></name>, <name><surname>Cho</surname><given-names>S</given-names><suffix>Il</suffix></name>, <name><surname>Sammel</surname><given-names>M</given-names></name>, <name><surname>You</surname><given-names>L</given-names></name>, <name><surname>Cui</surname><given-names>S</given-names></name>, <name><surname>Huang</surname><given-names>Y</given-names></name>, <name><surname>Ma</surname><given-names>G</given-names></name>, <name><surname>Padungtod</surname><given-names>C</given-names></name>, <name><surname>Pothier</surname><given-names>L</given-names></name>, <name><surname>Niu</surname><given-names>T</given-names></name>, <name><surname>Christiani</surname><given-names>D</given-names></name>, <name><surname>Smith</surname><given-names>T</given-names></name>, <name><surname>Ryan</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <year>1998</year>. <article-title>Association of petrochemical exposure with spontaneous abortion</article-title>. <source>Occup. Environ. Med</source>
<volume>55</volume>, <fpage>31</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">9536160</pub-id></mixed-citation></ref><ref id="R234"><mixed-citation publication-type="book"><name><surname>Zelensky</surname><given-names>M</given-names></name>, <year>2009</year>. <part-title>Appendix 2: Overview of Hydrogen Sulphide Lethality Data and Exposure Criteria</part-title>. <publisher-loc>Alberta, Canada</publisher-loc>, <comment>2004.</comment> In: <source>ERCBH2S, A Model for Calculating Emergency Response and Planning Zones for Sour Gas Facilities</source> Vol. <volume>2</volume>: <publisher-name>Emergency Response Planning Endpoints</publisher-name>. [<comment>accessed</comment>
<date-in-citation>2022 Oct 1</date-in-citation>]. <comment><ext-link xlink:href="https://static.aer.ca/prd/documents/directives/ERCBH2S_VOLUME_1.pdf" ext-link-type="uri">https://static.aer.ca/prd/documents/directives/ERCBH2S_VOLUME_1.pdf</ext-link>.</comment></mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><p id="P372">H<sub>2</sub>S emissions reported in the U.S. Toxics Release Inventory (TRI) to air and other media by the top emitting industry sectors, 2012&#x02013;2020. &#x0201c;Oil &#x00026; gas&#x0201d; includes releases from petroleum refineries, bulk plants and terminals, and NAICS industry code 999 (primarily oil and gas extraction); &#x0201c;Paper&#x0201d; includes pulp mills; &#x0201c;Other&#x0201d; includes primary metals, nonmetallic mineral products, water, wastewater, beverages, electric utilities, hazardous waste, wood products, leather, poultry and egg production, machinery, furniture, transportation equipment, and metal mining.</p></caption><graphic xlink:href="nihms-1917928-f0001" position="float"/></fig><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1.</label><caption><p id="P373">Summary of health symptoms and effects for concentrations and exposure durations of H<sub>2</sub>S reported in the cited studies. Co-exposures and concentration range and study population size shown, when available. Adapted in part from <xref rid="R1" ref-type="bibr">ACGIH (2001)</xref> and <xref rid="R199" ref-type="bibr">Skrtic (2006)</xref>.</p></caption><table frame="hsides" rules="rows"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="2" align="left" valign="middle" colspan="1">Concentration (ppm)</th><th rowspan="2" align="left" valign="middle" colspan="1">Exposure Duration</th><th rowspan="2" align="left" valign="middle" colspan="1">Effect</th><th rowspan="2" align="left" valign="middle" colspan="1">Source</th><th rowspan="2" align="left" valign="middle" colspan="1">Exposure group</th><th rowspan="2" align="left" valign="middle" colspan="1">H<sub>2</sub>S exposure range</th><th align="left" valign="middle" rowspan="1" colspan="1">Co-exposure (average, range, SD)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">5000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Immediate</td><td align="left" valign="middle" rowspan="1" colspan="1">Death</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R84" ref-type="bibr">Fuller and Suruda 2000</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Occupational</td><td align="left" valign="middle" rowspan="1" colspan="1">0.2&#x02013;5000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td rowspan="3" align="left" valign="middle" colspan="1">1000 &#x02013; 2000 ppm</td><td rowspan="3" align="left" valign="middle" colspan="1">NA but very short term</td><td rowspan="3" align="left" valign="middle" colspan="1">Loss of consciousness, collapse, paralysis of respiration, possible death</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">
<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>
</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">Occupational based on rat and human studies</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">0.0002&#x02013;2000 ppm</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">
<xref rid="R84" ref-type="bibr">Fuller and Suruda 2000</xref>
</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">Occupational</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">0.2&#x02013;5000 ppm</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R149" ref-type="bibr">Milby and Baselt 1999</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Occupational</td><td align="left" valign="middle" rowspan="1" colspan="1">0.25&#x02013;1000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Cl, NH<sub>3</sub>, SO<sub>2</sub> noted, but not as co-exposures</td></tr><tr><td rowspan="3" align="left" valign="middle" colspan="1">500 &#x02013; 1000 ppm</td><td rowspan="3" align="left" valign="middle" colspan="1">Acute</td><td rowspan="3" align="left" valign="middle" colspan="1">Serious respiratory, central nervous, and cardiovascular system effects, e.g., stimulation of respiratory response, hyperpnea, apnea, unconsciousness, death</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">
<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>
</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">Occupational based on rat and human studies</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">0.0002&#x02013;2000 ppm</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">None</td></tr><tr style="border-bottom: hidden"><td align="left" valign="middle" rowspan="1" colspan="1">EPA 1993</td><td align="left" valign="middle" rowspan="1" colspan="1">Oil &#x00026; gas production</td><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;2000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Reduced sulfur gases, organic sulfides noted</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R84" ref-type="bibr">Fuller and Suruda 2000</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Occupational</td><td align="left" valign="middle" rowspan="1" colspan="1">0.2&#x02013;5000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td rowspan="2" align="left" valign="middle" colspan="1">250 ppm</td><td rowspan="2" align="left" valign="middle" colspan="1">Acute and Intermediate</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">Pulmonary edema, risk of death</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">
<xref rid="R149" ref-type="bibr">Milby and Baselt 1999</xref>
</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">Occupational</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">0.25&#x02013;1000 ppm</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">Cl, NH<sub>3</sub>, SO<sub>2</sub> noted, but not as co-exposures</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Damage to organs, nervous system, depression of cellular metabolism</td><td align="left" valign="middle" rowspan="1" colspan="1">EPA 1993</td><td align="left" valign="middle" rowspan="1" colspan="1">Oil &#x00026; gas production</td><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;2000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td rowspan="2" align="left" valign="middle" colspan="1">150 &#x02013; 200 ppm</td><td rowspan="2" align="left" valign="middle" colspan="1">NA</td><td rowspan="2" align="left" valign="middle" colspan="1">Olfactory fatigue, paralysis</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">
<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>
</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">Occupational based on rat and human studies</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">0.0002&#x02013;2000 ppm</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EPA 1993</td><td align="left" valign="middle" rowspan="1" colspan="1">Oil &#x00026; gas production</td><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;2000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">100 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">NA</td><td align="left" valign="middle" rowspan="1" colspan="1">Headaches, dizziness, lethargy</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Occupational based on rat and human studies</td><td align="left" valign="middle" rowspan="1" colspan="1">0.0002&#x02013;2000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td rowspan="2" align="left" valign="middle" colspan="1">50 &#x02013; 100 ppm</td><td rowspan="2" align="left" valign="middle" colspan="1">Prolonged</td><td rowspan="2" align="left" valign="middle" colspan="1">Intense eye irritation, conjunctivitis, cornea scarring, olfactory fatigue</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">EPA 1993</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">Oil &#x00026; gas production</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">0&#x02013;2000 ppm</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R149" ref-type="bibr">Milby and Baselt 1999</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Industrial</td><td align="left" valign="middle" rowspan="1" colspan="1">0.25&#x02013;1000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Cl, NH<sub>3</sub>, SO<sub>2</sub> noted, but not as co-exposures</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">50 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Prolonged</td><td align="left" valign="middle" rowspan="1" colspan="1">Olfactory fatigue, ocular pain</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R163" ref-type="bibr">OEHHA 2008</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Workplace</td><td align="left" valign="middle" rowspan="1" colspan="1">0.00007&#x02013;1000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">4&#x02013;50 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Prolonged</td><td align="left" valign="middle" rowspan="1" colspan="1">Nasal bleeding, headaches, fatigue</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R155" ref-type="bibr">Mousa 2015</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Oil field workers</td><td align="left" valign="middle" rowspan="1" colspan="1">4&#x02013;50 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">30 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">NA</td><td align="left" valign="middle" rowspan="1" colspan="1">Olfactory paralysis</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R201" ref-type="bibr">Snyder et al. 1995</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Occupational</td><td align="left" valign="middle" rowspan="1" colspan="1">30 - &#x0003e;700 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">5 &#x02013; 50 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">NA</td><td align="left" valign="middle" rowspan="1" colspan="1">Moderate irritation of the eyes, risk of pulmonary edema</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Occupational based on rat and human studies</td><td align="left" valign="middle" rowspan="1" colspan="1">0.0002&#x02013;2000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Carbon disulfide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">5 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Immediate</td><td align="left" valign="middle" rowspan="1" colspan="1">Increase in anxiety</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R16" ref-type="bibr">ATSDR 2006</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Inhalation</td><td align="left" valign="middle" rowspan="1" colspan="1">0-&#x0003e;500 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">NO<sub>X</sub>, SO<sub>2</sub>, CO, NH<sub>3</sub>, methyl mercaptan, methyl sulfide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">5 &#x02013; 10 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Immediate</td><td align="left" valign="middle" rowspan="1" colspan="1">Relatively minor metabolic changes in exercising individuals during short-term exposures.</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Occupational based on rat and human studies</td><td align="left" valign="middle" rowspan="1" colspan="1">0.0002&#x02013;2000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003c;10 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Various</td><td align="left" valign="middle" rowspan="1" colspan="1">Slowed development in infants, irritability, headache, fatigue.</td><td align="left" valign="middle" rowspan="1" colspan="1">EPA 1993</td><td align="left" valign="middle" rowspan="1" colspan="1">Oil &#x00026; gas production</td><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;2000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">5 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Acute</td><td align="left" valign="middle" rowspan="1" colspan="1">Increase in anxiety symptoms (single exposure)</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Occupational based on rat and human studies</td><td align="left" valign="middle" rowspan="1" colspan="1">0.0002&#x02013;2000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">5 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">NA</td><td align="left" valign="middle" rowspan="1" colspan="1">Start of the dose-response curve (short term exposure&#x02019;:</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Occupational based on rat and human studies</td><td align="left" valign="middle" rowspan="1" colspan="1">0.0002&#x02013;2000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003c;5 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">NA</td><td align="left" valign="middle" rowspan="1" colspan="1">Metabolic changes observed in exercising individuals, but not clinically significant</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R1" ref-type="bibr">ACGIH 2001</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Occupational based on rat and human studies</td><td align="left" valign="middle" rowspan="1" colspan="1">0.0002&#x02013;2000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Methyl mercaptan, dimethyl sulfide</td></tr><tr><td rowspan="3" align="left" valign="middle" colspan="1">2 &#x02013; 5 ppm</td><td rowspan="3" align="left" valign="middle" colspan="1">Acute</td><td rowspan="3" align="left" valign="middle" colspan="1">Higher oxygen intake</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1"><xref rid="R31" ref-type="bibr">Bhambhani et al. 1996</xref>;</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">Inhalation with exercise</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">0&#x02013;5 ppm</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">None</td></tr><tr style="border-bottom: hidden"><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R32" ref-type="bibr">Bhambhani and M. Singh 1991</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Inhalation with exercise</td><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;5 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">SO<sub>2</sub>, CO<sub>2</sub> noted, but not as co-exposures</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R112" ref-type="bibr">Jappinen et al. 1990</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Pulp mill workers</td><td align="left" valign="middle" rowspan="1" colspan="1">1&#x02013;11 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">SO<sub>2</sub> (0.03 ppm)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1 &#x02013; 5 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Acute to intermediate</td><td align="left" valign="middle" rowspan="1" colspan="1">Balance issues, delayed verbal recall, impaired color discrimination, decreased grip strength, reaction time impacts, recall issues</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R117" ref-type="bibr">Kilburn 1999</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">4 exposure groups: (1) residents with soil gas exposure in California (N-24); (2) residents near refinery (N=35); (3) residents near refinery explosion (N=48); (4) refinery workers (N=16); Controls from 4 towns (N=357)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.1 &#x02013; 8.8 ppm (24-hr), other measurements to 20 ppm reported</td><td align="left" valign="middle" rowspan="1" colspan="1">Group 2: carbon oxide sulfide (2.6&#x02013;52 ppm), mercaptans (1&#x02013;21.1 ppm)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.25 &#x02013; 0.30 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Chronic</td><td align="left" valign="middle" rowspan="1" colspan="1">Odor nuisance, nausea, disturbance to sleep</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R149" ref-type="bibr">Milby and Baselt 1999</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Industrial</td><td align="left" valign="middle" rowspan="1" colspan="1">0.25&#x02013;1000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Cl, NH<sub>3</sub>, SO<sub>2</sub> noted, but not as co-exposures</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.17 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Chronic</td><td align="left" valign="middle" rowspan="1" colspan="1">Increase in mortality from transportation accidents</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R133" ref-type="bibr">Lewis et al. 2003</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Petroleum workers(N=25,292; Transportation accidents with N=15)</td><td align="left" valign="middle" rowspan="1" colspan="1">H<sub>2</sub>S estimated for workers with transportation accidents (N=15); 0.01&#x02013;0.60 ppm for larger group</td><td align="left" valign="middle" rowspan="1" colspan="1">Fuels (0.01&#x02013;48 ppm), lubricants (0.1 &#x02013; 289 ppm), coke/catalyst (0.03&#x02013;84 &#x003bc;g/m<sup>3</sup>), vinyl chloride monomer, asbestos; smoking status</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.020&#x02013;0.027 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Chronic</td><td align="left" valign="middle" rowspan="1" colspan="1">Slightly reduced prevalence of wheeze; no other effects on asthma or respiratory symptoms</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R23" ref-type="bibr">Bates et al. 2013</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Adults in Rotorua at residential &#x00026; workplace locations (N=1637)</td><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;0.064 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.02&#x02013;0.13 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Acute</td><td align="left" valign="middle" rowspan="1" colspan="1">Odor recognition</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R49" ref-type="bibr">Costigan 2003</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Oil and water treatment industry - review of studies</td><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;2000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">SO<sub>2</sub>, CS<sub>2</sub>, H<sub>2</sub>SO<sub>4</sub></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.03 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Chronic</td><td align="left" valign="middle" rowspan="1" colspan="1">Aggravation of respiratory disease noted by increased hospital visits</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R39" ref-type="bibr">Campagna et al. 2004</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Unscheduled hospital visits for respiratory disease in Nebraska, USA near agricultural and tanning sources (Visits N=455 for asthma, N=5009 for all respiratory disease)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.03 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">TRS, SO<sub>2</sub> (0.03 ppm)</td></tr><tr><td rowspan="3" align="left" valign="middle" colspan="1">0.03&#x02013;0.05 ppm</td><td rowspan="3" align="left" valign="middle" colspan="1">Acute</td><td rowspan="3" align="left" valign="middle" colspan="1">Odor nuisance, headaches, nausea</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">
<xref rid="R80" ref-type="bibr">Fiedler et al. 2008</xref>
</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">Individuals exposed to low concentrations</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">0.05&#x02013;5 ppm</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">None</td></tr><tr style="border-bottom: hidden"><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R163" ref-type="bibr">OEHHA 2008</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Panel study (N=16)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.00007&#x02013;1,000 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">none - controlled study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R176" ref-type="bibr">Reynolds and Kamper 1984</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Sensitive population</td><td align="left" valign="middle" rowspan="1" colspan="1">0.012&#x02013;0.069 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">CO<sub>2</sub>, NO</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.008 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Intermediate</td><td align="left" valign="middle" rowspan="1" colspan="1">Nasal histological change in mice</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R163" ref-type="bibr">OEHHA 2008</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">90-day mouse exposure; N=10&#x02013;12 for each of 4 exposure groups</td><td align="left" valign="middle" rowspan="1" colspan="1">0 &#x02013; 80 ppm for 6 hr/day, 5 day/week for animals; 100-fold adjustments for humans</td><td align="left" valign="middle" rowspan="1" colspan="1">none - controlled study</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.007&#x02013;0.027 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Chronic</td><td align="left" valign="middle" rowspan="1" colspan="1">Neurophysiological abnormalities</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R131" ref-type="bibr">Legator et al. 2001</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Groups in Odessa, Texas (N=126) and Puna, Hawaii (N=97) compared to 170 controls</td><td align="left" valign="middle" rowspan="1" colspan="1">0.007&#x02013;0.027 ppm (average); 0.5 ppm for max 8-hr in Odessa; 0.5 ppm for max 1-hr in Puna</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td rowspan="6" align="left" valign="middle" colspan="1">0.007&#x02013;0.096 ppm</td><td rowspan="6" align="left" valign="middle" colspan="1">Acute &#x00026; Chronic</td><td rowspan="6" align="left" valign="middle" colspan="1">Eye irritation</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">
<xref rid="R94" ref-type="bibr">Haahtela et al. 1992</xref>
</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">Group near pulp mill during upset (N=60) and reference group (N=66)</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">0&#x02013;0.096 ppm (4-hr)</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">SO<sub>2</sub> (2&#x02013;3 &#x003bc;g/m<sup>3</sup>, average); mesityl oxide</td></tr><tr style="border-bottom: hidden"><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R99" ref-type="bibr">Heaney et al. 2011</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Adults living within 0.75 mile of landfills (N=23)</td><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;0.0023 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr style="border-bottom: hidden"><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R115" ref-type="bibr">Kilburn 2012</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Residents within 2.2 km of CAFO hog lagoons (N=25) in Ohio and unexposed individuals (N=22)</td><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;0.03 ppm (average); several measurements from 1&#x02013;2.1 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">CO in expired air (0&#x02013;27 ppm)</td></tr><tr style="border-bottom: hidden"><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R145" ref-type="bibr">Marttila et al. 1994</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Children living near pulp mill (N=134)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.0007&#x02013;0.053 ppm average; 0.01&#x02013;0.067 ppm 24-hr peaks (modeled)</td><td align="left" valign="middle" rowspan="1" colspan="1">CH<sub>3</sub>HS (2&#x02013;5 &#x003bc;g/m<sup>3</sup> average), SO<sub>2</sub> (2&#x02013;3 &#x003bc;g/m<sup>3</sup> average)</td></tr><tr style="border-bottom: hidden"><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R185" ref-type="bibr">Schiffman et al. 2005</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Volunteers in controlled tests (N=48)</td><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;0.024 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">NH<sub>3</sub> (0.046&#x02013;0.817 ppm), PM<sub>10</sub> (24 &#x003bc;g/m<sup>3</sup>), endotoxin (7.4 EU/m<sup>3</sup>)</td></tr><tr style="border-bottom: hidden"><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">see Horton below</td><td align="left" valign="middle" rowspan="1" colspan="1">see Horton below</td><td align="left" valign="middle" rowspan="1" colspan="1">see Horton below</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.002 ppm (TRS)</td><td align="left" valign="middle" rowspan="1" colspan="1">Intermediate</td><td align="left" valign="middle" rowspan="1" colspan="1">Eye and nasal symptoms, cough, headache/migraine</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R168" ref-type="bibr">Partti-Pellinen et al. 1996</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Residents near pulp &#x00026; paper mill and controls (N=336)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.002 ppm average; 0&#x02013;0.038 ppm for 24-hr; 0.104 ppm for 1-hr max (all as TRS)</td><td align="left" valign="middle" rowspan="1" colspan="1">SO<sub>2</sub> (average 1 &#x003bc;g/m<sup>3</sup>; 24-hr from 0&#x02013;24 &#x003bc;g/m<sup>3</sup>; 1-hr maximum of 152 &#x003bc;g/m<sup>3</sup>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;0.0067 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Chronic</td><td align="left" valign="middle" rowspan="1" colspan="1">Asthma exacerbation, indicated by increase in medication dispensed</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R41" ref-type="bibr">Carlsen et al. 2012</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Adults in Rotorua, Iceland dispensed anti-asthma drugs (N=up to 192 per day)</td><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;0.062 ppm (24-hr)</td><td align="left" valign="middle" rowspan="1" colspan="1">PM<sub>10</sub> (24-hr 23.2 &#x000b1;17.8 &#x003bc;g/m<sup>3</sup>); NO<sub>2</sub> (24-hr 21.9 &#x000b1;14.5 &#x003bc;g/m<sup>3</sup>); O<sup>3</sup> (8-hr 42.9 &#x000b1;15.2 &#x003bc;g/m<sup>3</sup>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x00394;0.005 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Chronic</td><td align="left" valign="middle" rowspan="1" colspan="1">Respiratory hospitalizations and mortality</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R162" ref-type="bibr">Nuvolone et al. 2019</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Residents near geothermal electric power plants (N=33,804)</td><td align="left" valign="middle" rowspan="1" colspan="1">Model predicted 90-day maximum</td><td align="left" valign="middle" rowspan="1" colspan="1">PM, NO<sub>2,</sub> O<sub>3</sub> noted as below limits</td></tr><tr style="border-bottom: hidden"><td align="left" valign="middle" rowspan="1" colspan="1">0.005 ppm</td><td align="left" valign="middle" rowspan="1" colspan="1">Acute effects (7.5 year long study)</td><td align="left" valign="middle" rowspan="1" colspan="1">Emergency room visits associated with heart disease</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R81" ref-type="bibr">Finnbjornsdottir et al. 2016</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Residents exposed to geothermal power plant plume in Reykjavik, Iceland (N=13,381 hospital patients)</td><td align="left" valign="middle" rowspan="1" colspan="1">0.005 ppm average: 0&#x02013;0.047 ppm for 24-hr; plume model estimates</td><td align="left" valign="middle" rowspan="1" colspan="1">NO<sub>2</sub>, O<sub>3</sub>, PM<sub>10</sub>, SO<sub>2</sub> noted; values not given</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.00022 ppb</td><td align="left" valign="middle" rowspan="1" colspan="1">Acute</td><td align="left" valign="middle" rowspan="1" colspan="1">Emergency room visits associated with heart disease</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R99" ref-type="bibr">Heaney et al. 2011</xref>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Residents within 0.75 mile of municipal waste landfills (N=23)</td><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;2.3 ppb (1-hr)</td><td align="left" valign="middle" rowspan="1" colspan="1">None</td></tr><tr><td rowspan="2" align="left" valign="middle" colspan="1">0.0003&#x02013;0.001 ppm<xref rid="TFN2" ref-type="table-fn">*</xref></td><td rowspan="2" align="left" valign="middle" colspan="1">Chronic (2-yr)</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">Stress and negative mood</td><td align="left" valign="middle" style="border-bottom: hidden" rowspan="1" colspan="1">
<xref rid="R105" ref-type="bibr">Horton 2007</xref>
</td><td rowspan="2" align="left" valign="middle" colspan="1">Residents within 0.2 &#x02013; 1.4 miles of CAFO (swine) facility (N=101)</td><td rowspan="2" align="left" valign="middle" colspan="1">0.0003 &#x000b1;0.00186 ppm (1-hr average); 0&#x02013;0.0015 ppb (2-yr average across 16 areas)</td><td rowspan="2" align="left" valign="middle" colspan="1">Odor (1.3 &#x000b1;1.88); PM<sub>2.5</sub> (10.9 &#x000b1;5.6 &#x003bc;g/m<sup>3</sup>); PM<sub>10</sub> (19.4&#x000b1;11.8 &#x003bc;g/m<sup>3</sup>), endotoxin</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Nose and eye irritation, difficulty breathing, wheezing</td><td align="left" valign="middle" rowspan="1" colspan="1">
<xref rid="R186" ref-type="bibr">Schinasi et al. 2011</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P374">&#x02018;NA&#x02019; means not available (not provided).&#x02019;&#x00394;&#x02019; means change in concentration;</p></fn><fn id="TFN2"><label>*</label><p id="P400">analyzed a 0.001 ppm change in the exposure concentration.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2.</label><caption><p id="P375">Summary of existing H<sub>2</sub>S exposure recommendations for the general public in the U.S. Derived and updated from <xref rid="R13" ref-type="bibr">Armstrong et al. (2004)</xref>.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Parameter</th><th align="left" valign="bottom" rowspan="1" colspan="1">EPA</th><th align="left" valign="bottom" rowspan="1" colspan="1">California OEHHA</th><th align="left" valign="bottom" rowspan="1" colspan="1">ATSDR</th><th align="left" valign="bottom" rowspan="1" colspan="1">ATSDR</th><th align="left" valign="bottom" rowspan="1" colspan="1">WHO</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Standard or guideline</td><td align="left" valign="top" rowspan="1" colspan="1">RfC</td><td align="left" valign="top" rowspan="1" colspan="1">REL (inhalation)</td><td align="left" valign="top" rowspan="1" colspan="1">Acute MRL</td><td align="left" valign="top" rowspan="1" colspan="1">Intermediate MRL</td><td align="left" valign="top" rowspan="1" colspan="1">Guidance value</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Concentration (ug/m<sup>3</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">100</td><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="left" valign="top" rowspan="1" colspan="1">150</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Concentration (ppm)</td><td align="left" valign="top" rowspan="1" colspan="1">0.0015</td><td align="left" valign="top" rowspan="1" colspan="1">0.008</td><td align="left" valign="top" rowspan="1" colspan="1">0.070</td><td align="left" valign="top" rowspan="1" colspan="1">0.020</td><td align="left" valign="top" rowspan="1" colspan="1">0.101</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exposure period</td><td align="left" valign="top" rowspan="1" colspan="1">continuous (lifetime)</td><td align="left" valign="top" rowspan="1" colspan="1">continuous (i.e., 8 yrs)</td><td align="left" valign="top" rowspan="1" colspan="1">continuous, acute duration (&#x02264; 2 wks)</td><td align="left" valign="top" rowspan="1" colspan="1">continuous, intermediate duration (&#x02264;1 yr)</td><td align="left" valign="top" rowspan="1" colspan="1">24 hr</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Target population</td><td align="left" valign="top" rowspan="1" colspan="1">general population, including sensitive groups</td><td align="left" valign="top" rowspan="1" colspan="1">general population</td><td align="left" valign="top" rowspan="1" colspan="1">general population, including sensitive groups</td><td align="left" valign="top" rowspan="1" colspan="1">general population, including sensitive groups</td><td align="left" valign="top" rowspan="1" colspan="1">general population</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LOAEL (ppm)</td><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="left" valign="top" rowspan="1" colspan="1">-</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">-</td><td align="left" valign="top" rowspan="1" colspan="1">15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NOAEL (ppm)</td><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">30.5</td><td align="left" valign="top" rowspan="1" colspan="1">-</td><td align="left" valign="top" rowspan="1" colspan="1">30.5</td><td align="left" valign="top" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Critical study</td><td align="left" valign="top" rowspan="1" colspan="1">subchronic rat study by <xref rid="R36" ref-type="bibr">Brenneman et al. 2000</xref></td><td align="left" valign="top" rowspan="1" colspan="1">subchronic mouse study by CIIT 1983</td><td align="left" valign="top" rowspan="1" colspan="1">acute experimental human study by <xref rid="R112" ref-type="bibr">Jappinen et al. 1990</xref></td><td align="left" valign="top" rowspan="1" colspan="1">subchronic rat study by <xref rid="R36" ref-type="bibr">Brenneman et al. 2000</xref></td><td align="left" valign="top" rowspan="1" colspan="1"><xref rid="R184" ref-type="bibr">Savolainen et al. 1982</xref> for ocular effects; <xref rid="R206" ref-type="bibr">Tenhunen et al. 1983</xref> for haem synthesis</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Critical effects</td><td align="left" valign="top" rowspan="1" colspan="1">no destruction of olfactory neurons or inflammation/necrosis of nasal epithelium</td><td align="left" valign="top" rowspan="1" colspan="1">no inflammation of nasal epithelium</td><td align="left" valign="top" rowspan="1" colspan="1">increase in airway resistance</td><td align="left" valign="top" rowspan="1" colspan="1">no inflammation of nasal epithelium</td><td align="left" valign="top" rowspan="1" colspan="1">ocular irritation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Adjustments</td><td align="left" valign="top" rowspan="1" colspan="1">intermittent = continuous exposure, rat = human, dosimetry, interspecies, sensitive humans, subchronic = chronic exposure</td><td align="left" valign="top" rowspan="1" colspan="1">intermittent = continuous exposure, rat = human, dosimetry, interspecies, sensitive humans, subchronic = chronic exposure</td><td align="left" valign="top" rowspan="1" colspan="1">LOAEL= NOAEL, interspecies sensitivity</td><td align="left" valign="top" rowspan="1" colspan="1">intermittent = continuous exposure, rat = human, dosimetry, interspecies, sensitive humans</td><td align="left" valign="top" rowspan="1" colspan="1">uncertainty factor due to steep dose-effect curve; also single report of haem synthesis impacts at 1.5 mg/m<sup>3</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Year developed</td><td align="left" valign="top" rowspan="1" colspan="1">2003</td><td align="left" valign="top" rowspan="1" colspan="1">2000, maintained in 2008</td><td align="left" valign="top" rowspan="1" colspan="1">1999, maintained in 2016</td><td align="left" valign="top" rowspan="1" colspan="1">2006, maintained in 2016</td><td align="left" valign="top" rowspan="1" colspan="1">2000, maintained in 2003</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Comments</td><td align="left" valign="top" rowspan="1" colspan="1">RfCs can be derived for non-carcinogenic effects of known carcinogens and for non-inhalation routes.</td><td align="left" valign="top" rowspan="1" colspan="1">same as ATSDR except for subchronic, chronic factor and rounding differences</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" style="border-bottom: solid 1px" rowspan="1" colspan="1">Also recommends a 30-min mean exposure limit of 0.005 ppm or 7 &#x003bc;g/m<sup>3</sup> for odor annoyance.</td></tr></tbody></table></table-wrap></floats-group></article>